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Abstract
Between E9.5 and El2.5 of mouse embryonic development the gut undergoes a series of changes
such that it is transformed from a midline endodermal tube to an asymmetric patterned system. The need
to understand the processes underlying this patterning cannot be underestimated as gut defects are the
most common human congenital malformations.
This thesis establishes methods to investigate early spleen development in the mouse embryo. An
expression analysis of early Nkx2-5 expression is reported, along with the finding that Nkx2-5 may be the
earliest marker of splenic precursors in the mouse. Expression of Nkx2-5 is also shown for the first time to
overlap considerably with that of Bapxl (Nkx3-2) - a major gut development gene upstream of Nkx2-5. An
in silico analysis of the evolutionary conserved regions upstream ofNkx2-5 is presented along with the
establishment and analysis of stable transgenic reporter lines expressing LacZ under the control of an
Nkx2-5 gut regulatory sequence (NGRS). NGRS confers spleen, posterior stomach, and pyloric sphincter
expression, with very little of the cardiac expression associated with endogenous Nkx2-5. This enhancer is
thus ideal for gut studies, providing a tool for directing gut-specific expression and genetic manipulations.
NGRS was also found not to require Bapxl for its activity. Finally, NGRS is demonstrated to have the
potential to mark abnormal spleen development, in a previously unreported splenic mutant: the Rwhs
mutant.
Potential uses for NGRS are explored; two different strategies to generate a gut-specific
tamoxifen-inducible lineage tracing system are reported. These were unsuccessful and, consequently, an
alternative approach was taken to marking and following spleen development, using NGRS-LacZ in an
organ culture system. Data generated from these experiments shed some light on how the El 1.5 spleen
develops, providing evidence for migration of splenic precursors along the stomach, and suggesting that
an inhibitory "anchor" effect is normally exerted by the posterior spleno-pancreatic mesenchyme,
disruption of which permits precocious spleen development. Attempts to investigate the existence of a
spleen cell chemoattractant in the anterior stomach are also reported.
Finally, an analysis of the role ofWnt signalling in development of the spleno-pancreatic region
is presented. A preliminary report of ectopic Wnt3 and Wnt8a expression in the abnormal posterior
stomach of the Bapxl gut was investigated and found not to be supported. However, analysis of wild
type guts revealed that canonical Wnt signalling is active in the developing spleen at El 1.5, E12.5 and
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The student of Nature wonders the more
and is astonished the less, the more
conversant he becomes with her
operations; but of all of the perennial
miracles she offers to his inspection,
perhaps the most worthy of admiration is
the development of a plant or of an
animal from its embryo"
- Thomas Henry Huxley
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1.1 Introduction to thesis
"Compared to readily accessible organs such as the limb, or to organs such as the heart and
pancreas that are the focus of resourceful charities, the gut has been left behind. However, it is clear...
that the many fascinating developmental, evolutionary, and medical aspects of the gut will continue to
attract much attention and generate pertinent information "
(Stainier, 2005)
The gastrointestinal (GI) tract is a conserved feature of multicellular animals; its
derivate organs are essential for a variety of processes including digestion, respiration,
haematopoiesis, and immunity. Some aspects of the patterning of the gut organ
primordia and of the subsequent processes of organogenesis are well understood; there
are, however, gaps in our knowledge of how this essential system develops. The need to
fill these gaps cannot be underestimated as gut defects present a major disease burden
and are the most common human congenital malformations (de Santa et al., 2002).
Congenital gut defects cause considerable perinatal morbidity and can prove lethal.
The early development of the gut provides an opportunity to view an
unparalleled array of fundamental morphogenetic processes. In the 72-hour-period
between E9.5 (embryonic day 9.5) and El 2.5 of mouse development the gut undergoes a
series of complex and rapid changes; as a result the midline uniform gut tube is
transformed into an asymmetric patterned system containing the primordia of the
accessory organs.
Important developmental phenomena such as epithelial-mesenchymal (EM)
interaction, axial patterning, cell migration, and budding morphogenesis are documented
in the gut. Many major developmental molecules have been shown to be required for gut
development; information collected about their roles in the gut is extremely important as
many of these factors also have roles in other aspects of vertebrate development. Yet
there still remain many unanswered questions about early gut development, particularly
with regard to the spleen. This thesis describes attempts through a variety of methods to
provide information on, and tools for, the further study of early spleen and, to a lesser
extent, pyloric sphincter development in the mouse embryo.
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1.2 Overview of gut development
1.2.1 Early gut development
The GI tract and its accessory organs develop from a sheet, and subsequently a
tube, of endoderm lying along the anterior-posterior (AP) axis of the embryo (for an
excellent primer see (Roberts, 1999)). The anterior end of this endodermal sheet folds
back on itself ventrally at the start of mouse somitogenesis (-E8.0), thus forming the
foregut pocket with the anterior intestinal portal (AIP) at its leading edge. The AIP
elongates such that folding continues in a posterior direction until -E8.5 when the AIP
reaches the yolk stalk (umbilicus) and meets the caudal intestinal portal (CIP) which has
travelled from the posterior of the embryo. The CIP invaginates at a later stage than the
AIP (at -E8.5). The enclosed space posterior to the CIP constitutes the hindgut pocket.
Convergence of the AIP and CIP is aided by turning of the mouse embryo at
E8.5-9.0. Apart from the turning, the process of gut folding shows evolutionary
conservation and is remarkably similar between mouse and chick, though Xenopus gut
folding is somewhat different (Grapin-Botton and Melton, 2000). Closure of the gut tube
is complete once the AIP and CIP make contact. The ventral part of the completed gut
tube is composed of endodermal cells which migrated with the AIP and CIP, whereas
the dorsal portion is comprised of midline endoderm which remained relatively static.
The lateral walls of the tube arise from folding of the endoderm which underlies the
lateral plate mesoderm (LPM); this is again facilitated by turning.
Following closure of the tube, the multipotent stem cells within the gut endoderm
differentiate and become organised into the major organ precursors. The endodermal
component of the stomach, pancreas, intestine, lungs, liver, bladder and thyroid all
originate from this tube. Correct development of the gut is hence essential for numerous
vital processes.
The majority of the gut tube lies posterior to the branchial arches and becomes
surrounded by splanchnic mesoderm, derived from the LPM (Hogan and Zaret, 2002;
Funayama et al., 1999). This splanchnic mesoderm undergoes differentiation into
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mesenchyme which plays signalling roles during gut morphogenesis. The splanchnic
mesoderm and the mesenchyme derived from it are the main tissues of interest in this
thesis. The region of gut tube that is focussed upon encompasses the stomach, pyloric
sphincter, pancreatic buds, and spleen. The development of these organs is described in
Sections 1.3-1.6, Figure 1.1 depicts the stages of interest in mammalian gut
development.
1.2.2 Axial patterning and EM interactions in the gut
The gut tube is patterned along four axes: AP (cranial-caudal), dorsal-ventral
(DV), left-right (LR), and radial. AP patterning of the gut is one of the first steps in
polarising the symmetrical embryo. Initial AP patterning of the endoderm is established
by the late primitive streak stage, and refined at later stages (E8.5-12.5) through the
combinatorial action of transcription factors and signalling molecules whose expression
patterns are regionalised within the endoderm and/or mesenchyme (Hogan and Zaret,
2002). Accordingly, EM (epithelial-mesenchymal) interactions specify regions between
which morphological and gene expression differences emerge. These distinct regions
give rise later in development to different organs. Genes that exhibit such differential
expression patterns include members of the Nkx, Hox, and Pax families.
EM interactions are a fundamental feature of morphogenesis across a range of
tissues and many examples exist in the developing gut. Sonic hedgehog (Shh) and Indian
hedgehog (Ihh), for instance, have overlapping expression domains within the
developing posterior stomach epithelium, from where they are secreted to act on
mesodermal/mesenchymal targets including Bmp4 (Bitgood and McMahon, 1995). Both
factors induce smooth muscle differentiation in the target splanchnic mesoderm tissue,
and are essential for murine GI tract organogenesis (Apelqvist et al., 1997; Ramalho-
Santos et al., 2000; Litingtung et al., 1998). Loss of Shh expression causes gut defects
the length of the gut tube: the stomach epithelium is transformed to an intestinal
phenotype, duodenal stenosis and imperforate anus occur, and pancreatic development,
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gut rotation, and enteric nervous system (ENS) development are all disrupted (Ramalho-
Santos et al., 2000). Endodermal Shh also induces Hoxd-13 expression in the splanchnic
mesoderm, and both Bmp4 and Hoxd-13 act to modulate the action of Shh (Roberts et
al., 1998). Bmp4 counteracts Shh-induced mesodermal proliferation, whilst Hoxd-13
signals back to direct the hindgut endoderm towards a region-specific epithelial fate - a
second level of EM interaction. Recombination experiments reveal the inductive nature
of the mesenchyme as it can induce a fate specific to its indigenous region in epithelium
taken from a different part of the gut (Yasugi, 1993). Such EM interactions are central to
gut development (reviewed in (Fukuda and Yasugi, 2005)).
A gut Hox code functions to specify and regionalise the mesenchyme along the
AP axis. The formation of many morphological and functional boundaries within the gut
appears to be dictated by the regional subsets of Hox genes expressed in the
mesenchyme which pattern the underlying epithelium through EM interactions (Roberts
et al., 1995b; Kawazoe et al., 2002).
The DV axis is the second axis to be patterned. The accessory organs of the gut
(thyroid, lungs, liver, and pancreas) emerge following budding morphogenesis of the gut
tube along the DV axis. Ventral specification of the gut is required for these budding
events, though the pancreas also possesses a dorsal bud. Budding morphogenesis is one
of the fundamental common processes of the "morphogenetic code" of development
(Hogan, 1999).
Differentiation along the LR axis provides the third level of axial pattering. The
organs of the adult GI tract are positioned asymmetrically along the body's LR axis, and
establishment of this asymmetry is essential for correct organ development (discussed
further in Section 1.9). The first indication of gut asymmetry is the bulging of the
stomach to the left between E9.5 and El0.5.
The final level of gut patterning occurs along a radial axis. In cross-section, the
fully developed gut tube contains a series of distinct tissue morphologies across the
radial axis - i.e. from the serosa through to the lumen. The gut epithelium is regenerated
and repatterned along this radial axis throughout adult life.
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Figure 1.1 Development of the mammalian gut
a) Optical projection tomography (OPT) images of gut development in mouse embryos
(courtesy of Robert Watson). The gut tubes are stained with an antibody against E-cadherin
(an epithelial marker) to aid visualisation and are shown either within the context of the
embryo (E9.5, E10.5) or as dissected guts (E11.5, E12.5).
At E9.5 the gut tube follows the curve of the embryo but is itself relatively uniform. The
pancreatic buds (DPB, VPB) bulge out slightly along the dorsal-ventral axis. No constrictions
are visible between gut regions. By E10.5, however, the pyloric sphincter (PS) constriction
can be detected. The oesophagus is located at the anterior tip of the stomach at E10.5,
but has shifted posteriorly onto the inner curvature by E11.5. The gut has a more familiar
appearance by E12.5 and from this point growth becomes the predominant developmental
force. Spleen growth occurs in close proximity to that of the mesenchyme surrounding the
dorsal pancreatic bud; the putative splenic mesenchyme (E10.5, E11.5) and developing
spleen (E12.5) are denoted by a dashed yellow line.
Oe: oesophagus, St: stomach, DPB: dorsal pancreatic bud, VPB: ventral pancreatic bud,
Du: duodenum, PS: pyloric sphincter, Sp: spleen








1.3.1 Development of the stomach
The stomach is an evolutionary adaptation of the gut tube that frees the organism
from having to continually feed, instead permitting storage of food during digestion. The
primitive chordate Amphioxus does not possess a stomach, nor do some primitive fish
such as the hagfish (Smith et al., 2000a). The stomach is one of the first morphologically
distinct regions to develop from the uniform endodermal gut tube. It is first
distinguishable at -E9.5 as a bulge in the posterior foregut. The mechanism underlying
this bulging is unknown, though perhaps some insight can be drawn from Drosophila in
which organ shape is determined by orientated cell division (Baena-Lopez et al., 2005).
Alternatively, increased cell proliferation may facilitate this bulging. However, recent
evidence from our lab has indicated that the main mechanism is actually regulated
decreased proliferation, as this creates the constrictions which demarcate the gut regions
(Watson et al., 2007). Thus constriction events appear to be the major mechanism for AP
patterning of the gut at E9.5-10.5. Thereafter, between E10.5 and E12.5, controlled
outgrowth is most important (Watson et al., 2007).
The anterior of the stomach is closed and the posterior leads into the duodenum,
through the pyloric sphincter. The concave surface of the stomach is termed the 'lesser
curvature'; the oesophagus enters through this surface. The 'greater curvature' refers to
the convex edge of the stomach; the spleen is nearest to this curvature. The surfaces and
axes of the developing stomach are illustrated later in this thesis, in Figure 4.2.
The murine stomach can be functionally and morphologically divided into two
regions: the anterior/proximal stomach (fundus), and the posterior/distal stomach
(antrum/pylorus). The former is lined with folds of stratified squamous epithelium and
gastric glands; the latter features villi, mucosal glands and a simpler epithelial lining.
Regional epithelial differentiation initiates in the stomach at -E12.5 and is the result of
signalling from the overlying mesenchyme - another example of EM interaction (Hogan
and Zaret, 2002). A reciprocal example of EM interaction is the differentiation of
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splanchnic mesoderm into smooth muscle which is dependent on signals from the
underlying endoderm.
The stomach wall is radially patterned into three smooth muscle layers: the
longitudinal (outer), circular (middle), and muscularis mucosae (inner) layers (Smith et
al., 2000a; Hogan and Zaret, 2002). An additional highly cellular submucosa layer lies
between the middle and inner layers, and a mesothelial layer (the serosa) forms the final
barrier with the coelomic cavity. The circular layer forms first, at El 1.0-13.0, followed
by the longitudinal muscle at El5.0 in the proximal stomach and at birth in the distal
stomach (Hogan and Zaret, 2002). The muscularis mucosae layer does not form fully
until after birth, though a thin layer of smooth muscle pertaining to this layer can be
detected at El 8.5 (Watson et al., 2007).
1.3.2 Genes implicated in stomach development
A number of genes have been implicated in the development of the mammalian
stomach including Bapxl (Nkx3-2), FgflO, Tgfa, Shh, and Gli3 (Fukuda and Yasugi,
2005; Kim et al., 2005b). Hedgehog signalling underlies many aspects of stomach
patterning. A putative hedgehog target is Nr2f2 (COUP-TFIl), which is expressed in
both the mesenchyme and epithelium (Takamoto et al., 2005). Conditional (Bapxl-Cre
directed) loss of this gene from the mesenchyme causes major stomach patterning
defects along both the AP and radial axes. These defects are reminiscent of those seen
when hedgehog signalling is inhibited: the stomach is reduced in size, and epithelial and
circular smooth muscle differentiation is adversely affected, as is the distribution of ENS
neurons. The presence of epithelial defects following ablation of Nr2f2 specifically from
the mesenchyme demonstrates the importance of EM interactions in stomach patterning.
Barxl is also expressed in the stomach mesenchyme and is another important
stomach development gene. Expression commences at E9.5 in the presumptive stomach
region of the gut (Tissier-Seta et al., 1995). This expression is maintained in the stomach
mesenchyme until E16.5 and also appears to mark the splenic mesenchyme at El 1.5. No
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expression is detected elsewhere in the gut. Barxl loss causes a shrunken stomach
phenotype with disorganisation and infolding of the epithelial lining, resulting in failure
of lumen formation (Kim et al., 2005a). An intestinal epithelium marker, Cdx2, becomes
ectopically expressed in the abnormal stomach epithelium. Conversely, the
endogenously expressed genes Sfrpl and Sfrp2 are down-regulated in the mesenchyme.
The secreted protein products of these genes normally negatively regulate Wnt
signalling in the endoderm/epithelium. Thus mesenchymal Barxl normally regulates the
specification of the stomach epithelium through inhibition of canonical Wnt signalling in
the latter tissue - a further example of EM interaction.
1.4 The pyloric sphincter
1.4.1 Development of the pyloric sphincter
The pyloric sphincter demarcates the boundary between the stomach and
duodenum and acts to slow the passage of food, thus allowing adequate digestion and
mixing. A reasonable amount of data has been published on the structure, function, and
innervation of the neonatal and adult pyloric sphincter across a range of species. There
is, however, little known about the origin and embryonic development of this tissue.
In humans, the pyloric sphincter is a ring of thickened circular muscle, covered
by the folds of the mucosa layer (Gray and Carter, 1998). The earliest identification of a
pyloric sphincter structure has been made at day 321 of human embryonic development
when the anterior duodenum is noted to be dilated (Bourdelat et al., 1992). The circular
and longitudinal muscle layers have noticeably thickened by day 40 , pre-empting the
final structure: a thickened circular muscle ring populated by bundles of fibres from the
outer longitudinal layer. Smooth muscle a-actin and desmin can be detected in these
1
Carnegie stage 14; comparable to mouse stage El 1.5
2
Carnegie stage 16; comparable to mouse stage El 2.5
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fibres (Bourdelat et al., 1992). The pyloric sphincter of the guinea pig shows a similar
anatomy (Cai and Gabella, 1984).
The murine pyloric sphincter constriction is first detectable at El0.5 (personal
observation). The identity of the muscle populating the sphincter is unclear. Smooth
muscle a-actin is not detectable at high levels in the sphincter until El 8.5 (S. Burn, MSc
(Res) thesis, University of Edinburgh, 2003). The late appearance of smooth muscle may
be reconcilable with the fact that the pyloric sphincter does not function as a classical
sphincter; it remains open much of the time, acting as a constriction rather than a
controlled opening (Schulze-Delrieu and Shirazi, 1983). It is, however, unlikely that de
novo smooth muscle formation would occur so late in development. The late appearance
of smooth muscle markers may thus be explained by a report in the guinea pig that the
pyloric sphincter is actually a "funnel" of stomach muscle which hangs into the
duodenum (Cai and Gabella, 1984). One further possibility is that the sphincter is
populated by muscle cells from elsewhere. Indeed, it has recently been reported that the
anal sphincter is populated by somitic muscle cells which migrate from the hind limb
(Valasek et al., 2005). In addition to the unknown origins of the pyloric sphincter, there
is also little consensus in the literature as to what actually constitutes the sphincter. In
rat, for example, it has been reported to actually comprise two connected muscle loops
(the proximal and distal sphincters) (Kudo et al., 1998).
1.4.2 Genes implicated in pyloric sphincter development
Although differences exist between gut development in mouse and chick
(particularly the existence of a two chambered stomach in chick), they have enough in
common to merit comparative studies (Smith et al., 2000a). Both species have a
glandular anterior stomach, with non-glandular morphology in the posterior. Expression
patterns also show conservation, for example: Wnt5a and Bmp4 are expressed in the
anterior stomach, whilst the posterior stomach is characterised by expression/increased
expression of Six2, Barxl, and Bmprlb (Smith et al., 2000a). The pyloric sphincter of
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both organisms is marked by Nkx2-5 expression and a similar - albeit broader -
expression domain is noted in Xenopus (Smith et al., 2000a). The sphincter itself can
also be found in amphibians and some fish, though not in primitive fish such as the
hagfish or in Amphioxus (Smith et al., 2000a).
Pyloric sphincter development has been well characterised in chick due to the
ability to ectopically express genes, or dominant-negative forms of genes, in specific
cells/tissues using viral constructs. These findings are summarised in Figure 1.2 and
details are provided in the figure legend (Roberts et al., 1998; Smith and Tabin, 1999;
Smith et al., 2000b; Nielsen et al., 2001; Moniot et al., 2004; Theodosiou and Tabin,
2005). A central aspect of this patterning is the differential regulation of Bmp4 along the
gut due to inhibition by Bapxl in the gizzard (Nielsen et al., 2001). Formation of the
pyloric sphincter from the gizzard is therefore induced by Bmp4 secreted from the
adjacent duodenal mesenchyme in response to endodermal Shh (Smith and Tabin, 1999).
Accordingly, the Bmp4 receptor gene Bmprlb is specifically expressed in the gizzard
(Smith et al., 2000b). The mesoderm becomes thinner in the sphincter than in the gizzard
due to increased apoptosis and decreased proliferation in the Bmp4/Bmprlb-selected
gizzard mesoderm (Smith et al., 2000b).
Bmp4 is also necessary and sufficient for pyloric cNkx2-5 expression (Smith and
Tabin, 1999). The cNkx2-5 expression domain specifically marks the pyloric sphincter
mesoderm, overlapping that of mesodermal Bmprlb in the gizzard, and bordering that of
duodenal Bmp4 (Smith and Tabin, 1999). Ectopic Bmp4 or Bmprlb expression directly
induces ectopic cNkx2-5 in the mesoderm of the gizzard, but not the duodenum, pointing
to the gizzard as the origin of the sphincter (Smith and Tabin, 1999; Smith et al., 2000b).
The endoderm underlying this ectopic cNkx2-5 expression develops features of the
pyloric sphincter (e.g. bulbous microvilli); mesodermal cNkx2-5 is necessary and
sufficient for epithelial pyloric sphincter formation (Smith et al., 2000b). This is yet
another example of the importance of EM interactions during gut development.
Most recently it has been discovered that mesenchymal Sox9 is also required for
correct pyloric sphincter development in chick, as it is both necessary and sufficient to




Figure 1.2 Regulation of pyloric sphincter development in chick
Differential regulation of Bmp4 along the gut tube produces differential patterns of muscle
growth and differentiation. Bmp4 is not expressed in the gizzard (posterior stomach
chamber), due to inhibition by Bapxl (Nkx3.2); however, Bmp4 protein secreted from the
neighbouring duodenum induces formation of the pyloric sphincter from the gizzard.
cNkx2.5 expression specifically marks the pyloric sphincter mesoderm; Bmp4 is both
necessary and sufficient for this expression. Ectopic cNkx2.5 expression (induced by
Bmp4 or BMPR1B) can only be induced in the mesoderm of the gizzard, but not the
duodenum, pointing to the gizzard as the origin of the sphincter. Mesodermal cNkx2.5
is both necessary and sufficient for epithelial pyloric sphincter formation. Mesodermal
Sox9 is also required for correct pyloric sphincter development in chick, as it is necessary
and sufficient to specify the epithelial component. Sox9 positively controls expression of
Gremlin, a modulator of the BMP pathway which may relay signals from mesodermal
Sox9 to the underlying epithelium. Details are provided in Section 1.4.2 of the main text.
References: 1) Roberts et a!., 1998, 2) Smith et at., 2000, 3) Theodosiou and Tabin,
2005, 4) Moniot et at., 2004, 5) Nielsen et al., 2001, 6) Smith and Tabin, 1999
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Once again this effect is realised through EM signalling. The mesodermal Sox9
expression is controlled by BMP signalling; in turn, Sox9 itself positively controls the
expression of Greml (Gremlin), a modulator of the BMP pathway (Moniot et al., 2004).
Greml is a diffusible factor and thus may relay signals from mesodermal Sox9 to the
underlying epithelium. Sox9 and Nkx2-5 are independently regulated by BMP signalling;
no interaction has been detected between these genes at the transcriptional level, though
their products may interact to specify the sphincter epithelium (Theodosiou and Tabin,
2005). Misexpression of either gene in the gizzard mesoderm produces the same
phenotype as misexpression of both (i.e. transformation of the underlying epithelium to
a pyloric sphincter phenotype). Nkx2-5 and Sox9 may therefore perform partially
redundant roles in pyloric sphincter formation in chick.
Development of the pyloric sphincter in mice is less understood, though it is
already apparent that it is regulated differently to in chick. Data from our lab indicates
that Shh is not expressed in the posterior stomach epithelium of mice (Hill lab,
unpublished data), whereas it is in chick. Conversely, whilst Bmp4 is not expressed in
the chick gizzard, it appears to be expressed at low levels throughout the stomach in
mice (Hill lab, unpublished data). Also, murine Bapxl does not appear to act upstream
of Bmp4, as Bmp4 expression is not increased in Bapxl" guts (Hill lab, unpublished
data). Nkx2-5 expression is lost in these mutants guts, but a relationship between these
two homeobox genes does not appear to be maintained in chick, as ectopic Bapxl
expression does not affect Nkx2-5 gut expression (Nielsen et al., 2001).
There are however some shared features of mouse and chick pyloric sphincter
development, mainly in the molecules involved and their expression patterns. Bapxl is
expressed in the posterior stomach mesenchyme (Akazawa et al., 2000; Nielsen et al.,
2001) and mesenchymal Nkx2-5 expression marks the pyloric sphincter in both species
(Lints et al., 1993b; Tanaka et al., 1998b; Buchberger et al., 1996). Bmprlb expression
in the posterior stomach is also conserved (Smith et al., 2000a). Beyond expression data,
however, virtually nothing is known about the genetics of murine pyloric sphincter
development. The one piece of information available is that Hoxd genes may play a role
in patterning the pyloric sphincter, as deletion of the Hoxd complex results in abnormal
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cell differentiation in the pyloric region of the stomach epithelium (Zakany and
Duboule, 1999). The need for mouse mutants with pyloric sphincter defects is thus a
major one.
1.4.3 Pyloric stenosis and other human defects
Pyloric stenosis is one of the most common congenital abnormalities in humans,
affecting -3/1000 live births (Carter and Evans, 1969). It is this clinical importance that
makes the quest for knowledge about the origins and development of the pyloric
sphincter so important. Pyloric stenosis (also known as hypertrophic pyloric stenosis) is
characterised by morphological abnormalities of the sphincter region, leading to
obstruction and manifesting as severe vomiting in the neonate (de Santa et al., 2002).
Both muscle and neural development are affected. The circular and longitudinal smooth
muscle layers are hypertrophic, with the enteric nerves in the former layer being
enlarged and lacking in nitric oxide synthase (NOS) activity, and those in the latter being
shortened (Vanderwinden et al., 1992; Abel, 2000). The Interstitial Cells of Cajal (ICCs)
are largely absent from affected sphincters (Vanderwinden et al., 1996). This may
explain the lack of coordination observed between the sphincter and stomach muscle
contractions, as the "pacemaker" action of the ICCs normally regulates gut motility.
There is some evidence that pyloric stenosis may be a result of developmental
immaturity of the muscle layers. The distribution of desmin in hypertrophic neonatal
pyloric sphincters is comparable to that found during normal foetal development,
whereas desmin is not detected in normal, age-matched tissue (Guarino et al., 2000).
This excess of desmin may affect the organisation of the muscle and prevent correct co¬
ordination of contraction and relaxation. Transforming growth factor-a (Tgfa),
epidermal growth factor (Egf), and Egf-receptor (Egfr) are other genes inappropriately
overexpressed in the circular and longitudinal muscle layers of pyloric stenosis patients,
3 A cytoskeletal protein found in intermediate filaments of the muscle
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and these may promote smooth muscle overgrowth (Shima and Puri, 1999; Shima et al.,
2000).
Although no major candidate gene for pyloric stenosis has been identified, there
is a definite genetic component, with a family history being present in -12% of cases
(Hulka et al., 1997). Mutations in the nitric oxide synthase gene (Nosl) or its promoter
may confer susceptibility to pyloric stenosis in some families (Chung et al., 1996; Saur
et al., 2004). The mouse Nosl knockout has pyloric stenosis, as well as a grossly
enlarged stomach (also seen in human pyloric stenosis) and hypertrophic circular muscle
layer (Huang et al., 1993). The mouse model of phenylketonuria (the hph-1 mouse) also
displays transient pyloric stenosis and has thus been the subject of studies into the
underlying muscular changes involved (Abel, 2000; Abel et al., 2004). Hphl mice are
deficient for tetrahydrobiopterin which is a cofactor for phenylalanine hydroxylase and
also, intriguingly, NOS. Human phenylketonuria has been associated with pyloric
stenosis in cases when the phenylketonuria is left untreated (Johnson et al., 1978).
There also appears to be some association between pyloric stenosis and
duplication of the proximal region of chromosome 9q, although the significance of this
has been disputed (Yamamoto et al., 1988; Chung et al., 1993). Inheritance is complex,
and a multifactorial sex-modified4 threshold model seems likely, though multiple
interacting loci may also be responsible (Carter and Evans, 1969; Carter et al., 1980;
Chakraborty, 1986; Mitchell and Risch, 1993). Simple autosomal dominant inheritance
has also been reported in one large family (Fried et al., 1981). Pyloric stenosis can also
occur in conjunction with other congenital malformations, sometimes as part of a
syndrome. In a survey of 13 patients with right-sided congenital diaphragmatic hernia,
for example, Khwaja and colleagues found that three of these also suffered from pyloric
stenosis (Khwaja et al., 1989).
It is unclear whether pyloric stenosis develops postnatally or if an existing
perinatal form precedes postnatal detection. An incident of perinatal occurrence has
however been reported (de Santa et al., 2002). The pyloric sphincter constriction is also
malformed, expanded, or lost during embryonic development in mice with mutations in
4 Males are affected more than females by 5:1, particularly first-born males.
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Bapxl, Soxll, and the gene affected by the Dominant hemimelia mutation (Akazawa et
al., 2000; Sock et al., 2004)(unpublished data, Hill lab). These mutants are discussed in
Section 1.9.4.
1.5 The spleen
1.5.1 Development of the spleen
"To anyone looking over the literature on the development of the mammalian spleen the
necessity formore work on the finer details of the process is evident"
(Thiel and Downey, 1921) ...
... 85 years on from this seminal paper the later stages of spleen development -
such as differentiation of the various cell types within the spleen - are well studied, but
questions about the very earliest stages have remained unanswered until recently. Many
details are still unknown due to a deficit of early splenic markers and mutations affecting
early spleen development. Insights cannot be gained from lower organisms as the spleen
is a vertebrate-specific organ.
The common description of the earliest spleen rudiment is that of a condensation
of mesenchyme lying dorsal to the developing stomach, within the left-side of the dorsal
mesogastrium5 at -E10.5-11.0 (marked in yellow in Figure 1.1a) (Thiel and Downey,
1921; Green, 1967; Brendolan et al., 2005; Brendolan et al., 2007). This putative splenic
mesenchyme underlies the Splanchnic Mesothelial Plate (SMP), a structure which plays
a key role in spleen development (Hecksher-Sorensen et al., 2004). The SMP is
discussed in detail in Section 1.9.3. The condensed mesenchyme expresses a number of
markers expressed in later spleen development (see below), thus implicating it as the
source of splenic precursor cells (Hecksher-Sorensen et al., 2004). The events prior to
condensation are unclear, although there may be some initial contribution of cells from
5 The sheet of mesenchyme connecting the stomach with the dorsal body wall
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the overlying thickened coelomic epithelium (peritoneum) (Thiel and Downey, 1921).
The origin (pre-E10.5) of the condensed mesenchyme is the first question that our lab is
interested in, the second being how the mesenchyme then develops into a recognisable
elongated spleen form (from El 1.5).
To address the first question, spleen development must be traced back further
than E10.5, to discover when and where splenic precursors are first identifiable. Xenopus
splenic precursors appear to be initially located on both sides of the embryo; the left-side
pool preferentially develops into the spleen (Patterson et al., 2000). If a comparable
situation were to exist in mammals then defects in this system could provide a
mechanism for asplenia and polysplenia. Both of these developmental abnormalities are
reported in humans and are of clinical importance given their association with other LR
asymmetry defects, including cardiac disorders (Bartram et al., 2005).
The second question concerns what happens to the splenic mesenchyme
following condensation. The details of how this patch of tissue undergoes the transition
from lying at the posterior of the stomach to becoming an elongated structure along the
AP length of the stomach are unclear. This change occurs within a -24 hour window,
between El 1.5-12.5. Most studies agree that there is a single initial patch of splenic
mesenchyme at -El 1.5, and that a single elongated spleen structure extends from this
region by -E12.5. However there are also exceptions, such as the description that the
spleen develops inside the omentum6 as two thickenings extending from the lower left
and upper right areas of the omentum (Godin et al., 1999). It is also clear that the spleen
is formed in a posterior-to-anterior manner, such that the anterior limit of an El2.0
spleen will be somewhere between that seen at El 1.5 and E12.5. But the mechanism for
this development is far from clear. Migration of the splenic precursor cells up towards
the anterior stomach is conceivable, though equally possible is that the posterior of the
spleen is derived from the El 1.5 condensed mesenchyme whilst the remainder is
composed of cells contributed by the underlying stomach mesenchyme in a posterior-to-
anterior manner. Experimental distinction between these models will be difficult, and is
addressed in Chapter 4.
6 The part of the peritoneal membrane surrounding the gut
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1.5.2 Genes implicated in spleen development
The condensed splenic mesenchyme lies dorsal to the dorsal pancreatic bud, and
expresses a range of genes known to mark the spleen at later stages: Bapxl, Nkx2-5,
Hoxll (Tlxl), Capsulin (Podl/Tcf21), Wtl, and Pbxl (Hecksher-Sorensen et al., 2004;
Roberts et al., 1994; Lu et al., 1998; Rackley et al., 1993; Brendolan et al., 2005). Loss
of most of these genes results in asplenia, with the exception of Nkx2-5, loss of which
proves lethal before spleen development initiates (Lettice et al., 1999b; Lyons et al.,
1995; Roberts et al., 1994; Lu et al., 2000; Herzer et al., 1999; Brendolan et al., 2005).
Soxll'1', Nkx2-3~'~, and Dh homozygous mutant mice are also asplenic (Sock et al., 2004;
Pabst et al., 1999; Green, 1967).
The first gene shown to be required for spleen development was Hoxll (Tlx-1),
loss of which causes a spleen-specific phenotype (Roberts et al., 1994; Dear et al., 1995;
Roberts et al., 1995a). The earliest report indicated that Hoxll is required for initiation
of spleen development (Roberts et al., 1994). However, a later study showed that Hoxll
is in fact required for cell survival, as Hoxll loss halts proliferation (and may to a lesser
extent promote apoptosis7) of the splenic mesenchyme leading to regression of the
spleen anlage between El3.0-13.5 (Dear et al., 1995; Kanzler and Dear, 2001). Splenic
cells do persist beyond this time, albeit in a disorganised tissue into which
haematopoietic cells do not migrate (Kanzler and Dear, 2001). Incomplete separation of
the dorsal mesogastrium (splenic precursor region) from the stomach has also been
reported (Roberts et al., 1995a). HoxlrA cells cannot contribute to spleen development
in chimaeras, indicating a cell-autonomous action of Hox 11 in spleen development, and
are in fact actively excluded from chimaeric spleens (Kanzler and Dear, 2001). It is
possible that the excluded splenic cells instead contribute to the enlarged stomach - and
perhaps pancreas - seen in these mutants (Roberts et al., 1995a).
Homozygous loss of Capsulin also causes asplenia, due to apoptosis of the
splenic primordium at E12.5 (Lu et al., 2000). A similar apoptotic fate occurs in Wtl'1'
7 This has, however, been disputed. Roberts and colleagues detected no increase in cell death at the site of
normal spleen development (Roberts et al., 1995a).
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spleens from El3.5, demonstrating a requirement for Wtl in maintenance of the spleen
primordium (Herzer et al., 1999). Thus Capsulin, Wtl, and Hoxll are all required for
spleen cell survival but not for the initial development of the spleen primordium (Lu et
al., 2000; Herzer et al., 1999; Dear et al., 1995).
Expression of Capsulin, Wtl, Hoxll, and Nkx2-5 overlaps in the El0.5 dorsal
mesenchyme, implicating it as the spleen primordium (Hecksher-Sorensen et al., 2004).
Marking of cells at this early stage in mouse development is of particular importance as
the splenic mesenchyme is not yet so intimately associated with the stomach. Hoxl 1 is
strongly expressed in this splanchnic mesenchyme and is regarded as the earliest marker
of the presumptive spleen (Roberts et al., 1994). However, recent evidence suggests that
Nkx2-5 is the earliest marker of splenic precursors in Xenopus (Patterson et al., 2000).
Strong Nkx2-5 expression is also seen in the putative splenic mesenchyme of the mouse
at El 0.5 ((Hecksher-Sorensen et al., 2004), Section 2.2.2 of this thesis).
Hoxll and Nkx2-5 expression is lost from the El 1-12.5 condensing splenic
mesenchyme of Pbxl'1' mutants (Brendolan et al., 2005). Hoxl 1 is a direct target of
Pbxl and is positively regulated by the synergistic action of Pbxl with Hoxll itself in
splenic mesenchyme cells. Pbxl'1' mice are asplenic by El3.5, due to splenic agenesis
which occurs as a result of decreased proliferation following normal establishment of the
spleen primordium (Brendolan et al., 2005). A hypoplastic spleen is present at El 1.0-
12.5 and this maintains Bapxl and Capsulin expression, though Wtl expression is lost in
addition to that of Hoxll and Nkx2-5 (Brendolan et al., 2005). The loss of Wtl may be
an effect of Hoxl 1 loss, as Wtl expression is significantly reduced in Hoxl l'1' mutants
(Koehler et al., 2000). It should be, however, noted that this relationship has been
disputed in another study in which Wtl expression was maintained in the El 2.5 Hoxl 1'
spleen (Herzer et al., 1999). This contradiction may however simply be a result of
differing genetic backgrounds as the mutant spleen in the latter study appears to still be
relatively intact by El 2.5.
Splanchnic mesoderm development prior to El 1.0 is apparently normal in Pbxl'1'
mutants (Brendolan et al., 2005). Bapxl is not downstream of Pbxl in the spleen
development hierarchy, as Bapxl loss causes a defect of the splenic mesenchyme at an
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earlier stage than the splenic agenesis caused by Pbxl loss, and Bapxl expression is
intact in the Pbxl" spleen (Hecksher-Sorensen et al., 2004; Brendolan et al., 2005).
However, it is unlikely that a single, linear spleen development genetic cascade exists.
The authors of the Pbxl'1' spleen agenesis paper propose instead that Pbxl plays a
central role in spleen development by regulating both the essential Bapxl- and Capsulin
(Podl)- dependent spleen development pathways via control of their downstream
targets, Hoxll and Nkx2-5 (Brendolan et al., 2005). Pbxl also plays a role later in spleen
development by promoting proliferation of the spleen at El 3.5 (Brendolan et al., 2005).
A summary of the genetic pathways underlying spleen development is provided
in Figure 1.3.
1.5.3 Functions of the spleen
"To the left ofyour stomach, a deep violet-red,
A filter's at workfilling blood cells with dread:
The red blood cell graveyard! It's not Halloween.
I'm talking about that blood basher, the spleen."
- Allan Wolf, The Blood-Hungry Spleen
Following the initial establishment and growth of the splenic primordium (the
stages with which this thesis is concerned), haematopoietic stem cells migrate from the
developing liver into the spleen by E12.5-13.0 and the spleen itself commences
haematopoietic cell production at E14.5 (Godin et al., 1999; Bertrand et al., 2006).
Correct development of the foetal spleen is dependent on interaction between the
stromal and haematopoietic cells; for example, the stroma drives macrophage
commitment (Bertrand et al., 2006). Cell differentiation occurs throughout the rest of
foetal spleen development such that the spleen becomes populated by a range of
specialised cell types.
The adult spleen is the biggest lymphoid organ in the mammalian body and acts


















Hox11 -/- Wt1 (decreased) 5 Pbx1 6
Nkx2.5 4
Wt1 4
Pod1 (Capsulin) -/- Nkx2.5 4 Bapxl 4
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Wt1 -/- Hox11 e J
J
Figure 1.3 The genetic regulation of murine spleen development
a) A table of expression data from published asplenic mutants
b) The possible regulatory pathways underlying spleen development. Two major pathways
are predicted to exist, based on the available data: the Bapxl and the Pod1 (Capsulin)
pathways. Both of these factors regulate Nkx2.b expression. Pbx1 may act as a master
regulator as it can act on the downstream targets of both pathways.
References: 1) Lettice et al., 1999, 2) Akazawa et al., 2000, 3) Watson et al., 2007,
4) Brendolan et al., 2005, 5) Koehler et al., 2000, 6) Herzer et al., 1999, 7) Lu et al.,
2000
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erythrocytes from the blood, the spleen also recycles iron and plays an important role in
both innate and adaptive immunity. The spleen is arranged as a network of branching
arterial vessels, and comprises two main components: the red and the white pulp. The
red pulp acts as a filter to take old or damaged erythrocytes out of circulation, and
consists of macrophages, plasma cells and stroma cells. The white pulp contains
lymphocytes, including B and T cells which undergo activation and maturation in this
tissue. Lymphocytes are white blood cells which play crucial roles in the immune
response; these enter the spleen through the marginal sinus, which is located between the
white pulp and the marginal zone. The marginal zone is populated by naive B cells,
specialised macrophages and other cell types, including the sinus-lining non-lymphoid
cells which express the mucosal addressin cell adhesion molecule-1 (Madcaml) gene
and are thought to regulate passage of lymphocytes and antigens into the white pulp
from the blood (Tanaka et al., 1996).
A reservoir of haematopoietic stem cells is maintained in the adult spleen and
this can be used to supplement those produced by the bone marrow in response to
disease or trauma. More recently, it has been discovered that the spleen also contains
non-lymphoid stem cells which have the potential to differentiate into fully functional
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pancreatic islet and ductal epithelial cells (Kodama et al., 2003) . These adult stem cells
can also differentiate into other cell types (osteoblast-like cells), and this capacity may
be a result of persistent Hoxll expression (Kodama et al., 2005).
The existence of splenic stem cells may shed some light on the association
between splenectomies and the development of diabetes in certain disease situations
(Kodama et al., 2005). It may also provide an explanation for how functional ectopic
islets develop specifically in the spleen of PTFl-p48 deficient mice which undergo
defective pancreatic development (Krapp et al., 1998). Similarly, cells from the
regressing spleen primordium in Hoxll null mice relocate to the pancreatic mesenchyme
(Kanzler and Dear, 2001). These facts are particularly interesting given the close
relationship of the spleen and dorsal pancreatic mesoderm during development. These
8 There has, however, been some debate over whether spleen cells can truly contribute to the recovered
pancreatic islets (Chong et al., 2006; Nishio et al., 2006; Suri et al., 2006; Faustman et al., 2006).
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tissues undergo major developmental changes in close proximity to one another between
E10.5-12.5; the mesenchyme of the spleen and that overlying the dorsal pancreas are
contiguous at these stages. A common origin could explain the presence of splenic stem
cells which are capable of differentiation into pancreatic islet cells. The spleno-
pancreatic mesenchyme is, however, of unknown origin; it is not detectable at E9.5 yet
is by El0.5. The thickened splanchnic mesothelium of the SMP is a candidate precursor
tissue as defects of this tissue cause disruption of the spleno-pancreatic region (Green,
1967; Hecksher-Sorensen et al., 2004). The earlier, broader paraaortic
splanchnopleura/aorta-gonad-mesonephros (P-Sp/AGM) region mesoderm is another
candidate as cells from this tissue are multipotent and so the persistence of
undifferentiated P-Sp/AGM cells in the spleen could serve as an explanation for the
range of fates that splenic stem cells can adopt in the laboratory (Kodama et ah, 2005).
1.5.4 Defects of the human spleen
Development of the spleen is almost always abnormal in individuals with
heterotaxia (defects in LR asymmetric development) (Bartram et ah, 2005). Any defect
in LR asymmetric development is of clinical note as congenital heart disease - due to
abnormal cardiac asymmetry - is often also present. Spleen abnormalities associated
with heterotaxia mainly take the form of polysplenia or asplenia and are usually
sporadic. Familial cases occur more rarely and mostly show autosomal recessive
inheritance (Bartram et ah, 2005). Though most commonly found in individuals with
defects in asymmetric patterning of other organs, spleen defects may also occur in
isolation. The occurrence of "polyasplenia" (with either associated anomalies or in
isolation) is -1/24,000-40,000 (Aylsworth, 2001). "Polyasplenia" encompasses both
poly- and asplenia and reflects the view held by some that they are part of the same
spectrum of disorders.
Polysplenia is a result of bilateral left-handedness, such that spleen tissue can be
present on both sides of the body. The form that this tissue takes varies and includes
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multi-lobed spleens, clusters of small spenuli, and mixtures of small and large spleens;
these multiple spleens are actually most commonly (64-75% of cases) only located on
the right side of the body, despite the label of "bilateral left-handedness" (Bartram et al.,
2005). Malformations associated with polysplenia include a bilaterally symmetrical
liver, bilaterally bilobed lungs, an absent gallbladder, a right-sided stomach, and a
reduced pancreas (in up to 50% of cases) (Bartram et al., 2005). Polysplenia does not,
however, present any major health challenges in isolation
Asplenia is regarded as bilateral right-handedness (dextro-isomerism) and results
in a total absence of splenic tissue. Defects associated with asplenia include bilaterally
trilobed lungs, an enlarged bilaterally symmetrical liver, and a variety of cardiac defects
(Bartram et al., 2005). Congenital heart disease is present in up to 99% of asplenic
individuals9 (Aylsworth, 2001). In addition to the characteristic cardiac defects,
congenital asplenia (Ivemark syndrome) shows an association with other gut
abnormalities, including situs inversus/heterotaxia and intestinal malrotation, and can
prove fatal through sepsis associated with lack of a spleen (Mishalany et al., 1982;
Phoon and Neill, 1994). Experiments in mice have shown that the main issue associated
with absence of the spleen (either congenitally or by splenectomy) is a lack of B-la cells
(Wardemann et al., 2002). These specialised B cells provide the body's main source of
antibodies and form part of the immune response to bacterial and viral infection.
There is an intriguing predominance of asplenic male sufferers, echoing the
situation seen with pyloric stenosis (Mishalany et al., 1982). Whilst polysplenia is
equally common between the sexes, there is also a male predominance of individuals
with a single right-sided spleen (Bartram et al., 2005). The presence of a single spleen
on the right side of the body is a rarer occurrence than poly- or asplenia (Bartram et al.,
2005). If splenic precursors do initially exist bilaterally then preferential survival of
those on the right - perhaps in response to an abnormally sided inductive signal - could
serve as an explanation for this condition. The three types of spleen defect show
overlapping associated defects, suggesting a common developmental basis. Individuals
9 This may be an overestimate as patients are reported on the basis of their cardiac defects, whereas
isolated asplenia may escape medical attention
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with a single right-sided spleen have the most in common with asplenic individuals; this
may support the notion that splenic precursors are originally located bilaterally, and if
bilateral right-handedness is inappropriately induced the result is asplenia or, more
rarely, survival of precursors on the right-hand side.
1.6 The pancreas
1.6.1 Development of the pancreas
The pancreas is a vertebrate-specific derivate of the gut tube which plays roles in
digestion and hormonal regulation (Slack, 1995). Two distinct cell populations exist in
the differentiated pancreatic endoderm: exocrine (secrete enzymes into the intestine) and
endocrine (release hormones into the bloodstream). The pancreas is not of direct
relevance to this thesis, but its development is so intertwined with that of the spleen that
it merits a brief discussion. As mentioned in the previous section, the splenic and
pancreatic primordia both emerge in the dorsal mesogastrium. Whilst the spleen is
entirely mesenchymal, the pancreas is an endodermal organ with associated pancreatic
mesenchyme. This dorsal pancreatic mesenchyme is indistinguishable from the splenic
mesenchyme at E10.5, and these two tissues remain in contact throughout much of
development (personal observations). Adult splenic stem cells retain the potential to
differentiate into functional pancreatic islet cells (Kodama et al., 2003).
The endodermal component of the pancreas initially takes the form of two buds -
dorsal and ventral - which emerge from the posterior foregut (for an in-depth review see
(Slack, 1995)). It is the dorsal pancreatic bud which is closely associated with the spleen
whilst the ventral bud lies in closer contact with the hepatic duct and duodenum. These
two buds undergo branching morphogenesis and fuse following gut rotation.
The pancreatic mesenchyme can be first detected as an accumulation of
mesodermal cells which appears between the dorsal aorta and dorsal endoderm at the 22-
25 somite stage, just before and/or concomitant with leftward growth of the gut
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(personal observations and (Wessells and Cohen, 1967)). This splanchnic mesenchyme
gathers around the dorsal pancreatic bud and promotes growth and differentiation of the
pancreatic epithelium through EM interactions (Kim and Hebrok, 2001; Edlund, 2002).
One prime example of these interactions is the requirement of mesenchymal FgflO for
the differentiation and branching morphogenesis of the pancreatic epithelium (Bhushan
et al., 2001).
1.6.2 Genes implicated in pancreas development
Many other genes, in addition to FgflO, are also known to play essential roles in
pancreatic development. The homeobox gene Pdxl, for example, is expressed in the
pancreatic endoderm and is essential for pancreatic development (Jonsson et al., 1994;
Ahlgren et al., 1996). Conversely, exclusion of endodermal Shh expression from the
pancreas is essential for correct pancreatic (and spleen) mesenchyme development
(Apelqvist et al., 1997). Genes required for pancreatic budding include Onecutl (Hnf-6,
OC-1), P48 (Ptfla), Hesl, and IslF, genes required for the establishment of endocrine
cells include NeuroD and Ngn3\ endocrine differentiation genes include Pax4, Pax6,
Nkx2-2, Nkx6-1 and Nkx6-2 (reviewed in (Grapin-Botton and Melton, 2000; Collombat
et al., 2006)). The spleen differentiation gene Hoxll is also expressed in the pancreatic
mesenchyme from El2.5 (when expression is contiguous with that in the spleen) to
El4.5 (Kanzler and Dear, 2001).
The homeobox gene Hex is responsible for specification of the ventral pancreas
(Bort et al., 2004). The morphogenetic mechanism of this gene's action is particularly
interesting: controlling proliferation and consequently the position of the pancreatic
endoderm so that these cells escape the influence of the cardiogenic mesoderm, which
induces a liver fate. Control of organ position appears to be a central theme in pancreas
development, as the pancreatic primordium must also become physically separated from
the splenic mesenchyme if correct pancreatic development is to occur. Prolonged
interaction with the spleen - either in vitro or in the Bapxl'1' mouse - results in
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metaplastic transformation of the pancreas into ectopic gut-like structures (Asayesh et
al., 2006).
1.7 Gut development genes
The search for genes expressed during gut development is of utmost importance,
as gut abnormalities are the most common human congenital defect, and many occur in
familial and syndromic forms, suggesting a genetic basis (de Santa et al., 2002). A
number of genes and gene families known to play roles in gut development have been
discussed in the previous sections, and many more undoubtedly exist given the
complexity of gut morphogenesis. Indeed, a recent study of the expression of nearly
every known and predicted transcription factor gene during murine gut organogenesis
showed that around 1000 transcription factor genes are expressed in the developing gut
(small intestine or stomach) between El 1.0-17.0 (Choi et al., 2006).
Members of the Hedgehog, Hox, Fgf, Bmp, Sox, and Pax gene families have
essential functions in gut development, often across a range of vertebrate species. The
Nkx gene family has also been mentioned a number of times in the discussion thus far.
Nkx genes play key roles in development of many regions of the GI tract, and a number
are essential for murine spleen development. Homologues also play roles in invertebrate
gut development. These facts, along with the central role of Nkx2-5 - and Bapxl (Nkx3-
2) - in this thesis, merit the Nkx genes a section of their own; this follows next.
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1.8 Nkx genes in development
1.8.1. Identification of the NK gene family in Drosophila
melanogaster
NK/Nkx genes regulate many aspects of mesodermal patterning, and a number of
these are expressed in the invertebrate and vertebrate developing gut. Members of the
NK/Nkx gene family encode homeobox-containing proteins, implying a role in
transcriptional regulation. Homeoboxes - also known as homeodomains - are a common
feature of developmental transcription factors, and are thought to facilitate sequence-
specific DNA binding, allowing regulation of target genes (Gehring, 1987). It was by
probing the Drosophila melanogaster genome for a homeodomain-encoding sequence
that the first invertebrate NK genes (NK-}, NK-2, NK-3, and NK-4) were identified by
Kim & Nirenberg (hence "NK") in 1989 (Kim and Nirenberg, 1989). The NK-2, -3, and
-4 homeobox amino acid sequences show 59-66% homology to one another - greater
than to any other known Drosophila homeodomain - whereas that of NK-1 has greater
homology with non-NK factors. On the basis of these findings, NK-1 was put into a class
of its own (NK-1), whilst NK-2, -3, and -4 became known as NK-2 genes (Harvey,
1996). Vertebrate homologues of both classes have since been identified across a range
of phyla and species, although, as will become apparent throughout this discussion, the
naming of these genes often does not reflect their ancestral links. The four original
Drosophila NK genes have also now been renamed with reference to their mutant
phenotypes: NK-1 is referred to as slouch (slou), NK-2 as ventral nervous system
defective (vnd), NK-3 as bagpipe (bap), and NK-4 as tinman (tin). The roles and mutant
phenotypes of bap and tin are discussed in Section 1.8.2.
Proteins encoded by NK-2 group genes share not only overall homeodomain
homology, but also an NK-2-specific tyrosine at amino acid 54 of the domain (Harvey,
1996). This residue is conserved from sponge to human, and is thought to be involved in
binding preferentially to a CAAG core motif as opposed to the classical TAAT
homeodomain binding site (Harvey, 1996; Damante et al., 1996). A further subdivision
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of the NK-2 class of genes is made on the presence (Type I) or absence (Type II) of an
NK2-Specific domain (NK2-SD), C-terminal to the homeodomain (Harvey, 1996). The
function of this domain is unknown. Most NK-2 proteins - including Bap and the
vertebrate Tin homologues - are Type I but Tin is a Type II protein. Given the
particularly high similarity between the tin and bap homeodomain sequences, as well as
their genomic proximity, it is possible that tin arose from a duplication of the ancestral
bap gene and subsequently lost this domain.
The four original Drosophila NK genes share similarity not only in their
homeodomain-encoding sequences, but also in genomic location. Whilst NK-2/vnd
resides on the X chromosome, NK-l/slou, NK-3/bap, and NK-4/tin are clustered on the
third chromosome, in the 93E1-5 region of the right arm (Kim and Nirenberg, 1989). An
approximately 180kb genomic region including this section also contains three other
homeobox genes (ladybird early (Ibl), ladybird late (Ibe), C15), and the six genes are
collectively known as the 93DE gene cluster - the second largest cluster of physically
linked homeobox genes in the Drosophila genome (Jagla et al., 2001). Distinct
vertebrate homologues exist for most of these genes and this, along with the degree of
divergence seen between the homeodomain sequences within the cluster, strongly
suggests that the cluster is not the result of a recent genomic duplication.
A unifying feature of the genes in the 93DE cluster is that they encode proteins
containing an N-terminal "TN" domain, similar to the Ehl repression domain found in
transcriptional repressors of the Engrailed family (Smith and Jaynes, 1996; Harvey,
1996; Jagla et al., 2001). Negative regulation of target genes may thus be a shared trait
of the 93DE gene products. On the basis of TN domain and homeobox similarity, the
two most similar genes in the 93DE complex are tin and bap (Jagla et al., 2001).
In addition to the two classes of NK2 genes already discussed, a Type III class
also exists, members of which have neither the NK2-SD nor the TN domain (Harvey,
1996). This class includes NK2 genes from flatworms and C.elegans, vertebrate Nkx5-1
genes, and jVA7-type genes. Only one gene is known to have the NK2-SD but not the
TN domain: Nkx2-9, a murine gene involved in neural development (Pabst et al., 1998).
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The six 93DE cluster genes are involved in regulating progressive mesoderm
specification, through a cascade of interactions under the initial control of tin (Jagla et
al., 2001; Azpiazu and Frasch, 1993). Tin is required for the specification of the dorsal
mesoderm to cardiac, somatic, and visceral fates (Azpiazu and Frasch, 1993; Bodmer,
1993). Subsequent activation of bap by Tin is required for the specification of visceral
muscle precursors (Azpiazu and Frasch, 1993). The other 93DE genes are then activated
by Tin to control the downstream specification of other mesodermal cell types.
1.8.2 Tin and bap are required for visceral mesoderm
formation
Tin is alternatively named mesoderm specific homeobox-containing gene 2
(msh.2) (Bodmer et al., 1990), reflecting the essential role Tin plays in specifying the
Drosophila dorsal mesoderm to become either cardiac or visceral muscle (Bodmer,
1993). Tin is the first of the 93DE cluster genes to be expressed and this expression
occurs at an early point during mesoderm formation, downstream of maternal dorsal and
zygotic twist and snail (Bodmer et al., 1990). Expression is initially found in all the
mesodermal cells of the segmented embryo, but then becomes restricted to the dorsal
mesoderm (Bodmer et al., 1990). The specific activation of tin in the dorsal mesoderm
requires binding by - and the synergistic action of - activating Smad proteins and
inhibitory autoregulatory Tin (Xu et al., 1998a). Activation of tin in the dorsal
mesoderm is also dependent on decapentaplegic (dpp) expression in the dorsal ectoderm
(Frasch, 1995).
Tin expression is essential for correct patterning of the dorsal mesoderm and the
resulting specification of the component cells to cardiac, visceral, and somatic (body
wall) muscle fates (Azpiazu and Frasch, 1993; Bodmer, 1993). Tin mutants lack a heart,
visceral mesoderm, and the midgut muscles normally derived from this latter tissue.
Exogenous expression of tin rescues these tissues, although no ectopic cardiac tissue is
generated indicating that the role of tin is in patterning of the mesoderm rather than as a
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master cardiac development gene (Bodmer, 1993). Recent work has shown that the
cardiac role of tin is, more specifically, to allow cells to adopt a fully functional
myocardial fate (including post-embryonic maturation) over an inflow tract fate (Zaffran
et al., 2006).
Both tin and the downstream mesoderm specification gene bap possess dpp-
responsive elements which drive their dorsal mesoderm expression (Xu et al., 1998c).
Activation of bap by Tin specifically in the dorsal mesoderm is dependent on dpp from
the ectoderm overlying this region (Staehling-Hampton et al., 1994). Expression of bap
is stimulated by Tin within eleven segments of the dorsal-most region of the mesodermal
tin expression domain (Azpiazu and Frasch, 1993). As bap is expressed only within
sections of the tin expression domain there are presumably other genes involved in
establishing this segmented pattern; these may take the form of epidermal segmentation
genes, as the anterior borders of the bap expression segments perfectly match the
epidermal parasegments (Azpiazu and Frasch, 1993). Within the segments, an interplay
between Hedgehog and Wingless creates differences in bap expression: Hedgehog
promotes bap expression in the anterior, whilst Wingless (via induction of sloppy
paired) suppresses expression in the posterior (Azpiazu et al., 1996b; Lee and Frasch,
2000).
Both Tin and Bap are required for visceral mesoderm formation. More
specifically, both are required for the specification of the segmentally positioned bap-
expressing cells to develop into the somatic and visceral mesoderm (Azpiazu and
Frasch, 1993). The feap-expressing cells rearrange such that each segment elongates
along the AP axis of the embryo and the cells begin to surround the midgut endoderm. A
ventral subset of the cells in each segment adopts a columnar morphology and, when AP
elongation is complete, the patches of columnar cells connect, forming the visceral
mesoderm (Azpiazu and Frasch, 1993). The midgut musculature subsequently develops
from this tissue after the formation of the midgut constrictions. Tin mutants, however,
lack these constrictions. Formation of the midgut constrictions is also known to be
dependent on dpp-mediated transduction of signals from the visceral mesoderm to the
underlying endoderm, as formation is disrupted in Dpp mutants (Panganiban et al.,
31
1990). Correct visceral mesoderm development also appears be required for migration of
the midgut endoderm as this process is disrupted in tin mutants (Azpiazu and Frasch,
1993; Bodmer, 1993). It should be noted that whilst the midgut is severely affected in tin
mutants, the proventriculus, foregut, and hindgut develop apparently normally (Azpiazu
and Frasch, 1993).
Visceral mesoderm differentiation is disrupted in bap mutants such that the
visceral mesoderm suffers segmental disruptions (-70% of cells are missing); the tissue
that is present does not have columnar morphology (Azpiazu and Frasch, 1993). The
mesodermal defects appear to be specific to the midgut, even though bap is also
expressed in the foregut and hindgut mesoderm. The derivative midgut musculature fails
to form and some precursor cells are transformed into body wall musculature or gonadal
mesoderm (Azpiazu and Frasch, 1993). As in tin mutants, the midgut constrictions are
also absent in bap mutant embryos and midgut endoderm migration is retarded (Azpiazu
and Frasch, 1993). Whilst capable of rescuing visceral mesoderm development in bap
null embryos, ectopic bap expression cannot achieve this in tin null mutants, indicating
an essential upstream role for tin in visceral development (Park et al., 1998a). There is
no requirement for bap in Tin-mediated cardiac development (Azpiazu and Frasch,
1993).
A couple of Bap target genes have been identified. Vimar is expressed in the
mid/hindgut visceral mesoderm progenitors and this expression is dependent on Bap (Lo
and Frasch, 1998). Another target is biniou (bin) which is an essential regulator of
visceral mesoderm development and is required for differentiation of the circular and
longitudinal midgut muscle layers (Zaffran et al., 2001). Murine homologues of tin
(Nkx2-5), bap (Bapxl/Nkx3-2), and bin (FoxFl) are all expressed in the gut splanchnic
mesoderm at E9.5 (data presented in Section 2.2.1; (Hecksher-Sorensen et al., 2004;
Mahlapuu et al., 2001b)). FoxFl is required for correct patterning of the mouse
oesophagus and trachea, both foregut-derivatives (Mahlapuu et al., 2001a). Xenopus
FoxFl is also required for normal gut mesoderm differentiation, but acts upstream of
Xbap in this process (Tseng et al., 2004).
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1.8.3 Vertebrate Nkx genes
The 93DE NK cluster is essential for mesoderm specification. Clustering of
related developmentally important genes is a well documented feature of the Drosophila
genome, most notably the Hox complexes, which also happen to reside on the right arm
of chromosome 3 (Kaufman et al., 1980). In the 17 years since the first identification of
the NK genes many vertebrate Nkx genes have been isolated and found to play key roles
in the development of the heart, nervous system, and - most importantly for this thesis -
the gut. The 93DE NK cluster is present in Amphioxus as a series of three "mini" clusters
scattered along one chromosome: the first contains the orthologues of tin and bap, the
second contains two orthologues of slou, and the third contains the C15 and Lbx
orthologues (Luke et al., 2003). During vertebrate evolution this series of three clusters
has been duplicated and sections lost such that the human genome contains four
dispersed clusters. The tin orthologue NKX2-6 and the bap orthologue NKX3-1 lie in
extremely close proximity to one another on 8p, and the respective Ibx and CI5
orthologues LBX2 and TLX2 lie very close on 2p (Luke et al., 2003). These occurrences
suggest selection for their linkage, potentially on the basis of coregulation. Similarly, a
near-full complement of genes is retained on lOq, where orthologues of tin (NKX2-3),
Lbx (LBX1), CI5 (TLX1), and slou (NKX1-2) can be found in the same order in which
they lie in the amphioxus genome (Luke et al., 2003). Finally, NKX2-5 (tin) and TLX3
(Tlx) are both on chromosome 5q, and NKX3-2 (bap) and NKX1-1 (slou) co-reside on 4p
(Luke et al., 2003).
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1.8.4 Nkx2-5
1.8.4.1 Similarities to tin
Many homologues of the Drosophila NK-2 genes can be found across a range of
vertebrate genomes, highlighting their developmental importance. These homologues
tend to share high homeodomain sequence identity with either NK2/vnd (vertebrate Nkx2
genes) or NK3/bap (vertebrate Nkx3 genes) (Harvey, 1996). Despite this nomenclature, a
number of the vertebrate Nkx2 genes are functionally equivalent to tin. It should also be
noted that when greater weighting is given to putatively important homeodomain
residues these Nkx2 genes show greater similarity to tin and bap than vnd (Lints et al.,
1993b). Nkx2-5/CSX is regarded as the major vertebrate tin homologue on the basis of its
expression (in pharyngeal endoderm and during early cardiogenesis) and function (it is
essential for cardiac development across a range of species) (Harvey, 1996). The tin
cardiac expression pattern is highly conserved in vertebrate Nkx2-5 genes: expression
initiates in splanchnic mesoderm-derived myocardial progenitor cells, and is maintained
during differentiation into the heart tube (Harvey, 1996).
Rescue experiments in Drosophila using chimaeric Tin proteins - containing
various regions of vertebrate Nkx2 proteins - have shown that the cardiac and visceral
specification function of the Tin homeodomain has been conserved during evolution,
even if the cardiac specification role is not utilised in mice (more on this later)
(Ranganayakulu et al., 1998; Park et al., 1998a; Lyons et al., 1995). The divergent
regions outside of the homeodomain confer specificity as full-length vertebrate Nkx2-5
cannot functionally substitute for Tin in Drosophila cardiac development (Park et al.,
1998a; Ranganayakulu et al., 1998). Visceral mesoderm formation and downstream bap
expression are, however, rescued. The inability to rescue cardiac specification is
probably a consequence of fine-tuning for roles in vertebrate cardiac differentiation, and
this being too divergent from the arthropod heart development program. The only full-
length vertebrate tin homologue able to rescue Drosophila cardiac-specific gene
expression is zebrafish Nkx2-3 (Park et al., 1998a). The reason for this is not entirely
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clear as of all the zebrafish tin homologues Nkx2-3 shows the weakest heart expression;
nor does it share any greater sequence or structural similarity with tin than any other
vertebrate homologues. The ability of this poorly expressed cardiac gene to rescue heart
development - and of other predominantly heart-expressed Nkx genes to rescue only
visceral development - may allude to the fact that common developmental mechanisms
are shared between organs, but that these become interchanged and placed under
different regulation during evolution.
Chimaeric protein studies also showed that the cardiogenic domain is located in
the N-terminal first 52 amino acids of Tin, as full-length murine Nkx2-5 can rescue
Drosophila heart development when it is engineered to contain this region
(Ranganayakulu et al., 1998). This domain may have been lost during vertebrate
evolution, may have diverged to respond to different upstream factors or have different
functions, or may have arisen in Drosophila following the vertebrate-invertebrate
evolutionary split.
Two pieces of evidence from these substitution assays suggest that, despite the
marginally closer identity of vertebrate tin homologues with bap in the homeodomain
and NK2-SD sequences, the vertebrate tin homologues are functionally most related to
tin. Firstly, whilst the full-length Tin homologues Nkx2-5, ZNkx2-7, and XNkx2-3 can
rescue visceral mesoderm in tin mutants, bap cannot (Park et al., 1998a). Secondly, this
ability appears to be due to a tin-like function, as Nkx2-5 cannot rescue visceral
mesoderm in bap mutant embryos (Ranganayakulu et al., 1998).
It is plausible that the ancestral role of tin was in visceral mesoderm
development, and that the cardiac functions evolved independently in the vertebrate and
invertebrate lineages. This would fit with the previous suggestion that tin may have
arisen from duplication of an ancestral bap gene and then diverged. Such divergence in
sequence and function might explain the differences in heart development between
arthropods and vertebrates, and the inability of full-length vertebrate tin homologues to
rescue heart development in tin mutants. The ability of the tin homologues'
homeodomains to rescue cardiac specification may demonstrate that this conserved
domain can be put to multiple uses depending on its genomic context and the selection
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of factors with which it associates. Indeed, zebrafish Nkx2-5 (predominantly expressed
in the heart) can rescue pharyngeal muscle development in the C.elegans ceh-22 (Nkx2-
5/tin homologue) mutant, supporting the notion of a conserved mechanism underlying
vertebrate/insect heart and nematode pharyngeal development (Haun et al., 1998). The
nematode pharyngeal muscle develops from foregut visceral mesoderm, and is not only
involved in circulation (in place of a cardiac heart), but also in feeding. It has been
postulated that the cardiac and gut lineages evolved from an ancestral coelomic structure
expressing tin-like genes in early multicellular organisms (the "gastroderm") (Bishopric,
2005). Cardiac mesoderm and pharyngeal mesoderm remain the main sites of expression
associated with vertebrate tin homologues.
1.8.4.2 Differences to tin
The likening of Nkx2-5/CSX to tin is based on similarities in expression and
function, but there are also some important differences in both of these aspects. Most
notably, an essential role cannot be demonstrated for Nkx2-5 in gut development, due to
the early lethality of knockout mice (Lyons et al., 1995). Another major difference is
that whilst tin is essential for specification of the cardiac precursors destined to form the
heart tube, Nkx2-5 loss causes only a differentiation defect which does not become lethal
until E9-10, after the beating heart tube has been successfully established (Lyons et al.,
1995; Biben et al., 2000; Jay et al., 2004). Commitment of cells to a cardiac lineage is
not affected and the linear tube forms normally; it does not, however, express the earliest
marker of ventricular differentiation, nor does it undergo looping morphogenesis at
E8.25-8.5 (Lyons et al., 1995). Looping of the heart tube is essential for physical
separation of the atrial and ventricular chambers and is thought to be under LR control.
It should be noted at this juncture that in a further Nkx2-5 knockout study in which the
entire coding sequence was removed - thus ensuring a true null allele - cardiac looping
did occur and embryos died slightly later, between E9.5-11.5 (Tanaka et al., 1999a). The
reason for this difference is unclear, as other aspects of the reported knockout phenotype
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were recapitulated. Null embryos in all published studies have been severely retarded in
growth and development, and exhibit pericardial oedema and distension of the veins; it
is these factors which appear to cause the embryonic lethality (Lyons et al., 1995).
Embryos homozygous for the completely null Nkx2-5 allele also have major yolk sac
defects (Tanaka et al., 1999a).
Interpretation of the differential effect of tin and Nkx2-5 loss on heart
development is of course complicated by the differences between vertebrate and
arthropod heart development: a ventral complex chambered heart arising from the LPM,
versus a dorsal mesoderm-derived tube composed of four rows of cells, respectively
(Bodmer and Venkatesh, 1998).
Redundancy between vertebrate tin homologues could also serve as an
explanation for the less severe cardiac defect. Three members of the vertebrate Nkx2
family that are very closely related at the sequence level are Nkx2-3, Nkx2-5, and Nkx2-6
(Harvey, 1996). These three genes also show overlapping spatio-temporal expression
patterns in a range of vertebrate organisms (see Table 1.1 and references therein) and
loss of function studies have suggested that functional redundancy may indeed exist
between them (Lyons et al., 1995; Pabst et al., 1999; Tanaka et al., 2000).
1.8.4.3 Murine Nkx2-5 expression
Murine Nkx2-5 is located on chromosome 17, in the vicinity of the t-locus
(Himmelbauer et al., 1994). Nkx2-5 transcripts and Nkx2-5 protein are detectable within
the cardiac crescent from E7.5, in the resulting linear heart tube at E9.0, in the
subsequently looped heart tube at E9.5, and in the atrial and ventricular myocardium
throughout development and into adulthood (Lints et al., 1993b; Lints et al., 1993a;
Komuro and Izumo, 1993; Tanaka et al., 1998a; Kasahara et al., 1998). In addition to the
main body of the heart, Nkx2-5 is expressed in the precursors of the outflow tract which
is derived from a secondary heart field, dorsal to the heart (Stanley et al., 2002). Nkx2-5
associates with Tbx5, Tbx20, and Gata4 to promote cardiac differentiation (Hiroi et al.,
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2001; Stennard et al., 2003; Durocher et al., 1997), and overexpression during
embryonic development results in major heart defects and lethality between El4.5 and
birth (Kasahara et al., 2001). Nkx2-5 is also an early marker of the heart primordia in
human, chick, zebrafish and Xenopus (Shiojima et al., 1996; Schultheiss et al., 1995;
Chen and Fishman, 1996; Tonissen et al., 1994).
Nkx2-5 expression can also be detected in the pharyngeal endoderm precursor
region from E8.5-9.5 (Lints et al., 1993b). This may be relevant to cardiac development,
as the pharyngeal endoderm is thought to secrete the heart inducer. The pharyngeal-
derived thyroid primordium also expresses Nkx2-5, as does the developing tongue (Lints
et al., 1993b; Kasahara et al., 1998). Nkx2-5 expression overlaps with that of Nkx2-3 in
the pharyngeal endoderm, Nkx2-1 in the thyroid, and Nkx2-6 in the pharyngeal pouches
and tongue (Harvey, 1996). Expression can also be detected in a subset of the cranial
skeletal muscles, and Nkx2-5 has been shown to have a role in skeletal myoblast
differentiation in vitro (Riazi et al., 2005). The full Nkx2-5 expression pattern is the
result of complex regulation; an array of cardiac, thyroid, pharyngeal, and gut enhancers
lie upstream of Nkx2-5 (Schwartz and Olson, 1999). These are discussed in Chapter 2.
1.8.4.4 Nkx2-5 in nut development
The expression of tin in the developing Drosophila gut is an evolutionary
conserved feature of its homologues: ceh-22 is expressed in the nematode pharynx
(feeding muscle), and Nkx2-5 expression is present in the developing gut of mouse,
chick, and Xenopus (Lints et al., 1993b; Buchberger et al., 1996; Tonissen et al., 1994).
On the basis of its expression pattern, murine Nkx2-5 does not appear to be active in gut
muscle development, but does appear to be central to other aspects of gut
morphogenesis. Nkx2-5 protein is detectable in the El 1.5 stomach, E12.5 spleen, and
E13.5 dorsal mesentery, with a few positive cells detectable in the E12.5 and E15.5 liver
(Kasahara et al., 1998). Expression also rings the distal stomach at El 1.5 and E14.5,
marking the developing pyloric sphincter (Hecksher-Sorensen et al., 2004; Kasahara et
38
al., 1998; Lints et al., 1993b). No expression has been detected in the neonatal or adult
stomach.
A similar pyloric sphincter expression pattern is noted during chick development.
cNkx2-5 is expressed in the developing gut from stage 18, when it overlaps with cNkx-
2.3 in the mesodermal midgut in which cNkx-2.3 is more caudally expressed
(Buchberger et al., 1996). These domains become increasingly distinct during
development until cNkx2-5 marks only the pyloric sphincter, whilst cNkx-2.3 is
expressed throughout the midgut and hindgut with highest expression abutting the
posterior limit of cNkx2-5 expression. Repression of endogenous cNkx2-5 activity using
a retroviral dominant-negative construct shifts the boundary of cNkx2-5 expression
anteriorly into the gizzard and proventricular mesoderm, and also expands the anterior
limit of cNkx2-3 expression into the gizzard and proventriculus (Smith et al., 2000b).
cNkx2-5 is both necessary and sufficient for development of the epithelial component of
the pyloric sphincter (Smith et al., 2000b).
The requirement for Nkx2-5 in gut development cannot be assessed using any of
the published Nkx2-5 homozygous knockout mice, as these not only die by 9-10dpc
(days post coitum), but are also severely growth retarded and so do not develop beyond
the 24 somite stage (Lyons et al., 1995). A ventricular-specific knockout has been
generated by crossing Nkx2-5 "floxed" allele mice with mice harbouring a ventricular
myocyte-specific Cre, and these survive into adulthood when they present with heart
defects similar to those in human NKX2-5 mutants (Pashmforoush et al., 2004). If a
suitable gut mesenchyme-specific Cre line were available then this might provide a way
of circumventing the issue of early embryonic lethality. This is discussed further in
Chapter 3.
1.8.4.5 Nkx2-5 in spleen development
Nkx2-5 is a marker of the developing spleen, and this splenic expression has been
seen to connect with the distal stomach expression - or the aforementioned dorsal
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mesentery expression domain - perhaps suggesting a common mesenchymal origin
(Lints et al., 1993b). At E12.5 nearly all cells in the spleen produce Nkx2-5, as do a
handful of cells in the neonatal spleen (Kasahara et al., 1998). Embryonic Nkx2-5
expression appears to reside in the splenic stroma as opposed to the haematopoietic
cells, but is not found in stromal cells from other haematopoietic tissues (Lints et al.,
1993b). Splenic expression persists into adulthood (Lints et al., 1993b).
Expression of Nkx2-5 in the spleen is dependent on Capsulin and Pbxl at El 2-
12.5, but not on Hoxl 1 (Brendolan et al., 2005). Brendolan and colleagues also suggest
that splenic Nkx2-5 expression is not affected by Bapxl loss - a finding contradictory to
evidence from our lab. It should be noted, however, that the Bapxl" mutants in the
Brendolan study are not those generated by and used in our lab's work, but those
obtained from Drs W. Zimmer and R. Schwartz. These mutant mice do not appear to
have as severe a spleen phenotype as they still possess splenic tissue by El2.5
(Brendolan et al., 2005). Research in our lab supports the dependence of Nkx2-5
expression on Bapxl, and the requirement for Bapxl in spleen development.
The earliest reported origin of the spleen is a patch of condensed mesenchyme
lying dorsal to the stomach, close to the pancreas, on the left side of the body cavity at
around E10.5-11.0 (reviewed in (Brendolan et al., 2007) and references therein). This
tissue is marked by Nkx2-5 expression from E10.5-12.5 (Lints et al., 1993b; Hecksher-
Sorensen et al., 2004). Expression of splenic markers has not been traced earlier than
this stage, at which the putative splenic mesenchyme is already located on the left-side
of the gut. In Xenopus, however, bilateral expression of XNkx2-5 has been observed in
two patches of splenic precursor tissue, one on either side of the body (Patterson et al.,
2000).
XNkx2-5 has been implicated in the establishment of asymmetry in the heart and
spleen, acting downstream of the left-side-expressed Pitx2, and the handedness of gut
looping is also correlated with XNkx2-5 expression (Patterson et al., 2000). XNkx2-5-
marked splenic precursor cells are initially located on both sides of the embryo, but only
the left side cells form the spleen. This loss of right-sided XMct2-5-marked splenic
tissue is not due to migration to the left-side or due to loss of these right-side cells by
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apoptosis. Instead, the right-hand cells lose XNkx2-5 expression and their ability to react
to spleen induction signals, presumably adopting a different developmental fate
(Patterson et al., 2000). Explant studies showed this XNkx2-5 downregulation to be due
to a local signal. If cells competent to become spleen tissue were to initially exist on
both sides of the embryo in other vertebrate species, then this might provide a possible
explanation for polysplenia. Indeed, mutations in human NKX2-5 can cause defects in
LR visceral asymmetry, including polysplenia (Watanabe et al., 2002).
1.8.4.6 Nkx2-5 in LR asymmetry
Murine Nkx2-5 is intimately associated with the development of LR asymmetry.
The homeobox gene Pitx2 is required for LR asymmetry in the embryo and is itself
asymmetrically expressed, on the left side of the LPM and in its derivative organs
(Yoshioka et al., 1998; Lu et al., 1999; Lin et al., 1999). Early Pitx2 expression in the
LPM is initiated by Nodal signalling, but maintenance of late (eight somite pair stage
through to El0.5) expression in specific organ primordia is achieved through binding of
Nkx2-5 to a high-affinity binding site in the Pitx2 left side-specific enhancer (ASE)
(Shiratori et al., 2001). Transgenic embryos in which this enhancer drives LacZ exhibit
X-gal staining specifically in the left-side of the El0.5 anterior gut dorsal mesentery and
heart. Specific mutation of the ASE Nkx2-5 binding site ablates this late expression. The
ASE is evolutionary conserved, and can be found in Xenopus (Shiratori et al., 2001).
Transgenic mouse embryos in which LacZ is driven by the Xenopus ASE display X-gal
staining in most of the endogenous ASE locations, including the E10.5 dorsal mesentery
of the anterior gut.
In addition to the above role in maintaining asymmetric gene expression, Nkx2-5
is also itself under control of the LR asymmetry cascade. Nkx2-5 is expressed in the left¬
side mesenchyme of the gut at El0.5, and this expression is ablated when the LR
asymmetry gene Bapxl is lost (Jacob Hecksher-Sorensen, PhD thesis, University of
Edinburgh, 2001).
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1.8.4.7 NKX2-5 mutations - cardiac yhenotypes
Human NKX2-5 (CSX) is located at 5q34-25 and shares 100% identity with
murine Nkx2-5 in its homeodomain (Shiojima et al., 1996). Like Nkx2-5, NKX2-5 is
expressed during cardiac development and also in the adult heart (Shiojima et al., 1996).
Many NKX2-5 mutations have been reported. All affected individuals have cardiac
defects, and so are detected and reported with respect to these, often with no mention of
whether gut defects were investigated. A number of cases of associated gut defects have,
however, been described.
A range of cardiac defects are found in patients with NKX2-5 mutations (Schott
et al., 1998; Benson et al., 1999; Hosoda et al., 1999; Zhu et al., 2000; Goldmuntz et al.,
2001; Gutierrez-Roelens et al., 2002; Ikeda et al., 2002; Watanabe et al., 2002;
McElhinney et al., 2003; Sarkozy et al., 2005; Gutierrez-Roelens et al., 2006). The most
common are atrial septal defect (ASD) and AV (atrioventricular) conduction block.
Other common phenotypes include left ventricular hypertrophy, ventricular septal defect
(VSD), pulmonary valve stenosis/atresia, and mirror-image arch branching. Less
frequent effects include sub valvular aortic stenosis, and the presence of a double outlet
(outflow tract) in the right ventricle (DORV). Many of these malformations are
commonly associated with defects in LR asymmetry, particularly ASD, VSD, and
DORV (Ramsdell, 2005). Accordingly, many of these defects also overlap with those
associated with asplenia and polysplenia. For example, DORV is found in ~82% of
asplenia cases, and AV conduction block is present in -22% of polysplenic individuals
(Bartram et al., 2005).
All reported NKX2-5 mutations are heterozygous; this is in contrast to the
situation in mouse in which both copies of the gene must be non-functional to cause a
phenotype. When survival permits reproduction, the human mutations are transmitted in
an autosomal dominant fashion. Multiple mutations (up to 14) can be present in one
individual; these are usually of a somatic origin and are specific to the diseased tissue
(Reamon-Buettner and Borlak, 2004). Multiple mutations have also been detected in
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Down's syndrome patients with cardiac abnormalities (Reamon-Buettner and Borlak,
2004).
A correlation between genotype and phenotype is not obvious from the mutations
reported thus far, although it has been proposed that missense mutations in the
homeodomain and nonsense/frameshift mutations confer the most severe AV block
(Hirayama-Yamada et al., 2005). Reported functional effects include reduction/loss of
DNA binding affinity, reduction/loss of transactivation ability, loss of homodimerisation
ability, and dominant-negative reduction of transactivation by the wild type protein
through homodimerisation (Kasahara et al., 2000). Expression of a mutant Nkx2-5
which cannot bind DNA, on a wild type background from embryonic stages and into
adulthood, also causes progressive heart failure in mice, most notably due to AV
conduction block (Kasahara et al., 2001).
The reason for the difference in severity between mouse and human Nkx2-
5/NKX2-5 loss is unclear. Heterozygous loss of murine Nkx2-5 has produced no obvious
effect in two studies (Lyons et al., 1995; Tanaka et al., 1999a). This may be indicative of
functional redundancy between murine cardiac (Nkx) genes. Yet as the homozygous null
phenotype is so severe it also seems that there is an essential requirement for Nkx2-5
during early cardiogenesis. This requirement appears to be even more profound during
human development as a mutant phenotype is produced by the functional loss of just one
copy of NKX2-5 and no homozygous mutants have been recorded. Of course, an element
of detection bias may exist if only the most severely affected heterozygotes require
medical treatment. This may corroborate with findings from two more recent studies
which showed that Nkx2-5 haploinsufficieny can occur in mice, with the result that
heterozygous knockout mice can have cardiac development phenotypes; such
occurrences are, however, rare or difficult to detect (Biben et al., 2000; Jay et al., 2004).
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1.8.4.8 NKX2-5 mutations - sut yhenotxpes
Four deletions have been reported that result in total loss of the NKX2-5
homeodomain (Watanabe et al., 2002; Hirayama-Yamada et al., 2005; Konig et al.,
2006). One of these deletions removes seven nucleotides (nucleotides 215-221) resulting
in a frameshift from residue 72 and subsequent loss of the homeodomain and truncation
at amino acid 172 (Watanabe et al., 2002). This was associated with a number of cardiac
abnormalities typical of NKX2-5 mutations, but also a range of gut defects. One of the
members of the affected family had cardiac abnormalities and also presented with a
midline liver, gut malrotation and polysplenia - all suggestive of fundamental defects in
the development of gut asymmetry. This heterotaxy was specific to the gut as the heart
and lung were correctly positioned. Furthermore, one of the offspring of this individual
had pyloric stenosis in addition to heart defects, and thus both the gut tissues in which
Nkx2-5 is developmental^ expressed were abnormal in individuals with this mutation.
This may be the first evidence that NKX2-5 plays an essential role in the development of
the spleen and pyloric sphincter. Intriguingly, an association between pyloric stenosis
and congenital heart defects (of unknown aetiology) has been proposed, though this does
not seem to be major (Mehta and Ambalavanan, 1997). These two birth defects also
occur together in a number of syndromes.
The loss of the homeodomain in the above mutation is particularly interesting
given that such loss is predicted to prevent dimerisation, and that positive autoregulation
of/by Nkx2-5 is proposed to exist in the murine gut (Tanaka et al., 1999c). This
homeodomain-less protein may also be exerting a dominant-negative effect as a
heterozygous 2.2Mb 5q35 deletion - which totally removes the NKX2-5 gene - confers
only heart defects, and not any reported gut abnormalities (Baekvad-Hansen et al.,
2006). It would thus appear that simple loss of one copy of NKX2-5 is compatible with
normal gut development, though of course interacting loci could modulate this situation.
The link between Nkx2-5 haploinsufficieny and cardiac defects in heterozygous
knockout mice - discussed earlier - was significantly affected by genetic background
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(Biben et al., 2000; Jay et al., 2004); a similar caveat may therefore apply to human gut
defects.
Why gut defects have only been seen in two affected individuals is an interesting
issue. It may of course be that the gut defects were the effect of a second mutated gene,
either directly or through interplay with NKX2-5. Another hypothesis is that gut defects
may be a more prevalent component of the NKX2-5 mutant phenotype but that they
simply go undetected. Although pyloric stenosis would require medical attention,
polysplenia often goes undiagnosed as it does not present any major health issues. The
role of NKX2-5/Nkx2-5 in gut development is thus a very interesting, yet poorly
understood, area of research.
In addition to heart and gut abnormalities, thyroid dysgenesis has also been
reported in four NKX2-5 missense mutation patients (Dentice et al., 2006).
Consequently, thyroid development was re-examined in Nkx2-5~/' embryos and found to
be disrupted due to a reduction (<50%) in the number of precursor cells in the thyroid
buds (Dentice et al., 2006).
1.8.5 Bapxl (Nkx3-2)
1.8.5.1 Bapxl in vertebrate development
The sequences of the bap homeodomain, TN, and NK-2 domains are well
conserved in the vertebrate homologue Bapxl (Nkx3-2), as are aspects of bap function
and expression (Tribioli et al., 1997). One novel aspect of Bapxl function is its role in
regulating patterning of the mammalian middle ear (Tucker et al., 2004). This is an
evolutionary adaptation of the role of Bapxl in jaw development in non-mammalian
vertebrates (Miller et al., 2003). Bapxl also plays an important role in skeletal patterning
and development of the basal skull (Lettice et al., 1999b) - another function not
associated with fly bap. Bapx 1 promotes somitic chondrogenesis through its action as a
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transcriptional repressor, and a chondrogenic Bapxl/Sox9 positive autoregulatory loop is
established and maintained in response to Shh/BMP signals (Murtaugh et al., 2001;
Zeng et al., 2002). In addition, Bapxl plays roles in limb development in chick (Provot
et al., 2006; Church et al., 2005). Murine Bapxl is also expressed in the proliferative
zone of the limb bud, though no limb defects have been observed in mice deficient for
Bapxl (Lettice et al., 1999b).
1.8.5.2 Bapxl mutants
A number of Bapxl knockout mouse lines have been generated, and the resulting
phenotypes are fairly consistent (Lettice et al., 1999b; Tribioli and Lufkin, 1999;
Akazawa et al., 2000). In the first report, Lettice and colleagues engineered an insertion
mutation by placing the neomycin-resistance cassette into the first exon of Bapxl
(Lettice et al., 1999b). Skeletal and spleen development were disrupted in mice
homozygous for this allele (discussed in Section 1.8.5.5), and these died neonatally due
to respiratory problems. There was however the possibility that the mutants expressed a
weak allele of Bapxl, as a spliced transcript (corresponding to the 3' coding region) was
detected at low-levels. This interpretation is supported by the existence of a slightly
more severe array of skeletal defects in the null mice generated in two further studies
(described below), though it should be noted that the majority of the phenotypes
observed are shared between all three lines.
Akazawa and colleagues produced a total null allele by replacing the entire
Bapxl coding sequence with a cassette including LacZ, thus allowing analysis of
expression in heterozygotes (Akazawa et al., 2000). Expression was observed in
previously reported regions of endogenous Bapxl expression, and the gut expression
was confirmed to be solely mesenchymal. Major expression occurred in the El3.5
mesenchymal spleen and this persisted in the red pulp, capsule, and central arterioles of
the adult spleen. The adult gut also expressed LacZ in the muscle layers of the stomach,
pyloric sphincter, and - to a lesser extent - duodenum. The homozygous knockout mice
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exhibited asplenia, gastroduodenal malformations, and neonatal lethal skeletal dysplasia.
In the third study, Tribioli and Lufkin generated a similar null allele - removing nearly
all the Bapxl coding sequence - and observed comparable effects in homozygous
mutants (Tribioli and Lufkin, 1999).
Based on the murine Bapxl knockout phenotypes, mutations in human BAPX1
might be expected to produce similar effects. Intriguingly, axial skeleton defects show
some association with poly- and asplenia in humans (Aylsworth, 2001). However, whilst
the genomic region in which BAPX1 resides has been associated with inherited skeletal
disorders, BAPX1 itself has not been reported to be mutated in any human diseases.
Despite this lack of disease-causing mutations, BAPX1 has however been implicated in a
human disorder: oculo-auriculo-vertebral spectrum (OAVS) (Fischer et al., 2006b).
OAVS is the second most common craniofacial birth defect, and comprises a range of
developmental anomalies - often unilaterally - including ear malformation, vertebral
defects, and facial abnormalities. Bapxl-deficient mice exhibit the first two of these
phenotypes (Tucker et al., 2004; Lettice et al., 1999b). The cause of OAVS is not,
however, due to simple loss of BAPX1 expression, but instead attributed to a strong
allelic expression imbalance (Fischer et al., 2006b). This imbalance is dependent on
histone deacetylation - i.e. epigenetic BAPX1 dysregulation. This imbalance appears to
predispose to OAVS, as a similar imbalance is also observed in unaffected relatives of
patients but not in unrelated unaffected controls. Gut defects were not however detected
in this study, nor are they a known component of OAVS, though anal atresia and
tracheo-oeosophageal fistula have been seen in two OAVS sufferers (aetiology
unknown) (B. Horsthemke, personal communication).
1.8.5.3 Bapxl in cut development
Like Bap, Bapxl is essential for correct visceral mesoderm development; it does
not, however, share Bap's role in controlling midgut muscle development (Akazawa et
al., 2000; Tribioli and Lufkin, 1999). Nor does the other mammalian Bap-like gene,
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Nkx-3.1, perform this role, suggesting that the function of bap in midgut musculature
development has not been retained in mammals. This is not to say that it has not been
conserved in vertebrates, as the role appears to have been delegated to a third,
amphibian-specific homologue: XNkx-3.3/zax (Lettice et al., 2001).
1.8.5.4 Bapxl: a target and promoter of the LR asymmetry pathway in the sut
One striking difference between the expression pattern of bap and Bapxl is that
whilst the former is expressed in a bilaterally symmetrical manner, the vertebrate
homologue exhibits LR asymmetric expression and serves as a link between gut
development and the signalling pathway that establishes LR asymmetry (Schneider et
al., 1999; Hecksher-Sorensen et al., 2004). This is discussed in more detail in Section
1.9.
Human, mouse, chick, and Xenopus BAPX1/Bapxl/Xbapl are expressed in the
splanchnic mesoderm from which the visceral musculature is derived (Tribioli and
Lufkin, 1997; Tribioli et al., 1997; Schneider et al., 1999; Newman et al., 1997). The
role of Bapxl (cNkx3-2) has been well studied in chick. cNkx3-2 is initially expressed on
the left-side of the anterior LPM - overlapping the left-side marker Pitx2 - due to
promotion by the left-side genetic pathway headed by Shh and repression on the right-
side by Fgf8 (Schneider et al., 1999). Expression then shifts to a more bilateral state in
the anterior gut mesoderm and becomes restricted to the gizzard, with no expression in
the flanking proventriculus or duodenum; expression then becomes strongest in the
distal-most portion of the gizzard, bordering the pyloric sphincter from which it is absent
(Schneider et al., 1999; Nielsen et al., 2001). Ectopic cNkx3-2 expression in the
proventricular mesoderm is sufficient to induce a gizzard phenotype in the underlying
epithelium (Nielsen et al., 2001). This proventricular misexpression also affects the
mesoderm itself and causes inappropriate thickening such that the normally left-sided
bulge of the proventriculus is at the midline or flipped to the right. This disruption of
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normal asymmetry may be the result of the inappropriate bilateral expression of ectopic
cNkx3-2 in the presumptive stomach mesoderm when it ought to be only left-sided.
The requirement for cNkx3-2 in avian gut development has been assessed using a
"reverse-function" mutant, so called because cNkx3-2 was transformed from a
transcriptional repressor into an activator (Nielsen et al., 2001). This reversal of function
(specifically in the endogenous gizzard mesoderm expression site) produced a reduced
stomach with a thin muscle layer, as seen with ectopic Bmp4 expression in the gizzard
(Nielsen et al., 2001). This suggests that cNkx3-2 may normally inhibit Bmp4 in the
gizzard, and is supported by the presence of ectopic Bmp4 (and Wnt5a) expression in
this tissue. The role of cNkx3-2 in chick gut development thus appears to be in
regulating muscle thickness.
The initially left-sided expression in chick is the reverse of the situation in
mouse, in which Bapxl is expressed on the right-side of the LPM at E8.5 (Schneider et
al., 1999). However, by E9.5 expression is roughly symmetric (Lettice et al., 2001). By
El0.5, expression has shifted to the left of the embryo, in the splenic mesenchyme
underlying the splanchnic mesothelial plate (SMP) and in the lateral-most part of the
SMP (Lettice et al., 2001). Despite the differences in early asymmetric expression
between mammalian and avian Bapxl, both genes are under the control of the LR
signalling pathway, as shown by disruption of these expression patterns in embryos with
altered LR asymmetry (Schneider et al., 1999) 10. Following establishment of LR
asymmetry, Bapxl expression is maintained during gut organogenesis in the mesoderm
overlying the stomach, midgut, and splenic primordium, and is downregulated at El6.5
(Tribioli et al., 1997).
10 More specifically, following ectopic expression of chick asymmetry factors, and in the inv (inversion of
turning) mouse mutant which has complete situs inversus (Yokoyama et al., 1993)
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1.8.5.5 Effects ofBapxl loss in the eat
A major aspect of the mouse Bapxl-loss phenotype is abnormal morphogenesis
of the stomach-duodenal region (Akazawa et al., 2000). Bapxl regulates the shape of the
stomach and duodenum by controlling regional cell proliferation rates (Watson et al.,
2007). More specifically, Bapxl is required to downregulate proliferation in the
endoderm of the duodenum and therefore maintain the narrow diameter of this section of
the gut tube; thus in Bapxl'' mutants inappropriate proliferation occurs and so the
duodenum becomes abnormally wide (Watson et al., 2007). This widened duodenum is
indistinguishable from the posterior stomach as early as El0.5 and thus Bapxl is
required for specifying the AP boundary in this region. The mutant duodenum also folds
back and fuses with the stomach by -E12.5, and may branch ectopically. A further
aspect of the Bapxl'1' phenotype is that the dorsal pancreatic bud remains at the midline
and develops along an axis almost parallel to the stomach, as opposed to lying
perpendicular to it (Hecksher-Sorensen et al., 2004).
The pyloric sphincter constriction is absent in Bapxl'1' mutants and the
abnormally shaped stomach does not narrow before meeting the region where the
sphincter would normally be located (Akazawa et al., 2000; Watson et al., 2007). The
abnormal pyloric region is still, however, populated by normally differentiated smooth
muscle cells; this indicates that the role of bap in midgut musculature development has
not been retained by Bapxl (Akazawa et al., 2000). Some aspects of duodenal
morphology are observable in the enlarged posterior stomach (Watson et al., 2007). The
stomach villi appear to be transformed to an elongated duodenal phenotype.
Additionally, the circular muscle layer is thinner, the longitudinal layer develops
precociously, and the muscularis mucosa layer is absent in the posterior stomach of
El 8.5 Bapxl'1' mutants - all characteristics of the duodenum (Watson et al., 2007).
However, given that the duodenum is already expanded, and thus indistinguishable from
the posterior stomach, by El0.5 it would seem that the abnormal foregut-midgut tissue
seen at El 8.5 is not the result of transformation of stomach to duodenal tissue, but rather
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due to the "transformed" stomach tissue actually being expanded duodenal tissue in the
first place. This expanded duodenal tissue does, however, take on expression of some
stomach-specific markers11.
Although Bapxl and Nkx2-5 expression do not overlap within the established
pyloric sphincter12, their domains do show some slight overlap in the SMP at El0.5
(Hecksher-Sorensen et al., 2004). This is also the point at which the pyloric sphincter is
thought to begin developing and thus at which its absence is first conspicuous. Loss of
the pyloric sphincter is associated with loss of pyloric Nkx2-5 expression at El2.5 in
Bapxl'' mice (Watson et ah, 2007). This suggests that Bapxl may regulate Nkx2-5.
Alternatively, loss of this pyloric marker could simply be a consequence of a sphincter
cell deficiency due to absence of another Bapxl-mediated mechanism. A role for Nkx2-5
in pyloric sphincter development has been demonstrated in chick (Smith et ah, 2000b).
However, the hierarchy of Nkx genes in the chick gut appears to be different to that in
the mouse: Nkx2-5 expression - along with that of Nkx2-3, Pitx2, and Pdxl - is not
affected by ectopic Bapxl expression in chick (Nielsen et ah, 2001).
1.8.5.6 Bapxl in spleen development
As with bap inactivation, loss of Bapxl expression causes abnormalities in the
visceral mesoderm. However, whilst gut muscle development is disrupted in the
Drosophila mutants, mice null for Bapxl show other visceral abnormalities including
disrupted spleen development (Lettice et ah, 1999b; Tribioli and Lufkin, 1999; Akazawa
et ah, 2000). This role in spleen development is an evolutionary adaptation as the spleen
is a vertebrate-specific organ.
"
SOX2, a marker of the stomach epithelium, is expressed, whilst the duodenal markers Shh and alkaline
phosphatase activity are absent (Watson et ah, 2007).
2 Nkx3.2 is expressed anterior to the pyloric sphincter but not within the constriction itself. Nkx2-5 is
expressed at a more posterior level, including in the pyloric sphincter constriction
The coelomic splanchnic mesothelium and underlying mesenchymal cells which
condense to form the spleen express Bapxl at El0.5; these precursors appear to be
absent from Bapxl'1' mutants at El 1.5 - the point at which spleen development would
normally be observed (Tribioli and Lufkin, 1999). It has alternatively been reported that
some spleen precursors are still present at E14.5, and form a sparse splenic "scaffold"
which fails to condense and subsequently regresses (Akazawa et al., 2000). The loss of
this scaffold and the mesenchymal cells therein has been attributed to failure of
lymphocytes to home to the region, perhaps due to loss of interactions with splenic
mesenchyme (Akazawa et al., 2000). Our observation is that fatty mesentery tissue is
present in place of the spleen, and ectopic intestine-like cysts are present in the splenic
region in approximately half of the Bapxl'1' mutants (discussed in Section 1.9.4.1)
(Asayesh et al., 2006). Bapxl may normally promote maintenance of the spleen through
Hoxll, as this splenic marker is not expressed at El2.0 or El4.5 in Bapxl'1' mutants
(Lettice et al., 1999b; Akazawa et al., 2000).
1.8.6 Other vertebrate Nkx genes
Vertebrate homologues exist for all of the genes in the Drosophila 93DE NK
cluster, with multiple homologues existing for some within a single species. Vertebrate
Nkx genes also exist which have no direct homologue in the 93DE cluster (murine Nkx5-
1/Hmx3, Nkx5-2/Hmx2)13 (Bober et al., 1994). Details of the vertebrate Nkx genes are
summarised in Table 1.1.
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1.8.6.1 Other vertebrate Nkx series in eut development
A number of other Nkx genes are expressed in the developing gut. A common
feature of these genes is that they are involved in patterning of the gut along the DV
axis. Most of the organ primordia of the GI tract are formed by budding
morphogenesis of the gut tube along the DV axis, and these endodermal gut
derivatives often express Nkx genes or underlie Mx-expressing mesoderm. Examples
include the thyroid (Nkx2-1, Nkx2-5), lungs (Nkx2-1), and pancreas (endodermal
Nkx2-2, Nkx2-6, Nkx6-1, Nkx6-2; mesenchymal Nkx2-5, Nkx3-2) (see Table 1.1 for
references). Nkx2-5, Nkx3-2 and Nkx5-1 are expressed in the E10.5 gut mesoderm,
with the first two of these genes also being splenic markers ((Hecksher-Sorensen et
al., 2004; Wang et al., 2000b); Weidong Wang, personal communication).
The spleen is a hub of Nkx gene activity. Nkx2-3, Nkx2-5, Nkx3-2, and Hoxl 1
are all expressed during spleen development (Pabst et al., 1999; Lints et al., 1993b;
Lettice et al., 1999b; Roberts et al., 1994; Roberts et al., 1995a). Hoxl 1 (Tlx!) is one
of the three murine homologues of Drosophila C15/93Bal/311, the other two being
77x2 (HoxllLl) and Tlx3 (HoxllL2) (Kennedy et al., 1991; Dear et al., 1993; Dear
and Rabbitts, 1994). Hoxl/-null mice are asplenic (Roberts et al., 1994; Dear et al.,
1995).
A further splenic Nkx gene is Nkx2-3. This tin-Yike gene is expressed in the
gut mesenchyme at a level posterior to the stomach from E9.5; intestinal
mesenchyme represents the predominant expression site both during development
and in adulthood (Pabst et al., 1997). Loss of Nkx2-3 leads to abnormal development
of the spleen and small intestine, and in >30% of births results in postnatal lethality
due to intestinal malabsorption (Pabst et al., 1999; Wang et al., 2000a). Nkx2-3 is
also expressed in mesenchymal (stromal) cells of the developing spleen, and in the
adult spleen (Pabst et al., 1999). Nkx2-3~'~ mice have a variable spleen defect in
addition to a decrease in the number and size of Peyer's patches - another secondary
lymphoid organ (Wang et al., 2000a). Surviving postnatal mutants have an abnormal
T cell-dependent immune response (Wang et al., 2000a). Spleen abnormalities range
from a severe reduction in the size of the organ (and the number of lymphatic cells
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therein) and disorganisation, to full asplenia (20-36% of births) (Pabst et al., 1999;
Pabst et al., 2000; Wang et al., 2000a).
The splenic disorganisation in Nkx2-3~'~ mice is a result of stromal rather than
haematopoietic defects, as bone marrow reconstitution cannot rescue the mutant
spleen phenotypes (Tarlinton et al., 2003). Abnormal lymphocyte homing causes the
reduction in certain cell types in the spleen. Nkx2-3 can activate transcription of
Madcaml, expression of which is lost in the knockout mice, apparently leading to the
failure of lymphocyte homing in the spleen (Pabst et al., 2000; Wang et al., 2000a).
The sinus-lining non-lymphoid cells which normally express Madcaml are thought
to regulate passage of lymphocytes and antigens into the white pulp from the blood
(Tanaka et al., 1996).
1.8.7 An Nkx code?
The overlapping expression patterns, functions, and DNA-binding
specificities of Nkx gene family members, coupled with null phenotypes less severe
than predicted, is suggestive of genetic redundancy. Specific combinations of Nkx
genes in particular regions may be required for the specification of developmental
fates, and form an "Nkx code". Examples may include heart (Nkx2-3, Nkx2-5, Nkx2-
6), pharynx (Nkx2-5, Nkx2-3, Nkx2-6), gut (Nkx2-2, Nkx2-5, Nkx2-3, Nkx2-6, Bapxl),
and spleen (Nkx2-3, Nkx2-5, Bapxl, Hoxll) codes. An overview of Nkx gene
expression in the gut is provided in Figure 1.4.
Mice null for Nkx2-5 provide no insight into the role of this gene in gut
development as they die before gut morphogenesis initiates (Lyons et al., 1995).
Many human mutants have been identified, but of these only two have gut
abnormalities (Watanabe et al., 2002). Is this lack of gut defects indicative of
functional redundancy between Nkx genes in the gut? An extremely interesting - and
ambitious - approach to this problem would be to generate gut-specific knockouts of
Nkx2-2, 2.3, 2.5, 2.6, and Bapxl, and to examine the ensuing mutant gut phenotypes






















Figure 1.4 Nkx genes in gut development: an Nkx gut code?
A number of Nkx genes are expressed in the developing mouse gut, across a range of
tissue types. This schematic shows a stylised E12.5 gut and is overlaid with the names
of genes expressed around this time. It should of course be noted that these expression
patterns differ at earlier and later developmental stages. The tissue type in which expression
has been detected is denoted after the gene name by "e" (endoderm), "m" (mesenchyme),
or "ep" (epithelium), when this information is known. Broad expression domains are
denoted by pink boxes. Only the dorsal pancreatic bud (blue) is illustrated, but expressed
genes are listed for both buds. The spleen is shown in purple.
References: see Table 1.1
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Another point to note about the Nkx2 gene family is that the same gene may
have different functions or expression in different species (e.g. cardiac expression of
Nkx2-3 in chick and Xenopus, but not in mouse and zebrafish). This may be due to
homologues being placed under the control of different regulatory cascades within
different species. Indeed, whilst tin/Nkx2-5 and bap/Bapxl are both players in gut
development in Drosophila, chick, and mouse, their hierarchical order of activity
appears to have changed. Tin is upstream of bap in fly, no relationship has been
noted in chick, and Bapxl is upstream of Nkx2-5 in mouse (Azpiazu and Frasch,
1993; Nielsen et al., 2001; Watson et al., 2007).
1.9 Role of LR asymmetry in gut development
1.9.1 LR asymmetry in general development
Many aspects of vertebrate development require morphological asymmetry.
Normal left-right (LR) asymmetry is termed situs solitus; both mouse and human
mutants exist with complete mirror-image reversal of this arrangement (situs
inversus). Not all reversals are complete though, and thus a spectrum of intermediate
defects (situs ambiguus) exists, including heterotaxy (discordance between
asymmetry of different organs), isomerism (one side is duplicated), and isolated
abnormalities in normally asymmetric organs (for an excellent primer see
(Aylsworth, 2001)). Heterotaxia can be caused by mutations in single genes, and
estimates of its occurrence range between 1 in 6,000-20,000 live births, and in 0.03-
1.1% of foetuses once abortions and stillbirths are taken into account (Belmont et al.,
2004; Bartram et al., 2005).
There are four stages in the establishment of LR asymmetry (reviewed in
(Hamada et al., 2002)):
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1) Breaking of symmetry14 and subsequent initiation of LR polarity relative to
the DV and AP axes, mediated by the node (located at the midline, at the
anterior tip of the primitive streak). This is followed by...
2) Transmission of LR positional signals from the node to LPM15, inducing...
3) Asymmetric gene expression of signalling molecules in the LPM (e.g.
Nodal, Lefty2\ both transiently expressed in the left LPM16), thus initiating...
4) Asymmetric organ morphogenesis. Three main mechanisms appear to exist:
directional tube looping (e.g. heart, gut), differential lobation (e.g. lungs,
liver), and regression of one side of the primordia (e.g. blood vessels). How
factors (e.g. Pitx2) involved in this stage exert control is unknown but this
may be through regulation of differential cell proliferation, migration, and
adhesion.
The importance of LR asymmetry in development is alluded to by the
conservation within the chordate phyla of mechanisms and genes involved in at least
the first three stages (reviewed in (Boorman and Shimeld, 2002)). However, whilst
most of the components of the asymmetry pathway are conserved between mouse
and chicken, some have adopted different roles. Most notably, the chick right-side
determinant Fgf8 promotes left-side gene expression in mouse; also, whilst Shh
promotes expression of left-side determinants in chick, its mode of action in mouse is
suppression of these on the right side of the LPM (Meyers and Martin, 1999).
Whilst quite a lot is known about the first three stages of LR asymmetry
establishment, the final stage is less understood, i.e. how organ primordia interpret
asymmetric gene expression and translate this into asymmetric morphogenesis. This
is addressed with respect to the gut in the next section.
14
Possibly by nodal flow (cilia in node rotate such that a leftward flow of extra-embryonic fluid is
established, potentially allowing leftward flow of an unknown left-side determinant molecule), though
it remains contentious whether this is truly the symmetry breaking event (Tabin, 2005)
15 Either by relay through signaling cascades or by diffusion of molecules
16 Mice with loss of these genes have LR asymmetry defects, and mutations have also been detected in
the human homologues in individuals with laterality disorders (Hamada et al., 2002; Peeters and
Devriendt, 2006)
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1.9.2 Role of LR asymmetry in gut development
LR asymmetry is essential for correct gut patterning in vertebrates. The
mechanisms for establishing gut LR asymmetry vary across species: for example, gut
rotation is essential in mammals, whereas the avian stomach becomes asymmetric
due to differential growth (reviewed in (Schneider et al., 1999)). The Xenopus gut
tube becomes asymmetric (loops) through differential rates of elongation of the left
and right sides, such that the left becomes concave and the right convex (Muller et
al., 2003). Xenopus gut tube concavity (slow elongation) correlates with and is
induced by Pitx2 expression (Muller et al., 2003).
In normal asymmetric morphology (situs solitus) the stomach and spleen are
located to the left of the midline; this is illustrated in Figure 1.5, along with
deviations from the normal state. As described in Section 1.5.4 asplenia (bilateral
right-sidedness) and polysplenia (bilateral left-sidedness) are common in individuals
with situs ambiguus, and often occur in conjunction with abnormal sidedness of other
normally asymmetric organs (Bartram et al., 2005). Many mouse mutants have also
been documented which have defects in gut LR asymmetry. Mutation or loss of
genes involved in all four stages of LR asymmetry establishment underlies many of
these phenotypes. The final stage of the process - LR asymmetric morphogenesis of
organ primordia - is least understood. However, recent work in our lab has shed
some light on how this is controlled. This is discussed in the following section.
1.9.3 The SMP
In 1967, Green described a transient thickening of the mesothelium
(epithelium) which has a columnar structure and covers the spleno-pancreatic
mesoderm (Green, 1967). She termed this the Anterior Splanchnic Mesodermal Plate
(ASMP) and suggested that it is required for correct development of the gut. Nearly
40 years later, workers in our lab further characterised this layer as a physical feature
of the mesoderm which acts as an organiser, mediating transduction of signals from
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Figure 1.5: LR asymmetric
development is required for
correct organ placement.
A: the normal arrangement of
organs in the adult human - situs
solitus.
B,C,D: abnormalities of this
arrangement.
Whilst asymmetry is largely similar
in the mouse, some differences do
exist. In human the left lung is
bilobed and the right trilobed; in mice
the left lung has one large lobe and
the right is comprised of four smaller
lobes.
Figure taken from (Capdevila et at.
2000)
J
the LR pathway to gut organ primordia (Hecksher-Sorensen et al., 2004). The
Splanchnic Mesodermal Plate (SMP) directs spleen and pancreatic laterality by
inducing leftward growth of the spleno-pancreatic mesenchyme. The SMP is itself
under control of the LR pathway as its growth is regulated by Bapxl, which is
asymmetrically expressed (Schneider et al., 1999).
The SMP takes the form of a distinct columnar epithelial layer (Hecksher-
Sorensen et al., 2004). It is first detectable at E9.5 as a bilateral layer of thickened
splanchnic mesoderm surrounding the endoderm of the midline stomach and dorsal
pancreatic bud; few mesenchymal cells lie between it and the endoderm. The SMP
initiates leftward lateral growth in response to the LR asymmetry pathway, and by
El0.5 the underlying mesenchyme and endodermal dorsal pancreatic bud bulge to
the left (Hecksher-Sorensen et al., 2004). At this latter stage the SMP appears as a
triangle shape in cross-sections of the gut, capping the left-dorsal aspect of the gut at
Lfvet Stomach Spleen
S/TUS SOUTUS RIGHT ISOMERISM
c
LEFT ISOMERISM SITUS INVERSUS
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the foregut-midgut boundary (from the posterior stomach to the pancreatic buds).
The SMP is a transient feature of the gut, as it is lost by El 1.5. Development of the
SMP between E9.5 and El0.5 is depicted in Figure 1.6.
The transition between the bilateral and asymmetric (left-sided) states of the
SMP occurs over a 24-hour-period, between E9.5-10.5. The left-side undergoes
lateral growth and maintains its thickened columnar epithelial morphology, whilst
the cells on the right remain at the midline and lose their elongated appearance in a
ventral-to-dorsal manner (Hecksher-Sorensen et al., 2004). The right-side cells
eventually become indistinguishable from the underlying mesenchyme or adjacent
gut mesothelial lining. The SMP is 50-60pm thick and is noticeably distinct from the
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Figure 1.6: The splanchnic mesodermal plate (SMP)
a. The SMP at E9.5 and E10.5. Adapted from Hecksher-Sorensen et al.,
2004
b. Orientation for figure in (a)
c. E10.5 sectioning plane used in (a). The thick black line denotes the cutting
level
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A similar highly organised columnar epithelial layer flanks the initially
symmetrical endodermal gut tube in the developing zebrafish gut and is
autonomously (independent of the endoderm) required for correct gut looping
(Horne-Badovinac et al., 2003). This structure is derived from the LPM, as is the
murine SMP, though whether these epithelial layers are homologous is not clear.
Certainly, the processes of asymmetric morphogenesis in which they are involved
differ. The SMP grows out to the left, and the underlying gut mesenchyme and dorsal
pancreatic endoderm seem to follow in its wake (Hecksher-Sorensen et al., 2004). In
zebrafish, however, the LPM appears to actively push the underlying gut endoderm
to adopt an asymmetric position (Horne-Badovinac et al., 2003). The left and right
sides of the LPM undergo asymmetric, yet coordinated, tissue migration and thus
adopt an asymmetrical morphology and position with the result that the gut tube is
forced to adopt a leftward bend. It should of course be noted at this juncture that only
tentative comparisons can be drawn between fish and mammalian gut development
as many aspects of the final gut pattern are different. Finally, as mentioned
previously, there is also evidence in Xenopus that asymmetric differences exist in the
thickness and structure of the endodermal epithelium between the left and right sides
during midgut looping (Muller et al., 2003).
1.9.3.1 The SMP in spleen development
The thickened columnar epithelium of the SMP was first documented in 1921
by Thiel & Downey who thought it may participate in spleen development by
contributing cells to the underlying mesenchyme, with which it is continuous and yet
distinct from (Thiel and Downey, 1921). They described the columnar epithelium as
being a condensed region of mesenchyme, rather than distinct epithelium per se.
The earliest report of splenic precursors has been in the El0.5 SMP region.
The dorsal mesenchyme underlying the SMP expresses Hoxll, Capsulin, Wtl, and
Nkx2-5, thus implicating this patch of cells as the origin of the splenic mesenchyme
(Hecksher-Sorensen et al., 2004). This putative splenic mesenchyme is not detectable
at E9.5 but instead emerges over the next 24 hours as the SMP undergoes leftward
lateral growth; whether the mesenchyme is de novo - perhaps derived from the SMP
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itself - or has migrated from another location is unclear. The SMP itself does not
express splenic marker genes - or at least not at a high level - but does exist in tight
association with this splenic primordium.
A characteristic of the SMP is that the cells within it proliferate at a high rate
(Hecksher-Sorensen et al., 2004). This may drive the outward growth required for
asymmetric pancreatic morphology and spleen formation, thus linking these two
developmental events. Spleen and pancreatic laterality have been shown to be
associated in Xenopus (Patterson et al., 2000). High proliferation and the resultant
outgrowth of the SMP may also provide a space into which mesenchymal cells from
elsewhere can migrate. Alternatively, the mesenchymal splenic precursor cells may
themselves be the product of SMP proliferation. A similar conclusion was reached in
1921, when Thiel & Downey proposed that proliferation of the coelomic epithelium
resulted in "crowding" of some of the resulting cells into the underlying
mesenchyme during spleen development in pig (Thiel and Downey, 1921). Holyoke
found that the coelomic epithelium overlying the site of human spleen development
is in a similar state of active proliferation (Holyoke, 1936). Even if there is no direct
contribution from the thickened epithelium to the underlying splenic mesenchyme,
there is a distinct possibility that essential EM interactions may occur between these
layers.
1.9.3.2 The SMP and LR asymmetric gene expression
The SMP exhibits LR asymmetric gene expression and leftward growth in
response to upstream LR signalling cascades. Asymmetric gene expression is
established in the morphologically symmetrical SMP by E9.5, as Pitx2 and Barxl are
predominantly left-sided at this stage (Hecksher-Sorensen et al., 2004). Invs
(inversion of body turning) homozygous mutants have situs inversus and the SMP is
transposed onto the right side of the embryo, demonstrating its dependence on the
genetic establishment of LR asymmetry (Hecksher-Sorensen et al., 2004).
Bapxl expression is bilateral in the SMP at E9.5, and is then wholly left-sided
in the tip of the SMP and underlying mesenchyme by El0.5 (Hecksher-Sorensen et
al., 2004). Bapxl conveys LR information to the SMP, which relays this on to the
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underlying mesenchyme and endoderm; thus the SMP itself is essential for
downstream LR gut patterning (Hecksher-Sorensen et al., 2004). Leftward growth of
the pancreas is dependent on the SMP. Conversely, the lateral growth of the SMP is
autonomous and does not require involvement of the pancreatic endoderm - as
demonstrated by normal SMP outgrowth in Fg/70-deficient mutants which have no
gut endoderm in the spleno-pancreatic region (Hecksher-Sorensen et al., 2004).
Fgf9, FgflO, Fgfll, and Fgfl3 are all expressed in the El0.5 SMP-associated
mesenchyme (Hecksher-Sorensen et al., 2004). Fgf9 is specifically expressed in the
lateral tip of the SMP and the underlying dorsal mesenchyme; FgflO is detected in
the ventral SMP and associated mesenchyme. One hypothesis is that secretion of
these growth factors may encourage the leftward growth of the SMP. This may be
substantiated by the expression of the gene encoding a high affinity FGF9 receptor -
Fgfr3 - in the extreme tip of the SMP (Hecksher-Sorensen et al., 2004).
1.9.4 SMP mutants
Two mouse mutant strains exist in which SMP development is disturbed and
the spleen fails to form: the Bapxl'1' and Dh mutants (Hecksher-Sorensen et al., 2004;
Green, 1967). Pancreatic laterality is also defective in these mutants. The loss of the
distinctive SMP structure and the subsequent failure of leftward growth in these
mutants may indicate that the rigid structure of the SMP somehow guides this
outgrowth. Credence may be given to this idea by the accumulation of f-actin around
the thickened SMP epithelium during normal development, as actin filaments have
been proposed to play a role in tissue outgrowth (Hecksher-Sorensen et al., 2004;
Quinlan et al., 2004).
1.9.4.1 Bapxl knockoutmice
Knocking out Bapxl results in adverse effects on splanchnic mesoderm
derivatives in the spleno-pancreatic region, and this was discussed fully in Section
1.8.5.5, The mesenchyme surrounding the posterior stomach and duodenum is
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abnormal, and mice are born with gut and pancreatic morphological abnormalities.
Additionally, mutants do not have a spleen or a pyloric sphincter constriction.
The SMP is defective in Bapxl'1' mutants; its shape is altered and leftward
growth is inferior to that in wild type embryos (Hecksher-Sorensen et al., 2004).
Bapxl thus regulates leftward growth of the SMP and underlying mesenchyme and
appears to act as a link between the LR asymmetry pathway and asymmetric organ
morphogenesis. Expression of FgflO in the SMP is greatly downregulated in the
Bapxl''' SMP at El 0.5 (Hecksher-Sorensen et al., 2004). Wild type FgflO expression
normally resides in the ventral SMP and underlying mesenchyme at El0.5, to the left
of the dorsal pancreatic bud. Given that FGF10 can act as a chemoattractant (Park et
al., 1998b), it is plausible that the dorsal pancreas grows towards this, i.e. producing
leftward movement of the bud and surrounding mesenchyme. Indeed, FgflO is
already known to be required for early pancreatic morphogenesis, although this is
due to its role in maintaining proliferation in the pancreatic epithelium (Bhushan et
al., 2001). Fgf9 expression is also reduced in the SMP of Bapxl'1' mutants at El0.5
(Hecksher-Sorensen et al., 2004).
The Bapxl1' mutant gut provides an excellent opportunity to examine the
interrelationship between spleen and pancreas development, demonstrating that
highly coordinated interactions between these tissues are necessary for their correct
development (Asayesh et al., 2006). The splenic and pancreatic tissues do not
correctly separate in the Bapxl'1' mutant and thus the pancreas remains in prolonged
contact with the spleen, resulting in a metaplastic transformation such that these
tissues develop into ectopic gut-like structures in -50% of mutant embryos17. These
structures are first detectable at -El4-14.5 as cyst-like outgrowths from the dorsal
pancreatic endoderm into the mesenchyme where the spleen would normally
develop. Markers of pancreatic endoderm are lost from these cysts which appear to
adopt an intestinal epithelium phenotype. The cysts can induce the surrounding
mesenchyme to adopt intestinal - versus spleen - mesenchyme characteristics; this
may be due to the ectopic activation of Shh signalling observed in the transformed
pancreatic epithelium. Shh is normally excluded from the developing pancreas;
17
Apoptosis occurs in the disorganised splenic mesenchyme of the remaining -50% of mutants
(Asayesh et al., 2006).
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ectopic expression induces a mixed pancreatic-intestinal phenotype (Apelqvist et al.,
1997).
Ectopic gut structures can also be induced from wild-type pancreatic
epithelium co-cultured with Bapxl'1' splenic mesenchyme, suggesting that it is this
latter tissue which mediates the transformations (Asayesh et al., 2006). Further co-
culture experiments demonstrated that it is indeed the splenic mesenchyme which
induces cyst development, but not as a result of being Bapjt/-deficient. Wild type
splenic mesenchyme also induces cyst formation when co-cultured with wild type
pancreatic epithelium, as the normally precise spatially and temporally controlled
interactions between these two tissues are disrupted. Bapxl'1' splenic mesenchyme
therefore induces cyst formation not through some inherent quality per se, but by
being left in close apposition with the pancreas during development. This may be due
to short-range signalling from the splenic mesenchyme (possibly via Activin A)
(Asayesh et al., 2006).
The transformation in the Bapxl '" mutant also explains the failure of spleen
development. The mutant splenic mesenchyme becomes established and expresses
splenic markers such as Pbxl and Capsulin\ however, this mesenchyme then fails to
condense and instead persists as loosely organised cells (Brendolan et al., 2005;
Asayesh et al., 2006). Normal separation of the condensed splenic mesenchyme from
the pancreas therefore fails, and so these cells remain adjacent to the dorsal
pancreatic bud (Asayesh et al., 2006). This apposition of the pancreas and spleen is
likely related to the observation that leftward growth of the SMP fails in Bapxl'1'
mutants (Hecksher-Sorensen et al., 2004).
1.9.4.2 The dominant hemimelia mutation
The dominant hemimelia (Dh) mutation arose spontaneously and is
characterised by skeletal and hindlimb abnormalities, most noticeable as an alteration
in the number of digits (Green, 1967; Morin et al., 1999). The limb defects have been
attributed to disruption of EM interactions and anterior mesenchyme formation in the
limb bud (Lettice et al., 1999a). Major gut defects are also present in both Dh/+ and
Dh/Dh mutants, though these are more severe in the latter. The spleen is absent in
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Dh mutants and this appears to be due to a deficit of the SMP, which is thinner or
absent by E9.5 (Green, 1967; Hecksher-Sorensen et al., 2004). Unorganised
mesenchyme is found in place of the specialised SMP cells. The leftward growth of
the SMP and underlying spleno-pancreatic mesenchyme normally observed between
E9.5 and El0.5 does not occur; this may be attributable to loss of inductive (leftward
growth) signals from the SMP to the underlying spleno-pancreatic mesenchyme.
Indeed, Fgf9 and FgflO are both downregulated in Dh mutants (Hecksher-Sorensen
et al., 2004).
Overall the gut is smaller (smaller stomach; shorter, thinner digestive tract) in
Dh mutants than in wild type embryos (Green, 1967). Again, this is more
pronounced in the homozygous mutants, who have a particularly small stomach and
pancreas. Additional phenotypes in both classes of Dh mutant include misplacement
of the vitelline vein with respect to the duodenum, and abnormal development of the
kidneys and female genitourinary system. The primary tissue affected is the
splanchnic mesoderm, and all the defects are predicted to stem from the disrupted
development of this tissue. The Dh mutant phenotype also extends to another area of
the spleno-pancreatic region: the pyloric sphincter, which is widened or absent (Hill
lab, unpublished data).
The genetic defect underlying the Dh phenotype is unknown though the
affected gene resides on chromosome 1 (Hill et al., 1987). Past candidates for this
gene include En-1 and G/t'2, but these have since been discounted (Higgins et al.,
1992; Hughes et al., 1997). More recently our lab has focused on Inhbb as a possible
candidate (unpublished).
1.9.4.3 Other SMPmutants?
The Bapxl'1' and Dh mutants are the only currently known SMP mutants. An
SMP mutant would by definition possess defects in the spleen, pancreas, and
possibly the pyloric sphincter. One possible candidate mutant is therefore the Soxl 1
knockout mouse. Within the developing gut, Soxl 1 is expressed in the oesophagus,
stomach, and pancreas (Hargrave et al., 1997). Soxl 1 is predominantly expressed in
the mesenchyme surrounding the pancreatic buds at E9.5-10.5, though some
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expression can be detected in the epithelium (Lioubinski et al., 2003). By El2.5
Soxl 1 is restricted to the pancreatic epithelium. Expression of LacZ knocked into the
Soxl 1 locus also revealed contiguous expression in the mesenchyme of the spleen
and stomach at E14.5 (Sock et al., 2004). Loss of Soxl 1 causes asplenia and an
expanded pyloric sphincter phenotype (Sock et al., 2004). As the pancreas is also
affected (by hypoplasia) it is therefore possible that Soxl 1 may play an important
role in the SMP. Indeed, Soxl 1 expression is present in the SMP at El0.5, in a dorsal
region overlapping the prospective spleno-pancreatic mesenchyme (Lioubinski et al.,
2003). Loss of the splenic primordium is already obvious at El3.5, suggesting a
defect of mesenchymal versus haematopoietic development (Sock et al., 2004).
Additional abnormalities in Soxl 1 -deficient mice include lung and (caudal) stomach
hypoplasia, persistent gut herniation, skeletal and craniofacial defects, and failure of
closure of the abdominal wall and eyelids. A number of cardiac defects are also
present, and it is these that are the likely cause of the lethal cyanosis at birth.
If other SMP mutants do exist, then analysis of their defects may provide
pertinent information on development of this tissue and its derivatives. Genetic
markers of the region and tools to examine its development will be essential for this
task, along with as much knowledge as possible of what constitutes normal
development. This thesis reports efforts to achieve these goals.
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1.10 Aims of thesis
The mutant phenotypes discussed in the previous section demonstrate that
correct development of the spleno-pancreatic mesenchyme is of utmost significance.
Gaining a better understanding of the processes underlying this development is thus
extremely important. This thesis is concerned with a number of problems relating to
spleen morphogenesis, and these are summarised in the following aims:
1) To gain a better insight into the role of the homeobox
gene Nkx2-5 in gut development, particularly with
reference to the spleen. Areas of interest are: when Nkx2-5
expression initiates in the developing gut; how Nkx2-5 expression relates to
that of Bapxl\ whether an upstream regulatory region confers gut expression
and, if so, whether this can be used a) for Aim (2) below, and b) to direct a
gut-specific knockout of Nkx2-5. These initial lines of investigation form the
basis of the studies reported in Chapters 2 and 3.
2) To characterise a suitable marker of splenic precursors
in order to facilitate identification of these cells during
normal and mutant spleen development. The main stage of
interest is early spleen development and the aim is thus to ascertain whether
splenic precursors can be identified at an earlier stage than that already
published (i.e. El 0.5 dorsal mesenchyme underlying the SMP), and whether
these can be marked throughout development. This work is presented in
Chapter 2.
3) To develop Aim (2) and produce an inducible lineage
tracing system which will allow marking of splenic
precursors at a specific time-point. Such an approach is
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necessary if one is to accurately follow spleen development. Attempts to
produce such a system are detailed in Chapter 3.
4) To build on Aim (2) and develop a system for marking
splenic precursors in gut organ culture. Major morphogenetic
changes occur in the splenic primordium between El0.5 and El2.5 and it is
not possible to observe these occurring in utero. As such, explant culture may
provide the tool for observing these changes. This work is presented in
Chapter 4.
5) To use the above system to manipulate spleen
development and thus gain insights into how normal
splenogenesis proceeds. This is also reported in Chapter 4.
The overall aim can therefore be summarised as providing insights into early
spleen development. Chapter 5 also contains data pertaining to this central aim,
albeit not encompassed by the specific aims listed above.
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CHAPTER 2
Nkx2-5 as a marker of the
developing spleen
"It is the mystery and beauty of organic
form that sets the problem for us"
- Ross Harrison, embryologist (1913)
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2.1 Introduction
The origin and early development of the mammalian spleen is something of
an enigma. The earliest recognisable splenic primordium is a condensation of
mesenchyme at the posterior dorsal aspect of the stomach at El 1.5 (Thiel and
Downey, 1921). Splenic markers such as Hoxll are expressed in this tissue and are
also detected in the dorsal mesenchyme underlying the SMP at El0.5, suggesting this
to be the splenic precursor region (Hecksher-Sorensen et al., 2004). The El0.5
putative splenic mesenchyme is already located on the left of the body cavity. There
is, however, evidence in Xenopus that splenic precursors initially exist on both sides
of the embryo, but only the left-side pool develops into the spleen (Patterson et ah,
2000). Both populations express Nkx2-5, which is a marker of the developing spleen
in both Xenopus and mammals (Patterson et ah, 2000; Lints et ah, 1993b). It does not
necessarily follow that such an arrangement occurs during mammalian development,
particularly as multiple aspects of Xenopus gut development differ to those in
mammals; however, it is conceivable that disruption of an initially bilateral system
could explain mammalian polysplenia and/or asplenia. The potential existence of
splenic precursors on both sides of the mouse embryo is thus worthy of investigation.
The (putative splenic) mesenchyme underlying the SMP at El0.5 is of
unknown origin. Twenty-four hours earlier, at E9.5, very few if any mesenchymal
cells can be seen between the bilateral SMP and the endodermal gut tube (Hecksher-
Sorensen et ah, 2004). Mesenchyme populates the region concomitant with leftward
SMP growth. This could be due to migration of mesenchyme from elsewhere in the
embryo, or it may be a result of cellular contribution from the highly proliferative
SMP (Hecksher-Sorensen et ah, 2004).
A further mystery is how the condensed splenic mesenchyme observed at
El 1.5, lying adjacent to the posterior stomach, adopts the characteristic elongated
spleen shape by El2.5. There is thus a need for methods which reliably and
specifically mark splenic mesenchyme. This chapter reports investigations into the
value of Nkx2-5 in answering such questions. Endogenous Nkx2-5 expression is
examined in Section 2.2, whilst the remainder of the chapter is concerned with an
Nkx2-5 gut-specific upstream regulatory sequence.
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2.2 Nkx2-5 expression in the SMP
Nkx2-5 is expressed in two domains in the SMP at El0.5: dorsal (relating to
the putative splenic mesenchyme) and ventral (Hecksher-Sorensen et al., 2004).
Expression has not, however, been traced to an earlier point in gut development. An
analysis of Nkx2-5 expression was thus undertaken to investigate whether Nkx2-5-
expressing cells could be detected prior to E10.5 in the developing gut.
The second motivation for this study was to ascertain whether expression of
Nkx2-5 overlaps significantly with that of Bapxl (Nkx3-2), a major gut development
gene. Bapxl is required for correct SMP development and its loss causes a variety of
defects in the spleno-pancreatic region, including an expanded pyloric sphincter and
asplenia (Akazawa et al., 2000; Hecksher-Sorensen et al., 2004; Watson et al., 2007).
Nkx2-5 is normally expressed in both of these affected tissues, but this expression is
lost in the Bapxlmutant gut as is the earlier expression in the mesenchyme
underlying the defective SMP at El 0.5 (Jacob Hecksher-Sorensen, PhD thesis,
University of Edinburgh, 2001 )18. The effects of Bapxl on gut development may be
mediated through Nkx2-5. It is also possible, of course, that Nkx2-5 performs non¬
essential functions in the gut and that its absence is coincidental to the other effects
of Bapxl loss. Unfortunately, these two alternative hypotheses cannot be tested by
engineering loss of Nkx2-5, as Nkx2-5 homozygous null mice die from defects in
heart looping by -E9.0-10.0 (Lyons et al., 1995).
Regardless of the downstream details, it does appear that Bapxl is upstream
of Nkx2-5 in gut development; there are however a number of intriguing facets to this
relationship. Firstly, it does not appear to be an evolutionary conserved relationship:
reversal of chick Bapxl function does not affect cNkx2-5 expression, whilst the
relationship is completely reversed in Drosophila as tin activates bap (Nielsen et al.,
2001; Azpiazu and Frasch, 1993). Secondly, overlapping expression has not been
identified in the early developing mouse gut. Expression of both genes coincides in
the spleen later in development but does not fully overlap in the pyloric sphincter.
18 A recent study reported that Nkx2-5 expression is not lost from the Bapxl'1' splenic mesenchyme
(Brendolan et al., 2005). This is contradictory to data from our lab. However, the Bapxl1' mutants
used in this study were not those generated by and studied in our lab; these mice do not appear to have
as severe a spleen phenotype as they still possess splenic tissue at El2.5.
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Given that both the pyloric sphincter and spleen Nkx2-5 expression domains are lost
in the Bapxl'mutant, and that the BapxV'' phenotype manifests in early gut
development (between E9.5 and El0.5), it might be expected that they share an
expression domain at an early stage in gut development when these two tissues share
a common ancestor. In the El0.5 SMP, the two Nkx2-5 expression domains are
largely exclusive to that of Bapxl, which is expressed in the tip of the SMP. Nkx2-5
expression therefore needs to be examined at earlier stages to ascertain whether
significant overlap with Bapxl occurs. If such overlap does exist then this may infer
direct regulation of Nkx2-5 by Bapxl. The alternative is of course that Nkx2-5 may
be dependent on Bapxl indirectly via another Bapxl-dependent gene or feature of the
SMP.
To establish a point of early expressional overlap, in situ hybridisation was
performed with an RNA probe complementary to Nkx2-5 on whole E9.5 and El0.5
CD1 mouse embryos, with El 2.5 CD1 guts and E9.5 hearts used as control tissues.
Sufficient data on Bapxl expression at E9.5 and El0.5 already existed in the lab
(Hecksher-Sorensen et al., 2004). The sectioning angles used in order to visualise the
characteristic SMP shape are depicted in Figure 2.1, as these do not relate to
standard planes.
2.2.1 Nkx2-5 expression in the SMP at E9.5
Detection of Nkx2-5 expression in the ~E9.5 SMP is shown in Figure 2.2a i-
ii. Expression was detected at previously reported sites (pharyngeal endoderm,
heart), and also bilaterally throughout the SMP. At the level of the posterior stomach,
expression is only detected in the ventral aspect of the SMP (Figure 2.2a i). This
expression is specific to the thickened SMP structure and is not found in the gut
endoderm. At a more caudal level, Nkx2-5 expression is detected throughout the
SMP (Figure 2.2a ii). Signal was also detected in the putative liver precursor region,
which lies ventral to the gut endoderm. This may simply be a background signal,
although there are reports of Nkx2-5 detection in the developing liver (Kasahara et




Figure 2.1 Sectioning planes used to analyse gut (SMP) development at E9.5 and
E10.5
a: Planes used to section embryos. The sectioning planes used to study the gut (SMP)
at E9.5 and E10.5 are indicated by pink lines. The standard transverse (T) and frontal (F)
planes are depicted by black lines. The gut tube is illustrated in green and the forelimb
bud is outlined in yellow.
b: Sectioning angles superimposed on illustrations of the developing gut
c: Graphic of the resulting sections through the gut (SMP) (NB: images are, however,
presented so that dorsal lies at the top of the page in this thesis)
D: dorsal, V: ventral, lu: lung buds, st: stomach, dp: dorsal pancreatic bud, vp: ventral
pancreatic bud, L: left, R: right
V I /
IB
As signal was relatively low when detected with NBT/BCIP, Nkx2-5
detection was also performed using Fast Red and confocal microscopy (Figure 2.2a
iii). Fast Red has been found in our lab to be better suited to the detection of low-
level expression in the SMP than NBT/BCIP when analysed using laser scanning
confocal microscopy. Again, expression was noted in the heart and throughout the
SMP. The embryos analysed by this method were at a slightly later stage (-E9.75)
than those stained with NBT/BCIP, as the SMP had already begun to bulge to the
left. Gut mesenchyme can be first detected between the dorsal aorta and dorsal
pancreatic bud at this stage, and was also shown to express Nkx2-5. On the basis of
what we know of how the SMP develops, and of the position of this tissue, it is likely
that this mesenchyme relates to the putative splenic mesenchyme which underlies the
SMP at E10.5. This E10.5 mesenchyme also expresses Nkx2-5 (see below), along
with a selection of other splenic markers (Hecksher-Sorensen et al., 2004). The
-E9.75 /VCc2-5-expressing mesenchyme may therefore represent the earliest
occurrence of splenic precursors. The origin of the marked mesenchyme is unknown;
one suggestion is that the thickened mesothelium of the highly proliferative SMP
may contribute cells to the underlying splenic mesenchyme (discussed in Chapter
1). This may be evidenced by the expression of the splenic marker Nkx2-5 in both the
SMP at E9.5-9.75 and in the mesenchyme at -E9.75.
Expression was also examined at the later stage (-E9.75) using NBT/BCIP.
The gut shown exhibits an expression pattern intermediate between those seen at
E9.5 and El0.5 (Figure 2.2a iv). Nkx2-5 expression is localised to both sides of the
thickened SMP, though far more so on the outgrowing left-side. Between E9.5 and
E10.5 this thickened morphology is lost from the right-side; loss of Nkx2-5
expression from the right-side SMP may thus precede this physical change.
Expression was not detected in the right-side underlying mesenchyme, but was found
in the mesenchyme underlying the left-side Mct2-5-positive SMP. This left-side
SMP/mesenchyme domain might be related to the El0.5 ventral expression domain
(see Figure 2.2c).
A puzzling aspect of the E9.5-9.75 Nkx2-5 expression pattern is that it
appears to include the gut endoderm, at the level of the pancreatic buds. This is









Figure 2.2: In situ hybridisation analysis of Nkx2.5 expression in the E9.5-10.5 gut.
a. i) Expression in the ventral SMP at the posterior stomach level at -E9.5. ii) Nkx2.5 is
expressed throughout the SMP at the pancreatic bud level, iii) At -E9.75, Nkx2.5 is expressed
throughout the SMP and in the emerging dorsal spleno-pancreatic mesenchyme. Cardiac
expression is also present (*). iv) At a slightly later stage expression resembles the E10.5
ventral expression domain (SMP: yellow). Vibratome sections: 70pm (i-iii), 150pm (iv).
Yellow scale bars represent 100pm.
b. Bapxl expression in the E9.5 SMP.
c. i) At E10.5 Nkx2.5 is expressed in a left-ventral region of the mesenchyme and SMP at
the level of the posterior stomach, ii) Expression rings the presumptive pyloric sphincter,
and is now in the dorsal mesenchyme, iii) Nkx2.5 is expressed in two distinct regions at
the level of the dorsal pancreatic bud. iv-v) 20x magnifications of the SMP and underlying
mesenchyme. Vibratome sections: 80 pm. Red scale bars: 200pm, yellow bars: 100pm.
d. Bapxl expression in the E10.5 SMP tip and underlying mesenchyme
b&d are from Hecksher-Sorensen et al., 2004 and show Fast Red detection of expression visualised by confocal
microscopy, as does a-iii. All other images show NBT/BCIP signal detection and were obtained using standard
microscopy. All images were obtained at 10x magnification, unless otherwise stated, da: dorsal aorta, dp: dorsal
pancreatic bud, du: duodenum, e: endoderm, m: mesenchyme, ps: pyloric sphincter, psm: putative splenic
mesenchyme, SMP: splanchnic mesothelial plate, st: stomach,
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mesenchymal tissues, and Nkx2-5 expression at later stages of gut development is
mesenchyme-specific. It is perhaps significant then that Nkx2-5 is expressed in the
E8.0 foregut endoderm (Lints et al., 1993b). The endodermal expression observed
here could thus be related to this earlier expression. Alternatively, this may be an
experimental artefact. Endodermal expression did not persist beyond -E9.75 (Figure
2.2c).
Nkx2-5 expression in the developing gut has previously been regarded as a
left-sided event. However, the expression observed at E9.5-9.75 shows that Nkx2-5
expression is initially bilateral in the mammalian gut, mirroring the situation in
Xenopus spleen development (Patterson et al., 2000). Nkx2-5 may therefore be the
earliest marker of the mammalian spleen and as such is a promising candidate for a
genetic marker of this tissue.
2.2.2 Nkx2-5 expression in the SMP at E10.5
Expression of Nkx2-5 has been observed in two discrete domains within the
E10.5 SMP and underlying mesenchyme (Hecksher-Sorensen et al., 2004). The
subtleties of this expression pattern had not, however, been fully investigated. This
experiment was thus repeated and the presence of two distinct domains was
confirmed (Figure 2c). These two expression domains encompass cells from the
SMP and/or underlying mesenchyme, but not the endoderm.
Figure 2.2c i-iii shows three sections through the SMP from an El0.5
embryo, proceeding in an anterior-posterior direction, with high magnification
images of the SMP provided in iv-v. At the posterior stomach level (i) Nkx2-5
expression is detectable only in the mesenchyme to the left of the endodermal
stomach, in a ventral region underlying the SMP. Expression is also present in the
SMP. At the level of the stomach-duodenal boundary (ii) the ventral domain
surrounds the endodermal gut tube suggesting that, in addition to being expressed in
the developing pyloric sphincter structure, Nkx2-5 may also be a marker of the
pyloric sphincter rudiment. The ventral expression is located on both sides of the gut
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tube, and thus may be the direct derivative of the bilateral Nkx2-5 expression
observed at E9.5-9.75. The dorsal Nkx2-5 expression domain also becomes apparent
at the stomach-duodenal boundary level. The dorsal domain corresponds to a region
of mesenchyme abutting the SMP in which the early splenic markers Hoxl 1,
Capsulin, and Wtl are expressed (Hecksher-Sorensen et al., 2004). The dorsal Nkx2-
5 expression may be de novo at El0.5, or it may correspond to an earlier domain: the
mesenchymal expression that lies dorsal to the dorsal pancreatic bud at -E9.75.
Moving down the gut tube to the pancreatic bud level (iii), the dorsal expression
appears to intensify. The ventral domain is restricted at this level to a patch of
expression on the left of the SMP/underlying mesenchyme, and includes cells from
both these tissue types (iv, v).
The data presented here supports the existence of two distinct Nkx2-5
expression domains in the El0.5 spleno-pancreatic mesenchyme, suggesting either a
division of the single E9.5-9.75 expression domain, or the refinement of this domain
and concomitant de novo appearance of a second domain.
2.2.3 Nkx2-5 expression overlaps that of Bapxl
Expression of Bapxl in the SMP at E9.5 and El0.5 is shown in Figure 2.2b,
d. Significant expressional overlap occurs between Nkx2-5 and Bapxl in the bilateral
SMP at -E9.5 (e.g. compare Figure 2.2 a iii with Figure 2.2b). There is therefore
now a known point when the opportunity for direct regulatory interaction exists:
E9.5. Perhaps more crucially, it has now also been demonstrated that two markers of
spleen development {Bapxl, Nkx2-5) are expressed in a bilateral manner in the SMP
as early as E9.5.
By El0.5 the Bapxl and Nkx2-5 expression domains are largely exclusive,
with Bapxl expression localising to the SMP tip and underlying mesenchyme,
flanked by the two Nkx2-5 expression domains. One could imagine that the two
Nkx2-5 domains are directly related to the E9.5 Mcc2-5-positive SMP (and the
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emerging dorsal mesenchyme), whilst the Afcc2-5-negative mesenchyme is derived
from the Bapxl-positive SMP tip.
Many aspects of the Bapxl7' phenotype are manifest by El 0.5 and Nkx2-5
expression is lost from the mutant SMP region by this time (Jacob Hecksher-
Sorensen, PhD thesis, University of Edinburgh, 2001). The obvious next question is
therefore whether Nkx2-5 expression is absent from the Bapxl7 SMP at E9.5. This
question has not been answered during my studies as - despite numerous attempts
with a variety of different Nkx2-5 probes and protocols - expression in the gut was
often too weak to reliably detect in wild type controls.
2.3 Characterising a gut regulatory element upstream
of Nkx2-5
2.3.1 Modular control of Nkx2-5 expression
Expression of Nkx2-5 and Bapxl overlaps completely in the wild type SMP at
E9.5, and Nkx2-5 expression is lost in the Bapxl7' mutant gut. The possibility thus
exists that Bapxl may directly regulate Nkx2-5. Regulatory interaction between NK
genes is a central feature of Drosophila mesoderm development, and examples also
exist of dependence of vertebrate Nkx genes on other family members (see Chapter
1). Direct regulation of Nkx2-5 by Bapxl would most likely be mediated through
interaction with a regulatory region located in the genomic vicinity of Nkx2-5. A
number of such enhancer elements are known to exist in the genomic landscape
around Nkx2-5\ control of the Nkx2-5 expression pattern is modular, with different
regulatory regions required for different components of the overall pattern (Schwartz
and Olson, 1999).
Non-coding Nkx2-5 regulatory sequences are found in a range of vertebrate
species and also in Drosophila. The Drosophila tin-D enhancer is located 3' to tin
and drives expression in the dorsal mesoderm (Yin et al., 1997). Activation of tin by
tin-D occurs in response to dpp - facilitated by Smad proteins - and Tin itself (Xu et
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al., 1998b). Binding sites for Smad and BMP (the vertebrate Dpp orthologue)
proteins are also a functional feature of murine and chick Nkx2-5 enhancer sequences
(Liberatore et al., 2002; Lien et al., 2002; Brown, III et al., 2004; Lee et al., 2004).
The regulatory landscape around murine Nkx2-5 has been well studied, due to
the essential role this gene plays in heart development. As such, many of the
published enhancer regions have been analysed with respect to cardiac expression,
with elements conferring non-cardiac aspects of the Nkx2-5 expression pattern not
being investigated in depth. A review of the Nkx2-5 enhancer elements discovered in
the mouse genome is presented in Appendix Table 1, and these findings are
summarised in Figure 2.3. This schematic is an updated version of that of Schwartz
and Olson (1999), as this is largely in agreement with my interpretation of the
available expression data (Schwartz and Olson, 1999). The regulatory regions





















AR1: cardiac crescent. entire linear heart tube, outflow tract, right ventricle
AR2: anterior cardiac crescent anterior linear heart tube outflow tract, right ventricle
AR3; outflow tract, right ventricle
Figure 2.3 The regulatory elements in the genomic neighbourhood of Nkx2.5
The gut regulatory region used in this chapter (NGRS) is equivalent to AR7. Nkx2.5 has
two upstream exons (exon 1a, 1b), which may rarely be spliced into Nkx2.5 transcripts
{Reecy et al., 1999; Tanaka et al., 1999b). The arrow indicates the direction of transcription.




One upstream region has been identified which can confer reporter gene
expression in the distal stomach and spleen from El 0.5 and El 1.5, respectively
(Searcy et al., 1998; Lien et al., 1999; Reecy et al., 1999; Tanaka et al., 1999c; Lien
et al., 2002). In Figure 2.3, this gut regulatory region is equivalent to the proposed
AR7 (Activating Region 7) that confers thyroid, pharynx, stomach, and spleen
expression. The AR7 itself encompasses two other putative elements: the AR2
(outflow tract, basal right ventricle) and the IR2 (Inhibiting Region 2), which inhibits
cardiac expression. Hence this model can explain the findings of both Reecy et al.
(1999) and Searcy et al. (1998), which at first appear contradictory (Reecy et al.,
1999; Searcy et al., 1998). The Reecy data shows that nucleotides -1627 to -3512
upstream of the Nkx2-5 translational start point confer AR7 activity without
associated cardiac expression, which is predicted by inclusion of the IR2; the Searcy
study found that nucleotides -2776 to -3299 confer both AR7 and cardiac expression,
and this is explained by the lack of a complete IR2. Gut expression may be conferred
solely by the AR2, but this element alone has associated cardiac activity and so must
be kept in association with the IR2 to minimise cardiac expression. The gut-
specificity of the AR2 is supported by the fact that it is histone acetylated specifically
in the stomach at El2.5 (Chi et al., 2005). Furthermore, the AR2 sequence is
conserved down to Xenopus, and the Xenopus "AR2" sequence can drive gut
expression in transgenic mice (Sparrow et al., 2000).
2.3.2 An upstream Nkx2-5 Gut Regulatory Sequence
(NGRS)
The putative Nkx2-5 upstream gut enhancer region discussed above could be
of value to the study of gut development and the role of Nkx2-5 therein. This
genomic region has only been investigated from a cardiac perspective and, as such, a
detailed analysis of the expression conferred in the developing gut has not been
published. Expression is reported in the spleen and "posterior stomach", but it is not
clear how this relates to endogenous Nkx2-5 expression. Nor has it been shown how
early in spleen development this enhancer marks splenic cells. I therefore cloned a
1956bp genomic region comparable to the AR7 and used it to drive LacZ expression,
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in conjunction with the heterologous /3-globin promoter, in transient transgenic
mouse embryos (Sally Burn, MSc (Res) thesis, University of Edinburgh, 2002). The
cloning strategy is illustrated in Figure 2.4, and details are provided in the
Appendix. Nkx2-5 regulatory regions have been studied in conjunction with both
exogenous promoters and the Nkx2-5 promoter. In the study using an exogenous
(,hsp68) promoter, cardiac expression was less than in studies of comparable regions
used in conjunction with the endogenous promoter (Lien et al., 1999). The use of the
fi-globin promoter here may therefore be beneficial.
A similar genomic region had previously been demonstrated to drive
transgene expression in the thyroid, ventral pharynx, spleen primordium, and distal
stomach at El 2.5-13.5, with only minor cardiac expression in the inflow and outflow
tracts at E9.5 and El3.5 (Reecy et al., 1999). This expression pattern was
recapitulated with my construct at El2.5, and the "distal stomach" expression was
shown to be around the pyloric sphincter. Expression was also found in the spleen
and mesenchyme overlying the dorsal pancreas, whilst cardiac expression was
minimal. This cloned element is herein referred to as the Nkx2-5 Gut Regulatory
Sequence (NGRS) and the LacZ reporter construct as NGRS-LacZ.
The preliminary indication from this experiment was that the NGRS might be
a valuable tool for marking pyloric sphincter and spleen cells for lineage tracing
purposes. The element also had the potential to direct a gut-specific Nkx2-5 knockout
given its minimal cardiac expression at El2.5. A more in depth characterisation was
therefore undertaken to assess its usefulness. If the NGRS were to be used in lineage
tracing studies then it would need to be shown that the El2.5 gut expression was not
simply de novo, but instead related to earlier stages in gut development. Cardiac
expression would also need to be minimal throughout development. These issues
could be examined to an extent using transient transgenics but a stably expressing
line would be ultimately required to fully investigate the element. The in silico
characterisation of the NGRS, generation of stable transgenic lines, and an in depth
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Figure 2.4 Cloning of the NGRS and generation of NGRS-LacZ transient transgenic
embryos
a) Isolation of the 1956nt NGRS (yellow) and cloning of the NGRS-LacZ construct.
H: Hind\\\ recognition site; green box: \')-g!obin promoter.
b) Preparation of a ~5.5kb fragment for microinjection. This step was performed each time
transient transgenic embryos were needed.
c) Microinjection and embryo analysis. A typical LacZ/Myo genotyping PCR is shown in
which the upper (600bp) band is LacZ, and the lower (250bp) band is Myo.
s. ' J
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2.3.3 In silico analysis of NGRS
Non-coding regions of the genome might be expected to be free of
evolutionary constraints, as they are "non-functional" and thus their base
composition is irrelevant. However, it has become increasingly apparent that the
genome is littered with regions of DNA that have been highly conserved through
evolution and which perform essential regulatory functions. Such regions can be
identified by comparing the genomic landscape between multiple species and
identifying regions of high sequence homology, most commonly 70% identity over
lOObp of ungapped sequence (Dermitzakis et al., 2005). The insinuation is that if a
non-coding sequence shows high identity between species then it has been
specifically conserved and thus must perform a function - though conservation
across a range of species is not a mandatory prerequisite for functional enhancers
(Hill, 2004). Further analysis often reveals highly conserved binding sites for
transcription factors, the nature of which can offer insights into the roles of the
associated gene. An analysis of the evolutionary conservation of, and sequence
motifs within, the NGRS was hence undertaken.
The ECR (Evolutionary Conserved Region) browser programme
(Ovcharenko et al., 2004) was used in conjunction with the rVISTA 2.0 tool (Loots
and Ovcharenko, 2004) to analyse the region upstream of Nkx2-5. Two distinct ECRs
were identified within the NGRS region (Figure 2.5). Given their genomic locations,
the proximal ECR is most likely the IR2 element, and the distal ECR the AR2
element. The 3' half of this distal element shares high sequence identity with the
~300bp Xenopus sequence which drives AR2-type expression in transgenic mice
(Sparrow et al., 2000).
Conserved transcription factor binding sites, previously reported in the AR2,
were confirmed during the in silico analysis presented here: 6 GATA , 4 Smad, 1
HNF-3, and 1 Nkx2-5 sites (Sparrow et al., 2000; Lien et al., 2002). In addition to
confirming published sites, the ECR analysis revealed conserved binding sites for
Nkx2-2, Nkx2-5, and Nkx6-I in the IR2. A manual search for consensus binding
sequences also showed that four high affinity Bapxl sites (Kim et al., 2003) exist in
the murine NGRS (two in the AR2, two in the IR2).
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Figure 2.5 The evolutionary conserved regions (ECRs) upstream of Nkx2.5
The NGRS region of the mouse genome was aligned with the genomes of (from top to
bottom) fugu, zebrafish, Xenopus, chick, opossum, dog, human, and rat. Evolutionary
conserved regions were then detected using the ECRBrowser program. The parameters
for ECR detection were 70% identity over 100bp of ungapped sequence. The vertical axis
for each species represents percent sequence identity, from 50 to 100%. The results were
output as a smooth graph (smoothed version of a Pip-plot). Shading within the peaks
indicates the type of sequence: red - intergenic element, blue - coding exon, yellow -
untranslated region (UTR), pale pink - intron. Synteny is indicated by the blue line along
the bottom of each alignment.
The cloned NGRS region is outlined by a black box; two distinct ECR peaks are present
in this region. The ECRs upstream of Nkx2.5 are aligned with the proposed activating and
inhibitory regulatory regions presented in Figure 2.3. The approximate distances of the
main ECRs from the translational start point of Nkx2.5 are written in pink.
2.3.4 Generation and analysis of transient transgenic
NGRS-LacZ embryos
2.3.4.1 Generation of transient transgenic embryos
The NGRS appeared to be a good marker of the developing spleen and pyloric
sphincter on the basis of the expression observed at El 2.5. The next obvious question
was whether this expression can be traced to an earlier stage in development, or
whether it is de novo, therefore limiting the use of the NGRS as a tool. Three
microinjection sessions were undertaken to generate transient transgenic embryos
carrying the NGRS-LacZ construct used previously, in which LacZ is driven by the
NGRS and the fl-globin promoter. Embryos were genotyped by polymerase chain
reaction (PCR) using primers against LacZ and Myogenic, the former identifies
embryos carrying the transgene, the latter confirms the integrity of the DNA. The
results of the microinjections are summarised in Table 2.1.








I E9.5 4 11 1 None
2 E9.5 n/a 7 0 None
3 EIO.5 2 17 3 3/3 - described in
Section 2.3.4.2
Table 2.1 - Results of NGRS-LacZ microinjection sessions to generate transient
transgenic embryos
Transgenic embryos were identified by PCR for LacZ. Many of the embryos from the first
session were runted and reabsorptions had occurred. One of the embryos from the third





Figure 2.6 X-gal detection of NGRS-LacZexpression in E10.5 transient transgenic
embryos
Right (R) and left (L) side photos are at 2.5x magnification; the third column of images is
at increased magnification. Embryo 1 is developmentally retarded; Embryo 2 shows mosaic
expression; Embryo 3 shows strong expression. Note the left-sided gut expression in
Embryos 2 & 3. Pink arrow: pharyngeal endoderm expression; pink arrowhead: cardiac







2.3.4.2 NGRS-ImcZ expression analysis
Transgene expression in the three El0.5 transient transgenic embryos was
examined by whole mount X-gal staining (Figure 2.6). Expression was present in the
runted embryo (Embryo 1) in the pharyngeal endoderm. The other two embryos
showed expression in the pharyngeal endoderm, outflow tract, and gut. The outflow
tract expression was minimal, and the gut expression left-sided. Ectopic expression
was noted in the presumptive facial nerves of Embryo 3.
Embryos 2 & 3 were examined in more detail by sectioning (Figure 2.7).
Embryo 2 exhibited milder staining and so was cut into thick slices on a vibratome;
the strongly stained Embryo 3 was examined using thinner microtome sections.
Three representative sections through the gut are shown for each embryo,
progressing in an anterior-posterior direction. Embryo 2 was mosaic for transgene
expression, whereas Embryo 3 expressed LacZ in all cells within positive tissues.
The pharyngeal endoderm expression was localised to the thyroid primordium
(Figure 2.7a-iv).
The left-sided gut expression was localised to the SMP. In Embryo 2, gut
expression commenced in the ventral SMP and mesenchyme surrounding the exit of
the posterior stomach (Figure 2.7a-i), with some expression also apparent in the
dorsal mesenchyme - a staining pattern reminiscent of endogenous Nkx2-5
expression. Expression continued in these tissues to the level of the pancreatic buds
(Figure 2.7a-ii, iii). The finer sectioning technique employed for Embryo 3 revealed
that the most anterior gut expression is in the dorsal mesenchyme, perhaps relating to
the dorsal mesogastrium or the putative splenic mesenchyme (Figure 2.7b-i).
Expression then spread throughout the more posterior mesenchyme and SMP
(Figure 2.7b-ii, iii). It should be noted that whilst Figure 2.7 b-ii appears to depict
some endodermal expression, this was not noted in other sections and may be an
artefact of the sectioning process (c.f. Figure 2.7b-iii). The presence of staining
throughout the mesenchyme underlying the SMP is in contrast to the two distinct
domains of endogenous Nkx2-5 expression. The entirety of the SMP itself was also





a and b i-iii: progressive sections through the SMP at
E10.5.
a) iv: expression around the thyroid primordium. v: cardiac
outflow tract expression (pink arrow).
b) iv: pharyngeal endoderm expression, v: cardiac outflow
tract expression.
All images were taken at 10x magnification except a) v
which is at 5x. Embryo 2: 100pm agarose vibratome
sections. Embryo 3:9pm paraffin wax microtome sections.
Yellow scale bars represent 150pm.
c: X-gal staining in the E12.5 heart is minimal and is localised to the outflow tract (arrows).
NGRS-LacZ is also expressed in the thyroid primordium (*). 9pm wax section counterstained
with Nuclear Fast Red.
ps: pyloric sphincter; vp: ventral panreatic bud; du: duodenum; dp: dorsal pancreatic bud;
oe: oesophagus; tp: thyroid primordium; ba: branchial arch; rv: right ventricle; Iv: left
ventricle; oft: outflow tract; pst: posterior stomach; pe: pharyngeal endoderm.
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Figure 2.7X-gal detection of NGRS-LacZexpression
in transient transgenic embryos
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expression was also noted in the pharyngeal endoderm (Figure 2.7b-iv) and cardiac
outflow tract, contiguous with the pharyngeal endoderm expression (Figure 2.7b-v).
Cardiac expression was minimal and comparable to that reported for a similar
enhancer region (Reecy et al., 1999). Hearts from the two El2.5 transient transgenic
embryos generated previously were sectioned to further examine cardiac expression.
Expression was minimal at E12.5, with only a few X-gal stained cells in the outflow
tract and main body of the heart (basal right ventricle) (Figure 2.7c). Expression was
less than that reported for a -1 to -3300bp region by Searcy and colleagues (Searcy et
al., 1998) - who also traced expression back to the E7.5 cardiac crescent - and more
akin to that reported in studies in which the NGRS region is incapable of driving
cardiac expression at E7.5, and confers only sparse expression in the E9.5 and El0.5
heart (Reecy et al., 1999; Tanaka et al., 1999c).
The minimal cardiac expression at El 0.5 and El 2.5, along with the presence
of X-gal stained cells in the SMP and underlying putative splenic mesenchyme at
El0.5, suggested that the NGRS was of further interest. Stable transgenic lines were
therefore generated to facilitate a thorough examination of the developmental
expression pattern conferred by the NGRS.
2.3.5 Generation and analysis of stable transgenic
NGRS-LacZ lines
2.3.5.1 Generation of stable transgenic lines
Microinjection sessions were performed as described and the mice generated
were genotyped using combined LacZJMyo PCR. The results of these sessions and of








Transmission X-gal staining Line
established
1 15 0 - - -
2 35 0 HHH -
3 29 2 m x CD 1: yes Yes -








2 f x Fl: yes Yes "Line 21"
x Fl: no
(0/23; 3 litters)
Table 2.2 - Results of NGRS-LacZ microinjection sessions to generate stable
transgenic lines
Transgenic mice were identified by duplicate PCR for LacZ. Transmission was tested by
crossing founder males with CD1 females and genotyping E12.5 embryos, or mating founder
females with [CBA x C57BL/6] F1 males and genotyping the offspring. X-gal staining was
performed on E12.5 embryos from matings between founder males and CD1 females, or
from matings between sons of founder females with CD1 females,
m: male, f: female, F1: [CBA x C57BL/6] F1
f \
Figure 2.8 LacZ/Myo genotyping gel for NGRS-LacZ microinjection progeny
2% agarose gel of combined LacZ/Myo PCR on earclip DNAfrom 29 microinjection progeny
(5pl of 25pl PCR in each lane). Mice numbers 4, 6, 20, and 21 were positive for LacZ. The
penultimate sample lane contains a PCR on LacZ+ earclip DNAfrom an unrelated LacZ-
expressing line. The final sample lane is a PCR on water. The LacZ band (L) is approximately
600bp; the Myo band (M) is approximately 250bp and acts as an internal control for DNA
integrity. X = 1Kb ladder (278ng/lane; Invitrogen).
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2.3.5.2 NGRS-ImcZ expression in non-eut tissues
NGRS-dri\en LacZ expression was examined by X-gal staining of at least one
litter at half to one day intervals between E8.5 and El 8.5. Details of the numbers of
transgenic embryos in each litter are provided in Appendix Table 2 (Line 4) and
Table 3 (Line 21). Stained embryos from each stage are shown in Figure 2.9 (Line
4) and 2.10 (Line 21). Figure 2.11 (Line 4) and 2.12 (Line 21) contain sections of
stained embryos. Figures 2.13 (Line 4) and 2.14 (Line 21) show staining in
dissected guts and will be discussed in the next section.
At the earliest stage examined (E8.5) staining was restricted to the
pharyngeal endoderm in most embryos. Staining extended into the presumptive
outflow tract region in two embryos from Line 4 (not shown), though this was hard
to examine given the translucency of the heart tube and the intense underlying
pharyngeal staining. Similarly, the Line 21 embryo featured in Figure 2.10a appears
to have cardiac expression but does not - this is merely the underlying strong
pharyngeal expression. Pharyngeal expression was strong and extended towards the
neural tube. Sectioning of embryos from Line 4 confirmed the presence of stained
cells in the pharyngeal endoderm and outflow tract, and revealed expression in the
endoderm of the foregut diverticulum (Figure 2.11a).
The pharyngeal endoderm expression was recapitulated at E9.0 and E9.5.
Cardiac expression was lower in Line 21 than Line 4, and could not be seen in whole
embryos (Figure 2.10b). X-gal stained cells were, however, observed in sectioned
outflow tracts from both lines (Figure 2.11a,b; 2.12a). In addition to greater cardiac
expression, Line 4 also displayed increased ectopic LacZ expression. Ectopic sites
included the face, neural tube, and the nerves between the branchial arches and heart
by E10.5; ectopic expression was minimal in Line 21. Outflow tract expression
persisted in both lines at E10.5-13.5. Expression could also be observed in the
thyroid primordium. Ectopic expression in Line 4 persisted, particularly around the
snout, and by El 3.5 was also found in the whisker follicles and limbs (Figure 2.9g).
The expression pattern conferred by NGRS is very similar to that found in
mice in which LacZ has been knocked into the Hoxll gene, generating expression in
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2.3.5.3 NGRS-LacZ expression in the eut
Sections through guts X-gal stained for NGRS-LacZ expression are provided
in Figure 2.11 (Line 4) and Figure 2.12 (Line 21). Staining in isolated guts is
presented in Figure 2.13 (Line 4) and Figure 2.14 (Line 21). An analysis of the
differential staining intensities of the E13.5 pyloric sphincter and spleen following
various stain times is shown in Figure 2.15.
2.3.5.3.1 E8.5-10.5
The first indication of gut expression was in the endoderm of the foregut
diverticulum at E8.5 in Line 4 (Figure 2.11a iii-iv). Bilateral gut expression became
evident at E9.0 in Line 4, and was pronounced by E9.5 in both lines. Sections
through the SMP region of transgenic embryos at this stage show that the NGRS
drives expression in the SMP on both the left and right sides (Figure 2.11b iv-vii,
Figure 2.12a iii-iv), echoing the endogenous Nkx2-5 and Bapxl expression patterns.
The SMP expression continues into the flanking horns of thickened coelomic
epithelium (Figure 2.11b iv). The nascent mesenchyme, which lies between the
SMP and endodermal gut tube, is also marked. No expression is found in the
endoderm.
Whole mount X-gal staining of El 0.5 guts revealed strong expression in the
posterior stomach, extending into the presumptive pyloric sphincter region (Figure
2.13a, Figure 2.14a). Expression was absent from the anterior stomach, but ectopic
liver expression was noted in Line 4 (Figure 2.13a). This is specific to Line 4, as it
had not been noted in transient transgenics or embryos from Line 21; nor is Nkx2-5
expressed in the liver.
Whilst the NGRS expression pattern matches that of endogenous Nkx2-5 in
the SMP at E9.5, differences exist between these patterns by El0.5. Nkx2-5
expression is localised to two domains - ventral and dorsal - in the El0.5 SMP and
underlying mesenchyme; NGRS-LacZ, however, is detected throughout this region,
including in the tip of the SMP where Bapxl is expressed (Figure 2.11c, Figure
2.12b i-iv). However, it may be of significance that in the first two of the four serial
sections presented in Figure 2.12b, two domains of high transgene expression can be
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Figure 2.11 X-gal staining of NGRS-LacZ activity in embryos from Line 4
Embryos were stained wholemount with X-gal and sectioned on a microtome. Positive tissues
are labeled in pink, negative tissues in black. Images proceed in an anterior-posterior (cranial-
caudal) direction across the page. Sections are counterstained with Nuclear Fast Red.
a) 8pm sections, i, iii, iv: 5x magnification; ii: 10x magnification; b) 9pm , i-vii: 5x magnification;
viii-x: 10 x magnification; c) 9pm sections, 5x magnification; d) 10pm sections, 2.5x magnification.
Yellow scale bars: 100pm. Red scale bars: 400pm.
BA: branchial arch, BC: bulbus cordis, CE: coelomic epithelium, DA: dorsal aorta, DP: dorsal pancreas
(endoderm), Du: duodenum, FG: foregut, FL: forelimb, GE: gut endoderm, Ht: heart, NT: neural tube, OFT:
outflow tract, PE: pharyngeal endoderm, SM: splanchnic mesenchyme, SMP: Splanchnic Mesothelial Plate










Figure 2.12 X-gal staining of NGRS-LacZ activity in embryos from Line 21
Embryos were stained wholemount with X-gal; embryos (a,b) or guts (c,d) were then sectioned
on a vibratome (a-c) or microtome (d). Positive tissues are labeled in pink, negative tissues in
black. Embryo images proceed in an anterior-posterior (cranial-caudal) direction across the page;
gut images are presented in a ventral-dorsal series.
a) 50pm sections - i, ii: 5x magnification, iii, iv: 10x; b) 100pm sections - i-iv: 10x; v-vi: 5x;
c) 30pm sections- i-iv: 5x, v-vi: 10x; d) 7pm sections - 5x; counterstained with Nuclear Fast Red
Yellow scale bars: 100pm. Red scale bars: 200pm.
BA: branchial arch, CE: coelomic epithelium, DA: dorsal aorta, DP: dorsal pancreas (endoderm),
Du: duodenum, FL: forelimb, GE: gut endoderm, Ht: heart, Lu: lung buds, NT: neural tube, OFT:
outflow tract, PE: pharyngeal endoderm, PS: pyloric sphincter, SM: splanchnic mesenchyme,
SNIP: Splanchnic Mesothelial Plate, Sp: spleen, S-PM: spleno-pancreatic mesenchyme, St:
stomach, Th: thyroid primordium.
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seen; these correspond well with the two domains of endogenous Nkx2-5 expression.
NGRS-LacZ expression is specific to the SMP and underlying mesenchyme, and is
not present in the gut endoderm. Contiguous expression extends into the horns of the
coelomic epithelium (Figure 2.11c i), as seen at E9.5. Expression commences at the
ventral aspect of the posterior stomach and spreads across the SMP at increasingly
posterior levels down the gut until the whole SMP can be marked with X-gal. This
was at first interpreted as an experimental artefact (sectioning angle), but has since
been observed in most sectioned El0.5 (and E9.5) embryos from both lines. As such
it is probably a real effect - i.e. the most anterior limit of NGRS expression is on the
ventral face of the stomach.
2.3.5.3.2 El 1.5-13.5
The left-sided nature of NGRS-LacZ gut expression was apparent in most
whole embryos at El0.5, but was particularly noticeable by El 1.5 (Figure 2.9e,
Figure 2.10d). X-gal staining of guts from this stage revealed that a single gut
expression domain still exists, but that this now noticeably corresponds to the pyloric
sphincter and splenic mesenchyme (Figure 2.13b, Figure 2.14b). Given the
continuity of this domain, it seems likely that the splenic mesenchyme expression is
not de novo but is instead related to that seen in the El0.5 - and possibly the E9.5 -
mesenchyme underlying the SMP. Expression is more refined in guts from Line 21
as, although the pyloric sphincter and splenic mesenchyme expression domains are
still contiguous, far less of the posterior stomach mesenchyme is marked by
transgene expression. Sections through El 1.5 guts demonstrate the continuity of the
staining in the spleno-pancreatic mesenchyme with that in the mesenchyme of the
distal stomach (Figure 2.12c). The non-expressing pancreatic endoderm can also be
seen embedded in the stained spleno-pancreatic mesenchyme. The lower two images
in Figure 2.12c show the presence of an SMP-like ridge structure at the periphery of
the spleno-pancreatic mesenchyme.
The entire spleen is marked by NGRS-LacZ expression by El 2.5, and this
remains contiguous with expression in the pancreatic mesenchyme and pyloric





Figure 2.13 X-gal staining of NGRS-LacZ activity in guts from Line 4
a) E10.5, b) E11.5, c) E12.5, d) E13.5
Positive tissues are labeled in pink, negative tissues in black. Guts are not shown to
scale
Gut faces: i - ventral, ii - greater curvature, iii - dorsal
DPm: dorsal pancreatic mesenchyme, Du: duodenum, Li: liver bud, PS: pyloric sphincter,
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pancreatic mesenchyme by a "stalk" of stained cells (Figure 2.14c-iii - pink arrow).
This connection is visible until El4.5. Sections through the El2.5 stomach illustrate
this spleno-pancreatic mesenchyme expression and the connection it shares with the
mesenchyme of the posterior stomach/pyloric sphincter (Figure 2.12d). Though the
anterior tip of the spleen appears to be contiguous with the mesenchyme surrounding
the stomach, NGRS drives expression only in the splenic component. No expression
is present in the gut endoderm.
The El3.5 gut expression pattern in Line 21 embryos is much the same as
that established by El2.5, albeit with more intense staining (Figure 2.14d). The
pyloric sphincter and spleen expression domains are still continuous at this stage, and
are linked by a layer of NGRS-LacZ-express'ing mesenchyme which is distinct from
the stomach itself (Figure 2.14d-iii - yellow box). The effect of staining time on the
final expression pattern was studied at El3.5 and this is summarised in Figure 2.15.
This provided valuable data on the relative expression levels within the gut. The
pyloric sphincter is heavily stained after only 30 minutes exposure to X-gal,
suggesting that very high levels of P-gal exist in this tissue. Staining of the spleen
was not detectable until 2-4 hours, and was initially localised to just a handful of
cells. The number of marked cells increased slightly by 8 hours, when a few blue
cells could now also be seen overlying the pancreas. Uniform, low-level staining was
present throughout the spleen after 10 hours X-gal exposure, and had increased by 12
hours. The pyloric sphincter and spleen expression domains were still separate at this
point. Guts were stained for approximately 14 hours during the studies presented in
this chapter; it would thus appear that staining in the region between these two
domains becomes detectable between 12 and 14 hours of staining. By 24 hours
spleen staining was intense and some marked cells were noticeable along the greater
curvature of the stomach, extending from the pyloric expression domain.
Expression is no longer detectable in the pyloric sphincter and has been lost
from all but the anterior portion of the spleen by El 3.5 in embryos from Line 4
(Figure 2.13d). Endogenous Nkx2-5 expression persists in the former tissue until at
least El4.5, and in the latter until adulthood (Lints et al., 1993b). The loss of NGRS-
LacZ expression was specific to Line 4, as expression continues throughout gut
development in Line 21. The reduced ectopic and cardiac expression, and prolonged
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Figure 2.15 The effect of X-gal staining time on detection of NGRS-LacZ
activity in guts from Line 21
The pyloric sphincter expression domain stains strongly after only half an hour,
demonstrating the high expression of NGRS-LacZ in this tissue. The spleen takes
approximately 10 hours to become stained, reflecting lower activity of the transgene.
Positive tissues are labeled in pink, negative tissues in black.
Gut faces: D - dorsal, V - ventral, GC - greater curvature.
DPm: dorsal pancreatic mesenchyme, Du: duodenum, PS: pyloric sphincter, Sp:
spleen, St: stomach
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and greater gut expression, therefore makes Line 21 a preferable source of data on
the NGRS and, as such, only embryos from this line are used in the gut culture
experiments described in Chapter 4.
2.3.5.3.3 E14.5-18.5
E14.5 NGRS-LacZ expression is similar to that at E13.5, though at a
morphological level the spleen is now further from the pyloric sphincter (Figure
2.14e). By El5.5 the splenic and sphincter expression domains have become distinct,
the pancreatic mesenchyme expression is lost, and the spleen stains less intensely for
(3—gal activity - though this varied between embryos (Figure 2.14f). It is also at this
stage that two "horns" of stained tissue become particularly noticeable. These
projections extend in an anterior direction from either side of the pyloric sphincter. A
higher magnification image of these structures at El 6.5 is provided in Figure 2.14g-
iii, showing that they terminate in unstained duct-like tissue. The identity of these
"horns" is unclear, though they could be related to the bile ducts. The other sites of
El6.5 gut staining are the spleen and pyloric sphincter, with no expression present in
the intervening pancreatic mesenchyme (Figure 2.14g-ii). Pyloric sphincter
expression was also seen at El7.5 and El 8.5 (Figure 2.14h, i). Splenic expression
varied at these late stages, such that it was present in some guts and not in others,
even within litters. When the spleen did stain, not all cells were marked, suggesting
that only the mesenchymal-derived component of the spleen expresses NGRS-LacZ.
2.3.5.3.4 Summary of expression data
In summary, NGRS is a good marker of the SMP (E9.5-10.5), spleno-
pancreatic mesenchyme (El 1.5-12.5), developing spleen (El2.5 onwards), and
pyloric sphincter (El 1.5 onwards). The minimal ectopic and cardiac expression
conferred by this element in Line 21, and its consistent transmission and expression,
indicated that this stable transgenic reporter line would be of great use for marking
and tracing development of the above tissues.
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2.4 NGRS is not dependent on Bapxl
The results presented so far in this chapter, along with existing data, show the
following: 1) that Nkx2-5 and Bapxl share an expression domain in the SMP at E9.5,
2) that Nkx2-5 expression is lost in the Bapxl ' mutant gut, 3) that a highly conserved
Nkx2-5 upstream regulation region (NGRS) drives expression in the gut, and that this
overlaps Bapxl expression, and 4) that a conserved high affinity Bapxl binding site
- along with other general Nkx binding sites - is present in the NGRS. The next
question to ask is whether Bapx 1 regulation of Nkx2-5 is achieved through the
NGRS.
To address this question, expression of the NGRS was examined on the
Bapxl7 background. Mice from both stable NGRS-LacZ lines were crossed with
Bapxl+/~ (phenotypically normal) mice. Bapxl+/ offspring carrying the NGRS
transgene were genotyped for the Neomycin insertion which disrupts Bapxl and for
LacZ. Double heterozygotes were then crossed with Bapxl+/ mice; one-eighth of the
resulting embryos would be expected to carry NGRS-LacZ and have the Bapxl~'~
genotype. X-gal staining was performed at E9.5, 10.5, 11.5, and 12.5 for both NGRS-
LacZ lines, and also at E16.5 and El 8.5 for Line 21. Embryos were genotyped for
LacZ and also by a second Bapxl-based PCR, which can differentiate between the
three possible genotypes ("bap" primers in Chapter 7). Details of numbers of
embryos and genotypes are provided in Appendix Tables 4 & 5 for Line 4 and Line
21, respectively. As can be seen from the figures in these tables, there was some
difficulty in obtaining LacZ/Bapxl'1' embryos, particularly from Line 4.
X-gal staining patterns were compared with those of wild type and Bapxl+/~
littermates. On the Line 4 NGRS-LacZ background, LacZ/Bapxl'1' embryos were
successfully produced for three stages: E9.5, E10.5, and E12.5 (Appendix Table 4).
Images of these embryos are provided in Figure 2.16. On the Line 21 background,
LacZ/Bapxl1' embryos were obtained at E9.5, E10.5, El 1.5, and E12.5 (Appendix
Table 5). These are shown in Figure 2.17. At all stages, in both lines, LacZ
expression persisted despite the absence of Bapxl expression. However, the pattern
of expression is obviously not identical between the wild type/Bapxl+/' and Bapxl''
mutant guts as the latter are morphologically abnormal. Indeed, the pyloric sphincter
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domain appears to be reduced in the Line 4 gut shown in Figure 2.16d; however, the
twisted and abnormal nature of the mutant guts in this region impeded assignment of
staining to specific structures, and staining varied between embryos. Expression was
also found in Line 4 in the disorganised tissue that lies in place of the spleen
(asterisk in Figure 2.16d). This expression was absent from Line 21, with staining
instead being limited to the region around the pancreatic mesenchyme. It should,
however, be noted that Line 21 was crossed onto a Bapxl line with a more severe
spleen phenotype; the line with which Line 4 was crossed retains some disorganised
splenic tissue.
Perhaps most crucially, NGRS-LacZ expression was retained in the SMP of
Bapxl'1' embryos at E9.5 (Figure 2.17a). This is the point at which Nkx2-5 and
Bapxl expression overlaps and therefore at which dependence of Nkx2-5 on Bapxl
would be most expected.
The outcome of this experiment indicates that there may be other Nkx2-5 gut
enhancers through which Bapxl exerts its control. As the ECRs presented in Section
2.3.3 can be related to published cardiac elements, it seems unlikely that such an
enhancer might reside in the region investigated, unless it is poorly conserved or
murine-specific. Alternatively, a Bapxl-dependent gut enhancer may exist further
afield. How far afield is uncertain, as genomic regulatory regions can be located far
away from the gene they regulate; for example, the ZRS element can regulate Shh
expression from 1Mb away (Lettice et al., 2003).
2.4.1 Optical projection tomography (OPT) analysis of
NGRS-LacZ expression
Although NGRS-LacZ expression was maintained on the Bapxl1
background, exactly how this expression related to that in the wild type gut was
unclear. The Bapxl'1' gut has a twisted appearance, making imaging by standard
microscopy difficult. X-gal stained guts from wild type, Bapxl+/\ and Bapxl'1'
NGRS-LacZ-positi\e El 2.5 embryos (Line 21) were therefore examined using









Figure 2.16 NGRS-LacZactivity in Line 4 in the absence of Bapxl
Line 4 embryos on wildtype, Bapx1+I-, and Bapx1-I- backgrounds were analysed for NGRS-
LacZ expression by X-gal staining. The resulting staining patterns demonstrated that the NGRS
is not dependent on Bapxl for its activity.
NGRS-LacZ gut expression is marked by a pink arrow in a-c.
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Figure 2.17 NGRS-LacZactivity in Line 21 in the absence of Bapxl
Line 21 embryos on wildtype, Bapx1+I-, and Bapx1-I- backgrounds were analysed for NGRS-
LacZ expression by X-gal staining (heterozygote data not shown). The resulting staining patterns
demonstrated that the NGRS is not dependent on Bapxl for its activity.
NGRS-LacZ gut expression is marked by a pink arrow in a-b. The sections in (a) are 7pm wax
sections of X-gal stained tissue and are counterstained with Nuclear Fast Red.
Yellow scale bars: 100pm. L: left; R: right; GC: greater curvature.
DA: dorsal aorta; DPm: dorsal pancreatic mesenchyme; FL: forelimb; PS: pyloric sphincter; SMP:
Splanchnic Mesothelial Plate; Sp: spleen; S-PM: spleno-pancreatic mesenchyme
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anatomy and gene expression (Sharpe et al., 2002). The guts shown in Figure 2.17
were used to allow comparison of OPT and standard microscopy data.
Virtual sections through the stained guts are presented in Figure 2.18. The
NGRS is clearly active in the pyloric sphincter and spleen of normal (wild type and
Bapxl+/) guts, and continuity can be observed between these domains (e.g. Figure
2.18b ii). NGRS-LacZ is also strongly expressed in the abnormal pyloric sphincter
region of the Bapxl'1' guts, flanking the site where constriction would normally occur
(Figure 2.18 biii ,ciii). Expression is absent, however, from the tissue which
occupies the region where the spleen normally lies (Figure 2.18 biii, diii). This
tissue contains cysts (arrowed in Figure 2.18d iii) - as previously described by
Asayesh and colleagues (Asayesh et al., 2006) - and is similar in appearance to the
sparse splenic scaffold described by Akazawa et al. (Akazawa et al., 2000).
The images contained in Figure 2.18 are two-dimensional representations of
the OPT data. The three-dimensional movies of NGRS-LacZ expression can be found
on the CD included with this thesis. In addition to facilitating examination of NGRS
activity, the OPT analysis also allowed visualisation of components of the Bapxl'1'
gut phenotype in a way not possible with standard microscopy or sectioning: for
example, the folding of the duodenum back against the stomach (asterixed in Figure
2.18 aiii, ciii), the loss of the pyloric sphincter constriction, the cysts in the abnormal
splenic region, and the widened duodenum (Watson et al., 2007). Further OPT
analysis of NGRS-LacZ expression in wild type and Bapxl' guts from El 0.5














Figure 2.18 Virtual sections from OPT reconstructions of NGRS-LacZexpression in
wildtype and Bapxl mutant guts at E12.5
X-gal staining for NGRS-LacZ expression is shown in green against blue gut tissue,
a: Sagittal, b: frontal, c, d: transverse virtual sectioning planes. Drawings of guts illustrate
the sectioning planes (red). The direction from which sections are viewed is denoted by a
black arrow. The guts in a are "sectioned" at a comparable pyloric sphincter level. The
boxed insert in the Bapx1+I- image in b shows the contiguous nature of the spleen and
pyloric sphincter NGRS-LacZ expression domains.
St: stomach; PS: pyloric sphincter; Sp: spleen; PM: pancreatic mesenchyme; *: mutant
duodenum, folded back onto stomach; pink arrows: cysts
Transverse
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2.5 The NGRS can be used to mark abnormal spleen
development In the Rwhs mutant
The NGRS is a good marker of the wild type developing spleen. Mutants with
defects in spleen development are of obvious interest when trying to understand this
process, and so it was of interest to know whether NGRS-LacZ expression could also
be used to mark abnormal spleen development. Expression has already been shown
to persist in the Bapxl'1' asplenic mutant. Expression of NGRS-LacZ was therefore
examined in an unrelated spleen defective mutant: the Retinal white spots (Rwhs)
mutant.
The Rwhs mutation resides on chromosome 11 and was identified in a
dominant screen for ENU-induced eye phenotypes (Thaung et al., 2002). Rwhs
homozygotes die at birth due to breathing difficulties, and have small lungs,
congenital diaphragmatic hernia, and gut hypoplasia (spleen, pancreas, stomach, and
duodenum) (Dr Alan Hart, personal communication). An interesting case of
polysplenia, in the form of a bifurcating spleen, was also observed by Dr Rob
Watson in one embryo. I therefore decided to investigate this phenotype further,
using the NGRS-LacZ reporter as a marker for spleen development.
The Rwhs mutation and NGRS-LacZ (Line 21) were bred onto the same line.
Crosses were then set up between Rwhs heterozygotes and NGRS-LacZ/Rwhs
heterozygotes. Due to time restraints and false pregnancies, only one litter of
embryos was analysed during the course of my studies. Of the eight embryos, six
carried the NGRS-LacZ transgene, and one of these was homozygous for the Rwhs
mutation. The Rwhs genotype is identified by sequencing of the affected region and
detection of a T-to-C mutation therein. Details are provided in Chapter 7.
X-gal staining of wild type, Rwhs heterozygous, and Rwhs homozygous
El 2.5 guts is shown in Figure 2,19. Comparison of the stained Rwhs homozygous
mutant with an unstained (LacZ-negative) homozygous mutant littermate highlights
the need to specifically mark the affected spleen tissue, in order to assess the
phenotype (Figure 2.19b). X-gal staining of NGRS-LacZ expression showed how the
spleen does indeed bifurcate at its posterior base, producing a second, shorter spleen
along the greater curvature of the stomach (outlined in yellow in Figure 2.19).
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Sections through the affected region show that, in addition to the normally marked
spleen, a second column of blue cells is present along the greater curvature, and that
stained cells from this second "spleen" region actually extend relatively far up to the
anterior of the stomach (Figure 2.19c). An additional element of the phenotype
revealed by sectioning was the presence of a mass of unstained mesenchyme
between the dorsal pancreatic and splenic mesenchymes (red outline in Figure
2.19c). This has not been observed in wild type gut sections.
The initial analysis presented in this section confirmed the Rwhs bifurcating
spleen phenotype, which is of particular interest given the existence of polysplenia in
humans. The NGRS was also demonstrated to be capable of marking both wild type
and abnormal spleen development. The mechanism for development of the
bifurcating spleen phenotype is unknown, as is the gene underlying the Rwhs
mutation. The fact that cells extend up from the "ectopic spleen" towards the anterior
stomach suggests that the mutant tissue attempts to recapitulate normal aspects of
spleen development, perhaps including migration. Conversely, the mal-positioning of
the second "spleen" could also be the result of initial defects in migration of splenic



























Figure 2.19An analysis of the Rwhs mutant using NGRS-LacZas a marker of spleen
development
a) X-gal staining for NGRS-LacZ expression in E12.5 guts from wildtype (+/+), +/Rwhs,
and Rwhs/Rwhs embryos on the NGRS-LacZ background. A bifurcating spleen can be
seen on the greater curvature of the Rwhs/Rwhs stomach (outlined in yellow).
b) Comparison between visualisation of the bifurcating spleen phenotype on stained and
unstained (non-transgenic) guts. NGRS-LacZ aids visualisation greatly.
c) 30pm vibratome sections of +/+ and Rwhs/Rwhs guts X-gal stained for NGRS-LacZ
expression. The anterior extent of the putative ectopic spleen (outlined in yellow) is revealed
to be greater when viewed in sections than that observed in the wholemount gut. The
section in ii is from near the surface of the greater curvature of the stomach. A mass of
unstained mesenchyme (outlined in red) is present between the dorsal pancreatic and
splenic mesenchymes. Yellow scale bars: 100pm. Red scale bars: 200pm.
Du: duodenum, DPe: dorsal pancreatic endoderm, DPm: dorsal pancreatic mesenchyme,
PS: pyloric sphincter, Sp: spleen, St: stomach.
\\G
2.6 Discussion
In this chapter I have shown that the pyloric sphincter and spleen marker
Nkx2-5 is expressed bilaterally in the SMP and nascent underlying mesenchyme at
E9.5-9.75 - an earlier stage than previously reported. Nkx2-5 expression overlaps
significantly with that of the upstream gene Bapxl at this stage. By El 0.5 Nkx2-5
expression is localised to a ventral and a dorsal domain in the SMP. The dorsal
domain corresponds to the putative splenic mesenchyme, which expresses a range of
splenic markers including HoxlI and Capsulin (Hecksher-Sorensen et al., 2004).
Much progress has been recently made on dissecting the genetic regulation of spleen
development (e.g. Brendolan et al., 2005), but the role of Nkx2-5 is far from clear
owing to the lack of a gut-specific knockout. The main questions to address are: what
is the position of Nkx2-5 in the spleen development network, and is loss of Nkx2-5
responsible for the defective spleen and pyloric sphincter development observed in
Bapxl'' mice? One model to investigate is that in which Bapxl regulates Nkx2-5,
which in turn regulates Hoxl 1. Hoxl 1 expression overlaps that of Nkx2-5 in the SMP
at El0.5 (Hecksher-Sorensen et al., 2004), and is lost in the Bapxl '' gut (Lettice et
al., 1999b).
An interesting aspect of the early Nkx2-5 expression pattern is that transcripts
are detected bilaterally in the SMP at E9.5. Bapxl is expressed in the same manner;
thus there is now evidence that two spleen development markers are expressed
bilaterally at E9.5. This bilaterality echoes the situation in Xenopus, in which Nkx2-
5-expressing splenic precursors are initially located on both sides of the embryo, the
left-side of which preferentially undergo spleen development (Patterson et al., 2000).
The bilateral existence of cells with the potential to undergo differentiation into
splenic tissue - and the potential deregulation of this - could provide a mechanism
for the early establishment of polysplenia. The Rwhs mutant reported in this chapter
also has a polysplenic phenotype; it is, however, anticipated that this was caused by a
slightly later aberration in the spleen development program, as general gut
asymmetry was unaffected.
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Bilateral expression in the E9.5 SMP was also observed for NGRS-LacZ. The
NGRS was cloned based on published reports of sequences lying between -1.6 and -
3.5kb upstream of Nluc2-5 which confer gut expression. AR2 (thyroid, pharyngeal
endoderm, gut, outflow tract, right ventricle) and IR2 (inhibitory on cardiac
expression) elements have been proposed to exist in this region, with an AR7
element encompassing them (Schwartz and Olson, 1999). Most of the published data
on Nkx2-5 regulation supports this model. An exception is that in one study the
complete 3.3kb of DNA upstream of Nkx2-5 was found to confer both gut and major
heart expression despite including the IR2 (Searcy et al., 1998). Four other studies
have contradicted this finding and instead support the model that inclusion of the IR2
minimises cardiac expression (Lien et al., 1999; Reecy et al., 1999; Tanaka et al.,
1999c; Lien et al., 2002). The data presented in this chapter further supports this
model.
A number of conserved transcription factor binding sites previously reported
in the AR2 were confirmed during the in silico analysis: 6 GATA , 4 Smad, 1 HNF-
3, and 1 Nkx2-5 site (Sparrow et al., 2000; Lien et al., 2002). Two of these GATA
sites are required for spleen expression (Searcy et al., 1998), whilst the HNF-3 site is
not (Lien et al., 2002). The Nkx2-5 site has also been deemed to not be required for
gut expression at El 1.5 (Lien et al., 2002); the data presented to support this
conclusion appears, however, to indicate that gut expression is somewhat reduced
when this site is mutated. Novel transcription factor binding sites were also identified
during the in silico analysis, including four predicted Bapxl binding sites.
The NGRS has been demonstrated to be a good specific marker of spleen (and
pyloric sphincter) development, both in wild type and mutant embryos (including the
novel spleen mutant Rwhs). The putative splenic mesenchyme is marked by NGRS-
LacZ expression at E10.5-11.5, and the spleen primordium expresses this transgene
throughout development. As mentioned previously, the activity of the NGRS
throughout the SMP at E9.5 may provide information on the earliest origins of the
spleen.
NGRS activity is not dependent on Bapxl during gut morphogenesis. A
positive aspect to this lack of dependence is that it provides the potential for NGRS to
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drive transgene expression on the Bapxl '' background. This could be exploited in
experiments to rescue the Bapxl'' phenotype. The different stages and aspects of the
mutant phenotype could be examined by artificially expressing each of the
downstream genes known to be lost on the Bapxl '' background. Another potential
use for this Bapxl-independent gut enhancer is to mark pyloric sphincter and perhaps
splenic precursors and examine what happens to them during development of the
Bapxl' phenotype. The fact that LacZ expression was still present in the mutant guts
suggests that these two tissues are not lost in Bapxl'' mutants, but instead undergo
abnormal development and become disorganised. It is certainly known that spleen
cells persist in these mutants (Akazawa et al., 2000). What is now of interest is to
examine the subtleties of NGRS-driven expression on the Bapxl'' background,
especially with respect to the ectopic cysts recently noted in these mutants (Asayesh
et al., 2006).
The independence of the NGRS from Bapxl regulation may also be
evidenced by its expression pattern in wild type guts. Whereas Nkx2-5 is expressed
in two distinct domains of the SMP at El0.5, the NGRS drives expression
throughout. The additional NGRS expression is in the tip of the SMP and the
underlying mesenchyme. Bapxl is also normally expressed in these tissues in a
manner largely exclusive to that of Nkx2-5. It is therefore possible that Bapxl has a
two-fold role in Nkx2-5 regulation, and can also inhibit endogenous Nkx2-5
expression, modulating the pattern conferred by the NGRS. Further evidence for this
idea may be derived from the expression patterns later in development: NGRS
expression in the spleen and pyloric sphincter is contiguous, whereas Nkx2-5
expression in these tissues is separate; the gap in Nkx2-5 expression corresponds to
the posterior stomach region where NGRS expression overlaps Bapxl. Inhibition of
Nkx2-5 by Bapxl could be mediated by FgflO (which is downstream of Bapxl and
expressed in an appropriate part of the SMP (Hecksher-Sorensen et al., 2004)), as
Nkx2-5 expression appears to be extended into the mesenchyme underlying the tip of
the SMP at E10.5 in FgflO'1' embryos (data not shown). The proposed inhibition of
Nkx2-5 by Bapxl is not irreconcilable with the loss of Nkx2-5 expression in the
Bapxl''' gut, as expression of these genes overlaps in the SMP at E9.5 and so Bapxl
may be required for initial Nkx2-5 activation at this stage.
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The NGRS was used to drive LacZ in the studies presented here, but a variety
of other transgenes could be placed under its regulation. Depending on the choice of
reporter gene, NGRS could be exploited in lineage tracing or genetic manipulation




Lineage tracing using the NGRS
...or: "Science is a wonderful thing if one




3.1.1 The need for lineage tracing
The Nkx2-5 gut regulatory sequence (NGRS) discussed in the previous
chapter provides a way of tagging cells, by driving reporter gene expression in the
developing spleen and pyloric sphincter. Both these tissues are of clinical importance
and yet their origins are poorly understood. Some insight into these origins may be
drawn from the NGRS-LacZ expression data presented in Chapter 2. In addition to
marking the distinct spleen and pyloric sphincter structures from -E12.0 and El 1.5
respectively, the NGRS also confers LacZ expression in earlier tissues: the splenic
mesenchyme at E10.5 and El 1.5, the putative pyloric sphincter region at E10.5, and
throughout the SMP and nascent underlying mesenchyme at E9.5. Given these
expression patterns - and data from Xenopus suggesting that splenic precursors
initially reside on both sides of the embryo (Patterson et al., 2000) -1 hypothesise the
following: that the NGRS marks presumptive splenic mesenchyme underlying the
SMP on both sides of the gut from E9.5, that this expression becomes restricted at
E10.5 to a dorsal region of left-side gut mesenchyme, and that this patch of cells will
contribute entirely to the spleen. Lineage tracing is necessary to address these
hypotheses.
3.1.2 Inducible Cre systems
An appropriate way to perform lineage tracing during gut development would
be to use a tissue-specific marker that upon temporal induction becomes permanently
activated. In this way, cells could be marked at a specific time point and any
observed staining would be attributable to cells that were expressing the marker at
this stage only. An adaptation of the LacZ reporter system that would facilitate this
goal is activation by a tamoxifen-inducible Cre recombinase, expression of which is
driven by a tissue-specific enhancer. A number of versions of tamoxifen-inducible
Cre exist (CreER™, CreERT, CreERT2), each of which is a fusion protein
containing the PI phage recombinase Cre and a mutant oestrogen receptor (ER)
ligand-binding domain (LBD) (Danielian et al., 1998; Metzger et al., 1995; Feil et
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al., 1997). These fusion proteins are functionally inactive, as they are sequestered in
the cytoplasm due to interaction between the LBD and cellular heat shock proteins
(Scherrer et al., 1993). However, translocation to the nucleus can take place when the
synthetic oestrogen tamoxifen (or its metabolite 4-hydroxytamoxifen [OHT]'9) is
administered and this interaction is disrupted. The engineered mutations in the LBD
render it unable to interact with endogenous oestradiol (Feil et al., 1996; Feil et al.,
1997).
Once in the nucleus, the Cre portion of the fusion protein can utilise its
recombinase activity and recombine genomic DNA at artificially inserted 34bp LoxP
recognition sites (see (Schipani, 2002) for an introduction to the Cre-LoxP system)
(Feil et al., 1996). Lineage tracing can therefore be achieved using a Cre-inducible
reporter line, such as R26R (inducible LacZ) (Soriano, 1999). This system is
summarised in Figure 3.1.
The percentage of cells expressing an inducible reporter gene can be
controlled by altering the dosage and number of applications of tamoxifen. This drug
is usually administered by maternal intraperitoneal injection. Non-specific
toxicological effects occurred at high doses with earlier versions of tamoxifen-
inducible Cre; this issue was addressed with the creation of the more sensitive
CreERT2 line (Feil et al., 1997; Indra et al., 1999). Once the genomic R26R locus is
cleaved this change is faithfully transmitted to the daughter cells, thus allowing the
lineage of a recombined cell to be traced. Most studies report low to undetectable
recombination in the absence of tamoxifen. Suboptimal doses can be employed to
limit marking to only a few cells in a population (Fischer et al., 2006a).
Recombination by CreERT is induced within 6 hours of a single (3mg)
intraperitoneal tamoxifen injection, but cannot be detected at 3 hours (Hayashi and
McMahon, 2002). The level of P-gal activity, and the proportion of cells exhibiting
activity, increases dramatically between 6 and 12 hours post-injection. At the other
end of the scale, the duration of tamoxifen activity is a factor which needs to be taken
into account in order to perform a successful lineage tracing exercise. A single 3mg
tamoxifen injection administered at E8.5 will exert its main activity within 24 hours,
as shown by the major nuclear accumulation of Cre-ERT during this period; by 48
19
Metabolism occurs in the maternal liver, thus this metabolite must be used directly when being
applied to cells in a culture system
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Figure 3.1 Schematic showing how tamoxifen induces Cre recombinase-mediated
activation of reporter gene expression
1. A transgene encoding a Cre-ERT2 fusion protein, under the control of a tissue-specific
promoter (TSP), is transcribed. 2. The Cre-ERT2 transcript is exported from the nucleus
and translated into a fusion protein. 3. Cre-ERT2 proteins are sequestered in the cytoplasm
with heat shock proteins (HSP), preventing Cre activity. 4. Exogenous OHT (the metabolite
of tamoxifen) (T) binds to the ERT2 ligand binding domain and disrupts the interaction with
HSP. 5. Cre-ERT2 can now translocate to the nucleus. 6. In this example, Cre-mediated
recombination occurs at the R26R locus, which contains a ubiquitous promoter (UP), a
transcriptional termination STOP cassette (Neo, triple p(A)), and LacZ. 7. Recombination
of the Lox sites (white triangles) flanking the STOP cassette permits LacZ expression. 8.
The LacZ transcript is translated to produce (5-gal protein, which can be detected using
X-gal staining.
hours, the amount of CreERT in the nucleus is dramatically reduced, but some
recombination does still occur during the 24-48 hour period (Hayashi and McMahon,
2002).
The combined use of tamoxifen-inducible Cre with the Cre-inducible R26R
reporter has been employed in a number of excellent lineage tracing studies, most
notably in the developing limb (Kimmel et al., 2000; Guo et al., 2003; Ahn and
Joyner, 2004). Adult tissues and cells in culture can also be marked in this way
(Hayashi and McMahon, 2002). In addition to lineage studies, a second, greater body
of literature exists on initial studies into the utility of novel tissue-specific
CreERT/ERT2 lines as opposed to full lineage studies. Tissues studied in this way
include: limb ectoderm (Indra et al., 2005), epidermal keratinocytes (Indra et al.,
2000; Indra et al., 2005), heart (Sohal et al., 2001), liver (Tannour-Louet et al.,
2002), pancreatic islets (Zhang et al., 2005), and melanocytes (Yajima et al., 2006).
3.1.3 Experimental plan
The NGRS was demonstrated in Chapter 2 to be a suitable marker of spleen
development. No published lineage tracing study has addressed the development of
this tissue. We decided to use NGRS to drive CreERT2 on the R26R background, in
order to mark and trace the descendents of the SMP and splenic mesenchyme in a
temporally inducible manner. A second motive for creating an NGRS-CreERT2 line
was to direct a gut-specific Nkx2-5 knockout. The full Nkx2-5 knockout is not
informative about gut development, as homozygous null mice die before the onset of
spleen development (Lyons et al., 1995). Nor can information be derived from
chimaeric mutants, as embryonic lethal cardiac defects occur with as little as 20%
contribution of knockout cells (Tanaka et al., 1999a). However, inducible gut-
specific loss of Nkx2-5 could be achieved if mice carrying the NGRS-CreERT2 gene
were crossed to homozygous "Floxed" Nkx2-5 mice - a line already in existence
(Pashmforoush et al., 2004).
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3.2 NGRS-CreERT2
A cloning strategy was designed to place the NGRS and heterologous /?-
globin promoter (used in the NGRS-LacZ construct) upstream of CreERT2
(tamoxifen-inducible Cre), and express this transgene on the R26R (Cre-inducible
LacZ) background. It was envisaged that a number of important questions could be
answered about early gut and spleen development using this system, based on the
NGRS expression patterns in Chapter 2. Firstly, by inducing LacZ expression in the
bilateral SMP at the stage at which no mesenchyme lies between the SMP and the
gut endoderm (E9.25-9.5, therefore administering tamoxifen at -E8.5), the possible
derivation of this future mesenchyme from the SMP could be investigated. This
would obviously require careful timing of matings and injections, and the analysis of
many litters for the data to be valid. More generally, this experiment would allow
lineage tracing of the -E9.5 SMP, with particular attention paid to the contribution of
its descendents to the spleen. A similar analysis could be performed by marking the
SMP and underlying mesenchyme at E10.0 and El 0.5, again with particular
emphasis on development of the spleen (and pyloric sphincter).
3.2.1 Cloning of NGRS-CreERT2
An NGRS-CreERT2 construct was successfully generated, using the strategy
depicted in Figure 3.2. A detailed written description of the cloning process is
provided in the Appendix. An earlier cloning strategy was abandoned due to
problems in cloning the large intron-CreERT2-poly(A) fragment. This was eventually
circumvented by sub-cloning through the pZErO-1 vector, which confers lethality on
host bacterial cells unless a cloned fragment disrupts the gene responsible (ccdB),
thus allowing direct selection of rare cloning events. The rationale behind inclusion
of a rabbit P-globin intron is that introns increase transgene expression, albeit for not
entirely clear reasons (though probably due to the link between splicing and
transcription) (Choi et al., 1991; Clark et al., 1993). Similarly, a polyadenylation
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Figure 3.2 Schematic of NGRS-CreERT2 cloning strategy
Details are provided in the main text (Section 3.2.1) and in the Appendix.
Black box: rabbit j^-globin intron; white box: SV40 poly (A)
I2.1-
3.2.2 Generation of NGRS-CreERT2 lines
The construct was prepared for pronuclear microinjection and injected in
seven sessions. Progeny were genotyped at weaning by PCR for a ~0.25kb Cre
product ("ShCre" primers - detailed in Chapter 7). Positive mice were then
genotyped in a second confirmatory PCR, to detect a ~1.7kb product spanning the 3'
of the NGRS through to midway through Cre ("EPCreJn" primers). The integrity of
each DNA sample was confirmed by PCR for a region of the Myogenin gene.
The results of genotyping for the NGRS-CreERT2 transgene - and of
subsequent matings - are shown in Table 3.1. Of 242 mice generated by pronuclear
microinjection, 6 were transgenic (~2.5%). This is unusually low given that a
transgene integration frequency of ~28% is expected when microinjecting linear
DNA at a concentration of 2ng/pl, as was the case in these sessions (Brinster et al.,
1985). DNA preparation and microinjections were performed according to standard
protocols, so this is likely to be a construct-specific effect. Genotyping was
performed on mice at weaning, so it cannot be known whether more embryos
originally carried the transgene, but died in utero. Embryonic lethality directly
related to the injected DNA could be one explanation for the low frequency of
transgenic mice.
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Session Number of progeny Number transgenic Lines
1 45 1 m (Founder 1) x F1 - no line established
2 54 1 m (Founder 2) x F1 - "Line 2"
x R26R - line established
3 29 0 -
4 23 0 KBHHHHBBHHHHB
5 35 1 f (Founder 3)
1 m (Founder 4)
x R26R - "Line 3"
No line established
6 31 1 f (Founder 5) x R26R - "Line 5"
7 25 1 m (Founder 6) No line established
Table 3.1 - Results of NGRS-CreERT2 microinjection sessions and matings
Lines were established by breeding onto the [CBA x C57BL/6] F1 and/or R26R backgrounds.
Genotyping was performed using both described Cre primers sets and also primers for the
R26R locus, where appropriate. Founder 1 failed to produce offspring. Transmission was
tested from Founders 4 & 6 in embryos, and no lines were established,
m: male, f: female
3.2.3 NGRS-CreERT2 expression analysis
Tamoxifen is required for translocation of the NGRS-CreERT2 protein
product into the nucleus; expression of the transgene does not require induction.
NGRS-CreERT2 expression was therefore examined in embryos derived from timed
matings of the six founder mice or, more commonly, their offspring with CD1
partners. Two methods were employed to examine expression. Firstly, reverse-
transcription PCR (RT-PCR) was performed on El 2.5 embryos and guts. Secondly,
in situ hybridisation was performed on both whole mount embryos and isolated guts
using a Cre probe. These methods were preferable to crossing onto the R26R
background and attempting to induce LacZ expression by maternal tamoxifen
injections, as the use of tamoxifen can be a complex process, requiring optimisation
of dosage and preparation. A lack of recombination (reporter expression) could be
due to problems at a number of stages. Thus expression was chosen as the initial
criteria for analysing the embryos rather than detection of site-specific
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recombination. If expression was detected then tamoxifen induction would be
performed, along with genomic PCR to confirm recombination.
3.2.3.1 RT-PCR
Expression of the NGRS-CreERT2 transgene was analysed by RT-PCR on
El 2.5 gut tissue. Males from the F1 generation of each of the three stable lines
(Lines 2, 3, and 520), and Founders 4 and 6 were mated with CD1 females to
generate at least one litter of transgenic embryos per founder/line for use in RT-PCR
analysis. Embryos were genotyped using both Cre primer sets previously described.
RNA was then prepared from all Cre-positive guts and typically two negative
littermates' guts, and random-primed cDNA was synthesised. Hprt (Hypoxanthine
guanine phosphoribosyltransferase) RT-PCR was performed as a control. The
primers for Cre RT-PCR flank the rabbit /3-globin intron; there is thus a difference in
the size of the product amplified from cDNA and genomic DNA. The expressed
form is ~0.3kb long, the genomic form ~0.88kb.
Cre RT-PCR analyses were performed on El2.5 guts for each founder/line at
different times during my PhD studies, as microinjection sessions were undertaken
throughout. Once all five founders/lines had been tested, genotyping and RT-PCR
{Hprt, Cre) were repeated in single summary experiments, the results of which are
shown in Figure 3.3. An adult mouse carrying another CreERT2 transgene was
obtained (K5CE, created by Duncan Whittaker) and RNA extracted from its
depilated back-skin (a site of transgene expression) to act as a positive control in this
final RT-PCR. The Cre RT-PCR primers were complementary to sequences in this
transgene.
Cre RT-PCR produced only an unspliced ~0.88kb product from all of the
transgenic gut cDNA samples, with no product being amplified from the non-
transgenic samples or the water control (Figure 3.3c). The original RNA samples
were therefore DNase-treated to remove genomic DNA, and thus to investigate the
possibility that low level expression was occurring but was being masked by
amplification of the more abundant genomic transgene sequences. Fresh cDNA was
20 Lines 3 and 5 were established on the R26R background but the mice selected for these matings
carried only the NGRS-CreERT2 transgene, and not the R26R transgene.
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then synthesised and re-analysed by Hprt RT-PCR (Figure 3.3f). A spliced Hprt
band was detected in all samples, confirming that good quality cDNA was present.
Cre RT-PCR, however, failed to detect Cre transcripts from any founder/line,
demonstrating that NGRS-CreERT2 is not expressed in the transgenic mice (Figure
3.3e).
A minor complication was that the "positive" control cDNA from the K5CE
mouse produced only an unspliced band - even after DNase treatment. This band was
not present in the -RT (reverse transcriptase) reaction, and thus appeared to be a
genuine RT-PCR product (rather than a product of amplification of contaminating
genomic DNA). Sequencing confirmed the product to be the Cre region to which the
primers were targeted. This indicates that, at least in the tissue analysed, an unspliced
Cre transcript was expressed in the K5CE mouse. The line in question has been
problematic for the group using it, producing erratic low-level Cre-mediated
recombination. Aberrant splicing could be responsible for this effect. Splicing of the
fi-globin intron is expected to occur in CreERT2 constructs (Daniel Metzger,
personal communication).
3.2.3.2 In situ hybridisation
In situ hybridisation for the Cre transcript was performed on E10.5 and E12.5
whole mount embryos and on El2.5 guts. Two ~660bp probes (one to be transcribed
from the T7 promoter, one from SP6) complementary to Cre were designed and
transcribed from a PCR product amplified using the two sets of primers listed in
Chapter 7 ("CrelSH"'). The reverse primer of each of these sets contains at its 5'
terminus the recognition sequence for either T7 or SP6 polymerase. No Cre
expression was observed in any tissue (data not shown). The Cre probe was also used
on El 1.5 control tissue from the ZRS-Cre line21, and found to detect expression in
the limb (data not shown). No expression was detected in age-matched CD1 control
tissue. A Hand2 probe was also used as a positive experimental control.
21 A line expressing Cre under the control of the ZRS (ZPA [Zone ofpolarising activity] regulatory
sequence), created by Dr Laura Lettice. The ZRS is an upstream enhancer for Shh and confers
expression in the developing limb. Embryos from ZRS-Cre x CD1 matings were genotyped using the
"ShCre" PCR primers and program listed in Chapter 7.
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Figure 3.3 Genotyping and RT-PCR analysis of NGRS-CreERT2 mice
a. ShCre genotyping PCR
Lanes: 1-5 - transgenic founder/line yolk-sac DNA (Line 2, Line 3, Founder 4, Line 5, Founder
6); 6 - non-transgenic yolk-sac DNA; 7 - transgenic ear-clip DNA from K5CE\ 8 - dH20
b: EPCreJn genotyping PCR
Lanes: 1-5 - transgenic founder/line yolk-sac DNA (Line 2, Line 3, Founder 4, Line 5, Founder
6); 6 - non-transgenic yolk-sac DNA; 7 - dH20
c: Cre RT-PCR on cDNA prepared from non-DNase treated RNA
Lanes: 1 -5 - transgenic founder/line cDNA (Line 2, Line 3, Founder 4, Line 5, Founder 6); 6 -
non-transgenic cDNA; 7 - transgenic cDNAfrom K5CE\ 8 - transgenic genomic DNA; 9 - non-
transgenic genomic DNA; 10 - dH20
d: HPRTRT-PCR on cDNA prepared from non-DNase treated RNA
Lanes: as per (c). Un: Unspliced, Sp: spliced.
e: Cre RT-PCR on cDNA prepared from DNase-treated RNA
Lanes: 1-5 - transgenic founder/line cDNA (Line 2, Line 3, Founder 4, Line 5, Founder 6); 6 -
non-transgenic cDNA; 7 - transgenic cDNA from K5CE (+RT); 8 - transgenic cDNA from K5CE
(-RT); 9 - transgenic genomic DNA; 10 - non-transgenic genomic DNA; 11 - dH20
f: HPRT RT-PCR on cDNA prepared from DNase-treated RNA
Lanes: as per (e)
a-b: All lanes contain 5p.l of a 20|xl PCR reaction.
c-f: All lanes contain 5pl of a 25(xl RT-PCR reaction performed on 2pl cDNA (from 20|xl total
cDNA, reverse transcribed from approximately 0.9ug RNA).
All gels: Ladder lanes (X) contain 6pl of 55.6ng/pl1kb ladder. All gels are 2% agarose/TAE
and were run at 100V for 1 hour
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3.2.4 NGRS-CreERT2 discussion
The reasons for the lack of NGRS-CreERT2 expression are unknown. In
addition to the absence of detectable expression, very few transgenic mice were
actually produced (6/242; ~2.5%). Anecdotal accounts exist of difficulty in
generating transgenic mice containing CreERT2 transgenes by microinjection,
though no concrete reason for this supposed effect has been proposed. A fundamental
issue with delivery of DNA into the genome by microinjection is that copy number
cannot be controlled and so large numbers of tandemly repeated inserts may be
introduced. This could obviously be an issue when dealing with a gene such as
CreERT2 which produces a fusion protein which is sequestered along with essential
cellular components in the cytoplasm. It might therefore be that only transgenic
embryos with a low copy number, and low or no expression, survived. Alternatively,
copy number may have just generally been too low for expression, independently of
any effect on survival. Transgenes may have also inserted into the genome at
locations which prevented their expression. Such issues are inherent to the method of
creating transgenic animals through microinjection of DNA.
It should of course also be noted that many published accounts do exist of
transgenic mice successfully generated following microinjection of CreERT2
transgenes. The problem may therefore be specific to the NGRS. Expression of this
enhancer was not studied before E8.5, though major early cardiac expression was not
expected based on the agreement of my NGRS-LacZ expression data with similar
published accounts of this region. There could, however, be earlier expression in
other tissues. The cytoplasmic accumulation of the CreERT2 protein during early
development could thus pose problems. It may therefore be that the few transgenic
embryos that do survive to term are those which do not express the transgene.
This strategy was abandoned and a new direction pursued. This is described
in the next section.
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3.3 NGRS-LoxSTOPLox-LacZ
A second strategy for marking splenic precursors was designed following the
failure to establish a line expressing NGRS-CreERT2. In this new approach, the
NGRS and [i-globin promoter are placed upstream of a LoxSTOPLox (excisable
transcriptional termination sequence) cassette and LacZ, to create the NGRS-
LoxSTOPLox-LacZ transgene. Mice carrying this transgene would be crossed with
those ubiquitously expressing CreERT2, and the LoxSTOPLox sequence recombined
in all cells following tamoxifen induction, leaving a functional NGRS-LacZ
transgene. This genomic change would be transmitted to all descendents of the
induced cell; LacZ would only be expressed, however, in cells in which the NGRS is
active. A benefit of this strategy is that it circumvents the need to clone CreERT2 - a
cloning step which posed a number of problems during the previous approach - as a
ubiquitous CreERT2 line was available.
This method has the potential to address some of the questions outlined
previously as cells can be marked at a specified time; it also, however, has a major
limitation in that continued activity of the NGRS is required for LacZ expression. In
the first (NGRS-CreERT2) strategy, Cre-mediated recombination permanently
marked cells and their descendents at one specific time-point, thus permitting lineage
tracing. Lineage tracing is not possible in the second (NGRS-LoxSTOPLox-LacZ)
system as the descendents will no longer be tagged if NGRS activity ceases or if cells
move out of the region of NGRS activity (as LacZ is no longer driven by the NGRS).
Conversely, if an unrelated cell moves into the domain of NGRS activity, it may
commence LacZ expression (as the LoxSTOPLox sequence is already recombined in
all cells). The NGRS-LoxSTOPLox-LacZ strategy does however offer the opportunity
to perform a form of "clonal analysis", in which the behavioural history of a cell can
be visualised by examining the pattern of marked cells (its ancestors) (Petit et al.,
2005). The proportion of cells marked can be controlled by altering tamoxifen
dosage, thus allowing analysis of individual or small groups of cells. The behaviour
of cells in which the NGRS is active could be followed in this way.
Information on early spleen development could be gained by performing this
type of analysis at day intervals from E9.5-11.5, and examining the behaviour of
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marked cells from each stage. Findings would need to be confirmed in other ways,
for example by lineage tracing, but nonetheless could be insightful. The strategy of
using a ubiquitously expressed tamoxifen-inducible Cre with a tissue-specific
LoxSTOPLox has been used in published studies, including that of Hayashi &
McMahon, who traced cells in the E8.5 embryo (Hayashi and McMahon, 2002).
3.3.1 Cloning of NGRS-LoxSTOPLox-LacZ
The NGRS-LoxSTOPLox-LacZ cloning strategy is shown in Figure 3.4, and a
detailed written account is provided in the Appendix.
3.3.2 Generation ofNGRS-LoxSTOPLox-LacZ lines
The NGRS-LoxSTOPLox-LacZ construct was microinjected in two sessions.
The number of pups genotyped was small, due to low numbers of healthy
microinjected oocytes being generated and the death of one of the recipient mothers
prior to weaning resulting in the death of her offspring. Of the 58 pups genotyped by
duplicate PCR for LacZ/Myo, two were LacZ-positive (one male, one female). These
two founders were bred with [CBA x C57BL/6] Fl partners in order to establish
stable lines.
3.3.3 NGRS-LoxSTOPLox-LacZ analyses
The NGRS-LoxSTOPLox-LacZ mice were to ultimately be crossed with a line
expressing tamoxifen-inducible CreERTl under the control of a ubiquitous promoter.
However, as a proof of principle, males from both lines were first mated with
females expressing a standard (non-inducible) ubiquitous Cre, to test a) whether
NGRS-LoxSTOPLox-LacZ could be transmitted to embryos, and b) whether this
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Figure 3.4 Schematic of NGRS-LoxSTOPLox-LacZ cloning strategy
Details are provided in the main text (Section 3.3) and in the Appendix.
provided by Drs Dirk-Jan Kleinjan and Peter Hohenstein22. To confirm that any
observed LacZ activity was indeed the result of Cre-mediated excision of the STOP
signal, the NGRS-LoxSTOPLox-LacZ males were also mated with CD1 (Cre-
negative) females. Two litters of embryos were examined on the Cre background,
and two on the CD1 background, for each founder.
Embryos were recovered and analysed for LacZ expression by X-gal staining.
DNA was prepared from yolk-sacs and used for genotyping of sequences from the
NGRS-LoxSTOPLox-LacZ transgene. Cre genotyping was not performed as maternal
Cre is expressed in all oocytes (regardless of whether the zygotic genome carries the
transgene) and is known to faithfully instigate recombination, regardless of the
source of the Cre (Dirk-Jan Kleinjan, personal communication).
The genotyping procedure is explained in Figure 3.5a. Genotyping was
performed in at least duplicate for portions of the LacZ (PCR 1) and STOP (PCR 2)
sequences. A positive result from the latter PCR indicated that the embryo was
transgenic but that recombination (excision of the STOP sequence) had not occurred.
The lack of a STOP PCR product was indicative of one of two things: 1) that the
embryo was not carrying the transgene, or 2) that recombination had successfully
occurred (STOP excised). Thus a third PCR assay was performed in duplicate on
LacZ-positive embryos: for recombination (PCR 3). A ~230bp product was only
amplified if recombination had taken place; if the LoxSTOPLox sequence was still
intact then a ~1.6kb product was generated. The result of this final PCR often had to
be interpreted on the basis of the presence or absence of the small (recombined) band
as the large band could not usually be amplified from yolk sac DNA. The result of
these genotyping PCRs are provided for both lines in Table 6 in the Appendix, and
are summarised in Sections 3.3.3.1 and 3.3.3.2.
22gl-Cre is expressed from the ubiquitous CAGGS promoter (fi-actin promoter with upstream CMV
enhancer) in all cells, including the germline.
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3.3.3.1 Male founder
3.3.3.1.1 Male founder: Analysis
Two El 2.5 litters on the gl-Cre background (9 and 11 embryos; 20 total) and
two El2.5 litters on the CD1 background (10 and 19 embryos; 29 total) were
analysed. Two embryos on the gl-Cre background (1 from each litter) exhibited X-
gal staining in a pattern typical of NGRS-LacZ expression: strong staining could be
seen in the thyroid primordium and gut region, with sparse expression in the outflow
tract (Figure 3.5b i). Mild ectopic expression was also present in the limbs. The guts
were dissected out and expression was found to be localised to the pyloric sphincter,
spleen, and dorsal pancreatic mesenchyme (Figure 3.5b ii,iii). Gut expression was
low in one of the embryos; the other gut had strong sphincter staining, though
expression in the spleen and dorsal mesenchyme was still weaker than that typically
conferred by the NGRS in NGRS-LacZ embryos.
9/20 (including the two X-gal stained) embryos from the gl-Cre matings were
LacZ-positive; none of these carried the STOP sequence, suggesting that
recombination had occurred in all nine embryos. However, only two exhibited LacZ
expression. The recombination PCR subsequently revealed that only the two stained
embryos had undergone recombination (i.e. small band in PCR 3); no recombination
was detectable in the seven non-stained embryos. This produced a dichotomy as
these embryos were shown in triplicate LacZ PCRs to be transgenic and yet the
STOP and recombination PCR results taken together suggested that these embryos
had never carried the STOP sequence23. It is unlikely that the STOP and
recombination PCRs both failed, as they were performed up to three times for each
embryo and only small products needed to be amplified. It therefore seemed possible
that two transgenes might be being transmitted: the NGRS-LoxSTOPLox-LacZ and a
LacZ fragment.
23 The recombination PCR is not often directly informative for the presence of a non-recombined
LoxSTOPLox sequence as the ~1.6kb product can only rarely be amplified from yolk sac DNA;
absence of this large band is not therefore indicative of absence of the LoxSTOPLox cassette from the
genome. Thus only the presence or absence of the recombined (small) band is informative, when
interpreted with respect to the STOP PCR results.
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The confusion surrounding this line deepened upon analysis of the two litters
from CD1 mothers. Whilst no X-gal staining was observed in the first litter of ten
embryos (as expected), 4/19 embryos from the second litter exhibited major staining
in the gut (Figure 3.5b). NGRS-typic expression was also present in the thyroid and
outflow tract, with strong ectopic expression again noted in the limbs. Staining in
these embryos was stronger than in those on the gl-Cre background, though splenic
expression was still lower than in NGRS-LacZ embryos and was not contiguous with
the sphincter expression domain.
Genotyping of the embryos from CD1 mothers revealed that 4/10 in the first
litter (none of which stained) were LercZ-positive. Three of these transgenic embryos
also carried a non-recombined LoxSTOPLox sequence, as expected (i.e. STOP-
positive). A STOP sequence could not however be amplified from the fourth
embryo's DNA; this was not due to recombination of the sequence out of the genome
and so once again it appeared that the NGRS-LoxSTOPLox-LacZ transgene and a
separate LacZ fragment might be segregating independently.
In the second litter on a CD1 background 11/19 were LacZ-positive, and four
of these displayed X-gal staining. This was totally unexpected as the CD1 line does
not carry Cre and as such recombination should not occur. And indeed
recombination had not occurred: 8/11 of the LacZ-positive (including the four
stained) embryos were PCR-positive for the intact STOP sequence. The remaining
three LacZ-positive (non-stained) embryos did not carry a STOP sequence; once
again this was a genuine absence as opposed to a result of recombination (i.e. no
small band in recombination PCR, suggesting the presence of only a LacZ fragment).
3.3.3.1.2 Male founder: Interpretation
The male founder was of no immediate use for further experiments as gut-
specific X-gal staining occurred even in the absence of Cre on the CD1 background.
The reasons for this anomaly were unclear and the genotyping results confusing. I
propose the following explanation, which is summarised in Figure 3.5c: at least two
transgenes are propagated from the male founder. The first is the intact NGRS-
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Figure 3.5Analysis of NGRS-LoxSTOPLox-LacZ embryos
a) Genotyping primers. Embryos were genotyped in the first instance for part of the LacZ(PCR 1)
and STOP (PCR 2) sequences. LacZ-positive embryos were then subjected to a PCR assay for
recombination (PCR 3) which produces differentially sized bands dependent on whether recombination
has occurred. The results of the genotyping are presented in Table 6 of the Appendix.
b) X-gal staining of / acZ activity in offspring from the male founder: i-iii - embryos carrying a
recombined transgene, from gl-Cre mothers; iv-vi - embryos with a non-recombined transgene, from
CD1 mothers. Staining was present in embryos on both backgrounds in (i, iv) the outflow tract (arrow),
gut (asterisk), and ectopically in the limbs (boxed in i for clarity), and upon dissection was found
to be in the pyloric sphincter (ii,v) and spleen (iii, vi).
c) Possible explanation for the observed genotyping and staining results in embryos from the male
founder. This is a companion to the discussion in Section 3.3.3.1.2. The numbers in the table show
the number of embryos with each possible genotype; the numbers in brackets denote how many
exhibited X-gal staining. NTG: Non-transgenic, PS: pyloric sphincter, Sp: spleen, St: stomach, TG:
transgenic.V '
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The second transgene is a fragment containing LacZ (or at least the portion examined
by PCR), which was not expressed/functional in any of the embryos examined.
The finding that four of the eight embryos on the CD1 background carrying
an intact NGRS-LoxSTOPLox-LacZ transgene (LacZ-positive, 5T(9P-positive) could
still express LacZ may be explained by one of two possibilities:
1) NGRS-LoxSTOPLox-LacZ is "leaky" and some read-through of the
LoxSTOPLox sequence occurs in -half of the embryos (0/3 CD1 litter one,
4/8 CD1 litter two). The "leakiness" would go unnoticed on the gl-Cre
background, as recombination would occur regardless.
2) A third insertion event occurred, of a defective version of the NGRS-
LoxSTOPLox-LacZ transgene. Small deletions within the STOP sequence
would not be detectable as a size change in the STOP PCR product. Such
deletions could permit read-through/inactivation of the STOP sequence, thus
allowing LacZ-expression in the four stained LacZ+,STOP+ embryos on the
CD1 background. The DNA used for microinjection was re-sequenced and
confirmed to match that of the LoxSTOPLox cassette (in pBS302) from which
it was amplified, suggesting that there is no sequence-based reason for
inefficient transcriptional termination. However, the proposed alteration(s) of
NGRS-LoxSTOPLox-LacZ could have occurred following microinjection
(perhaps in the germline) or may have been present already in the injected
DNA at a lower copy number than the correct transgene. If the latter occurred
and the altered transgene were to integrate in multiple copies (as is the nature
of microinjected DNA) then this could also explain the more intense staining
noted in these four mice than on the gl-Cre background. A tandem array of
"correct" transgenes in this latter group might undergo Cre-mediated
recombination of all sequences between the first and last LoxP sequences in
the array, thus leaving only one functional copy; a tandem array of defective
transgenes which do not require Cre for their activity would, on the other
hand, possess many constitutively-active functional copies. It is also
conceivable that the "correct" transgene in one or both of the stained gl-Cre
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embryos was in fact the proposed third defective transgene, recombination of
which occurred.
The ideas above are purely speculative, and the likelihood of them occurring
is unknown. Regardless of the explanation, the line was of no further use.
3.3.3.2 Female founder
The X-gal staining and genotyping results from the female line were
decidedly easier to interpret. Two male offspring were mated with a gl-Cre and CD1
female each. A total of 6/14 embryos from the gl-Cre mothers were transgenic
(LacZ-positive), and all carried a recombined STOP sequence (S7W-negative; small
band in recombination PCR). None had only a LacZ fragment.
On the CD1 background, 26/30 embryos were transgenic (LacZ and STOP
positive) and none had undergone recombination, as expected. Again, LacZ and
STOP genotyping status correlated, demonstrating that the anomalies in the offspring
of the male founder were line-specific.
Despite the promising genotyping results none of the embryos displayed X-
gal staining. It is therefore assumed that the recombined NGRS-LoxSTOPLox-LacZ
was not expressed, possibly due to positional effects (silencing). This line was
therefore terminated.
3.3.4 NGRS-LoxSTOPLox-LacZ discussion
An NGRS-LoxSTOPLox-LacZ-based "clonal analysis" system was not
established. Often a relatively large number of microinjection sessions must be
performed before a line is successfully generated, but this was not an option for this
construct due to time restraints. It is this need for multiple sessions and the problems
outlined over the last few pages (potential fragmentation of DNA, copy number,
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positional effects) that highlight the limitations of microinjecting fertilised oocytes as
a method for generating transgenic mice. Though time did not permit it in this
instance, the option of introducing constructs into ES (embryonic stem) cells and
deriving transgenic mice from these should be given great consideration when
designing transgenic strategies. The ES cell approach allows isolation of cells
containing expressed single-copy transgenes, and permits "knocking-in" of
transgenes into a specified genomic locus.
Some mice from the male founder-derived NGRS-LoxSTOPLox-LacZ line are
still available and so the lab is now considering the possibility of breeding them to
try and transmit only the apparently "correct" transgene.
3.4 Discussion
Many of the questions surrounding SMP and early spleen development will
only be answered through lineage tracing studies. Given the large number of non-
transgenic and non-expressing mice generated during the NGRS-CreERT2
investigations, it is unlikely that this particular approach will be revisited by our lab.
There are of course other routes that can be explored, both utilising the NGRS and
otherwise. Upstream regulatory regions of other important spleen development
genes, particularly Hoxll, may provide a way to direct a spleen lineage tracing
exercise.
A knock-in of standard (non-inducible) Cre into the endogenous Nkx2-5
locus exists (Moses et al., 2001; Stanley et al., 2002). Although not inducible, when
used in conjunction with the ubiquitously expressed R26R reporter this would allow
tagging of the descendents of a splenic precursor to be marked even if expression
from the Nkx2-5 locus stopped (as permanent recombination of the R26R locus
occurred in the ancestral cell). Of course, LacZ expression in the Nkx2-5-Cre;R26R
line is obviously present in more tissues than that conferred by the NGRS (Moses et
al., 2001), and so this could confuse matters somewhat. However, such an approach
has been successfully used to map the fate of the cardiac neural crest (using Cre
under the control of the Writ I promoter and enhancer (Jiang et al., 2000)), the apical
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ectodermal ridge of the limb (with Cre knocked into the Enl locus (Kimmel et al.,
2000)), pancreatic epithelium {nestin controlled Cre (Esni et al., 2004)), and the
serosal mesothelium (using Cre inserted into a Wtl YAC (Wilm et al., 2005)).
Knocking Cre into an endogenous locus also overcomes the problem of position
effects - i.e. microinjected Cre DNA inserting in the genome at a position where it
comes under the regulation of local elements. Efforts to knock CreERT2 into the
endogenous Bapxl locus were made during my PhD studies; this is discussed later in
this section.
3.4.1 Alternative uses for the NGRS
Spleen-specific expression of GFP would be an ideal way to follow splenic
cells. In addition to the LoxSTOPLox-LacZ vector used in many lineage studies,
LoxSTOPLox-GFP also exists (Esni et al., 2004), and this could be used in
conjunction with an NGRS-driven inducible Cre line. The major advantage of GFP
detection is that it is immediate and can be performed on live tissue (unlike X-gal
staining). GFP is thus ideally suited to live imaging of reporter gene expression in
organ culture. An analysis of spleen development in an organ culture system has not
yet been reported, but data provided in the following chapter suggests that this is a
worthwhile avenue to explore.
A further way to perform lineage tracing is by specific cell ablation. The loss
of cells in the tissue of interest following ablation of precursor cells is an indicator of
lineage (though of course these absent cells may not be direct progenitors but simply
require some interaction with the actual ablated cells). Complete loss of Nkx2-5
expression would not be the way to achieve this, due to the early lethal effect (Lyons
et al., 1995; Ivanova et al., 2005)24. The NGRS could therefore be put to use to drive
24
Indeed, Nkx2-5-Cre has been used to drive diphtheria toxin subunit A expression, thus resulting in
specific ablation of /V£x2-5-expressing cells and a phenotype similar to the full knockout (lethal
cardiac defects by -E9.0) (Ivanova et al., 2005). A diphtheria toxin receptor is not required on the cell
surface in this strategy, as the A subunit is manufactured within and acts inside of the cell to inactivate
elongation factor 2. This leads to failure of protein synthesis and thus causes apoptosis (Ivanova et al.,
2005).
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ablation. One method to achieve this is by expressing the diphtheria toxin receptor on
the surface of cells in the tissue of interest and using maternal diphtheria toxin
injections to induce cell-autonomous ablation in the embryo (Saito et al., 2001). This
has been successfully used to dissect the islet cell lineage during pancreatic
development (Herrera et al., 1994).
3.4.2 Towards a gut-specific Nkx2-5 knockout
It was mentioned at the start of this chapter that an NGRS-CreERT2 line
would provide a way to direct a gut-specific Nkx2-5 knockout by crossing onto the
existing "floxed" Nkx2-5 strain. This "floxed" allele contains two LoxP sites which
flank the second (homeodomain-containing) exon of Nkx2-5 (Pashmforoush et al.,
2004). Mice carrying this floxed allele have been crossed with those expressing a
ventricle-specific Cre, thus generating a ventricle-specific Nkx2-5 knockout
(Pashmforoush et al., 2004). No gut mesenchyme-specific Cre lines exist and so this
is where the NGRS-CreERT2 line would have come into use. Though this line was
not established, generating a gut-specific knockout of Nkx2-5 should still remain a
major focus of work on early gut and spleen development. Using a gut-specific Cre
line in conjunction with the floxed-Mcc2-5 mouse seems the most logical approach,
and the use of a CreERT2 line would provide greater control. The NGRS could be
used to direct such a knockout, though awareness must be maintained that using a
regulatory element of the gene being knocked out could carry autoregulatory issues.
Indeed, autoregulation of Nkx2-5 in the embryonic gut has been proposed (Tanaka et
al., 1999c).
An alternative approach is to knock CreERT2 into another gene expressed in
regions of the gut comparable to those in which Nkx2-5 is expressed. To this end, I
made constructs to allow cloning of CreERT2 into the Bapxl locus (replacing the
Bapxl exon 1 coding sequence by homologous recombination), to be followed by
recombination of this DNA into the endogenous Bapxl locus; this was not, however,
completed. Nonetheless, this may be a method to investigate further as it circumvents
the issue of copy number because the transgene is homologously recombined into the
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genome in ES cells. Bapxl heterozygotes have normal gut development, so the
knock-in should not cause any complications. It should of course be noted that any
use of the CreERT2 system to produce a knockout could have a drawback in that the
knockout may not be 100% complete, for example if the pattern of recombined cells
is mosaic. However, dosage could be first optimised on the R26R background to
avoid this problem. Crossing of the Bapxl-CreERT2 line onto the R26R background




in an in vitro gut culture system
...Or: "Science may be described as
the art of systematic oversimplification"
- Karl Popper
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4.1 Introduction: Examining development in organ
culture
4.1.1 The need for organ culture systems
The laboratory mouse Mus musculus provides an excellent system in which to
study the fundamental processes of mammalian development. Another well-favoured
model is the zebrafish (Danio rerio); one of the main reasons for its popularity is that
the embryo is transparent and so cells can be tagged and followed during
development (Beis and Stainier, 2006). And herein lays a fundamental disadvantage
of using the mouse: developmental processes cannot be viewed as they happen
because mice develop within the uterus. All that can be achieved is to take a
"snapshot" at the stage at which the embryo was obtained - of what a tissue looked
like, of what genes it was expressing - and to try and relate this to comparable data
from earlier and later stages. Whilst such an approach can be informative there are
many questions which cannot be answered in this manner. Development is by
definition comprised of dynamic processes involving morphological change,
proliferation, apoptosis, and cell movement; the nuances of these processes cannot be
fully appreciated by looking at a time-course of staged embryos.
Progress has been made in recent years on imaging mouse development in
utero, by means of ultrasound (Turnbull et al., 1995) and magnetic resonance
microscopy (Hogers et al., 2000; Smith, 2001). External structures such as the heart
and neural tube have been examined by these methods (Turnbull et al., 1995).
However, in utero imaging is unlikely to become a reality for studying gut
development in detail. The emphasis must therefore fall on live imaging of explanted
organs and tissues. Embryonic mouse tissues which have been successfully cultured
as explants include the lung, limb, and ureteric buds, and even the whole embryo
(McAteer et al., 1983; Friedman, 1987; Srinivas et al., 1999; Moore-Scott et al.,
2003). Studies have focussed both on observing normal morphogenesis and on
manipulating development. A recent example of this latter type of study is the use of
siRNA-mediated repression of gene expression in embryonic kidney culture (Davies
et al., 2004).
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4.1.2 Foregut organ culture
Foregut organ culture is still a relatively unexplored technique, but one
extremely worthy of attention:
"Techniques to better study gut development are direly needed. If explant culture of the
entire gut as an organ early in development could be realized, then experimental embryologic and
molecular techniques could be combined, vastly improving the ability to study specific factors and
their role in gut patterning. These areas should be the focal points of research during the next
decade."
- (Roberts, 2000)
The majority of published gut explant studies have been concerned with the
intestine (Nishijima et al., 1990; Kapur et al., 1992; Young et al., 1996; Quaroni,
1985; Altmann and Quaroni, 1990; Hearn et al., 1999; Duh et al., 2000); there is a
relative dearth of information on the optimal ways to culture foregut (stomach)
tissue. Segments of embryonic intestine are tubular and initially uniform making
them ideal candidates for explant culture. However, the tissue of interest in this
chapter - the spleen - develops in close association with, and must therefore be
cultured in contact with, the stomach, which is not such a uniformly shaped piece of
tissue. Nonetheless, stomachs can be cultured: for example, Aubin and colleagues
cultured El2.5 stomachs for 72 hours in 1:2 MatrigekBGJb medium25 to study the
effects of FGFlO-soaked heparin beads on gene expression (Aubin et al., 2002).
Spleen-only cultures have also been performed: El3.0 spleens were reported to grow
for four days on Nucleopore membranes in complete medium26 (Bertrand et al.,
2006). However, explant morphology was not important in this latter study, as the
method of assessment was flow cytometry of cell suspensions obtained from the
cultures. The spleens were also in isolation from other gut tissues and thus this
system is not of any use when hoping to understand how normal spleen
morphogenesis progresses. Analysis of early spleen morphogenesis in culture
therefore remains unexplored territory.
25
Containing 0.2mg/ml ascorbic acid and 0.1% heat-inactivated foetal bovine serum.
26
OptiMEM, 10% foetal calf serum (FCS), 1% Pen/Strep.
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4.1.3 Experimental rationale
Development of the murine spleen is a rapid process and hence an ideal
candidate for investigation in organ culture. At El 1.5 the spleen is visible only as a
bulge of mesenchyme on the dorsal face of the posterior stomach, and yet by El2.5
the spleen is present along the length of the dorsal stomach as a distinct elongated
structure. An interesting feature of both these early spleen structures is the existence
of connections with the underlying stomach. A posterior connection links the splenic
mesenchyme with that surrounding the dorsal pancreatic bud, whilst an anterior
connection exists between the tip of the spleen and the stomach (Figure 4.1). The
nature of the cells constituting these connections is unknown, though from my own
observations they appear to be mesenchymal. The cells lying between these
connections - comprising the main body of the spleen - do not maintain a physical
connection with the underlying stomach; the mechanism for this separation is
unclear.
The anterior connection adopts an increasingly anterior position along the
stomach between ~E11.5-12.5, in conjunction with the leading edge of the spleen;
the anterior connection may therefore play a role in the expansion of the spleen
towards the anterior stomach. The mechanism for how this rapid expansion occurs is
unknown. Migration of the spleen primordium along the dorsal face of the stomach
(presumably with concomitant proliferation) is one attractive model, with many
aspects to investigate: what are the splenic cells migrating towards; by what
mechanism do they move along the stomach; is there cellular or tissue migration?
The anterior spleen connection could feasibly direct this migration towards the
anterior stomach, particularly if the leading edge is undergoing rapid proliferation.
An alternative view is that the splenic precursors arise from the stomach itself, in a
posterior-anterior wave along the length of the future spleen. Again, there are many
avenues to investigate with this model: what properties specify these cells as being
splenic precursors; can they be identified at an earlier stage; is the cue to commence
splenic development conferred by a signal which is propagated in a posterior-anterior
wave; if so, what is the nature of this signal? A role for the anterior connection could
again be envisaged in this model, if it represents the anterior limit of a splenic
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Figure 4.1: The connections of the E12.5 spleen
a: Section through an E12.5 gut showing the connections (black arrows) the spleen
mesenchyme makes with the underlying gut tissue. Blue cells are X-gal stained for
NGRS-LacZ activity. 7pm paraffin wax microtome section, counterstained with Nuclear
Fast Red to aid visualisation. 5x magnification.
b: The anterior spleen connection appears to be continuous with the outer layer of
stomach mesenchyme/mesothelium. The boundary of this apparent continuum is
marked by a dashed yellow line. NGRS-LacZ expression is denoted by X-gal
staining. 30pm agarose vibratome section. 10x magnification,
c: The posterior spleen connection is continuous with the mesenchyme surrounding
the dorsal pancreatic bud (dp). NGRS-LacZ expression can also be seen in the
mesenchyme of the primitive pyloric sphincter. 30pm agarose vibratome section. 10x
magnification.
Yellow scale bars: 100pm. Red scale bars: 200pm.
e: endoderm, m: mesenchyme, ps: pyloric sphincter, sp: spleen, st: stomach.
development wave, and is the point at which cells are contributed to the spleen from
the underlying stomach.
Explant culture may provide the ideal environment in which to investigate
these models. The chief stage of interest is El 1.0-11.5. At this stage, however, the
spleen primordium is largely indistinguishable from the stomach and associated
pancreatic mesenchyme. A splenic marker is therefore required to identify splenic
precursor cells and successfully track them. Hence the second use of the Nkx2-5 gut
enhancer element (NGRS) reported in this thesis is as a splenic marker in explant
culture.
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4.2 Initial aims of gut culture experiments
The first line of investigation was to assess whether El 1.5 foreguts could a)
survive in a culture system, and b) undergo growth and development to such an
extent that experimental findings could be related to normal development. El 1.5
whole gut (Natarajan et al., 1999) and El 2.5 stomach (Aubin et al., 2002) cultures
have been reported in the literature, but an account of culturing El 1.5 stomachs has
not been published.
A spleen marker was required, as the spleen is not easily distinguished from
the underlying stomach at El 1.5. The ideal marker would be one that is expressed
from the earliest stages of spleen morphogenesis, does not interfere with normal
development, and specifically marks splenic cells. The NGRS-LacZ transgene
discussed in Chapter 2 fulfils at least the first two of these criteria, and is likely to
be satisfactory for the third. NGRS-LacZ expression is detected in the elongated
spleen structure from El2.5, and is found in the region of condensed dorsal
mesenchyme known to express splenic markers at both El0.5 and El 1.5. These
transgene-marked tissues are the earliest reported primordia of the spleen, and thus
NGRS-LacZ satisfies the first criterion. The morphology of NGRS-LacZ-expressing
guts is identical to that in non-transgenic littermates, and adult mice carrying NGRS-
LacZ grow and reproduce normally; thus the second criterion is also fulfilled. The
final criterion - that the marker should be specific to splenic precursors - cannot
however be totally met by this enhancer. The non-gut expression sites (outflow tract,
pharyngeal endoderm, and thyroid primordium) are experimentally irrelevant as the
guts are to be cultured as explants, but the major pyloric sphincter expression could
complicate matters. The splenic and pyloric expression domains are linked at El 1.5,
and arise from an earlier single domain. It may not therefore be possible to ascribe a
LacZ-positive cell seen in the El 1.5 gut to the future spleen or pyloric sphincter.
Although this would obviously complicate lineage tracing analyses, NGRS-LacZ was
deemed sufficient for the purpose of merely visualising the spleen in order to
examine its development in a way not previously possible.
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4.3 Optimising the gut culture system
A number of factors are important when creating an environment in which an
explant can survive and, hopefully, grow. Firstly, the culture media must be suitable
and not contain exogenous growth factors. Secondly, the culture conditions must be
optimised (temperature, CO2 concentration) and, finally, the surface on which the
explant is grown must be appropriate. The initial studies into the ideal dissection and
growth conditions discussed in this section were performed by Dr Marit Boot,
adapting published culture methods. Explants in these optimisation studies were
grown on both reduced growth-factor Matrigel (BD Biosciences) and on filter-discs
(Millicell-CM culture plate inserts, Millipore). Both techniques supported explant
survival and growth; details are provided in Chapter 7 (Materials & Methods).
During the optimisation experiments it became apparent that landmarks were
required to correctly orientate the gut; the lungs, oesophagus, stomach, and a short
length of proximal duodenum were therefore isolated en bloc from El 1.5 embryos.
The lungs also provided an internal control for assessing explant health as lung buds
develop well in culture, undergoing branching morphogenesis (Bellusci et al., 1997).
Explants with these additional tissues did not display any behaviour to suggest that
the inclusion was detrimental. Embryos varied slightly in age depending on the time
of night at which they were conceived, the time of day at which they were dissected,
and both inter- and intra-litter differences. Only the second of these variables could
be controlled and so litters were taken at the same time each morning, with any
deviation noted.
The conclusions reached were that El 1.5 guts from CD1 embryos can survive
for periods of 24 and 48 hours, when cultured on either filter-discs or Matrigel27.
Guts cultured in Matrigel retained a slightly more three-dimensional shape. The
extent of growth and development was variable, but encouraging. An El 1.5 gut was
not as developed as an El2.5 gut after 24 hours in culture, and did not resemble an
El 3.5 gut after 48 hours. Retardation of cultured explants and embryos was expected
(Copp and Cockroft, 1990). The extent of growth and development was, however,
adequate for the planned experiments. Overall increases in growth were achieved,
27 And for 72 hours on Matrigel; filter-discs were not assessed at 72 hours
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and the anterior stomach grew out normally such that the oesophagus began to adopt
a position on the inner curvature rather than at the anterior limit of the stomach.
These findings were recapitulated in the explants shown throughout this chapter and
so images from these optimisation studies are not presented.
4.4 NGRS expression in culture
Expression of the NGRS-LacZ transgene was assessed by X-gal staining of
El 1.5 guts grown on both filter-discs and Matrigel. In addition to examining whether
expression could be detected following a period in culture, another key issue was the
extent to which this expression resembled that in non-cultured guts. The experiments
presented in this chapter were performed in collaboration with Dr Marit Boot.

















Figure 4.2. Terminology used in this chapter
. /
Gut explants are described as being cultured "dorsal" side upwards (i.e.: lying on their
ventral face) or "ventral" side upwards (i.e.: lying on their dorsal face); the former is
depicted in the first box, the latter in the second. The spleen develops on the dorsal face
during normal development.
Lu: lung buds, St: stomach, Spm: spleno-pancreatic mesenchyme,
Du: duodenum, L: left, R: right
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4.4.1 Culturing on filter-discs
NGRS-LacZ expression was examined in El 1.5 guts from an NGRS-LacZ
with CD1 mating; nine guts were recovered and cultured on filter-discs using the
method described in Chapter 7. Non-cultured controls were not retained in this
initial investigation. Half of the group was cultured dorsal ('spleen') side-up, and the
remainder ventral side-up. Illustrations of the faces of the gut and the terminology
used in this chapter are provided in Figure 4.2. Guts were photographed at tO (time =
0 hours) and then cultured for 24 hours at which point photographs were again taken
(t24). The guts were then fixed, washed, and X-gal stained as described. Following
overnight staining, three of the nine guts were positive for LacZ expression (Figure
4.3).
The NGRS drove LacZ expression in the appropriate domain in the cultured
guts: encompassing the pyloric sphincter and the spleno-pancreatic mesenchyme.
The side on which the gut was cultured (dorsal or ventral face) affected neither
growth nor transgene expression. The stained guts grew beyond their initial —El 1.5
size and displayed characteristics typical of later development: the anterior stomach
grew such that the oesophagus was displaced from the anterior tip of the stomach, the
lung buds developed well, and the pancreatic buds (outlined in red in Figure 4.3)
grew, pushing the tip of the overlying mesenchyme to a more anterior point along the
greater curvature of the stomach. However, overall El2.5 morphology was not
achieved and normal El2.5 spleen development (a column of mesenchyme along the
length of the stomach) was not observed. LacZ-positive cells were instead observed
in a smaller spleen-like domain (outlined in yellow in Figure 4.3) that extended from
the spleno-pancreatic mesenchyme towards the anterior stomach in all three stained
guts. These putative splenic expression domains were specific to the dorsal face of
the stomach, as in normal spleen development.
The LacZ-marked splenic growth was promising but perhaps not sufficient
for studies into spleen development. The next step was thus to examine transgene
expression after a longer culture period (48 hours). This was tested on Matrigel - as
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4.4.2 Culturing on Matrigel
Fourteen El 1.5 guts were obtained from an NGRS-LacZ with CD1 mating,
and cultured for 48 hours on Matrigel. Photographs were taken at tO, t24 and t48; the
guts were then fixed and stained overnight.
Five of the 14 guts showed LacZ expression, demonstrating that culture on
Matrigel is compatible with correct transgene expression and X-gal staining. Spleen
development was marked specifically on the dorsal side of the stomach by NGRS-
LacZ expression, but again did not extend all the way up to the anterior stomach as
would be expected by El2.5. Three representative explants are shown in Figure 4.4.
Patterns similar to those shown were observed for all intact gut explants cultured for
48 hours in subsequent experiments.
4.4.3 Recommendations following initial experiments
It is difficult to ascertain whether the spleen development seen in culture is
particularly retarded or if this delay is proportional to that of the rest of the gut. The
extent of development observed in the studies outlined above was not advanced
enough to indicate that this system would allow El 1.5-12.5 spleen development to be
fully recapitulated. Despite this, the planned splenic mesenchyme manipulation
experiments were still attempted. Serendipitously, these experiments produced some
interesting findings, and these are discussed in the subsequent sections.
During the initial experiments it became apparent that non-cultured controls
would be needed from each litter to monitor how the X-gal staining pattern at the end
of the culture period relates to that at tO. Thus in an attempt to control for the
differences in developmental stage between litters, a number of guts from each were
immediately fixed and stained to provide a record of transgene expression at tO for
each experiment, unless otherwise stated. This obviously cannot control for
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4.5 Migration versus stomach derivation
No published work has addressed the question of how the patch of splenic
mesenchyme associated with the posterior stomach at El 1.5 relates to the elongated
structure lying along the length of the stomach at E12.5. Two distinct models
(discussed previously in Section 4.1.3) can be invoked for how this transition might
occur:
1) The "migration" hypothesis: the splenic primordium proliferates
and "migrates" (as cells or a tissue) up the dorsal face of the
stomach towards its anterior limit, possibly with some role played
by the anterior connection of the spleen to the stomach.
2) The "stomach derivation" hypothesis: spleen cells are derived
from the stomach, with their contribution occurring in a posterior
to anterior wave, such that the anterior limit of the spleen is located
further towards the anterior tip of the stomach as time progresses
between El 1.5 and El 2.5.
Distinction between these models is not possible from a time-course of staged
guts between El 1.5 and E12.5, as their manifestations would look identical.
Manipulations, tailored to disrupt the outlined mechanisms, are therefore necessary
to distinguish between the two.
4.5.1 Physical obstruction experiments
The first manipulation to be attempted was to place a physical barrier
between the anterior limit of the El 1.5 splenic mesenchyme and the underlying
stomach, with the aim being to obstruct the migration proposed in the first model.
Although spleen development in culture is slow, it was hoped that some insight
might be gained since the detection of any blue cells anterior to the barrier would
lend credence to the second model (derivation from the stomach).
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Aluminium foil was chosen as the blocking material as it is malleable, yet
strong, and can be cut to a small size. It is also opaque, thus aiding visualisation. Ten
guts from an NGRS-LacZ with CD1 mating were cultured on Matrigel for 48 hours;
six had a foil barrier inserted. Three manipulated guts and five guts in total were
positive for LacZ expression following X-gal staining. Overall growth and health
was good, and transgene expression was as expected.
The foil was positioned in the intended location - between the anterior limit
of the putative splenic mesenchyme and the underlying stomach - in two of the three
stained manipulated guts. X-gal staining was normal around the pyloric sphincter
region, and continued up to the foil (Figure 4.5). No stained cells were observed
beyond the foil, whereas they had been observed beyond this point in non-
manipulated guts; this provides evidence against the second model (stomach
derivation). The first model (migration) may be supported by the fact that staining
extended right up to, but stopped abruptly at, the foil (e.g. Figure 4.5 2vi).
The above conclusions are tentative as it is impossible to know for each
individual explant how much of the mesenchyme posterior to the foil insert was
initially LacZ positive at tO. Additionally, development in explant culture is
inherently variable, and only two explants were examined. Recombination
experiments to further investigate the migratory potential of the splenic mesenchyme
are therefore reported in the next section.
A criticism of the experimental technique employed is that the effect exerted
by the physical obstruction cannot be distinguished from the effects of cutting the
explant in order to insert this obstruction. The effects of cutting alone are, however,
investigated later in this chapter. A further criticism could be that if a posterior-to-
anterior signalling wave exists (as in the second model) then this would also be
disrupted by the barrier. The aforementioned recombination experiments were
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4.5.2 Recombination experiments
4.5.2.1 Posterior stomach recombinations
The posterior halves of NGRS-LacZ stomachs were recombined with the
anterior portions of stage-matched CD1 guts to test the migration hypothesis. The
premise of this experiment was that if the splenic mesenchyme (attached to the
posterior NGRS-LacZ gut portion) does indeed harbour migratory potential then cells
may move in an anterior direction onto the adjacent CD1 stomach. The
recombination of a transgenic with a non-transgenic gut provided the opportunity to
examine the origin of any splenic tissue observed. The abilities of isolated anterior
and posterior stomach halves to survive in a 48 hour culture were confirmed in a
separate experiment (Section 4.7.2).
El 1.5 litters were taken simultaneously from a) CD1 with CD1 and b) CD1
with NGRS-LacZ matings, and the embryos matched by developmental stage. Seven
guts were dissected out from each litter and cut in half; suitably staged posterior
NGRS-LacZ and anterior CD1 gut halves were then recombined by forcing them into
close proximity (illustrated in Figure 4.6a). The reciprocal recombination was also
performed for each gut pair (CD1 posterior with transgenic anterior); any stained
cells found on the anterior NGRS-LacZ stomach portion would support the notion of
derivation of the spleen from the stomach. There were thus 14 recombination
experiments performed in total. Three additional NGRS-LacZ guts and one CD1 gut
were kept intact as cultured controls for health, growth, and staining. All explants
were cultured on Matrigel for 48 hours.
X-gal staining was observed in all three intact NGRS-LacZ control explants,
and in four of the seven gut pairs, two of which are shown in Figure 4.6b. Whilst the
expected staining pattern was observed in the pyloric sphincter and spleno-pancreatic
mesenchyme, no evidence was found for migration of marked splenic precursors
onto the CD1 anterior stomach. However, nor was support found for the stomach
derivation hypothesis as no stained "spleen" cells were found in the anterior NGRS-
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Figure 4.6 Recombinations between CD1 and NGRS-LacZguts to investigate migration
of splenic precursors
Stage-matched E11.5 guts from CD1 or NGRS-LacZ with CD1 matings were recombined
as illustrated in (a).
a) CD1 guts are shown in yellow, NGRS-LacZ guts in blue. Recombinations of transgenic
posterior gut portions with CD1 anterior gut portions were performed to investigate whether
splenic precursors (marked by NGRS-LacZ expression) would migrate towards the anterior
stomach from the splenic mesenchyme. The reciprocal recombination (CD1 posterior gut
with transgenic anterior gut) was also performed for each gut pair, to test whether spleen
precursors are derived from the stomach, but is not presented in the examples shown in
(b).
b)Two examples of recombinations. Explants were stained with X-gal after 48 hours in
culture. Migration of transgenic splenic precursors onto the CD1 anterior gut tissue was
not observed.
Culture images were taken at 5x magnification, stained images at 8x. Lu: lung buds
4.5.2.2 Spleno-pancreatic mesenchyme recombinations
A refinement of the previous experiment was performed in a separate set of
cultures: isolated NGRS-LacZ spleno-pancreatic mesenchyme was used instead of a
larger posterior gut portion. The endogenous mesenchyme was removed from the
CD1 guts, and the NGRS-LacZ mesenchyme used to replace this (illustrated in
Figure 4.7a). The premise of this experiment was as before: if splenic precursor cells
in the splenic mesenchyme have migratory potential, then they may move onto the
CD1 gut. Once again, lack of spleen development on the mesenchyme-less NGRS-
LacZ guts would provide evidence against stomach derivation.
Matings were set up as before, and an equal number (seven) of El 1.5 CD1
and NGRS-LacZ guts were prepared for culturing. The two gut components
(transgenic spleno-pancreatic mesenchyme and CD1 gut with the analogous
mesenchyme removed) were recombined and cultured on Matrigel for 48 hours. The
mesenchyme-less transgenic guts and the CD1 mesenchyme were retained and
cultured separately.
Both the recombined CD1 stomach + NGRS-LacZ mesenchyme and the
mesenchyme-less NGRS-LacZ stomachs grew well and appeared healthy throughout
the culture process. Conversely, the isolated CD1 mesenchymes - which were not in
contact with stomach tissue - either did not appear to undergo any growth (2/7) or,
more commonly, deteriorated markedly during culture (5/7).
Three of the seven recombinations exhibited LacZ expression; two examples
are provided in Figure 4.7b. In the first, the recombination was stained in the donor
transgenic mesenchyme, but no cells from this tissue had migrated onto the recipient
CD1 gut (Figure 4.7b 1 iii-iv). Staining of the mesenchyme-less NGRS-LacZ gut
showed expression was retained in the pyloric sphincter but that all of the spleno-
pancreatic mesenchyme had been successfully removed (Figure 4.7b 1 vii-viii). No
spleen formation was detected, again suggesting that contribution from the splenic
mesenchyme is required and that derivation of NGRS-LacZ-expressing splenic cells
from the stomach does not occur.
In the second recombination shown (Figure 4.7b 2) some stained tissue
appeared to extend from the NGRS-LacZ mesenchyme onto both the CD1 stomach
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and duodenum (asterisked on Figure 4.7b 2 iv). This may have been due to one of
two things: firstly, the transgenic mesenchymal cells may have indeed migrated onto
the CD1 stomach or, alternatively, this effect may be due to non-migratory effects
such as the initial positioning or non-specific growth of the NGRS-LacZ tissue. The
presence of stained cells on the CD1 gut is more noticeable on the ventral face - as
opposed to the dorsal side where spleen development normally occurs - supporting
the notion of random growth. The potential for directed migration of splenic
precursors thus does not appear to have been demonstrated.
Not all of the spleno-pancreatic mesenchyme was successfully removed from
the NGRS-LacZ gut in the second recombination shown (Figure 4.7b 2 v-viii). A
small piece of the anterior splenic mesenchyme can still be seen attached to the
stomach at tO (arrowed), and by t48 this had apparently contributed to a structure
reminiscent of the anterior tip of the spleen - a phenomenon revisited in Section 4.7.
As residual mesenchyme could be seen at tO, this is not viewed as support for the
stomach derivation hypothesis.
In the final recombination (not shown), transgene activity was detected in the
pyloric sphincter region of the NGRS-LacZ gut and yet not in the removed
recombined mesenchyme. This may be explicable by the small amount of
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Figure 4.7Spleno-pancreatic mesenchyme recombinations to examine migration of
transgenic splenic precursor cells
a. Schematic of experimental strategy. CD1 guts are in yellow, NGRS-LacZ guts in blue.
b. Two examples of recombinations. The transplanted transgenic (NGRS-LacZ) mesenchyme
is outlined with a dotted blue line. The stained cells observed on the CD1 gut tissue in
recombination 2 (discussed in the main text) are marked with a black asterisk. The
splenic mesenchyme left attached to the NGRS-LacZ gut (again, discussed in the text) is
marked by a blue arrow, and the resulting spleen development by a blue arrowhead.
Magnifications at which images were obtained are in the bottom left of each image.
Lu: lung buds
4.6 An inhibitory signal from the posterior stomach?
4.6.1 Preliminary evidence from physical obstruction
experiments
The foil barrier was only correctly positioned in two of the three LacZ-
positive manipulated guts discussed in Section 4.5.1. The foil was inserted in too
posterior a position in the third explant, such that X-gal stained cells were found
anterior to the foil at t48. This explant was thus of no use in addressing the models
outlined in Section 4.5. It did, however, provide an interesting result: spleen
development - or at the very least the presence of transgene-expressing cells -
extended up to a far more anterior level of the stomach and was greatly increased
compared to that in non-damaged explants (marked in red in Figure 4.8 iv, vi). The
outline of the "spleen" structure also seemed to extend slightly beyond that marked
by LacZ expression. In addition to the spleen-like expression, a crescent of
transgene-expressing cells was also present anterior to the foil.
One possible explanation for the apparently advanced spleen development
was that the gut had been disrupted such that the anterior-most splenic mesenchyme
remained in contact with the stomach whilst being freed from connections with more
posterior gut tissue (posterior to the barrier). This raises the possibility of an
inhibitory signal or physical anchoring from/by the posterior stomach which "holds
back" spleen development, providing tight control during normal development.
Additional culture experiments were thus performed to investigate this serendipitous
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Figure 4.8Separation of the anterior and posterior spleno-pancreatic mesenchyme
appears to cause advanced spleen development
The spleno-pancreatic mesenchyme is outlined in yellow. Some mesenchyme
remained anterior to the foil and appeared to contribute to an X-gal stained spleen
structure by t48 (outlined in red); this "splenic" tissue was far more developmentally
advanced than those in intact explants. The final image is taken from above the
greater curvature. Magnifications at which images were obtained are at the bottom
left of each image.
lu: lung buds, st: stomach, spm: spleno-pancreatic mesenchyme,
du:duodenum
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4.7 Investigating an inhibitory effect of the posterior
spleno-pancreatic mesenchyme on spleen
development
The potential inhibitory role of the posterior spleno-pancreatic mesenchyme
was investigated by attempting to separate the anterior (putative splenic)
mesenchyme from this negative influence. Separation was achieved by two methods:
1) by making incisions (Sections 4.7.1) and 2) by dividing (bisecting) (Section
4.7.2) guts in the spleno-pancreatic mesenchyme. The manipulations were performed
across three separate culture experiments; the explants grew well on all occasions
and were X-gal stained after 48 hours in culture on Matrigel.
4.7.1 Releasing inhibition: incisions
An incision was made in the spleno-pancreatic mesenchyme of eight guts,
three of which stained. No tissue was removed in this process, and so the only factor
under investigation was the loss of physical contact between the two gut regions.
Spleen development was observed in all three stained explants; stained cells
extended as a column out from the spleno-pancreatic mesenchyme NGRS-LacZ
domain towards the anterior stomach. Images of two of the stained guts are shown in
Figure 4.9. The third gut generally stained poorly, though spleen development was
still marked (data not shown).
The extent of spleen development in explant 1 was greater than that seen in
any intact explant (n=13) examined during the course of the studies in this chapter,
and was more akin to that seen in utero. Spleen development in explant 2 was also
more pronounced than in intact guts. The observed spleen development was not
explicable by developmental stage, as the two depicted guts were no more advanced
at tO than in other experiments. These findings may therefore support the notion of an
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Figure 4.9 Releasing inhibition: Incisions
Disruption of the E11.5 spleno-pancreatic mesenchyme with an incision
(black line) results in dramatic spleen development after 48 hours in culture.
The boundary of the spleno-pancreatic mesenchyme with the stomach in
the unstained explants is indicated by a solid yellow line; the pancreatic
bud is outlined in red. The putative spleen tissue is outlined with a dotted
yellow line in the stained images. The images in (1) are at 8x magnification,
bar vi which was obtained at 10x. The images in (2) were taken at 5x, with
the exception of vi which is at 10x.
lu: lung buds, st: stomach, spm: spleno-pancreatic mesenchyme,
du: duodenum
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splenic mesenchyme can be freed by physical manipulation. However, the numbers
analysed are low and so can only be treated as preliminary data.
4.7.2 Releasing inhibition: division
Nine gut explants were completely divided into two portions. Variations were
made on the level of the cut so that information could be extrapolated on where a
spleen "anchor" signal might reside and also on how much spleno-pancreatic
mesenchyme is required for spleen development. The bisection levels are indicated
on the gut illustrations included in Figure 4.10. Both portions of the severed guts
were retained and cultured in separate wells. All tissue remained healthy, and was
cultured for 48 hours.
Six of the nine explants stained with X-gal; staining patterns for all six are
presented in Figure 4.10. One explant (explant 1) exhibited spleen development
akin to that seen in the incised explant 2 described in the previous. However, a novel
staining pattern was found in four of the other guts (with explant 2 in Figure 4.10
providing a pattern intermediate between the two). In these four guts (explants 3, 4,
5, 6), a faint trail of stained cells could be seen leading from the main patch of
mesenchymal staining; at the end of this trail - at the anterior of the stomach - was a
patch of stained cells in a position and shape reminiscent of the anterior of the El2.5
spleen (yellow asterisks in Figure 4.10 3iii, 4ix/x, 5xi/xii, 6). The remainder of each
of these explants was certainly not representative of an El 2.5 gut, and thus it would
appear that precocious spleen development may have occurred as a consequence of
removing the posterior tissues (duodenum, pancreatic buds, and associated posterior
spleno-pancreatic mesenchyme). This lends credence to the idea of a posterior
stomach/mesenchyme inhibitory effect.
It is difficult to draw conclusions on what influence the anterior-posterior
level of bisection has on spleen development from the limited number of guts
examined. A general trend seemed to be that removal of only the most posterior part
of the spleno-pancreatic mesenchyme is required for the novel pattern of advanced
"spleen" development. However, this is tentative.
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As a note in proof, it should be stated that a stained "precocious spleen
leading edge" was also observed in two other guts following removal of the most
posterior spleno-pancreatic mesenchyme. These are not presented, as the posterior
halves were used in unrelated experiments. "Precocious" development was also
observed in one of the recombinant experiments described in Section 4.5.2, in which
some splenic mesenchyme was left attached to the anterior transgenic gut portion
(e.g. blue arrowhead in Figure 4.7b 2vii). This type of development was not,
however, seen when all of the splenic mesenchyme was successfully removed (e.g.
Figure 4.7b lvii), indicating that the blue cells seen on the anterior stomach are
derived from the spleno-pancreatic mesenchyme and not the stomach.
4.7.3 Releasing inhibition: conclusions
The data presented in this section is derived from a limited number of
explants as a consequence of the time required for each experiment and the
unpredictability of which guts will be transgenic and/or grow well. Nonetheless, the
initial findings support the existence of a posterior spleno-pancreatic mesenchymal
"anchor" effect. The novel pattern of advanced anterior "spleen" development
reported in this section has not been observed in any intact guts (n=13). The
supposition is thus that the posterior spleno-pancreatic mesenchyme exerts a
negative, restraining effect on spleen development - an effect presumably necessary
for regulated growth during normal development. Physical separation from this









































Figure 4.10 Releasing inhibition: Division
E11.5 NGRS-LacZ gut explants were cut at a number of levels (1, 2, 3/4/5/6) within the
spleno-pancreatic mesenchyme in an attempt to release the splenic mesenchyme from the
proposed inhibitory effect of the more posterior tissue. The resulting "spleen" development
was greater than that in intact guts, supporting such an effect.
The third division level produced a novel staining pattern: an apparently precocious "spleen"
leading edge (anterior tip). Four explants are presented for the third division level (explants
3, 4, 5, 6). Only stained images are shown for explants 4, 5, & 6. The views of the greater
curvature for 4 & 5 (images x, xii) emphasise the absence of staining from the main body
of the spleen; only the leading edge (anterior tip) of the spleen is stained.
The red lines on the gut illustrations indicate where explants were bisected. The observed
X-gal staining patterns are marked in blue on the illustrations. The boundary of the spleno-
pancreatic mesenchyme with the stomach is indicated by a solid yellow line in the tO
images. The putative spleen tissue is indicated by a yellow asterisk on the stained explants.
D: dorsal, GC: greater curvature; lu: lung buds, st: stomach, spm: spleno-pancreatic
mesenchyme, du: duodenum
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4.8 Investigating the existence of a chemoattractant
in the anterior stomach
Between El 1.5 and E12.5 of in utero mouse development, the spleen
undergoes a transition from a clump of mesenchyme at the dorsal posterior aspect of
the stomach, to an elongated column of tissue extending up to the anterior stomach.
Spleen development in culture does not progress as dramatically, but certainly begins
this transition. The progress of spleen development towards the anterior stomach in
culture is apparently accelerated by separation of the splenic mesenchyme from the
more posterior mesenchyme or gut tissues.
Migration seems the most likely mechanism for elongation of the spleen
towards the anterior stomach. This raises the question of how spleen precursors
'know' where they should go. The existence of a chemoattractant at the anterior tip
of the stomach is an attractive idea to investigate. The anterior limit (leading edge) of
the spleen becomes situated towards the anterior of the dorsal face of the stomach by
El 2.5 of normal development. Despite the apparently precocious nature of the spleen
development observed in the manipulated gut explants in Section 4.7.2 - and, by
definition, the artificial nature of these manipulations - the leading edge of the spleen
was always located in the correct position. This implies that the information required
to correctly position the spleen is contained either in the anterior stomach or in the
splenic leading edge itself. The latter is unlikely, as external cues would be
necessary. Most logically the information would take the form of a signal to which
the splenic cells can "home" to - a chemoattractant. Cells at the leading edge of a
tissue can become polarised in the direction of chemoattractants and commence
movement up a chemoattractant gradient - chemotaxis (reviewed in (Firtel and
Chung, 2000)). The role of chemoattractants in development has been well
documented, for example that of FGF10 in lung morphogenesis, as shown in explant
culture studies (Park et al., 1998b). FGF10 also acts in the gut as a chemoattractant
for cecal epithelium, as shown in cecal explant cultures (Zhang et al., 2006). Explant
culture could therefore provide an ideal system in which to investigate spleen
chemotaxis; experiments were thus undertaken and are reported in this section.
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The existence of a chemoattractant signal in the El 1.5 anterior stomach was
investigated by co-culturing intact CD1 guts alongside stage-matched NGRS-LacZ
gut tissue: either a) guts with the anterior stomach removed (Section 4.8.1), or b) the
spleno-pancreatic mesenchyme alone (Section 4.8.2). The rationale was that if
splenic precursors do migrate towards an anterior stomach chemoattractant signal
then, in the absence of an endogenous anterior stomach, NGRS-LacZ-express'mg
splenic cells may migrate towards and perhaps onto the CD1 anterior gut.
One litter each of El 1.5 CD1 and NGRS-LacZ embryos were removed from
uteri simultaneously. Embryos were stage-matched, and the guts dissected out. An
equal number (eight) of CD 1 and transgenic guts were recovered. Four of the NGRS-
LacZ guts were divided such that they were devoid of an anterior stomach region; the
final four guts were separated into the spleno-pancreatic mesenchyme alone and the
remainder of the explant. All gut tissues were retained and cultured to confirm that
the spleen cannot form without contribution from the spleno-pancreatic
mesenchyme, and thus provide further evidence against derivation of the spleen from
the stomach.
4.8.1 Co-culture of CD1 guts with NGRS-LacZ
posterior gut portions
One of the four co-cultures displayed LacZ expression, with staining present
in the NGRS-LacZ posterior gut portion but not in the removed anterior gut portion
or on the CDl gut (Figure 4.11a). The existence of a spleen chemoattractant in the
anterior stomach was thus not supported, as no stained cells were detected on the
CDl gut. However, the lack of staining in the removed anterior NGRS-LacZ gut
portion (data not shown) confirmed that (VG/?S-marked splenic precursors are not
endogenous to this region at El 1.5, once again disputing the stomach derivation
hypothesis. The staining in the posterior NGRS-LacZ gut portion was not, however,
as expected; whilst normal pyloric sphincter expression was present, the spleno-
pancreatic mesenchyme was devoid of staining. The reason for this loss is unknown,
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though a similar effect was noted in an isolated NGRS-LacZ spleno-pancreatic
mesenchyme in the recombination experiments reported in Section 4.5.2.2,
4.8.2 Co-culture of CD1 guts with NGRS-LacZ spleno-
pancreatic mesenchyme
Three of the four NGRS-LacZ mesenchyme + CDl gut co-cultures stained
with X-gal; all are presented in Figure 4.11b. These studies were performed on
filter-discs. The mesenchyme-less NGRS-LacZ guts exhibited pyloric sphincter
staining (data nor shown) but no spleen development; this again provides evidence
against derivation of the spleen from the stomach mesenchyme. The removed NGRS-
LacZ spleno-pancreatic mesenchymes stained, but cells from these transplanted
mesenchymes failed to colonise the CDl guts, arguing against migration towards an
anterior stomach chemoattractant. Of course, the expectation that cells would move
onto foreign tissue may have been overly ambitious. Indeed, the two observations
outlined below may provide some evidence for movement towards an anterior
stomach chemoattractant.
Firstly, whilst cells did not move from the transplanted mesenchyme onto the
CDl guts, the mesenchyme as a whole appeared to move in the direction of the
anterior gut (in all three stained and one non-stained co-cultures) as it had a more
anterior limit with respect to the CDl gut by t48 (denoted by black dashed lines in
Figure 4.11b). It may therefore be that an anterior chemoattractant signal does
indeed exist and that this has been demonstrated by the apparent movement of the
mesenchymal explants specifically in this direction (movement towards a more
posterior point is not observed, and there is no major growth to account for the
change in anterior limit). The splenic mesenchyme may therefore move as a tissue
rather than as lone cells - a recognised trend in migrational morphogenesis
(Lecaudey and Gilmour, 2006). It may also be of course that the mesenchymes
simply adhered to the CDl guts and were pulled along with their growth.
Additionally, growth of the pancreatic bud within the NGRS-LacZ mesenchymal












Figure 4.11 Investigating a chemoattractant at the anterior of the stomach
CD1 gut explants were co-cultured with NGRS-LacZ a) posterior gut portions or b) spleno-
pancreatic mesenchyme (as illustrated) to investigate whether marked splenic precursors
would migrate towards and onto the CD1 stomach, in the absence of endogenous anterior
stomach signals. This was not demonstrated, though the anterior limit of the transgenic
mesenchymes in (b) appeared to become located more anteriorly (with respect to the CD1
stomach) by t48 - as denoted by the black dashed lines. Note that the positioning of the
explants is disrupted during X-gal staining and hence the relative positions differ between
the non-stained and stained t48 images.
The boundary of the spleno-pancreatic mesenchyme with the stomach is indicated by a
yellow line for the CD1 guts, and a solid blue line for the NGRS-LacZ guts. The isolated
NGRS-LacZ mesenchymes are outlined by a dashed blue line. All images were taken
at 5x magnification, bar (a) iii (10x), (b) 2-iii (8x), 3-iii (10x).
lu: lung buds, st: stomach, spm: spleno-pancreatic mesenchyme, du: duodenum.
A final observation was that the cells in which the NGRS is active are
localised to the anterior of the transplanted mesenchymes by t48. Whilst the absence
of staining at the posterior end could be due to overgrowth of the pancreatic
endoderm (which does not express the transgene), the majority of the transplanted
tissue would be expected to stain in the endogenous situation. It is therefore possible
that the Mj/?S-marked splenic precursors have migrated towards the anterior end,
perhaps in response to a chemoattractant in the CD1 anterior stomach. The NGRS-
LacZ-marked cells could therefore be responsible for the apparent anterior extension
of the mesenchymes, constituting a migratory "leading edge". Leading edges are
found at the forefront of migratory groups of cells, and are thought to contain the
cells which are competent to respond to extrinsic cues such as chemoattractants
(Lecaudey and Gilmour, 2006). These leader cells can then instruct the cells
following them to act accordingly. The application of this concept to spleen
development is, however, only casual, as the experimental numbers are too low to
draw conclusions.
4.9 Discussion
4.9.1 Appraisal of gut culture system
The main concern with explant cultures is whether the observed effects are
real - reflecting normal development or genuine responses to manipulation - or are
simply artefacts of the experimental procedure. Conditions must therefore be kept
constant between studies in order to allow accurate comparison and analysis of
results. Experimental artefacts may be a result of suboptimal conditions (oxygen
concentration, temperature, serum, and media) or of mechanical damage to the
explants. This latter problem is even more common when culturing early gut explants
as opposed to, for example, the externally placed limb buds. Careful gut dissection is
time-consuming and must be balanced against the need for rapid entry of tissue into
culture. The numbers of experimental and control explants in - and thus the statistical
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significance of - gut culture studies may therefore be less than in other systems, again
such as the limb. Nonetheless, the findings presented in this chapter demonstrate that
culture of El 1.5 mouse guts provides a good system in which to study and
manipulate spleen development.
Cultures were performed on filter-disc or Matrigel supports; an issue with
both methods is that after 48 hours the explants are flat and retain little three-
dimensional morphology (though Matrigel reduced this effect slightly). A potential
solution to this problem could be free-floating cultures. However, free-floating
cultures may not offer any advantage for spleen development studies, as growth has
28 •
been most noticeable in the intestines in published accounts , with little growth
observed in the stomach region. Such cultures are also obviously not of any use when
performing recombination experiments.
In conclusion, the experimental system used was suitable for the objectives
and should permit future investigations into spleen development. A major aim now is
to adapt this system for live imaging, as splenogenesis is a rapid and dynamic
process.
4.9.2 Mechanisms of spleen morphogenesis:
migration
Directed cell movement is central to many morphogenetic processes
(Lecaudey and Gilmour, 2006). The studies presented here support the notion of
posterior-anterior "migration" of splenic precursors from the spleno-pancreatic
mesenchyme versus derivation in a posterior-anterior wave from the stomach. No
spleen development was observed in stained explants totally devoid of spleno-
pancreatic mesenchyme (n=10 across all experiments), nor did it occur anterior to a
barrier placed between the stained spleno-pancreatic mesenchyme and stomach
(n=2).
It should be noted at this point that expression of the NGRS-LacZ transgene in
the spleno-pancreatic mesenchyme has been regarded as being synonymous with
28E11.5 guts (oesophagus to large intestine) (Natarajan et al., 1999)
E10.5 whole guts (Pitera et al., 2001)
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splenic identity in these studies. There is thus a danger that observations have been
made not of spleen cells per se, but rather of NGRS activation. It could therefore be
argued that specified mesenchymal splenic precursors might already exist along the
AP axis of the stomach, and that subsequently a posterior-anterior wave of NGRS-
LacZ activity occurs. However, this does not seem likely given the observed
correlation of NGRS-LacZ expression and spleen development from E10.5 onwards
(summarised in Chapter 2), and general histological observations of stained guts
between El 1.5-12.5. Subsequent to these studies being performed, clonal analysis of
randomly tagged cells lead to the observation that the mesenchymal cells of the
spleen are not derived from the underlying stomach mesenchyme (Dr Marit Boot,
unpublished data). Migration is thus assumed, though it would be certainly
worthwhile - if not absolutely necessary - to repeat the experiments presented in this
chapter using a second spleen marker (Hoxl 1 for example).
4.9.3 Three mechanism hypotheses
Three potential mechanisms for the regulated control of spleen development
can be proposed following analysis of the results presented. It is predicted that these
mechanisms would not be mutually exclusive and, indeed, would have a
combinatorial effect to allow tight regulation. They are as follows:
1) Migratory potential resides in the leading edge (anterior tip) of the
spleen
2) A restraining "anchor" effect from the posterior spleno-pancreatic
mesenchyme acts on the anterior splenic mesenchyme
3) A chemoattractant exists at the anterior of the stomach and so the spleen
migrates or develops in this direction
Each of these points is discussed in the following sections.
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4.9.3.1 The leading edse of the spleen has migratory potential
The evidence outlined points to the spleno-pancreatic mesenchyme as the
source of splenic precursor cells and implies some role for migration; it is unclear,
however, whether the spleen is entirely constituted of cells migrating out from the
mesenchyme or whether other mechanisms (such as proliferation) are also involved
in elongation of the spleen towards the anterior stomach. One possibility is that the
ability to migrate resides in the leading edge (anterior tip) of the spleen, which may
also undergo proliferation. The concept of a leading edge is well-founded in
developmental biology, and has been implicated in a range of developmental
processes (Lecaudey and Gilmour, 2006). In a generalised model, cells form a
cohesive organised group, the leading edge of which elongates in the direction of
migration; at the rear of this migratory group lays the trailing edge, which displays a
lack of adhesion. Only cells in the leading edge are thought to be responsive to
extrinsic cues (such as chemoattractants); the leading cells may then instruct the
lagging cells in how to act.
Applying the above concept to spleen morphogenesis, the leader cells would
be located in the anterior limit of the splenic mesenchyme and would forge forward,
colonising a path towards the anterior limit of the stomach. The anterior connection
of the spleen primordium with the stomach shown in Figure 4,1 may play a role in
this. The spleen cells posterior to this leading edge would be instructed to follow, and
would also need to sever their physical connection with the stomach to create the gap
normally found between the stomach and majority of the spleen. Proliferation may
also occur concomitantly with migration, given the relatively larger size of the El2.5
spleen versus the El 1.5 splenic mesenchyme. Whether the leading edge would
contain the youngest cells, with the older cells forming the main body of the spleen,
or whether instead the oldest cells would form this edge and proliferate to populate
the lagging bulk of the spleen is unclear. An important future direction is thus to
examine the dynamics of cell proliferation and death during this period of spleen
development, by using markers for these processes in culture. Clonal analysis could
also be a valuable tool.
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The presence of a patch of NGRS-LacZ-marked "splenic" tissue at the
anterior tip of the stomach, without concomitant spleen formation posterior to this, in
the manipulated guts is certainly reminiscent of the above description of a migratory
leading edge. This patch of expression was in some cases separated from the main
splenic mesenchyme, and in other cases was connected by a faint trail of blue cells.
In non-cultured guts, however, the spleen is marked throughout by expression of the
NGRS-LacZ transgene, regardless of how far up the stomach spleen development has
progressed. One possible explanation for the lack of staining between the "leading
edge" and spleno-pancreatic mesenchyme in the cultured guts is that splenic
precursors destined to populate the mid-section were left in the posterior part of the
gut following cutting/division of the explant. This would imply that the splenic
mesenchyme already possesses positional identity at El 1.5, with cells destined to
adopt a specific AP position along the spleen. The alternative - though not
necessarily mutually exclusive - explanation is that the potential to migrate up to the
anterior stomach is the property of only a subgroup of splenic precursors, which
reside in the leading edge. This is certainly a recognised phenomenon: the ability to
migrate is located in the tip of Dictyostelium slugs (migrating bodies of cells), and
separation of the tip from the main slug body results in continued migration of the tip
and an immobilised collection of body cells (Dormann and Weijer, 2001). A pattern
very similar to this was observed in the studies presented.
During normal spleen development the leading edge cells might also
proliferate to fill the void posterior to them; coupled migration and proliferation
would ensure that the leading edge moves in a controlled manner such that the region
posterior to it is always populated. Release of these migratory cells from the
inhibitory influence of the posterior mesenchyme may therefore not only permit too
rapid a migration towards the anterior stomach, but also decouple migration from
proliferation to populate the main body of the spleen. This inhibitory influence is
discussed in the next section.
A final point to note is that the putative splenic mesenchyme was
demonstrated to form a structure reminiscent of the anterior limit of the El2.5 spleen
at an earlier stage in culture than in normal development. The gut explants were
taken at El 1.5 and cultured for 48 hours, during which time they did not adopt the
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physical characteristics of an El2.5 gut. This may therefore suggest that the ability to
form a spleen is an innate property of the splenic mesenchyme from at least El 1.5.
One past hypothesis on spleen development was that a general dorsal pancreatic
mesenchyme exists up until -E13.0 and it is only at this stage that commitment to a
splenic fate occurs in a subset of Hoxl 1 -expressing cells, in response to a second
spleen development signal (Kanzler and Dear, 2001)29. Whilst the authors of that
study largely dismissed the possibility of late commitment to a splenic fate, the data
presented here further rejects the theory.
4.9.3.2 Posterior anchoring by the spleno-pancreatic mesenchyme
A restraining "anchor" effect appears to be exerted by the posterior spleno-
pancreatic mesenchyme on the more anterior, migratory portion of this tissue. The
existence of an inhibitory effect is suggested by the observations that removal or
disconnection of the posterior-most mesenchyme permits apparently accelerated
development of an anterior "spleen leading edge" structure. The "anchor" may
therefore be required during normal development to ensure tight control of the
posterior-anterior progression of spleen development. It is perhaps of significance
then that the spleen and pancreatic tissues fail to correctly separate in the asplenic
Bapxl'1' mutant. The splenic mesenchyme remains in prolonged contact with the
pancreatic mesenchyme and subsequently fails to develop into a spleen (Asayesh et
al„ 2006).
The nature of the "anchor" is unknown, but a couple of possibilities exist:
1) Signalling from the posterior mesenchyme (via an unknown pathway) may
prevent precocious spleen development during normal morphogenesis.
Accelerated "spleen leading edge" development only occurred following
29 This was one possible explanation for the findings that Hoxl l'1' embryos initiate spleen
development and that this does not arrest until -E13.0, implying Hoxl I is not required for initial
spleen development (Kanzler and Dear, 2001). -E13.0 is also the stage at which Hoxll '' cells fail to
aggregate with and thus become excluded from chimaeric spleens, most probably due to lack of some
cell adhesion molecule (Kanzler and Dear, 2001). It was thus postulated that Hoxl l'1' mesenchymal
cells might not be competent to respond to a second signal and hence fail to aggregate with wild type
splenic cells.
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complete removal of posterior spleno-pancreatic mesenchyme tissue and was
not observed in guts which were simply cut. This could imply that a signal is
responsible for the inhibition and that this can still act across the cut surface.
2) The inhibition could alternatively be due to physical retention of the splenic
mesenchyme by the more posterior mesenchyme. An incision might not
release the splenic mesenchyme from such retention as fully as bisection,
again fitting the trend outlined above. A physical anchor could act very
simply, physically preventing the spleen from advancing up the stomach at
too rapid a rate. It could also act in a more elegant way, as mechanical stress
has been shown to activate gene expression during Drosophila foregut
development (Farge, 2003; Scott and Stainier, 2003) and mechanical forces
are known to be central to tissue migration (Lecaudey and Gilmour, 2006).
The stress exerted on splenic precursor cells by being physically "restrained"
might therefore regulate gene expression such that spleen development
progresses in a controlled manner. Mechanical induction of gene expression
in the Drosophila embryo can be mediated through P-catenin, which also
plays roles in cell adhesion (Scott and Stainier, 2003). This is particularly
interesting given my findings that the p-catenin (canonical) Wnt signalling
pathway is active in the developing spleen (presented in Chapter 5).
4.9.3.3 A chemoattractant at the anterior of the stomach
The existence of a chemoattractant in the anterior stomach, to which spleen
cells "migrate" was postulated as this would be an obvious explanation for how the
spleen leading edge always arrives at the same location, both during normal
development and when "precocious" development occurs in manipulated explants.
The assays used to investigate such a signal - migration of NGRS-LacZ-marked
spleen cells onto CD1 guts - did not provide evidence for this idea. This is not to say
that a chemoattractant does not exist, however, as the concept that cells might
migrate across a junction and colonise a gut from a different genetic strain to reach a
foreign chemoattractant may be overly optimistic. Cells also move more commonly
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as large units or tissues rather than as individuals (Lecaudey and Gilmour, 2006). A
variation on these studies is now being performed in the lab, in which only the
anterior stomach region from a CD1 gut will be placed alongside the lesser curvature
of a posterior NGRS-LacZ gut portion. If a chemoattractant signal does exist, then it
is hoped that cells from the NGRS-LacZ spleno-pancreatic mesenchyme will alter
their migration path from along the greater curvature, and instead traverse the
stomach to reach the foreign signal at the lesser curvature. Migration across the host
stomach seems more likely than moving onto a foreign tissue.
Migration of gut cells is certainly known to be possible in culture. Fu and
colleagues added GDNF (Glial cell Derived Neurotrophic Factor) to their culture
medium, inducing marked (LacZ-positive) enteric neural crest cells to migrate
through the intestine and out onto a Millipore filter, from where they were collected
and counted by flow cytometry (Fu et al., 2004). This demonstrates the potential to
use a suitable pro-migratory factor to induce migration in culture, and that cells can
indeed migrate out of explanted gut tissue onto an artificial substratum.
The nature of the proposed chemoattractant is unknown. Chemoattractants
can take the form of signalling pathway components which induce changes in the
cytoskeleton of cells at the leading edge, thus facilitating alteration of cell polarity
and subsequent chemotaxis (Chung et al., 2001). However, the chemoattractant itself
is not the only component of the migration tool box which lends itself to further
investigation. Factors involved in other aspects of migration could be focused upon.
For example, cells must alter their adhesion to their neighbours to allow passage
through the tissue, and this conversely includes increasing adhesion to other cells
involved in the movement, most commonly using cadherins (Grapin-Botton and
Melton, 2000). Migrating cells must also be able to degrade the surrounding
extracellular matrix by secreting suitable enzymes, such as metalloproteinases
(Grapin-Botton and Melton, 2000). Appropriate cell movement is dependent upon
orientation signals and, although these mainly take the form of chemoattractants,
endogenous electric fields are also known to elicit directional cell migration
(galvanotaxis) (Mycielska and Djamgoz, 2004). Changes in cell polarity and number,
and cell-cell contacts are also likely to play roles in migration (Hogan, 1999; Young
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et al., 2004). There are thus many further paths of investigation which can be
followed in pursuit of the migrating spleen.
4.10 Future work
The use of a culture system in these studies allowed spleen development to be
monitored over a 24 or 48 hour time period - a feat not possible in utero. A number
of interesting observations were made which now need to be confirmed - or
otherwise - by increasing the numbers of explants analysed.
A major restriction on these studies was that whilst gross development could
be observed, specific visualisation of spleen development required fixing and X-gal
staining of the tissue. The next step is thus to adapt the culture system such that live
imaging can be realised. A fluorescent protein such as green fluorescent protein
(GFP) is an excellent candidate for tagging spleen precursors in explant culture; for
an introduction to the use of fluorescent proteins in live imaging see Hadjantonakis et
al., 2003 (Hadjantonakis et al., 2003). Tagged cells producing GFP can be visualised
whenever required during the culture period, by excitation of GFP with a suitable
light source. Thus the movement of marked cells can be visualised without the need
to disturb manipulated or recombined guts. GFP has already been successfully used
to visualise and measure the speed of neural crest-derived cell migration during
hindgut development in explant culture (Young et al., 2004). GFP might also
therefore provide the opportunity to examine the migration versus stomach
derivation hypotheses outlined in Section 4.5. Likewise, movement towards an
anterior stomach chemoattractant, and the precocious development of spleen tissue
upon removal of a posterior inhibitory signal, could be further investigated using
GFP in place of LacZ.
An obvious strategy would be to use the NGRS to drive gut-specific GFP
expression. As an alternative, there already exists a knock-in of the GFP gene into
the Nkx2-5 locus (exon 1) which recapitulates the full Nkx2-5 expression pattern
(Biben et al., 2000). The conferred GFP expression pattern is therefore not gut-
specific, but in a gut explant culture system this would be irrelevant. A disadvantage
of this approach is that mild heart defects occur in a low percentage of the GFP-
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expressing heterozygotes, variable by genetic background (Biben et al., 2000). Nkx2-
5-GFP BAC mice also exist, in which IRES-hrGFP replaces the first exon and intron
of Nkx2-5 in a BAC containing the Nkx2-5 coding sequence and all the reported
regulatory elements (Chi et al., 2003). The endogenous Nkx2-5 expression pattern is
again marked by GFP, albeit with an absence of tongue expression. Pyloric sphincter
and spleen GFP activity is strong in embryos from this line, probably due to insertion
of multiple copies of the BAC. More importantly, these two gut expression domains
remain separate at El3.5, unlike in the NGRS-LacZ mice, which would be an
advantage when investigating spleen morphogenesis.
Other spleen development markers, such as Hoxl 1 and Wtl, could also be
exploited to drive GFP-based studies. Indeed, a mouse line carrying a knock-in of
GFP into the Wtl locus has been obtained and is to be used in our lab in studies to
follow up the findings presented in this chapter. A final strategy would be to use
inducible GFP expression, to facilitate lineage tracing in culture.
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CHAPTER 5
An analysis of Wnt signalling in
spleen development
...Or: "Science never solves a problem
without creating ten more"
- George Bernard Shaw
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5.1 Background to research
A major aspect of the Bapxl (Nkx3-2phenotype is the overgrowth of the
posterior stomach, with concomitant loss of the pyloric sphincter constriction
(Akazawa et al., 2000; Watson et al., 2007). This overgrowth is specific to the region
of the stomach which normally expresses Bapxl. It is thus tempting to speculate that
Bapxl loss may permit expression or upregulation of growth factors which would
normally not be active in the posterior stomach, leading to disorganised overgrowth.
Certainly, Nkx3-2 is known to act as a transcriptional repressor in chick, and
transcriptional repression is a general feature of Drosophila NK genes (Murtaugh et
al., 2001; Smith and Jaynes, 1996). Furthermore, conversion of chick Nkx3-2 into a
transcriptional activator produces ectopic Bmp4 and Wnt5a expression in the gizzard
(posterior stomach) (Nielsen et al., 2001 )30.
A collaborator - Dr Jacob Hecksher-Sprensen (Hagedorn Research Institute,
Denmark) - compared the expression of a number of growth factors between wild
type and Bapxl'1' posterior stomachs at El 1.0 (when the expanded stomach
phenotype is first observed). RNA was extracted from two regions: 1) the spleno-
pancreatic mesenchyme and 2) the posterior stomach (mesenchyme plus underlying
endoderm). Following cDNA synthesis, multiplex RT-PCR was performed for a
range of genes. Multiplex RT-PCR uses multiple primer pairs within a single
reaction to allow amplification of multiple specific sequences from a sample. The
products of this multiplex PCR were analysed by gel electrophoresis and are shown
in Figure 5.1.
The validity of this technique was demonstrated by the inclusion of primers
specific to known Bapxl targets, thus confirming known expression changes in the
Bapxl''' gut: loss ofHoxll expression from the spleno-pancreatic mesenchyme, loss
of Bapxl expression from both the spleno-pancreatic mesenchyme and posterior
stomach tissues, and loss or downregulation of Nkx2-5 from both regions. Three
factors were novelly shown to be upregulated in the mutant posterior stomach
(mesenchyme or endoderm): Bmp6, Wnt3, and Wnt8a. This final results chapter
describes my initial investigation into the potential roles of Wnt3 and Wnt8a in the
3,1
Though it also produces a thinner stomach muscle layer
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Bapxl' phenotype, and the subsequent work on Wnt signalling in the developing
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Figure 5.1 Multiplex RT-PCR for
changes in gene expression in
the Bapxl gut
Expression of a number of growth
factors was compared between
wildtype (+/+) and Bapxl' (-/-)
posterior stomachs at E11.0 by Dr
Jacob Hecksher-Sorensen. Two
tissues were analysed: spleno-
pancreatic mesenchyme (SpM),
and posterior stomach (PSt)
(mesenchyme plus underlying
endoderm). Shown here is a
selection of the results. Hox11,
Bapxl and Nkx2.5 expression
changed as expected (decreased
Hox11 expression in the SpM, loss
of Bapxl expression in both the
SpM and PSt, downregulation of
Nkx2.5 in both tissues), thus
providing controls.
Three factors were novelly shown
to be upregulated in the mutant
posterior stomach (mesenchyme




Wnt signalling is one of the major components of the developmental tool box
and as such its functions are well-studied. Wnt family members play fundamental
roles in an array of key processes across a range of tissues, including cell
proliferation, differentiation, migration (adhesion), and polarity. Wnt genes are
highly conserved between vertebrate species, and encode secreted glycoproteins
which signal to neighbouring cells. The murine Wnt gene family contains 19
members (Miller, 2002).
Binding of secreted Wnt factors to transmembrane Frizzled (Fzd) receptors
activates a signalling cascade, resulting in transcriptional activation of target genes.
The events occurring between receptor binding and transcription are best understood
for the canonical P-catenin pathway (see (Huelsken and Behrens, 2002) and (Miller,
2002) for a detailed review). Receptor binding triggers a series of interactions
involving Dsh and GSK3, amongst others, culminating in stabilisation and nuclear
translocation of P-catenin. The subsequent association of P-catenin with TCF/LEF
transcription factors leads to activation of target genes.
The concept of a singleWnt signalling "pathway" has in recent years become
something of a misnomer as signalling can proceed through at least two non-
canonical pathways: the Wnt/Ca2+ and the Wnt/JNK31 pathways (Kuhl et al., 2000;
Huelsken and Behrens, 2002; Pandur et al., 2002). The latter pathway exerts its
effects on the cytoskeleton as opposed to gene transcription, facilitating cell
polarisation within epithelial sheets.
5.2.1 Wnt signalling in the developing gut
Several components of the Wnt signalling pathways are expressed during
murine gut development. These expression patterns are summarised in Table 5.1.
Examples also exist of functional Wnt signalling in the developing gut. A major role
of this signalling may be to regulate EM interactions in order to specify regional
31
Comparable to the planar cell polarity path in Drosophila
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identity within the foregut. For example, WntI is not expressed in the pancreas until
El5.0, but transgenic misexpression of Wntl from the earliest stages of pancreatic
development (under the control of the promoter of the foregut/pancreatic epithelium
gene Pdxl) causes a transition from a duodenal to stomach phenotype (Heller et al.,
2002). The posterior boundary of gastric markers is shifted and the stomach is
extended posteriorly: the proximal duodenum is widened and the pyloric sphincter
constriction is lost. Pancreatic and spleen development are also aberrant, to the extent
that these structures are often absent. This is most interesting as these phenotypes
echo those seen in Bapxl~'~ mice (Akazawa et al., 2000; Watson et al., 2007). There
is thus a precedent for misexpression of Wnt genes in the spleno-pancreatic region
causing inappropriate growth of the posterior stomach. Overexpression of Wnt5a in
the Pdxl-driven assay does not appear to alter tissue identity, but instead causes a
reduction in the size of the stomach, spleen, and pancreas (Heller et al., 2002). The
pancreatic tissue is also observed to invade the spleen in some cases.
A further example ofWnt signalling directing EM interaction and thus gut
patterning is that of mesenchymal Barxl, which regulates specification of the
stomach epithelium through inhibition of canonical Wnt signalling in this latter
tissue. Barxl is expressed in the stomach mesenchyme at E9.5-16.5, and loss of this
expression produces a shrunken stomach with disorganisation and infolding of the
epithelial lining, resulting in failure of lumen formation (Tissier-Seta et al., 1995;
Kim et al., 2005a). The endogenously expressed Sfrpl and Sfrp2 Wnt inhibitor genes
are down-regulated in the mutant mesenchyme. The secreted products of these genes
are normally responsible for the negative regulation of Wnt signalling in the
epithelium, and this inhibition is required for correct epithelial differentiation,
following initial activation of the canonical pathway. Similarly, Foxfl- and Foxf2-
mediated inhibition ofWnt signalling is necessary for correct intestinal development
(Ormestad et al., 2006). Loss of this inhibition results in excessive proliferation and a
lack of normal apoptosis, resulting in a range of gut defects. Again, these are
examples of inappropriate activation ofWnt signalling leading to defective gut
development.
Though no link has yet been shown between Wnt signalling and Bapxl, Wnt
signalling in Drosophila plays a vital role in bap-mediated development of the
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midgut (Azpiazu et al., 1996a). Interplay between Hedgehog and Wingless creates
differences in bap expression within the dorsal mesoderm parasegments: Hedgehog
promotes bap expression in the anterior part, whilst Wingless suppresses expression
in the posterior.
Gene Stage Tissue Reference
Wntl E15.0 Pancreatic mesenchyme (Heller et al., 2002)
Wnt2b
(Wntl3)
E8.5 Foregut diverticulum (Zakin etal., 1998)
E12.0-17.0 Pancreas (Heller et al., 2002)
E12.5 Caecal epithelium (Burns et al., 2004)
Wnt4 E12.5 Pyloric sphincter, intestinal epithelium,
oesophagus (weak)
(Lickert et al., 2001)
Wntia El 1.0 Pancreatic epithelium and mesenchyme (Heller et al., 2002)
El 1.5 Anterior stomach (Smith et al., 2000a)
El 2.5 Anterior stomach, intestinal mesenchyme (Lickert et al., 2001)
E14.5 Tip of anterior stomach (Lickert et al., 2001)
WntSb E16.5 Oesophageal epithelium (Lickert et al., 2001)
El 2.0-17.0 Pancreas (Heller et al., 2002)
Wnt6 El 6.5 Oesophageal epithelium (Lickert et al., 2001)
Wnt7b El 1.0 Pancreatic mesenchyme (Heller et al., 2002)
Wntll E14.5 Stomach mesenchyme, oesophageal and colon
epithelium
(Lickert et al., 2001)
E12.0-17.0 Pancreas (Heller et al., 2002)
Fzdl El 2.0-17.0 Pancreas (Heller et al., 2002)
Fzd2 El 1.0 Pancreatic epithelium and mesenchyme (Heller et al., 2002)
Fzd3 El 1.0 Pancreatic mesenchyme (Heller et al., 2002)
Fzd4 E12.0-17.0 Pancreas (Heller et al., 2002)
Fzd5 E12.0-17.0 Pancreas (Heller et al., 2002)
Fzd6 El 2.0-17.0 Pancreas (Heller et al., 2002)
Fzd7 E17.5 Pancreas (endocrine cells) (Heller et al., 2002)
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Fzd8 El 2.0-17.0 Pancreas (Heller et al., 2002)
Fzd9 El 2.0-17.0 Pancreas (Heller et al., 2002)
Sfrpl32 El 1.0 Pancreatic mesenchyme (Heller et al., 2002)
SfrP2 El 7.5 Pancreas (endocrine ceils) (Heller et al., 2002)
Sfrp3 E17.5 Pancreas (endocrine cells) (Heller et al., 2002)
Sfrp4 El 2.0-17.0 Pancreas (Heller et al., 2002)
Table 5.1 - Expression of Wnt signalling component genes during mouse
development
5.2.2 Wnt3 and Wnt8a
Wnt3 and Wnt8a are proposed to be upregulated in the absence of Bapxl
(Figure 5.1). Wnt3 is expressed in the posterior epiblast and mesoderm layers at
E6.5, in the diencephalon and spinal cord at E9.5, in the El 0.5 nasal ectoderm, El 1.0
head, El 1.5-12.5 whole embryo, and in the thalamus at E14.5 (Perea-Gomez et al.,
2001; Parr et al., 1993; Lan et al., 2006; Juriloff et al., 2005; Roelink et al., 1990;
Warren and Price, 1997). Loss of Wnt3 results in embryonic lethality by E10.5, due
to an essential role in AP axis formation (Liu et al., 1999). Wnt8a is expressed at
E9.5-10.5 in the developing head and brain, and in the eye from E9.5-18.5 (Ang et
al., 2004).
Given that Wnt3 may be upregulated in the absence of Bapxl, and that Nkx2-
5 is downstream of Bapxl, it may be of interest that a conserved high-affinity Nkx2-
5 binding site (5' -TCAAGTG-3') lies upstream of the Wnt3 gene (Katoh, 2005). Nkx
genes are predicted to encode transcriptional repressors (Smith and Jaynes, 1996;
Harvey, 1996; Jagla et al., 2001) and so Nkx2-5 loss might be predicted to allow
target gene expression.
12 Secreted frizzled-related protein (Sfrp)
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5.3 Investigations into potential upregulation of Wnt
signalling in the BapxT1' posterior stomach
5.3.1 Examination of Wnt3 and Wnt8a expression by
in situ hybridisation
DIG-labelled RNA probes for Wnt3 and Wnt8a were designed and
synthesised as described in Chapter 7. In situ hybridisation was performed on
~E11.25 and El2.5 wild type and Bapxlv guts, and on appropriate control tissues. A
probe known to work well was included as an experimental control (Hand2 on El0.5
embryos).
Whilst appropriate staining was seen in the control tissues (El0.5 heads; data
not shown) for both probes, no signal was detected in the guts on either genetic
background (Figure 5.2). This finding confirms the multiplex RT-PCR data that
these Wnt genes are not expressed in the wild type posterior stomach, but does not
support their expression on the Bapxl null background. Very low level expression,








Figure 5.2 In situ hybridisation analysis of Wnt3 and Wnt8a gene expression
Expression of Wnt3 and Wnt8a was investigated in wildtype and Bapxlguts at -E11.25
by in situ hybridisation, using DIG-labelled RNA probes. No expression was detected in
the guts on either genetic background.
Lu: lung buds, St: stomach, Du: duodenum
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5.3.2 Analysis of canonical Wnt signalling in the gut
using the BAT-gal reporter line
The expression patterns of most Wnt genes have been well studied. However,
Wnt factors act non-cell autonomously and so it is also imperative to know in which
cells signalling has been initiated in response to these factors. Activation of the
canonical p-catenin pathway can be used to infer the presence and activity of Wnt
factors in a tissue, and so a number of reporter strains have been engineered to
visualise this. One such model is the BAT-gal mouse in which LacZ is downstream of
seven TCF/LEF binding sites and the siamois minimal promoter (Maretto et al.,
2003). P-catenin, stabilised and translocated to the nucleus in response to Wnt
signalling, activates expression of this transgene. BAT-gal expression marks sites of
known Wnt activity, and has also been used to detect novel regions of signalling
(Maretto et al., 2003).
The BAT-gal line was used to examine canonical Wnt signalling in the gut.
Mice from this line were mated with Bapxl+/ mice and the offspring genotyped at
weaning for LacZ/Myo and Neo (knocked into the Bapxl locus). Compound
heterozygotes were crossed with Bapxl+I~ mice to allow examination of the BAT-gal
expression pattern on the Bapxl homozygous null background. Embryos from plug-
checked matings were taken at -E10.5, 11.25, 12.5, 14.5, 17.5, and 18.5, and stained
with X-gal. Genotyping for LacZ/Myo and Bapxl was performed on yolk sac DNA.
No differences in morphology or staining were observed between wild type and
heterozygous mutants, as expected, and so only the wild type and homozygous
knockout staining patterns are discussed.
The earliest stage examined was E10.5. Embryos were stained intact, thus
providing numerous control tissues. X-gal can penetrate through to the gut at this
stage, as shown by the studies in Chapter 2. Activity of the canonical Wnt pathway
was apparent in the lung buds33 of wild type and Bapxl '' mice at El0.5 but was not
significant in the gut tube of either (Figure 5.3a). Some stained cells were located
along the left-side of the wild type gut, with fewer cells on the right. A more bilateral
distribution was noted in the mutant gut shown in Figure 5.3a. However, there was
53 Wni2b (Wntl3) is expressed in the lung buds from E9.5 (Zakin et al., 1998)
196
not an appreciable overall difference between the number and distribution of stained
cells between these genotypes, particularly given the variation between guts of the
same genotype. In no instance though were cells clustered in the posterior stomach.
By ~E11.25 (the stage most relevant to the multiplex RT-PCR findings),
BAT-gal expression is evident in the oesophagus34 - and perhaps the most anterior
limit of the stomach - and lungs of embryos of both genotypes (Figure 5.3b). No
staining was observed in the mutant posterior stomachs. The multiplex RT-PCR data
is thus not supported by this assay. There were, however, some stained cells present
in the spleno-pancreatic mesenchyme of both genotypes (discussed further in Section
5.4).
LacZ expression was also absent from both the wild type and Bapxl'1'
posterior stomach at later stages (El2.5, 14.5, 17.5, 18.5). These older guts were
dissected out from the embryo prior to staining, and lungs (El2.5, 14.5) or heads
(E17.5, 18.5) retained as control tissues in which canonical Wnt signalling is known
to be active. The E12.5, E14.5, and E18.5 staining patterns are shown in Figures 5.3
c, d, & e respectively. Whilst no posterior stomach staining was observed, the
canonical Wnt signalling pathway was found to be active in several other regions of
the gut. Staining was found in the oesophagus at El2.5 and E14.5, and in the anterior
stomach from E12.5, in both wild type and mutant guts. These staining patterns
support the validity of this assay, as Wnt4 and Wntl 1 are expressed in the El 2.5
oesophagus, whilst Wnt4, Wnt5b, and Wnt6 have been detected in the El4.5 and
El6.5 oesophagus (Lickert et al., 2001). The anterior stomach domain of X-gal
staining matches that of Wnt5a expression at E12.5 and E14.5 (Lickert et al., 2001).
Whilst no difference was observed in BAT-gal expression between the wild
type and mutant posterior stomachs, there was one tissue which did display
differential staining: the wild type spleen appears to be a novel site of canonical Wnt
signalling, and this is disrupted in the asplenic Bapxl ' gut. Wnt signalling has not
previously been reported in the developing spleen, and so these findings are
discussed in more detail in Section 5.4.
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-/■. ~\Figure 5.3 Canonical Wnt signalling in wildtype and Bapxl embryos and guts
Activity of the canonical (p-catenin) Wnt signalling pathway was visualised by X-gal staining
of embryos and guts carrying the BAT-gal transgene at a) E10.5, b) -E11.25, c) E12.5,
d) E14.5, and e) E18.5. Posterior stomach activity was not detected on the wildtype or the
Bapx1~^~ background. The expanded posterior stomach is indicated by a yellow box in
the mutant guts. Yellow scale bars represent 200pm, red scale bars respresent 500pm.
L: left, R: right, D: dorsal, V: ventral, Lu: lung buds, Oe: oesophagus, St: stomach, Du:
duodenum
m
5.3.3 Upregulation of Writ signalling in the BapxT
posterior stomach is not supported
Neither the in situ hybridisation nor the BAT-gal reporter assays supported
the findings from multiplex RT-PCR that Wnt3 and Wnt8a are upregulated in the
Bapxl~'~ posterior stomach. There are, however, a few caveats to this conclusion.
Firstly, low level gene expression may be detectable by RT-PCR, but fail to be
recognised by in situ hybridisation. The gut is a particularly troublesome tissue in
which to perform in situ hybridisation, and often presents high background staining
as well as trapping in the lumen, making signal recognition difficult. However, it
should be noted that staining of control tissues (E10.5 heads) indicated that the
probes could successfully detect both genes.
Known sites ofWnt activity were identified using the BAT-gal reporter assay
and so this appears to be a reliable method for detecting Wnt signalling. BAT-gal
expression was not seen in the mutant posterior stomach, again contradicting the
multiplex RT-PCR results. It should, however, be borne in mind that some instances
of Wnt signalling are not detected with this system. Firstly, BAT-gal activity is not
found in the intestinal crypt cells - a known site of Tcf4-mediated Wnt signalling
(Maretto et al., 2003). There is thus the possibility that activity below a certain
threshold is not detected, or that some activity is not registered for other unknown
reasons. Secondly, this reporter recognises only the canonical P-catenin pathway and
so there may be regions ofWnt activity which will not be detected. Wnt3 can act
through the canonical pathway during limb development, as well as during primitive
streak and mesoderm formation (Barrow et al., 2003; Morkel et al., 2003), but it may
not utilise this pathway in all of the tissues in which it is secreted. In addition, even if
Wnt3 and Wnt8a are upregulated, downstream signalling may not necessarily be
activated, as inhibitors could also be present.
In conclusion, the assertion that Wnt3 and Wnt8a are upregulated as a result
ofBapxl loss in the developing posterior stomach is not supported by the data
presented here. Contamination of the RNA used in the original multiplex RT-PCR -
or of the PCR itself - is one potential explanation for the original data. This potential
contamination would probably not be from the rest of the stomach as BAT-gal
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staining did not reveal significant canonical Wnt activity in the —El 1.25 gut. There
are, however, many other sites ofWnt activity in the relatively compact space of the
El 1.0 embryo and so tissue contamination is certainly a possibility.
5.4 Analysis of canonical Wnt signalling in the
developing spleen
Wnt signalling is not known to play a role in spleen development. However,
as discussed earlier, misexpression of Wntl or Wnt5a in the foregut/pancreatic
epithelium disrupts mesenchymal spleen development, suggesting that the absence of
certain Wnt factors is essential for correct patterning of the spleno-pancreatic region
(Heller et al., 2002). A search forWnt genes expressed in the spleen at the Mouse
Genome Informatics (MGI) gene expression database identified seven Wnt genes as
being expressed in the spleen. These genes are, however, only detected in the spleens
of postnatal weeks 6-8 (Wntl, 3, 5a, 11) or adult (Wnt9b, 10a, 10b) mice, and not
during development. The report here of canonical Wnt signalling in the embryonic
spleen is therefore extremely interesting.
5.4.1 BAT-gal expression in the spleen
Sparse BAT-gal expression was first detected in wild type spleno-pancreatic
mesenchyme at El l .5 (Figure 5.4a); very few stained cells were present in the
Bapxl" mutant mesenchyme. By El2.5, X-gal stained cells were present throughout
the wild type spleen (Figure 5.4b), and also in the mesenchyme overlying the
pancreatic buds. Staining was absent from the rest of the posterior stomach region,
suggesting specificity for the spleno-pancreatic mesenchyme. The proportion of
35 As at 13.9.06
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spleen cells stained by X-gal varied between embryos within a litter. Whether this
variance reflects different levels of activity at the different stages of development
found within a litter, or is simply an artefact of the transgene expression and/or
staining protocol is unclear. It is perhaps timely at this juncture to remember that the
BAT-gal reporter does not reflect Wnt gene expression per se, but instead non-cell
autonomous responses to such expression. It is perhaps therefore to be expected that
variation will be found when factors such as developmental stage, Wnt expression
levels, Wnt secretion levels, and differential responses are considered. Expression
was, however, consistently low in Bapxl'1' mutant guts, with the majority of stained
cells localised over the dorsal pancreatic bud. Distinct spleen staining was not
observed, as would be expected given the asplenic phenotype.
The El2.5 spleno-pancreatic expression pattern was recapitulated at E14.5,
again with intra-litter variance in staining (Figure 5.4c). A greater proportion of
splenic cells were stained at El4.5 compared to 48 hours earlier, whilst pancreatic
mesenchyme staining was far less. Some pancreatic mesenchyme staining was also
observed on the Bapxl'1' background, but no splenic expression was present.
Embryos were also assessed for P-gal activity at E17.5 and El 8.5
(Figure5.4d). A small proportion of the wild type spleen cells were positive at these
stages, though some spleens were totally devoid of staining. This may suggest that
Wnt signalling functions during earlier spleen development, but may also be an
experimental artefact as the late embryonic spleen is packed with blood cells and
often stains poorly with X-gal. No splenic expression was noted in the mutant guts,
whilst some stained cells were still present in the pancreatic mesenchyme (though

















Figure 5.4 X-gal staining for BAT-gal activity reveals that the canonical Wnt signalling
pathway is active in the developing spleen of BAT-gal mice
a) At E11.5 stained cells are present in the spleno-pancreatic mesenchyme (outlined in
yellow) of wildtype guts, with few cells noted in the Bapxf ' posterior stomach.
b) By E12.5 staining is present throughout the wildtype spleen, extending into the
mesenchyme overlying the pancreatic buds. Few stained cells are present in the asplenic
Bapxl' ' mutant; these are located in the pancreatic mesenchyme.
c) Stained cells are located throughout the wildtype spleen at E14.5.
d) The proportion of stained cells in the spleen is diminished by E18.5.
Yellow scale bars represent 200pm, red scale bars represent 500pm.Lu: lung buds, St:
stomach, DPm: dorsal pancreatic mesenchyme, DP: dorsal pancreas, Du: duodenum, Sp:









In summary, the major onset ofWnt signalling through the canonical
pathway in the spleen was at El 2.5, though some activity was also detected in the
El 1.5 spleno-pancreatic mesenchyme. Signalling then persisted until at least E14.5,
but had been largely attenuated by El 7.5. Thus the main period ofWnt activity in the
spleen appears to be between El 2.5 and El4.5 - a key period of splenic growth and
differentiation. This activity is lost in the asplenic Bapxl'1' mutant, though stained
cells were detected in the pancreatic mesenchyme.
Many Wnt factors act through the canonical pathway and so there are
numerous candidates for which family member(s) are involved in spleen
development. Thus degenerate RT-PCR approachs to identify the splenic Wnt(s)
(Section 5.5), and the Fzd receptor(s) through which signalling is achieved (Section
5.6), are described in the following sections.
5.5 Screen for expression of Wnt genes in the E14.5
spleen
A number of the murine Wnt genes were first identified by RT-PCR using
degenerate primers described by Gavin et al., 1990 (Gavin et al., 1990). These
primers are specific to two highly conserved amino acid sequences first identified in
Wntl and Wnt2. Wnt4, Wnt5a, Wnt6, and Wnt7a were originally isolated using this
approach (Gavin et al., 1990). These primers have since been used in a number of
studies to examine the array of Wnt genes expressed in a specific tissue (Ricken et
al., 2002; Dabdoub et al., 2003), including the developing gut (Lickert et al., 2001).
Two stages of spleen development - El 2.5 and E14.5 - were of interest,
based on the BAT-gal expression pattern. It was felt, however, that only one stage
should be investigated - at least initially - given the large number of bacterial
colonies from which DNA would need to be prepared and sequenced. An analysis of
Wnt gene expression at El 2.5 would be very interesting as this thesis is primarily
concerned with spleen establishment and early development, as opposed to its
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ongoing development and differentiation. However, BAT-gal expression was
stronger at El4.5 and the spleen is also larger at this stage, thus providing a larger
amount of RNA. This larger size also facilitates easier separation of the spleen from
the stomach, decreasing the chances of contamination from stomach tissue. The
El4.5 spleen was thus considered more amenable to an initial screen of Wnt gene
expression.
A control tissue was also required, to check the validity of the screen. BAT-
gal analysis of the El4.5 embryo revealed heavy staining in the head, and a perusal
of the literature confirmed that many Wnt genes are expressed here. Detection of Wnt
genes known to be expressed in the head thus provided a positive control.
The screen was carried out largely as described in the original report (Gavin
et al., 1990), albeit without restriction digestion of RT-PCR products. Blunt-ended
products were instead ligated into pGEM-T Easy. An agarose gel of the RT-PCR
products is shown in Figure 5.5.
X SI S2 H
0.4kb
Figure 5.5 RT-PCR using degenerate
primers for Wnt genes
Degenerate RT-PCR was performed on
DNase-treated cDNA prepared from E14.5
spleens (S1: RNA extracted using an
RNeasy kit [QIAgen]; S2: RNA extracted
using TRIZOL [Invitrogen]) and heads (H),
and also on a water control (-). cDNA was
synthesised from 1pg DNase-treated RNA
in a 20pl standard first strand cDNA
synthesis reaction; 5pl of this was used in
a 50pl RT-PCR. Primers were as described
in Gavin et al. (1990), and amplified a
mixture of approximately 0.4kb products.
5pl of a 50pl PCR was electrophoresed on
a 2% agarose/TAE gel.
X: 1kb ladder (333ng/lane; Invitrogen)
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5.5.1 Control tissue (head) results
RNA was extracted from three E14.5 heads using TRIZOL and was DNase-
treated prior to cDNA synthesis. RT-PCR for Hprt was performed to check that
genomic DNA was no longer present36 (data not shown). The cDNA was then used
as a template for RT-PCR using the Wnt degenerate primers described above,
resulting in a mixture of ~0.4kb products (Figure 5.5) which were cloned as
described. DNA was prepared and sequenced (Ml3 forward and reverse primers)
from 96 clones. Sequences were assembled into contigs using the Sequencher
program (Gene Codes); contigs were then analysed using the nucleotide-nucleotide
BLASTn program (against the mouse genome) to find which genes they shared
sequence identity with. Individual sequences, not in contigs, were also analysed in
this way. A strict cut-off point for establishing homology was not required as each
contig or sequence showed homology to only one Wnt gene, with high identity across
the ~400bp.
The results of the head control screen are shown in Table 5.2 and Figure 5.6.
Four Wnt genes were found to be expressed in the head at El4.5: Wnt2, Wnt2b (13),
Wnt4, and Wnt7a. Wnt2b is expressed in the telencephalon at E14.5, Wnt4 in the
El4.0 salivary gland, and Wnt7a in the El4.5 eye - thus supporting the validity of
this assay (Grove et al., 1998; Hoffman et ah, 2002; Ang et ah, 2004). The facts that
these genes were detected in different proportions, and that not more of the 19
murine Wnt genes were identified, suggest that this method is a reliable way to detect
the genuine spectrum of gene expression in a tissue. Whilst this screening technique
is not quantitative per se, the relative frequencies may be informative.
16 RT-PCR of genomic DNA and cDNA for Hprt produces differentially sized bands as the primers
flank an intron (details in Chapter 7)
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Gene Wnt2 Wnt2b Wnt4 Wnt7a Other Fail Total
F 38 30 14 10 2 2 96
R 37 30 15 10 2 2 96
Total 75 60 29 20 4 4 192
Table 5.2- Results of Writ degenerate RT-PCR screen on E14.5 head cDNA
The figures in the table show the number of sequences sharing high sequence identity with
each Writ gene. There were unequal numbers of forward and reverse sequences generated,
as some sequencing reactions failed, and so the forward and reverse sequences were
analysed separately. ("F", "R"). "Other" includes vector and other genomic sequences. "Fail"


















Figure 5.6- Results of Writ degenerate RT-PCR screen on E14.5 head cDNA




Guts were dissected out from E14.5 CD1 embryos and cuts made such that
the main middle section of the spleen was taken for RNA extraction, whilst the
terminal connections with the stomach were left behind. Two tubes containing 18
spleens each were frozen in liquid nitrogen. RNA was subsequently extracted from
each of these by one of two methods: using 1) an RNeasy kit (QIAgen), or 2)
TRIZOL (Invitrogen) (see Chapter 7 for details). The two methods were tested so
that the procedure could be optimised for future use; both produced good quality
RNA at a similar concentration. Each RNA sample was DNase-treated prior to
cDNA preparation and the absence of genomic DNA confirmed by RT-PCR for Hprt
(data not shown). RT-PCR, cloning of products, and sequence analysis were then
performed as in Section 5.5.1. 96 colonies were sequenced from each preparation,
using forward and reverse Ml3 primers (192 sequencing reactions per preparation).
The results of the spleen screens are shown in Table 5.3 & Figure 5.7
(RNeasy RNA preparation) and Table 5.4 & Figure 5.8 (TRIZOL RNA
preparation). Six Wnt genes were found to be expressed in the screen ofRNA
prepared using RNeasy: Wnt2, Wnt2b (Wntl3), Wnt4, Wnt5a, Wnt7a, and WntlOb.
Wnt2 and Wnt2b were the most represented genes (27 and 23% of sequences,
respectively). Five of these genes were also detected in the screen on TRIZOL-
prepared RNA: Wnt2, Wnt4, Wnt5a, Wnt7a, and WntlOb. Wnt2b was not detected.
The most frequently detected gene was Wnt7a, which corresponded to 61% of the
sequences. Wnt4 was the least frequent (2%).
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Gene Wnt2 Wnt2b Wnt4 Wnt5a Wnt7a WntlOb Other Fail Total
F 25 21 11 10 8 4 12 5 96
R 23 21 12 10 9 4 12 5 96
Total 48 42 23 20 17 8 24 10 192
Table 5.3 - Results of Writ degenerate RT-PCR screen on E14.5 spleen cDNA,
synthesised from RNA extracted using an RNeasy kit
The figures in the table show the number of sequences sharing high sequence identity with
each Writ gene. There were unequal numbers of forward and reverse sequences generated,
as some sequencing reactions failed, and so the forward and reverse sequences were
analysed separately. ("P, "R"). "Other" includes vector and other genomic sequences. "Fail"
describes sequences which were of insufficient quality and/or length to produce a hit.








Figure 5.7 - Results of Wnt degenerate RT-PCR screen on E14.5 spleen cDNA,
synthesised from RNA extracted using an RNeasy kit
Graphical depiction of results presented in Table 5.3 (total sequences). Failed sequences
have been removed.
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Gene Wnt2 Wnt4 Wnt5a Wnt7a WntlOb Other Fail Total
F 9 3 2 51 11 9 11 96
R 7 0 10 55 11 4 9 96
Total 16 3 12 106 22 13 20 192
Table 5.4 - Results of Writ degenerate RT-PCR screen on E14.5 spleen cDNA,
synthesised from RNA extracted using TRIZOL
The figures in the table show the number of sequences sharing high sequence identity with
each Wnt gene. There were unequal numbers of forward and reverse sequences generated,
as some sequencing reactions failed, and so the forward and reverse sequences were
analysed separately. ("F", "R"). "Other" includes vector and other genomic sequences. "Fail"
describes sequences which were of insufficient quality and/or length to produce a hit.











Figure 5.8 - Results of Wnt degenerate RT-PCR screen on E14.5 spleen cDNA,
synthesised from RNA extracted using TRIZOL
Graphical depiction of results presented in Table 5.4 (total sequences). Failed sequences
have been removed.
A major peculiarity was that whilst Wnt2b was detected in cDNA synthesised
from RNA prepared using the RNeasy kit, it was not found in that prepared with
TRIZOL, using spleens from the same litter. The reason for this discrepancy is not
clear as both methods produce total RNA preparations. However, one published
report showed that RT-PCR failed to amplify two targets - including fi-actin - from
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cDNA prepared from TRIZOL-extracted RNA, whereas these RT-PCRs worked well
with five other extraction methods (Deng et al., 2005). The TRIZOL-prepared
transcripts only became amenable to RT-PCR once diluted down. This may relate to
the findings in other comparative studies that TRIZOL produces a higher yield
(Xiang et al., 2001; Lamarcq et al., 2002). Which method produces the higher purity
appears to vary between studies/samples (Xiang et al., 2001; Lamarcq et al., 2002).
The RNeasy method is based on selective binding by a silica gel-based
membrane; it is inefficient at recovery of RNA transcripts less than 200nt long,
resulting in a 15-20% loss of total RNA by this method (Xiang et al., 2001)(RNeasy
Mini Handbook, QIAgen). TRIZOL is based on the acid guanidinium thiocyanate-
phenol-chloroform technique. One major difference is that the RNeasy kit columns
contain DNase and so RNA prepared by this method is subjected to two DNase
treatments in total; TRIZOL-prepared RNA is treated only once. It may be that the
Wnt2b transcript is preferentially retained or lost when using one of the RNA
extraction methods, or that this transcript becomes more or less amenable to PCR
with one of the methods. This could be due to differing conditions such as salt
concentration, which may affect the specificity of the degenerate primers. Indeed,
varying the salt concentration in future assays might produce a different set of
results.
The relative frequencies of the other Wnt genes also varied between the
preparations. Most notably, Wnt7a was detected in 61% of the successful sequencing
reactions from the TRIZOL clones, but in only 9% of those from the RNeasy set.
This could be taken as an indication that the results of the screens are random.
However, this is not the case, as one would therefore expect the numbers of
sequences matching each Wnt gene to be roughly equal. Also, at least 13 more
murine Wnt genes exist and yet were not detected, despite the degenerate primers
having the ability to amplify other Wnt genes, including Wntl and Wnt6 (Gavin et al.,
1990), Wnt5b and Wntl 1 (Lickert et al., 2001), and Wnt7b and Wnt8 (Dabdoub et al.,
2003)37. In the first of these cited studies, Wnt2 was the most frequent hit (46%),
17 It was not possible to ascertain whether the primers would identify all known Wnt genes as BLAST
analysis is not possible using such degenerate sequences. The forward primer contains five degenerate
bases (two possibilities each) which translates to 32 possible primer sequences. Similarly, the reverse
primer contains four variable bases.
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whilst over 70% of sequences corresponded to Wnt4 in the second study, and more
than 50% related to Wnt7a in the third. Tissue-specific differences in the array of
expressed Wnt genes can therefore be detected using theses primers.
On a technical note, these screens performed favourably compared to
published studies using the same primers. For example, in the original study, 80
colonies were screened, of which only 28 contained an insert (25 pertained to Wnt
genes) (Gavin et al., 1990). Additionally, published studies have not tended to
include an independent screen on a control tissue to confirm known gene expression,
as performed with head cDNA here.
A final pie chart is provided in Figure 5.9 that summarises the combined









Figure 5.9- Combined results of Wnt degenerate RT-PCR screen on both E14.5
spleen cDNA preparations
Failed sequences have been removed.
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5.5.3 Confirmation of candidate Wnt genes
Two methods were chosen to confirm expression of the candidate Wnts.
Firstly, RT-PCR was repeated, but this time using primers specific to each individual
Wnt. Secondly, in situ hybridisation was performed.
5.5.3.1 RT-PCR
RT-PCR primer pairs were designed for each of the candidate spleen Wnt
genes (Wnt2, 2b, 4, 5a, 7a, and 10b). These primers were based on those available in
the literature, and are detailed in Table 7.4. All of the primers flanked introns, thus
allowing contaminating genomic DNA products to be distinguished from those
amplified from cDNA. In fact, the targeted Wnt introns are so large that a genomic
product would be too big to amplify. Each RT-PCR was performed on the El4.5
spleen (RNeasy preparation) cDNA, in addition to the following controls: cDNA
from a tissue known to express the gene of interest, genomic DNA, and sterile water.
The El4.5 head cDNA was also tested for Wnt2, Wnt4, and Wnt7a expression (there
was insufficient cDNA to test for Wnt2b). The positive cDNA controls were as
follows: E10.5 whole embryo (Wnt2, Wnt5a, Wnt7a), E10.5 head (Wnt2b/13), El 3.5
body (Wnt4), and El 3.5 head {Wnt10b).
The RT-PCR results can be seen in Figure 5.10. Splenic expression of Wnt2,
Wnt2b, Wnt4, and Wnt5a was confirmed, as was expression of Wnt2, Wnt4, and
Wnt7a in the head. Faint bands were also observed for Wnt7a and WntlOb in the
spleen, but were not strong enough to be taken as evidence for expression. Wnt7a
and WntlOb were also the least represented genes in the degenerate RT-PCR screen
on this cDNA. It should be noted, however, that Wnt7a was the most highly
expressed gene in the cDNA synthesised from the TRIZOL RNA preparation,
highlighting the major effect that cDNA preparation method can have on screens
such as those reported here. There is thus a necessity for in situ confirmation of
results from such screens.
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Figure 5.10 Individual RT-PCR for each candidate Wntgene potentially expressed
in the E14.5 spleen
a) Wnt2 - 513bp, b) Wnt2b (Wnt13) - 318bp, c) Wnt4 - 344bp, d) Wnt5a - 224bp,
e) Wnt7a - 307bp, f) Wnt10b - 179bp (expected genomic band of 2.1kb can be
faintly seen in the genomic DNA lane). RT-PCR products were analysed on 2%
agarose/TAE gels.
RT-PCR templates: S: spleen cDNA, H: head cDNA, +: positive control cDNA,
G: genomic DNA, -: water. X: 1kb ladder (333ng/lane; Invitrogen)
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5.5.3.2 In situ hybridisation
In situ hybridisation probes for Wnt2 and WntlOb were designed and
synthesised from PCR products containing a 3' T7 promoter site, as described in
Chapter 7. Wnt2b (WntI3), Wnt4, Wnt5a, and Wnt7a probes were transcribed from
plasmids. El4.5 CD1 guts were analysed, along with suitable control tissues: E9.5
embryos (Wnt2), El 1.5 embryos (WntlOb), El2.5 embryos (Wnt2b, Wnt5a, Wnt7a),
and El2.5 guts (Wnt4, Wnt5a). Expression was noted in control tissues for Wnt2b
(El2.5 retina), Wnt5a (El2.5 head/nasal/brain, forelimbs), and Wnt7a (El2.5
head/brain) (data not shown). However, no splenic expression was identified using
any of the probes (data not shown).
5.5.4 Writ genes are expressed in the developing
spleen
Embryonic spleen expression has not been previously demonstrated for any
Wnt gene. In this degenerate RT-PCR screen, Wnt2, 2b (13), 4, 5a, 7a, and IOb were
found to be expressed in the spleen at E14.5 by degenerate RT-PCR. Splenic
expression of the first four of these genes was confirmed by individual RT-PCR.
Wnt2 is expressed in the heart and surrounding tissues from E8.5 to E10.5
(Monkley et al., 1996), and in the lung at El 1.5-15.5 (Bellusci et al., 1996), but has
not been studied in the spleen. Wnt2b (Wnt13) is expressed in a variety of tissues
between E5.5 and E8.5, including the foregut diverticulum (Kemp et al., 2005; Zakin
et al., 1998), and is also expressed in the lung and brain at E9.5 (Zakin et al., 1998).
Again, it is not known to be expressed in the spleen. Nor has Wnt4 expression
previously been found in the spleen, though a number of expression domains exist in
the El 2.5-14.5 embryonic gut (Lickert et al., 2001). Wnt5a is expressed in the
anterior stomach as well as in more posterior regions of the gut tract at El2.5-14.5 -
a pattern also observed for chick Wnt5a (Lickert et al., 2001; Theodosiou and Tabin,
2003). Expression is also present in the developing limb and spinal cord (Parr et al.,
1993), and in the El4.0 liver (Austin et al., 1997), but has not been detected in the
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spleen. Wnt7a is expressed in the head, brain, limb, and eye from E9.5 (Parr et al.,
1993; Ang et al., 2004), but once again no spleen expression has been noted. WntlOb
is expressed in the mandible from El 1.5 and in developing molars from El3.5
(Dassule and McMahon, 1998), and also in the yolk sac at El 1.0 and liver at E14.0
(Austin et al., 1997). Interestingly, WntlOb is expressed in the adult spleen (Wang
and Shackleford, 1996).
The obvious next step is to confirm expression of these genes in the El4.5
spleen, by in situ hybridisation or other analyses such as immunohistochemistry.
Expression should also be investigated in the E12.5 spleen and El 1.5 splenic
mesenchyme. Similarly, it will be worthwhile to repeat the degenerate RT-PCR
screen on cDNA prepared from these earlier tissues. The method of RNA extraction
used had a profound effect on the outcome of the spleen expression screens, and so
this should be taken into account when performing further studies. The published
screens using these primers have only used one RNA preparation method and so
caution may need to be exercised when evaluating and comparing the outcomes of
such studies.
Most of the findings were confirmed by individual RT-PCRs on the same
spleen cDNA as which the screen was performed, but not by in situ hybridisation;
this could therefore be interpreted as evidence of contamination of the spleen RNA
sample with RNA from nearby tissues. Certainly, WntlOb is expressed in the El4.0
liver, and Wnt4 and Wnt5 in the E14.5 gut (Austin et al., 1997; Lickert et al., 2001).
However, this is unlikely to be the correct interpretation for a number of reasons.
Firstly, the spleens from which RNA was extracted were detached extremely
carefully from the underlying stomach and attached gut tissues. Secondly, in situ
hybridisation often fails to detect low-level expression.
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5.6 Screen for expression of Frizzled genes in the
E14.5 spleen
A similar screen to that performed for the Wnt genes was carried out to
identify which, if any, Fzd (Frizzled) genes are expressed in the El4.5 spleen. The
Fzd receptors encoded by these genes are an essential part of the canonical signalling
response to Wnt gene activity.
The screen was carried out on the same El4.5 head and spleen (RNeasy
preparation) cDNA samples as in the Wnt screen, using two published sets of Fzd
degenerate primers (Daudet et al., 2002; Ricken et al., 2002). These primer sets were
originally used to detect expression of rat Fzd genes and so it was uncertain how well
they would perform in a screen on mouse cDNA; hence the decision was made to
perform a screen with each set. An initial BLAST analysis revealed that these
primers are indeed complementary to Fzd sequences in the mouse genome. The
products of RT-PCR using these primers are expected to be 180-270bp ("Daudet")
(Daudet et al., 2002) and 210-340bp ("Ricken") (Ricken et al., 2002).
Following initial PCR confirmation that both pairs could amplify
appropriately sized products, they were used to perform a screen on spleen and head
cDNA. Agarose gels of the RT-PCR products are shown in Figure 5.11. The method
employed was the same as that used for the Wnt primers in Section 5.5, albeit with
two deviations. Firstly, sequencing was only performed using the Ml3 forward
primer, as the inserts were not large and thus there was no need to sequence in both
directions. This would certainly be more efficient given the time needed to analyse
all of the sequences. This also meant that results (number of Fzd-homoIogous
sequences) could be directly related to the number of clones matching each gene, as
in other published studies. Secondly, sequences were analysed by BLASTn analysis
individually, as opposed to within contigs. The reason for this is that upon initial
assembly of sequence contigs it became obvious that there was far greater homology
between members of the Fzd family than those of the Wnt family - at least in the
regions amplified in these studies - and so some sequences became grouped into
inappropriate contigs. This high degree of similarity also meant that one sequence
often showed homology to more than one Fzd gene during the individual BLAST
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Figure 5.11 RT-PCR using degenerate primers for Frz genes
Degenerate RT-PCR was performed on DNase-treated cDNA prepared from E14.5
spleens (S) and heads (H), and also on a water control (-). cDNA was synthesised from
1pg DNase-treated RNA in a 20pil standard first strand cDNA synthesis reaction; 3p,l
of this was used in a 50pl RT-PCR. The primer sets used were those described in
Daudet et al. (2002) ("Daudet") and Ricken et at. (2002) ("Ricken"), both of which
amplified mixes of approximately 0.2-0.3kb products (arrowed). 5pl of each 50pil PCR
were electrophoresed on a 2% agarose/TAE gel.
X: 1 kb ladder (333ng/lane; Invitrogen)
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analyses. However, one hit always exhibited far greater identity (typically 98-100%)
over a larger distance (~200bp), and so this was considered the true match.
5.6.1 Control tissue (head) results
An RT-PCR screen was performed on El4.5 CDl head cDNA using both
degenerate Fzd primer sets. As the head screen was merely a control, only the
products generated using the "Daudet" primers were subsequently cloned and
sequenced. The results of the BLASTn analysis of these sequences are shown in
Table 5.5 and Figure 5.12. A large proportion (72%) of the sequences were of
insufficient quality to produce a match with known genes, due to substandard
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sequencing reactions. Of the 27 colonies that did produce hits, approximately half
contained an insert homologous to Fzd2/10/10a3H.
Gene Fzdl Fzd2/
10/10a
Fzd4 Fzd5 Fzd6 Fzd7 Fzd9 Other Fail Total
Number of
sequences
2 14 2 1 1 1 2 4 69 96
Table 5.5- Results of Fzd degenerate RT-PCR screen on E14.5 head cDNA, using the
"Daudet" primer set
The figures in the table show the number of sequences sharing high sequence identity with
each Fzd gene. "Other" includes vector and other genomic sequences. "Fail" describes










Figure 5.12- Results of Fzd degenerate RT-PCR screen on E14.5 head cDNA, using
the "Daudet" primer set
Graphical depiction of results presented in Table 5.5. Failed sequences have been removed.
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Fzd2, FzdIO, and FzdIOa are synonyms for the same gene
218
Fzd genes known to be expressed in the head at El4.5 include: Fzdl (eye),
Fzd2 (eye), Fzd4 (head), Fzd5 (eye, brain), Fzd6 (salivary gland), Fzd7 (head), Fzd8
(brain), and Fzd9 (brain, eye) (MGI gene expression database at 1.12.06). All of
these genes - with the exception of Fzd8 - were detected in this study confirming the
validity of this technique. No additional Fzd genes (e.g. Fzd3) were picked up, again
supporting the specificity of this assay.
5.6.2 Spleen results
A degenerate screen for Fzd gene expression was performed on El4.5 spleen
cDNA (prepared from RNeasy-extracted RNA) using both the "Daudet" and
"Ricken" primer sets. Sequences were analysed from 96 clones for each set. The
results of both screens are shown in Table 5.6 and Figure 5.13.
RT-PCR analysis with the "Daudet" primers identified the five Fzd genes
detected in the "Ricken" screen {Fzdl, Fz,d2/10/10a, Fzd4, Fzd5, and FzdT), and also
Fzd6. The most frequently detected gene was Fzd2/10/10a, which was found in 27%
of clones. The next most abundant sequences were Fzdl and Fzd4, each constituting
17% of the total sequences. Fzd5 was similarly frequent, whilst Fzd6 and Fzd7 were
rare. The Fzd9 gene detected in the El4.5 head cDNA was not detected,
demonstrating the specificity of the assay.
Gene Fzdl Fzd2/
10/lOa
Fzd4 Fzd5 Fzd6 Fzd7 Other Fail Total
"Daudet" 16 24 16 12 1 2 21 5 97*
"Ricken" 6 4 8 9 0 1 0 68 96
Table 5.6 - Results of Fzd degenerate RT-PCR screen on E14.5 spleen cDNA, using
the "Daudet" and "Ricken" primer sets
The figures in the table show the number of sequences sharing high sequence identity with
each Fzd gene. "Other" includes vector and other genomic sequences. "Fail" describes
sequences which were of insufficient quality and/or length to produce a hit.
* The total number of sequences from the "Daudet" screen is 97, from 96 clones. This is
because one clone contained two inserts (Fzd2/10/10a and Fzd5).
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The pie charts in Figure 5.13 demonstrate the overall similarity between the











Figure 5.13- Results of Fzd degenerate RT-PCR screen on E14.5 spleen cDNA, using
the "Daudet" and "Ricken" primer sets
Graphical depiction of results presented in Table 5.6. Failed sequences have been removed.
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5.6.3 Fzd genes are expressed in the developing
spleen
A number of Fzd genes are known to be expressed in the postnatal and adult
spleen: Fzdl, Fzd3, Fzd6, Fzd7, Fzd8, and FzdlO (MGI gene expression database at
1.12.06) (Austin et al., 1997). Members of the Fzd gene family have not however
been implicated in embryonic spleen development. The degenerate RT-PCR screen
reported here showed that Fzdl, Fzd2/10/10a, Fzd4, Fzd5, Fzd6, and Fzd7 are
expressed in the El4.5 spleen. These genes were detected at different frequencies to
one another, suggesting that the results are not random and instead reflect genuine
expression. In addition, the results from the two primer sets were similar, supporting
their authenticity.
This screen was intended as a preliminary accompaniment to the Wnt screen
and thus the results have not been confirmed. Nonetheless, the detection of the same
set of Fzd genes by the two primer sets is both significant and promising. Though
Fzd3, 5, and 7 are expressed in the E14.0 liver (Austin et al., 1997), care was taken to
ensure no liver tissue contaminated the spleen samples, and so these results are
considered to be reliable. The next step is thus to confirm the findings and extend the
analysis to earlier spleen development.
5.7 Discussion
The original findings which initiated the work described in this chapter - that
Wnt3 and Wnt8a are upregulated in the Bapxl'1' posterior stomach - were not
supported. They did however lead to some unexpected results, as is the nature of
scientific serendipity. Canonical Wnt signalling was shown to be active in the splenic
mesenchyme at ~E11.25 and in the developing spleen at El 2.5 and E14.5. Staining
was also found in the left/dorsal region of the El 0.5 posterior stomach (Figure 5.3a).
This may relate to the presumptive splenic mesenchyme marked by Nkx2-5, NGRS-
LacZ, and other splenic markers at El0.5.
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Wnt signalling was active during the period of initial establishment of splenic
progenitor cells and their apparent migration towards the anterior tip of the stomach.
Likely roles for the signalling would therefore be in proliferation, differentiation, or
maintenance of splenic cells. Immunohistochemical analysis of the cell types in
which the canonical pathway is active would be extremely useful to address these
possibilities. As the major period ofWnt activity in the spleen was between El 2.5
and El4.5, there is a possibility that this is localised to haematopoietic cells, which
begin to populate the spleen at around this time. However, it is more probable that
signalling is active in cells of mesenchymal origin, given the following facts: BAT-
gal is expressed in the ~E11.25 splenic mesenchyme, BAT-gal is expressed in the
El2.5-14.5 pancreatic mesenchyme (which is contiguous with that of the spleen),
and staining was absent from the liver (the embryonic organ from which spleen-
colonising haematopoietic cells arise).
In addition to the spleen, the anterior stomach also displayed BAT-gal
expression. This is of particular interest as an anterior stomach chemoattractant for
spleen development was proposed in Chapter 4. The Wnt5a expression pattern
closely matches that of the X-gal staining observed in the anterior stomach (Lickert
et al., 2001), and so the potential expression of this gene in the spleen, and the
potential role of Wnt5a as a spleen chemoattractant, are of future interest.
Expression analysis revealed which specific components of the Wnt
signalling network are expressed in the E14.5 spleen. Wnt2, Wnt2b (WntI3), Wnt4,
Wnt5a, Wnt7a, WntlOb, Fzdl, Fzd2/10/10a, Fzd4, Fzd5, Fzd6, and Fzd7 were
detected at varying frequencies, the most abundant transcripts being Wnt2, Wnt2b,
Wnt7a, Fzd2/10/10a, Fzd4, and Fzd5. None of these genes have been previously
implicated in spleen development. Expression now needs to be confirmed using in
situ methods.
Wnt signalling is of critical importance to both development and adult life,
and has therefore been well studied in murine cells, tissues, and embryos. There is
accordingly a large pool of resources available for studying and manipulating the
Wnt signalling pathways. It will therefore be very exciting to follow up these results
and unmask a potential role forWnt signalling in mammalian spleen development.
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The first step towards this goal will be repeating both the Wnt and Fzd degenerate
RT-PCR screens at El2.5 and earlier (El 1.0-11.5), when the transition between
splenic mesenchyme and the distinct elongated spleen structure occurs. This
transition presumably involves a range of developmental processes, such as
proliferation, differentiation, migration, and controlled cell death - processes in




"We shall not cease from exploration
And the end of all our exploring
Will be to arrive where we started
And know the place for the first time"
- T.S. Eliot (Four Quartets)
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6.1 Summary of work
The initial aim underlying the work presented in this thesis was to
characterise a putative spleen regulatory region upstream of Nkx2-5. The isolation of
the Nkx2-5 gut regulatory sequence (NGRS), and investigations into the expression
pattern conferred by it, were reported in Chapter 2. The potential uses for the NGRS
as a genetic tool were explored in Chapter 3, and its use as a marker of spleen
development in explant culture was reported in Chapter 4. Finally, the initial
experiments in Chapter 5 were prompted by preliminary data on Bapxl, a gene
upstream of Nkx2-5. A potential novel role forWnt signalling in early spleen
development was revealed as a consequence.
The implications of the results presented are considered in this chapter.
6.2 The origin of the spleen
The spleen is a vertebrate-specific organ that performs both immunological
and haematopoietic functions. Loss of the spleen can have fatal consequences and its
abnormal placement within the body can be an indicator of life-threatening cardiac
defects related to aberrant development of left-right asymmetry. Yet, despite this
obvious clinical importance, the early development of the spleen is poorly
understood. A number of studies have attempted to address this problem in recent
years (Roberts et al., 1994; Dear et al., 1995; Patterson et ah, 2000; Kanzler and
Dear, 2001; Hecksher-Sorensen et ah, 2004; Brendolan et ah, 2005; Asayesh et ah,
2006) but there still remains a number of important questions to be answered.
The first major question is that of where the splenic precursors are derived
from. At El 0.5 a patch of mesenchyme underlying the SMP, lying dorsal to the
junction of the stomach and duodenum, expresses a number of genes known to mark
the spleen later in development (Hoxl 1, Capsulin, Wtl, Nkx2-5) (Hecksher-Sorensen
et ah, 2004). These same genes are expressed in the condensed mesenchyme which
lies dorsal to the posterior stomach at El 1.5 and is considered the classical splenic
primordium (Thiel and Downey, 1921). It thus seems logical to assume that the
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aforementioned El 0.5 dorsal mesenchyme is indeed the earliest known splenic
tissue, particularly given its abnormal development in the asplenic Bapxl (Nkx3-2)~'~
mutant (Hecksher-Sorensen et al., 2004).
But is the El0.5 dorsal mesenchyme the absolute origin of the splenic
precursor cells? This tissue is located on the left-side of the embryo, yet evidence
from Xenopus suggests that splenic precursors (marked by Nkx2-5 expression)
originate bilaterally and that the left-side preferentially develops into the spleen
(Patterson et al., 2000). Aberrant development of such an initially bilateral system
might provide a model to explain how asplenia and polysplenia occur. It is thus of
great interest that both Nkx2-5 and an upstream regulatory region of this gene (the
NGRS) were found to be expressed bilaterally in the SMP (and underlying
mesenchyme) at E9.5, as presented in Chapter 2. Given this expression pattern,
Nkx2-5 could potentially be the earliest marker of the spleen in mouse, as well as in
Xenopus. This cannot, unfortunately, be assessed in mouse embryos lacking Nkx2-5
expression, as such loss proves lethal before recognisable spleen development
initiates (Lints et al., 1993b). There is thus a need to develop suitable tools to
facilitate dissection of the role ofNkx2-5 in early spleen development.
The NGRS was shown in Chapter 2 to be an excellent marker of spleen
development when used to drive LacZ expression. The element drives expression in
the E9.5-E10.5 SMP and underlying mesenchyme, and in the spleno-pancreatic
mesenchyme at El 1.5. Expression is then present in the developing spleen until the
end of gestation. The NGRS might therefore be suitable to direct gut-specific loss of
Nkx2-5 expression. The NGRS also marks the developing pyloric sphincter - another
tissue of clinical importance with poorly understood development, due to a paucity of
mutants and early markers.
In addition to providing a good marker of normal spleen development, the
NGRS also has the potential to mark aberrant spleen morphogenesis, as shown by the
analysis of the Rwhs mutant. The data in Chapter 2 provides the first report of the
spleen defects in this mutant, and further characterisation ought to prove most
interesting, potentially providing a mouse model of polysplenia. Given the relative
normality of the rest of the spleno-pancreatic region, it is expected that the
underlying mutation causes the polysplenia phenotype at a later stage than that
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proposed to occur in response to the disruption of initial splenic bilaterality discussed
above.
6.3 The relationship between Bapxl and Nkx2-5
Nkx2-5 is not expressed in Bapxl'1' guts (Watson et al., 2007), suggesting that
Bapxl may regulate Nkx2-5. A point of expressional overlap between these two
genes had not, however, been previously detected. I found that Nkx2-5 is expressed
throughout the bilateral SMP at E9.5, as is Bapxl, thus providing a potential
interaction point. The phenotypic effects of Bapxl loss become noticeable in the 24
hours that follow (Watson et al., 2007), though loss of Nkx2-5 expression at E9.5 was
not successfully investigated.
Expression of the NGRS was found to be independent of Bapxl. It may
therefore be that whilst the NGRS can recapitulate the entire Nkx2-5 gut expression
pattern during normal development, a second regulatory sequence mediates the
dependence on Bapxl. The fact that the NGRS does not require Bapxl for its activity
may prove useful. Genes downstream of Bapxl could be rescued by driving their
expression with NGRS on the Bapxl'1' background. This would facilitate dissection
of the genetic cascades downstream of Bapx 1.
The NGRS expression domain is wider than that of endogenous Nkx2-5. Both
the regulatory element and the gene are expressed bilaterally in the SMP at E9.5, but
Nkx2-5 expression then becomes refined to two domains, whereas the NGRS is active
throughout the SMP at El0.5. The Nkx2-5 pyloric sphincter domain is also more
refined than that ofNGRS-LacZ from El 1.5, as the latter is contiguous with the
spleen expression domain.
The most interesting facet of the above disparity is that, from El0.5 onwards,
the regions in which NGRS but not Nkx2-5 is expressed are those in which Bapxl
expression is also detected. Bapxl is expressed in the tip of the SMP and the
underlying mesenchyme at E10.5, whilst Nkx2-5 is expressed in two domains
flanking this expression; the NGRS confers expression encompassing all of these
domains. Similarly, both Bapxl and NGRS-LacZ are expressed in the posterior
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stomach region just anterior to the pyloric sphincter from El 1.5; Nkx2-5 is not. It
may therefore be that the endogenous Nkx2-5 expression pattern conferred by the
NGRS (and possibly other elements) is negatively modulated by Bapxl from El0.5
onwards. As Nkx2-5 and Bapxl expression overlap fully in the SMP at E9.5, it must
be assumed that Bapxl does not exert an inhibitory effect at this stage. Conditional
loss ofBapxl expression at El 0.5 would thus be interesting to investigate.
6.4 Transgenic approaches to using the NGRS as a
tool
A major motivation behind cloning and characterising the NGRS was to use it
in lineage tracing exercises, to investigate the origins and development of the spleen
in a way not previously reported. Two approaches to realising this goal were
reported in Chapter 3: the first was a true lineage tracing approach (NGRS-
CreERTT), the second a clonal strategy in response to the failure of the first approach
(NGRS-LoxSTOPLox-LacZ). Both methods were designed to utilise the Cre-ERT2
temporally inducible expression system, but successful transgenic lines were not
established for either. The possible reasons for the failure of these strategies were
discussed in Chapter 3 and so will not be reiterated here. The important message is
that a temporally-inducible, tissue-specific lineage tracing system to investigate early
spleen development would be a valuable asset to the field of gut developmental
biology - if not an absolute necessity - and thus further efforts should be made to
pursue this goal. The NGRS could be central to driving these efforts, though a
number of other options exist, including the Hoxll gene or potential spleen
regulatory regions affiliated with it.
Given the problems experienced when creating transgenic lines by
microinjection (e.g. NGRS-LoxSTOPLox-LacZ, plus more general issues of copy
number and insertion effects), it may be sensible to target future transgenes directly
into the genome. Bapxl and Hoxll are good candidates for a knock-in approach as
they are expressed during spleen morphogenesis and heterozygous loss does not
produce an abnormal phenotype (Lettice et al., 1999b; Roberts et al., 1994; Dear et
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al., 1995). The placing of an inducible Cre transgene under the control of the
endogenous regulatory elements of either of these genes would provide a valid way
to engineer a spleen-specific lineage tracing system.
The origins of the splenic precursor cells could be addressed using an
inducible lineage tracing system, as could a number of other key questions. One such
question is that of the origin of the more general mesenchyme that populates the
region between the SMP and gut endoderm from E9.5-10.5. Later in development, an
important question is that of how the spleen makes the transition from a patch of
condensed mesenchyme dorsal to the posterior stomach at El 1.5 to an elongated
spleen structure by El 2.5. This question was examined in Chapter 4 using an
alternative culture-based approach, and is discussed in the next section.
6.5 Gut explant culture: a novel way to study spleen
morphogenesis
In Chapter 4, the NGRS-LacZ transgene was employed as a marker of spleen
development in gut explant cultures. The explant culture system provided the
opportunity to observe spleen morphogenesis and produced a number of insights into
how the spleen undergoes the transition from condensed mesenchyme at ~E11.5 to
an elongated structure at ~E12.5. The most unexpected of these findings was that,
whilst spleen development was poor in normal cultures, if the posterior region of the
El 1.5 spleno-pancreatic mesenchyme was damaged then accelerated splenic growth
apparently occurred. This inappropriate growth manifested as an apparent splenic
leading edge (anterior tip) - more appropriate to the spleen structure seen from El2.5
onwards - at the anterior of the stomach. Such precocious development was only
observed following disruption or removal of the posterior spleno-pancreatic
mesenchyme, suggesting that this tissue may normally exert an inhibitory or
"anchor" effect on spleen development. Once unleashed from this inhibition,
accelerated spleen development can occur. This phenomenon shows striking parallels
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with that of the leading edge migration that occurs upon separation of the tip (leading
edge) from the main body of Dictyostelium slugs (Dormann and Weijer, 2001).
Preliminary evidence from the culture experiments also suggested that the
spleen originates from the spleno-pancreatic mesenchyme located dorsal to the
posterior stomach at El 1.5, as opposed to being derived in a posterior-anterior wave
from the underlying stomach mesenchyme. Development from the spleno-pancreatic
mesenchyme has certainly seemed the most likely mechanism, given that this tissue -
and later the spleen - expresses spleen markers such as Hoxll, Wtl, Nkx2-5, and the
NGRS-LacZ transgene. Physical obstruction of the spleen using aluminium foil
barriers demonstrated that spleen development does not occur ifM?/?S-expressing
cells exist only posterior to this barrier. Similarly, NGRS-LacZ stomachs with their
spleno-pancreatic mesenchyme removed did not undergo spleen morphogenesis.
The mechanism by which splenic precursor cells from the spleno-pancreatic
mesenchyme might colonise the future spleen region between El 1.5 and E12.5 of
normal development is unknown, though roles for proliferation and migration seem
likely. Migration of NGRS-LacZ-expressing splenic precursor cells towards a
chemoattractant at the anterior of the stomach was also investigated, though the
existence of such a signal could not be confirmed. This may become possible in the
future with further honing of the gut culture and/or explant recombination
techniques. Similarly, the use of a fluorescent tag for spleen development may aid in
these studies. Indeed, a mouse line expressing a Wtl-GFP transgene has been
obtained for these experiments, the results of which should provide some exciting
insights in the near future.
6.6 Wnt signalling in spleen development
The expression pattern of Wnt5a closely matches that of where the proposed
spleen chemoattractant would be secreted. Wnt5a is expressed in the anterior
stomach at El 2.5 in mouse, and in a comparable region in chick and Xenopus
(Lickert et al., 2001; Theodosiou and Tabin, 2003; Smith et al., 2000a). A number of
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other Wnt genes are also expressed in the developing gut, but thus far none have
been detected in the embryonic spleen. However, I have found that the canonical
Wnt signalling pathway is active in the splenic mesenchyme at El 1.5 and in the
spleen itself at E12.5-14.5. More specifically, expression analyses revealed that
Wnt2, Wnt2b (Wnt13), Wnt4, Wnt5a, Wnt7a, WntlOb, Fzdl, Fzd2/10/10a, Fzd4,
Fzd5, Fzd6, and Fzd7 are expressed in the spleen at E14.5. Wnt signalling is a key
component of the developmental tool box and has been shown to be active in most
embryonic tissues. It is perhaps not surprising then that so many genes encoding
components of the Wnt signalling network should be expressed during spleen
morphogenesis. These findings therefore merit further investigation, particularly at
the earliest stages of spleen development.
A recent development in the Wnt signalling field lends credence to the
discovery that canonical Wnt signalling is active in the embryonic spleen. Mariyama
and colleagues developed GFP-based reporter lines for the canonical pathway and
found it to be active in the spleen of adult mice (Moriyama et al., 2007). The
application of such a reporter to the study of Wnt signalling during embryonic spleen
development could provide a further way to investigate the role of this pathway in
splenogenesis. Again, gut explant culture may provide the ideal system in which to
perform such a study.
6.7 Final thoughts
The work presented in this thesis has provided two types of information.
Firstly, it has provided a number of facts or insights into development of the murine
spleen. These include: the establishment of the point of expressional overlap between
Nkx2-5 and Bapxl \ the findings that a conserved upstream regulatory region (the
NGRS) can direct the gut component of the Nkx2-5 expression pattern and that this is
Bapxl-independent; the reporting of a novel spleen mutant (the Rwhs mutant);
evidence that the spleen is derived from the spleno-pancreatic mesenchyme and does
not receive contribution from the underlying stomach mesenchyme; the discovery of
an inhibitory effect on spleen development exerted by the posterior spleno-pancreatic
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mesenchyme; the finding that the canonical Wnt signalling pathway is active during
spleen development, and the detection of a number of Wnt and Fzd genes in the
developing spleen. Secondly, it has established tools and systems for investigating
spleen development further. These include the NGRS-LacZ gut reporter line, the
NGRS-LacZ line on the Bapxl~'~ background, the Rwhs novel spleen mutant, and the




"It ain't what you do it's the way that you do it
It ain't what you do it's the time that you do it
It aint what you do it's the place that you do it
And thafs what gets results"
- Bananarama (It Ain't What You Do)
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7.1 Manipulation of nucleic acids
7.1.1 General molecular biology reagents
Unless otherwise stated, reactions were performed in autoclaved DNase-free, RNase-free 0.5
or 1,5ml microcentrifuge tubes (Eppendorf). Chemicals were analytical grade and were supplied by
Sigma, Roche, Fisher, Invitrogen, and BDH, unless otherwise stated. Restriction enzymes were
obtained from Roche and New England BioLabs (NEB). The following general solutions were
prepared by MRC Human Genetics Unit (HGU) Core Scientific Services, then autoclaved and stored
at room temperature:
Tris.HCl
Tris base (tris[hydroxymethyl]aminomethane) was dissolved in sterile water and HC1 used to adjust
pH as required.
EDTA
EDTA (ethyldiaminetetra-acetic acid di-sodium salt) was dissolved in sterile water. Solid NaOH was
added to bring the solution to pH8.0.
TE buffer
lOmM Tris.HCl (pH7.5), ImM EDTA.
TAE buffer, 50X stock
Tris base 242g
Glacial acetic acid 57.1ml
0.5M EDTA 100ml
To a final volume of 1 litre with distilled water
Stock was diluted to IX with distilled or MilliQ water for use in agarose gel electrophoresis






Disssolved in 800ml distilled water, pH adjusted to 7.4, then brought to a final volume of 1 litre with
distilled water
20X Saline Sodium Citrate (SSC)
NaCl 175.3g
Sodium citrate 88.2g
Disssolved in 800ml distilled water, pH adjusted to 7.0, then brought to a final volume of 1 litre with
distilled water
7.1.1.1 DEPC-treatment ofsolutions
Sterile water (dH20), PBS and SSC were DEPC-treated in a fumehood by the addition of
1 pl/ml DEPC (diethylpyrocarbonate) (Sigma). Solutions were mixed overnight then autoclaved to
hydrolyse (inactivate) the DEPC.
7.1.2 Restriction enzyme digestion
Digestion of DNA was achieved using a suitable restriction enzyme - as determined by the
restriction sites available - and the appropriate lOx buffer for that enzyme. Typically, between O.lpg
and 5pg DNA was digested in a volume of 20-200pl. Enzyme was used at a concentration of 1-
lOU/pg DNA, depending on the duration of the digests (1U cuts lpg in lhr at 37°C, and a 10-fold
excess of enzyme was typically used). The final reaction volume was reached by adding dH20.
Digestions were incubated at the appropriate temperature for the enzyme, as recommended in the
manufacturer's instructions.
Digestion with multiple enzymes in a single reaction was possible when buffers and
incubation temperatures were compatible. If incubation temperatures were incompatible, then
digestion was first performed with one enzyme, then the second enzyme added and the incubation
temperature adjusted appropriately. Digests were performed sequentially in cases where enzymes
required different buffers. The first enzyme and associated buffer salts were removed by phenol-
chloroform extraction and ethanol precipitation, prior to digestion ofDNA with the second enzyme.
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7.1.3 Electrophoresis
7.1.3.1 Standard eel electrophoresis ofDNA samples
DNA fragments were separated by size using agarose gel electrophoresis. Standard (High
Pure, BioGene) or low melting point (LMP) (Invitrogen) agarose was dissolved in IX TAE by heating
in a microwave. Different amounts of agarose in IX TAE were used to make 0.7-4% (weight/volume)
gels as required; larger DNA fragments (> 1 kb) were analysed on a <1% gel, with smaller pieces
(< 1 kb) being run out on >2% gels. Molten agarose was cooled and ethidium bromide (BDH,
lOmg/ml) added to a final concentration of 50pg/ 100ml. Agarose was then poured into a suitable tray
and a plastic comb used to create the required number of sample wells.
DNA was mixed with loading buffer (see 7.1.3.3) and loaded onto the set gel in an
electrophoresis tank containing IX TAE. DNA size markers were run alongside to estimate the size
and amount of DNA in samples. The most commonly used size marker was the lkb DNA ladder
(Invitrogen); lOObp ladder was also used as required (NEB). Gels were typically run at between 60-
120V, depending on the separation required.
Electrophoresed DNA was visualised under UV illumination and photographed on a
BioDocit (UVP) imaging system.
7.1.3.2 Standard eel electrophoresis ofRNA samples
RNA samples were analysed by electrophoresis as per DNA samples, with the following
exceptions: tanks, combs, and gel trays were cleaned overnight by soaking in 0.02M NaOH, prepared
with DEPC water. These were rinsed with DEPC water prior to use. RNA gels were run at 160V for
10 minutes.
7.1.3.3 Agarose sel loading buffer







To a final volume of 50ml with TE, pH8.0.
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7.1.4 Determining the concentration of DNA and RNA
samples
Nucleic acid concentrations were determined by agarose gel electrophoresis and/or
spectroscopy (DNA absorbance).
By electrophoresis:
A number of different volumes of the DNA sample were run alongside various volumes of a
standard DNA size marker of known concentration, and an estimate of the DNA concentration made
by visual comparison between these.
By ultraviolet (UV) spectroscopy:
DNA and RNA samples were diluted 1:100 with dH20 or DEPC-dH20 respectively, and the
spectrophotometer (GeneQuant Pro) was set to recognise this dilution. The spectrophotometer was
calibrated using a water only sample. >70pl of the nucleic acid sample was placed in a clean cuvette
and the absorbance at 260nm (A26o) was measured. The concentration of the sample was given by the
machine in ng/pl, calculated on the following basis:
1 A26o unit of dsDNA = 50pg/ml H20
1 A260 unit of ssRNA = 40pg/ml H20
The concentration of the original sample in pg/ml is calculated as follows:
A260 value x dilution factor x 50pg/ml for DNA; 40pg/ml for RNA.
Concentrations provided by spectrophotometery were occasionally confirmed by running a
volume of sample predicted to contain a certain amount of DNA against the same amount of standard
marker DNA on an agarose gel.
7.1.5 Nucleic acid purification
Purification of DNA from reaction mixtures was performed by gel extraction, following
electrophoresis, and/or phenol-chloroform extraction.
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By gel extraction:
PCR products or restriction-digested DNA fragments were electrophoresed on LMP agarose
gels, then visualised on a UV light-box and excised from the gel using a clean scalpel blade. DNA was
extracted from the gel using a gel extraction kit (QIAGEN), according to the manufacturer's
instructions. All optional steps were included.
Depending on what the DNA was to be subsequently used for, gel extraction was sometimes
followed by phenol-chloroform extraction.
By phenol-chloroform extraction:
Sterile distilled water or TE was added to the DNA sample to reach a final volume of 200pl.
This was then mixed with 200pl phenol:chloroform:isoamyl alcohol (25:24:1), and briefly vortexed
before centrifugation for three minutes at 13,000 revolutions per minute (rpm). The upper aqueous
layer was transferred - carefully avoiding protein at the phase interface - to a clean 1.5ml tube and
200pl phenol:chloroform:isoamyl alcohol was again added, before mixing and centrifugation as
before. The upper layer was removed to a clean tube and 200|ll chloroform added to this, followed by
vortexing and centrifugation as before. The resulting final upper layer was transferred to a clean tube
and DNA precipitated from this (see 7.1.7).
RNA was similarly extracted, albeit using DEPC-treated water and reagents reserved for use
with RNA only.
7.1.6 Precipitation of nucleic acids
DNA was precipitated by the addition of 2.5 volumes EtOH (ethanol) and 1/10 volume 3M
sodium acetate (NaOAc, pH5.2). The precipitation reaction was then placed at -20°C for >2 hours, or
on dry-ice for lOmins, and centrifuged for 15-30 minutes at 4°C, 13,000rpm. The supernatant was
discarded and the pelleted sample washed in 70% EtOH/dH20. The supernatant was once again
removed and the DNA air dried before re-suspension in an appropriate volume of dH20.
RNA precipitation was performed as above, with DEPC-dH20 being used instead of standard
dH20 in the 70% EtOH and for resuspension.
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7.1.7 Ligations
7.1.7.1 Alkaline phosphatase treatment of vector DNA
To prevent self-ligation, the 5' termini of vector DNA were dephosphorylated using calf
intestinal phosphatase (CIP) (Roche). Linearised, purified DNA was made up to a final volume of
45pl with sterile dH20, then mixed with 5pl 10X CIP buffer and lpl CIP. The reaction was incubated
for 15min at 37°C, then at 56°C for a further 15min. I pi CIP was then added and the two incubations
repeated. 2pl 0.5M EDTA was used to stop the reaction, and the CIP heat-inactivated at 65°C for
20min. The resulting dephosphorylated vector DNA was recovered from the reaction by phenol-
chloroform extraction followed by ethanol precipitation.
7.1.7.2 Ligation
When performing a new ligation a number of vector:insert molar ratios were tried, most
commonly 1:1 and 1:3. A no insert (1:0) control ligation was also always performed. 20-50ng vector
was used as standard.
Ligations were performed either for 5-60 min at room temperature (RT), or overnight at
16°C, depending on the ligase used. Rapid ligations were performed in a final volume of 21 pi, using
the Rapid DNA Ligation Kit (Roche) according to the manufacturer's instructions. Overnight ligations
were carried out with standard T4 DNA ligase and ligation buffer (Roche), in a total reaction volume
of lOpl. Following overnight ligation, the ligase was inactivated by heating the reaction mixture to
65°C for 20 minutes.
7.1.8 Annealing of oligos
5pg of each (forward and reverse) oligo were annealed in a screw-cap 1.5ml Eppendorf tube
at 100°C for five minutes in a reaction including 5pl standard ligation buffer (salt), made up to 50pl
with sterile water. The reaction was left to cool for up to two hours and was then ethanol precipitated.
The precipitated annealed oligo was resuspended in 50pl sterile water.
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7.2 Microbiology
Aseptic technique was observed for all microbiological procedures (pouring agar plates,
picking colonies, setting up cultures, storage of bacterial stocks). Liquid cultures were grown under
antibiotic selection at 37°C with vigorous shaking (220rpm). Dry cultures were grown on selective
agar plates, inverted and incubated at 37°C overnight.
7.2.1 Growth media for bacterial cultures
Luria-Bertani broth (LB) and Luria-Bertani agar (L-Agar) were prepared by HGU Core










Made up to I litre with dH20 and then autoclaved







Made up to 950ml with dH20, brought to pH 7.5 with NaOH, then made up to 1 litre with dH20 and
autoclaved
L-Agar
To prepare solid media, 15.0g agar was added to 1 litre LB or low salt LB prior to autoclaving.
7.2.1.1 Antibiotic selection
Stock concentration
Ampicillin (Amp) lOOmg/ml in dH20
Zeocin (Zeo) lOOmg/ml in dH20





7.2.1.2 X-eal/IPTG indicator plates
X-gal (5-bromo-4-chloro-3-indoly-b-d-galactoside) (Melford) at 50mg/ml in DMF (N,N-
dimethylformamide) (BDH) and IPTG (Isopropyl-P-d-thiogalactopyranoside) were added to the
surface of plates. 150pl X-gal/lPTG solution (12pl lOOmM IPTG, 48pl 50mg/ml X-gal, 90pl SOC)
was spread over each L-Agar/antibiotic plate and allowed to adsorb for 30 minutes. Both plate
spreading and drying were performed in a hood.
7.2.2 Transforming electrocompetent cells
Following heat inactivation of the ligase and purification (salt removal) of the ligation
reaction using a nitro-cellulose filter (Millipore), electrocompetent (OneShot TOP10, Invitrogen)
E.coli cells were transformed with 10-100ng (l-2ul ligation) plasmid DNA by electroporation. Cells
were thawed on ice and 50pl were added to each DNA sample in an ice cold centrifuge tube.
Transformation reactions were gently mixed with a pipette tip and then transferred to a pre-chilled
0.1cm electroporation cuvette (EquiBio). Cells were electroporated using a BioRad Gene Pulser using
the following settings: 200Q, 25pF, 1.8kV. Immediately after electroporation 250pl RT L-Broth was
added to the cells and mixed with a pipette tip; the cells were then moved to 4ml snap-cap
polypropylene tubes and incubated at 37°C for lhr with shaking at 200rpm. 5pl and lOOpl aliquots of
transformed cells were then plated on L-Zeo plates and incubated overnight at 37°C.
7.2.3 Transforming DH5a competent cells
Library-efficiency DH5a competent cells were transformed by heat shock, according to the
manufacturer's protocol (Invitrogen).
7.2.4 Isolation of DNA
7.2.4.1 Plasmid DNA
Plasmid DNA was prepared using a commercially available kit (QIAGEN): a Miniprep kit
for production of small amounts of plasmid DNA, a Maxiprep kit for preparing large amounts.
Miniprep cultures were made by inoculating 3ml LB/antibiotic with a single plasmid-containing
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colony and growing this overnight at 37°C with shaking. Maxiprep cultures were prepared by
inoculating 200ml LB/antibiotic with a starter culture - either 1.5ml of an overnight culture or 2ml of
an 8hr culture - and growing this at 37°C overnight in a large conical flask to permit aeration of the
bacteria.
The following morning, plasmid DNA was extracted from the cultures using the chosen kit
according to the manufacturer's instructions. Miniprep DNA prepared was eluted in 30pl dH20,
Maxiprep DNA in 250-500pl dH20. DNA concentration was determined as described in Section
7.1.4. Appropriate restriction digests were performed to check the correct identity of the plasmid
DNA, and these analysed by agarose gel electrophoresis.
7.3 Polymerase chain reaction (PCR)
7.3.1 Reagents
dNTPs:
Deoxyribonucleotide triphosphates (dNTPs) were purchased from ABgene as lOOmM stocks
of each dNTP (dATP, dCTP, dGTP, dTTP), and were stored at -20°C in working stocks of 25mM,
prepared by mixing the four dNTPs in a 1:1:1:1 ratio. dNTPs were used in PCRs at a final
concentration of 0.2mM.
Oligonucleotide primers:
PCR primers were designed using the Primer3 program (see Section 7.9) and/or by manual
sequence analysis. The following guidelines were observed as far as possible when designing primers
for standard PCRs: a sequence length between 20 and 25 nucleotides long, -50% G/C content, and
limited ability to self-anneal or anneal with the other primer in the PCR. Longer primers were
designed when inclusion of an RNA promoter was necessary and for certain cloning procedures.
Primers were purchased from MWG, Invitrogen, and Sigma as lyophilised desalted compounds, and
from EuroGentec as desalted solutions. Stocks were kept at a concentration of lOOpM (in sterile
dH20) at -20°C; primers were used at a final concentration of 0.5-lpM.
Primer details are provided in Table 7.1 (general), Table 7.2 (sequencing), and Table 7.3
(genotyping).
Additional reagents:
Taq DNA polymerase [5u/pl] (Invitrogen) was used at 0.2pl per 20-25pl reaction. PCR
buffer (200mM Tris.HCl (pH 8.4), 500mM KC1) (Invitrogen) was a 10X stock and therefore used at
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1:10 in reactions. Mg2+ (Invitrogen) was used at a final concentration of 2.5mM unless stated
otherwise (range: l-2.5mM). The reaction was made up to the required volume with sterile dH20.
PCR amplification using the Bapxl primers required the addition of DMSO (dimethyl suphoxide;
Sigma) at a final concentration of 10% in order to enhance the efficiency of the PCR (DMSO
destabilises base-pairing, thus inhibiting DNA self-complementarity and allowing the strands to be
separated at a lower temperature; it is particularly useful for GC-rich templates). Routine PCRs were
performed in 0.5ml centrifuge tubes.
Some PCRs required the use of Platinum Taq polymerase (Invitrogen), Expand Hi-fidelity
Taq polymerase (Roche), or KOD Hot Start DNA polymerase (Novagen), in place of standard Taq
polymerase. These requirements are listed in Table 7.4. Platinum Taq was used as a direct
replacement for standard polymerase in otherwise standard PCRs; Hi-Fidelity and KOD polymerases






Product size (bp) Primer sequence 5' —♦ 3'
IfOligoIn 57 140 - in





60 -1400 F GATCATATGCATCCGGAACCCTTAATATAACTTCG
R GATCATATGCATCCTCTTCGAGGGACCTAATAAC














Product size (bp) Primer sequence 5' —► 3'
Rwhs 56 -600 F CTTTCCACCCCATTTCCTCT
R AGGCTCTGTCAGCCCAGTTA
M13
50 Variable F GTAAAACGACGGCCAGT
R GGAAACAGCTATGACCATG









Primer sequence 5' —► 3'
LacZ 60 0.6 F GCGACTTCCAGTTCAACATC
R GATGAGTTTGGACAAACCAC
Myo 60 0.25 F TTACGTCCATCGTGGACAGC
R TGGGCTGGGTGTTAGTCTTA




Neo 65 0.2 F CATCGCCTTCTATCGCCTTC
R CAGCCCCCTTCCTGGAGAAC
Rwhs 56 0.6 F CTTTCCACCCCATTTCCTCT
R AGGCTCTGTCAGCCCAGTTA
ShCre 57 0.28 F CAATTTACTGACCGTACAC
R CAGATTACGTATATCCTGG
EPCreJn 63 1.7 F GAGCGCGACTCTGCTCTTCG
R GTTACCCCCAGGCTAAGTGCC












Table 7.3- Genotyping PCR primers used
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7.3.2 PCR amplification programs and primers
PCR programs are provided in Table 7.4. Programs were run on an MJ Research DNA
Engine Tetrad.
Program 1 2 3 4 5 6 Product Taq used/
(°C/t) cat) (°C/t) (°C/t) (cycles) (°C/t) (~kb) [Mg2+]
Lac// Myo 94/3m 94/20s 59/30s 72/50s x 34 72/ 10m L 0.6 St
M 0.25
Bap 94/3m 94/15s 58/30s 72/2m x 34 72/10m WT: 0.28 PI
1.4 1.25mM Mg2+
Neo 94/3m 94/15s 65/25s 72/25s x 29 72/10m 0.2 St
Rwhs 94/3m 94/30s 57/30s 72/45s x 39 72/10m -0.6 St
ShCre 94/3m 94/1m 57/lm 72/lm x 29 72/10m 0.25 St
EPCreJn 94/3m 94/lm 61/lm 72/2m x 34 72/10m 1.7 PI
Hprt 94/3m 94/45s 58/45s 72/2m x 29 72/ 10m Sp 0.3 St
Un 1.2
CreRT 94/3m 94/45s 56/45s 72/50s x 34 72/10m Sp 0.3 PI
Un 0.88
CrelSH 94/2m 94/15s 54/30s 72/45s x 34 72/IOm 0.66 Hi
IfOligoIn 94/3m 94/45s 57/30s 72/25s x 34 72/IOrn In 0.14 St
Not 0.07
LSL 94/2m 94/15s 60/30s 68/90s x 29 68/l0m 1.4 KOD
OligoOri 94/2m 94/30s 55/30s 72/45s x 29 72/10m 0.4 St
LSLOri, LSL 94/2m 94/30s 55/30s 72/45s x 29 72/ 10m 0.37 St
genotyping
LSL 94/3m 94/45s 57/30s 72/lm x 34 72/10m R 0.23 St
recombination NR 1.6
M13 sequencing 96/2m 96/30s 50/15s 60/4m x 29 - Variable Big Dye
Wnt degenerate 94/2m 94/1m 55/90s 72/lm x 29 72/IOm 0.4 St
1.5mM Mg2+
Wnl2, Wnt7a RT 94/3m 94/30s 56/30s 72/30s x 34 72/10m 0.3 PI
0.5 2mM Mg2*
Wnt2b/l3,Wnt4, 94/3m 94/30s 60/30s 72/30s x 34 72/10m 0.32 PI
WntSa, WntlOb 0.34 2mM Mg2*
RT 0.22 Wnt4 1.5mM
0.18 WntlOb ImM
Wnt3/8a ISH 94/3m 94/30s 59/30s 72/30s x 34 72/10m 0.74 Hi
probe 0.4
Wnl2 ISH probe 94/2m 94/30s 55/30s 72/45s x 34 72/10m 0.47 PI
WntlOb ISH 94/2m 94/30s 55/30s 72/45s x 34 72/10m 0.6 PI
probe
Fzd degenerate 95/5m 95/lm 55/90s 72/90s x 34 72/10m 0.18-0.34 PI
1.5mM Mg2+
Table 7.4 - PCR programs used
This table includes details of programs used for cloning procedures, genotyping, RT-PCR,
making in situ probe templates, and for BigDye sequencing reactions.
Steps: (1) Initial denaturation, (2) denaturation, (3) annealing, (4) elongation, (5) repeat
stages 2-4 x n cycles, (6) final extension. Samples were maintained at 16°C following step
(6).
Key: t: time, m: minutes, s: seconds; Sp: spliced, Un: Unspliced; H: Hi-fidelity Taq
polymerase, St: standard Taq polymerase, PI: Platinum Taq polymerase, KOD: Hi-fidelity
Hot Start KOD polymerase; R: recombined, NR: non-recombined
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7.3.3 Molecular cloning of PCR products
7.3.3.1 Sub-cloning via pGEM-T Eas\ vector (Promesa)
PCR products amplified using standard Taq polymerase (without 3'-to-5' exonuclease
proofreading activity) - and hence mostly with a single adenine overhang - were ligated directly into
the pGEM-T Easy vector (Promega) according to the manufacturer's instructions. 3pl of the ligation
was transformed into library-efficiency DH5a competent cells according to the manufacturer's
protocol (Invitrogen).
7.3.3.2 Screening for transformants
Selection was performed on X-gal/IPTG/ampicillin L-agar plates. The pGEM-T Easy vector
confers ampicillin resistance on host cells, allowing positive selection of vector-containing cells.
Clones containing a successful insert:vector ligation were selected for by X-gal/IPTG, as insertion of
the PCR product into the pGEM-T Easy vector disrupts the LacZ gene; thus transformants were
identified as white, as opposed to blue, colonies.
Plasmid DNA for sequencing was prepared as described in Section 7.2.4.1 (Miniprep). DNA
was sequenced using the dye-labelled terminator BigDye (Applied Biosystems). Reagents were
thawed on ice and dyes protected from light as much as possible. Reactions (20pl final volume) were
prepared in 0.5ml centrifuge tubes as follows:
7.4 Sequencing
200-500ng plasmid DNA in dH20 llpl
BigDye reaction mix 8(xl
Primer (3.2 pmoles) lpl
Sequencing primers are provided in Table 7.2.
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Cycle sequencing was performed in an MJ Research DNA Engine Tetrad using the programs
listed in Table 7.4. Reactions were then transferred to a fresh 1,5ml centrifuge tube and were ethanol
precipitated as described in Section 7.1.7. Reactions were left on ice for 15 minutes to precipitate,
before centrifuging at 13,000rpm for 30 minutes at 4°C. Pellets were washed with 200(tl 70% EtOH.
The supernatant was removed following a second centrifugation step and pellets were dried at room
temperature for approximately 20 minutes. Samples were submitted to the HGU sequencing service
to be run on an ABI machine.
7.5 Animal husbandry
Mice were housed in two facilities: a barrier facility for animals created by transgenic
approaches (Transgenic Unit [TGU]), and a semi-barrier facility for all other mice (Biomedical
Research Facility [BRF]). All procedures were carried out under Home Office licence where required,
and with respect to the "3Rs" (Reduction, Refinement, Replacement). Wild type animals (CD1, CBA,
and C57BL/6) were obtained from Charles River Laboratories. For timed matings, embryonic day 0.5
(E0.5) was the morning when a vaginal plug was detected.
7.5.1 Genotyping of breeding mice
Ear clips were taken from breeding animals both as a means of identification and as a source
of genomic DNA for genotyping by PCR. Ear clips were collected in sterile 0.5ml tubes, and DNA
extracted from each clip by immersion in 50(0, l of 25mM NaOH, 0.2mM EDTA, followed by
incubation at 95°C for 20 minutes. Reactions were neutralised with 50pl of 40mM Tris.HCl, and then
briefly vortexed to break up the tissue. Genotyping PCRs were usually performed immediately on
samples, although genotyping after storage at 4°C or -20°C was also practiced. 2joI of extracted DNA
solution was typically used in a 20pl genotyping PCR assay; primer sequences are provided in Table
7.3. The use of filter tips, a dedicated PCR room under positive pressure, and care to avoid cross-
contamination of DNA samples reduced the chances of mis-genotyping.
The Rwhs mutation was detected by sequencing and identification of the following base
change: GGCCAAACGGAT=>C
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7.5.2 Harvesting of postimplantation embryos
Post-implantation embryos were harvested for use in RNA/cDNA preparation, X-gal
staining, in situ hybridisation, and gut culture studies. Pregnant mothers were sacrificed by cervical
dislocation, the abdominal cavity opened and the uterus removed. Uteri were placed in 50ml falcon
tubes containing ice-cold PBS, ice-cold DEPC-PBS (for RNA experiments), or 37°C DMEM culture
medium (for gut culture). Embryos were dissected out from the uteri in the above solutions, and the
extra-embryonic membranes removed using scissors and forceps. Extra-embryonic membranes (yolk
sacs) were retained for genomic DNA extraction if genotyping was required. Embryos were staged
according to the Emap "Theiler Staging Criteria for Mouse Embryo Development" chart
(http://genex.hgu.mrc.ac.uk/Atlas/theiler2.ppt)
7.5.2.1 Genotypins ofembryos
Genotyping of embryos was performed on genomic DNA extracted from extra-embryonic
membranes (yolk sacs). Each removed membrane was placed in an individual 1.5ml tube, and
digested overnight at 55°C using Proteinase K (Sigma); frozen stocks of lOmg/ml Proteinase K were
added to Tail Tip Buffer to a final concentration of O.lmg/ml, and 0.5ml of this placed in each tube.
Tail Tip Buffer /Proteinase K lvsis buffer!:
The following morning, DNA was extracted from the digestions. If the yolk sac had been
taken from an El0.5 or younger embryo, then the digest was briefly vortexed and then centrifuged for
a few seconds, to recover liquid from the tube cap, and this same tube used for the subsequent steps.
Digests of yolk sacs taken from El 1.5 or older embryos were vortexed briefly and then centrifuged for
10 minutes at 13,000rpm to pellet debris; the supernatant was removed to a new tube and this used for
subsequent steps. 1ml chilled 70% acetone/5% DMF (in 25% dH20) was added to each tube, and
mixed with the digest solution by inversion. DNA was then pelleted by centrifugation for 10 minutes
at 13,000rpm. The supernatant was then carefully decanted and the pelleted DNA washed in 70%
ethanol on a rotator for two hours at RT. Tubes were centrifuged for 5 minutes at 13,000rpm, the
supernatant discarded, and samples air-dried at RT. DNA was resuspended in 50-200pl TE, pH8.0











Genotyping PCRs were typically performed on 2pi of the yolk sac DNA, using primers and programs
detailed in Tables 7.2 and 7.4, and were examined by agarose gel electrophoresis.
7.5.3 Microscopy
Dissections of p ost-implantation embryos were visualised using a Leica Stereo MZFLIII
stereo fluorescence microscope (Leica Microsystems, Milton Keynes, UK) fitted with a fibre optic
cold light source and illuminated base for incident/transmission illumination. Images were captured
with a Photometries CoolSnap colour CCD camera (Roper Scientific, Tucson, Arizona) controlled by
scripts written for IPLab Spectrum (Scanalytics Inc., Fairfax, VA).
7.5.4 Production of transgenic mice
7.5.4.1 Preparation of linearised recombinant DNA for microinjection into
fertilised oocytes
Maxiprep plasmid DNA was linearised using the appropriate enzyme(s) to release the
transgene for microinjection (50-1 OOpg DNA in a lOOpl reaction). Pipette tips used for setting up the
digestion were first cleaned with MilliQ water. Digested DNA was electrophoresed on a 1% LMP
agarose gel in TAE alongside DNA size markers to check that digestion had worked correctly. The
band containing the transgene was then excised from the gel and the agarose digested by treatment
with Agarase (Roche) according to the manufacturer's instructions.
The DNA was purified and concentrated using Microcon-30 spin columns (Amicon)
according to the manufacturer's instructions. Briefly, DNA was passed through the column and
washed three times using O.lmM EDTA/lmM Tris pH7.4. The DNA was eluted in lOpI O.lmM
EDTA/lmM Tris pH7.4 and the eluate was then diluted 1:10 in microinjection buffer (O.lmM
EDTA/lOmM Tris pH7.4). The DNA concentration was determined by electrophoresis and
spectrophotometery. DNA was stored at -20°C until the day of microinjection, at which point it was
diluted in transgenic buffer to a final concentration of 2ng/pl and spun through a Spinex 0.22pm
column (Costar) according to the manufacturer's protocol. The final DNA preparation was provided in
individual aliquots for microinjection.
Alternatively, the digested DNA was run on a 1% SEAKEM GTG agarose/MilliQ TAE gel,
and the transgene recovered from the excised gel slice by electro-elution, using an Elutrap starter kit
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(Schleicher & Schuell) according to the manufacturer's instructions. The eluted DNA was then
subjected to precipitation with isopropanol (equal volume) and sodium acetate (1/10 volume) at -20°C
for two hours. Following centrifugation (as per EtOH precipitation), a 70% EtOH wash and further
centrifugation were performed and the pelleted DNA resuspended in microinjection buffer (as above).
The concentration of the DNA was determined by electrophoresis and spectrophotometery. When
needed the DNA was diluted in microinjection buffer to a final concentration of 2ng/pl and spun
through a Spinex 0.22pm column (Costar). Again, DNA was provided in individual aliquots for
microinjection.
7.5.4.2 Microinjection of recombinant DNA and oviductal transfers
Microinjections and subsequent oviductal transfers into pseudopregnant females were
performed by Brendan Doe, Simon Heaney, Paul Devenney, and Laura Lettice, as described in
(MacKenzie et al., 1997). The one-cell embryos used for microinjection were derived from
superovulated [CBA x C57BL/6] F1 females.
Progeny from recipient female mice were ear clipped at weaning (approximately 21 days of
age) to provide genomic DNA for genotyping to identify those in which the transgene DNA had
integrated. Genotyping was performed as described in Section 7.5.2.1, and was carried out in at least
duplicate. Mice carrying the transgene constituted the founders of subsequent lines, and were mated
with [CBA x C57BL/6] F1 mice from around 6-8 weeks of age (sexual maturity). Subsequent
generations were genotyped to confirm faithful transmission of the transgene. Male founders were
also mated with CD1 females to examine transgene expression during embryonic development.
7.5.5 Identification of transgenic mice
7.5.6 Analysis of transgenic mice
7.5.6.1 Solutions
Detergent wash:

















Bovine Serum Albumin (BSA) (Sigma) 0.5g 0.05%
The solution was made up to 1 litre with dH20.
X-eal staining solution:










The solution was made up to 250ml with detergent wash.
Prior to use, 30pl X-gal substrate (50mg/ml in DMF) (Melford) was added per 5ml staining solution
to the volume required.
7.5.6.2 X-eal staining protocol
LacZ expression was assayed using X-gal. Embryos were dissected in PBS and fixed in 4%
PFA/PBS at RT for the following times:
Whole embryos:
E8.5 - 30 min, E9.5 - 45 min, E10.5 - 1 hr, El 1.5 - Wt hr, E12.5 - 2 hr, E13.5-16.5 - 3 hr
Guts:
El 1.5-12.5 - 20 min, E13.5-14.5 - 30 min, E15.5-16.5 -45 min, E17.5-18.5 - lhr
Fixed embryos/guts were rinsed in PBS and then washed in detergent wash for 20 minutes,
three times, at room temperature. Staining was performed overnight in X-gal staining solution,
protected from light, at 37°C. The staining solution was removed the following morning and the
samples were rinsed in detergent wash for 20 minutes, three times, at room temperature before being
fixed a final time in 4% paraformaldehyde (PFA)/PBS at 4°C overnight. The fix was then removed
and the tissues washed, and stored, in PBS.
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7.6 Detection of gene expression
7.6.1 RNA in situ hybridisation
7.6.1.1 Preparation of templates for in vitro transcription
Details of probes used for in situ hybridisation can be found in Table 7.5. Digoxygenin
(DIG) labelled anti-sense RNA probes were transcribed in vitro from either cDNA-containing
plasmids or PCR products amplified from cDNA.
Plasmids were linearised by digestion with a suitable restriction endonuclease at the 5' end of
the cDNA insert, such that transcription progressing from the RNA polymerase promoter 3' to the
insert terminated at this cleaved point; this generates an RNA transcript complimentary to the region
of the gene being analysed. 20pg Maxiprep plasmid DNA was linearised overnight in a lOOpl reaction
and then purified by phenol-chloroform extraction followed by ethanol precipitation. From the
precipitation stage onwards, RNase-limiting precautions were taken, as described in Section 7.6.2.1.
70% EtOH was made with DEPC-dH20, and DNA was resuspended in 10-50pl DEPC-dH20. DNA
concentration was measured by gel electrophoresis and spectrophotometery as described in Section
7.1.4, and ~lpg used as the template for in vitro transcription.
The alternative type of template used was generated by PCR, using a standard forward
primer and a reverse primer incorporating a suitable RNA promoter at its 5' terminus. Primer details
and programs are given in Tables 7.4 and 7.5. PCR was performed in a 100pl reaction volume, using
Hi-Fidelity Taq polymerase (Invitrogen) and a cDNA template. If additional bands were generated in
the PCR, the desired product was excised and gel extracted. If no contaminating bands were present,
the PCR product was used directly as the template for in vitro transcription. DNA concentration was
estimated by gel electrophoresis, and 0.05-0.2pg used for in vitro transcription.
7.6.1.2 Preparation of labelled ribovrobes
Immediately prior to in vitro transcription, template DNA was heated to 55°C for two
minutes and then chilled on ice. In vitro transcription from the appropriate RNA polymerase promoter
(SP6, T3, or T7) and concomitant labelling of the transcript with DIG was achieved using the DIG
RNA labelling kit from Roche. The manufacturer's instructions were employed, with the following
alterations: reaction volumes were scaled up 2x, and only half of the total RNA polymerase was added
at the start of the 37°C incubation, with the remainder being added after 1 hour of incubation. After
two hours total incubation, residual template DNA was destroyed by the addition of 2pl RNase-free
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DNasel for 15 minutes at 37°C. The reaction was stopped with the addition of 0.8pil 0.5M EDTA
(pH8).
7.6.1.3 Purification of labelled riboprobes
Labelled riboprobes were purified using NucTrap Probe Purification columns (Stratagene),
according to the manufacturer's instructions. 2pl RNase inhibitor (Roche) was added to the probe
which was then aliquotted for storage at -20°C. Purified products were examined by electrophoresis
on a 1% agarose gel, using the conditions described in Section 7.1.3.2, Precautions were taken
throughout both the transcription and purification stages to limit RNA degradation, as described in
Section 7.6.2.1,
7.6.1.4 Whole mount in situ hybridisation
Gene expression in both embryos and embryonic guts was analysed by whole mount in situ
hybridisation.
7.6.1.4.1 Solutions for whole mount in situ hybridisation
To protect RNA from degradation by RNases, solutions were made using DEPC-dH20,
DEPC-PBS and DEPC-SSC for all steps prior to, and inclusive of, riboprobe hybridisation.
Additionally, the general precautions described in Section 7.6.2.1 were taken in order to limit RNA
degradation.
DEPC-PBT
PBT was made by adding 0.5ml 10% Triton X-100 (Sigma) to 50ml DEPC-PBS (final concentration
0.1%). DEPC-PBT was prepared fresh for each in situ hybridisation run.
4% paraformaldehyde (PFA)
4% PFA (Sigma) was freshly prepared on the day it was required, by dissolving PFA in DEPC-PBS
(weight/volume) at 65°C. NaOH was added to a concentration of 1.75mM to help get the PFA into
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Pre-hvbridisation solution (pre-hvb)
Compound Amount added per 50ml Final concentration
De-ionised formamide (Sigma) 25ml 50%
20XDEPC-SSC 12.5ml 5X
Blocking powder (Roche) lg 2%
Triton X-100 (10%) (Sigma) 0.5ml 0.1%
CHAPS (10%) (Sigma) 2.5ml 0.5%
Yeast RNA (50mg/ml) (Sigma) 1ml lmg/ml
EDTA (0.5M) 0.5ml 5mM
Heparin (lOmg/ml) (Sigma) 250pl 50pg/ml
The solution was made up to 50ml with DEPC-dH20 and gently mixed.
Post-hybridisation solution (post-hvhl
Compound Amount added per 50ml Final concentration
De-ionised formamide 25ml 50%
20XSSC 12.5ml 5X
Triton X-100 (10%) 0.5ml 0.1%
CHAPS (10%) 2.5ml 0.5%
The solution was made up to 50ml with dH2Q.
TNT
Compound Amount added per 50ml Final concentration
TRIS (1M, pH7.5) 2.5ml 50mM
NaCl (5M) 1.5ml 150mM
Triton X-100 (10%) 0.5ml 0.1%




















* Heat inactivated at 50°C for 1 hour.














The solution was made up to 50ml with dH20.
NMT-T
NMT-T was made by adding Triton X-100 (10%) to NMT to a final concentration of 0.1%
7.6.1.4.2 Preparation and storage of tissue for in situ hybridisation
Embryos were dissected in chilled DEPC-PBS and the extra-embryonic membranes saved for
genotyping purposes where necessary. Embryos and guts were fixed immediately after dissection in 4%
PFA (in DEPC-PBS) at overnight. The fix was removed the following morning and the tissue washed
with chilled DEPC-PBT for three times 10 minutes at 4°C. Unless the tissue was to be used immediately,
dehydration through a methanol (MeOH) series was performed. Tissues were washed for 15 minutes in
each increasing concentration of MeOH: 25%, 50%, 75% MeOH in DEPC-PBT, followed by storage at -
20°C in 85-100% MeOH.
7.6.1.4.3 Procedure for whole mount in situ hybridisation
Dehydrated tissue was rehydrated through a MeOH series consisting of decreasing concentrations
of MeOH in DEPC-PBT - 75%, 50% and 25% - and then washed three times in DEPC-PBT for five
minutes each. All washes were carried out at 4°C in 5ml solution, in 50m! tubes, and all solutions were
pre-chilled.
Tissues were subjected to mild digestion at RT with lOpg/ml Proteinase K (Roche) in DEPC-
PBT. Treatment time varied according to the size of the tissue: E9.5, E10.5, El 1.5, and E12.5 whole
embryos were treated for 20, 25, 25, and 30 minutes respectively; E11.5, El2.5, and El4.5 guts were
treated for 10, 15, and 20 minutes respectively. Tissue was then washed in chilled DEPC-PBT 3 times for
5 minutes each, and re-fixed in 4% PFA (in DEPC-PBT) for 30-45 minutes on ice.
Day 1
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Following re-fixation, tissues were subjected to another three 5 min chilled DEPC-PBT washes
and then transferred to 2ml cryotubes. The DEPC-PBT was replaced with RT pre-hyb solution and the
samples left for up to 30 minutes at RT to equilibrate (indicated by sinking). The pre-hyb solution was
then changed and samples again left to equilibrate. The pre-hyb was then once again replaced and samples
incubated in this solution at for 1 hour until the pre-hyb was replaced a final time. This final 65°C
incubation lasted 3-4 hours, after which as much as possible was removed prior to addition of the probes.
Samples were incubated overnight at 65°C with pre-hyb containing the appropriate DIG-labelled
riboprobe. Probes were thawed on ice and the required amount added to lOOpl chilled pre-hyb solution to
reach a probe final concentration of 250ng/ml. Precautions were taken to limit RNase activity, as
described in Section 7.6.2.1. Immediately before introduction of this probe mixture to samples, the probe
was denatured by heating to 80°C for 3 minutes in pre-hyb.
A control probe (Hand2/Hand2) was always used on an appropriate tissue (E10.5 whole CD1
embryo) to confirm that the in situ hybridisation procedure had worked (expression detected in limb buds,
heart, and arches).
Day 2
The probe hybridisation solution was removed and replaced with a series of pre-warmed 1 ml
washes in fresh post-hyb solutions, each for 10 minutes at 65°C: 100% post-hyb, 100% post-hyb again,
75% post-hyb/25% 2XSSC, 50% post-hyb/50% 2XSSC, 25% post-hyb/75% 2XSSC. Tissues were then
washed twice in 2XSSC/0.1% CHAPS for 30 minutes at 65°C and twice in 0.2XSSC/0.1% CHAPS, again
at 65°C for 30 minutes. Fresh TNT was used to wash the samples at RT, three times for 5 minutes each,
prior to blocking. Samples were incubated in fresh blocking solution for at least 4 hours (with 3 changes)
at 4°C.
Finally, tissues were incubated in 1ml antibody solution at 4°C overnight with gentle rocking.
The antibody solution was prepared by adding anti-DIG-AP fab fragments (Roche) at a 1:2000 dilution to
chilled blocking solution.
Day 3
Unbound anti-DIG antibody was removed from samples by washing 5 times in TNT/0.1% BSA
(filtered using a 0.45pm syringe filter) for 1 hour each at RT, with gentle rocking. Tissues were then left
in a further change of TNT/0.1 % BSA at 4°C, either overnight or for up to 2 days, again with gentle
rocking.
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7.6.1.4.4 Standard detection of riboprobes
Day 4
Prior to staining, tissues were washed 3 times for 30 minutes each in NMT-T at room
temperature. Staining solution was prepared by the addition of 3.3[xl/ml NBT (lOOmg/ml in DMF)
(Roche) and 3.5pl/ml BCIP (50mg/ml in DMF) (Roche) to NMT-T, and was filtered using a 0.45pm
syringe filter. Samples were stained at RT in the dark, in glass vials containing 3-5ml staining solution.
Staining progress was examined every 20 minutes until a suitable staining pattern had developed with
minimal background. Development time was dependent upon the probe used and expression pattern being
examined, but typically occurred within 1 to 3 hours. The staining reaction was terminated by washing
the samples 3 times in PBS, for 5 minutes each on ice. Stained tissues were then fixed in 4% PFA (in
PBS) overnight at 4°C.
7.6.1.4.5 Fast Red detection of riboprobes
Day 4
In preparation for Fast Red staining, embryos/foreguts were washed 3 times in 0.1 M TRIS pH8.2
for 20 minutes each. The staining solution was prepared by the addition of 1 Fast Red tablet (Roche) per
2ml 0.1M TRIS pH8.2, followed by vortexing the solution until the tablet was dissolved. Tissue was
stained at 37°C in the dark, monitored and the reaction terminated as described in Section 7.6.1.2.4. Fast
Red detection permitted both brightfield and fluorescence imaging of the resultant gene expression
pattern. Fluorescent signal was visualised by confocal microscopy (Section 7.7.4).
7.6.2 Expression analysis via RT-PCR
7.6.2.1 RNA extraction
RNA was extracted from the tissue of interest in order to make template cDNA for use in reverse
transcription (RT)-PCR. Extreme care was taken during RNA extraction to avoid contamination with
RNases: work surfaces were cleaned with the RNase-inactivating agent RNAZap (Ambion), tubes and
filter-tips used were guaranteed RNase-free, solutions were made with DEPC-dH20, reagents were kept
on ice until required, gloves were worn at all times, and only reagents reserved solely for RNA work were
258
used. RNA was extracted as quickly as possible after thawing samples in order to minimise the activity of
endogenous RNases and thus limit degradation.
Embryos were dissected in ice-cold DEPC-PBS and the tissues of interest transferred to chilled
screw-cap eppendorf tubes. Samples were then frozen in liquid nitrogen and stored at -70°C. To isolate
total RNA, the tissue was removed to dry ice and RNA extracted by one of two methods: using the
RNeasy Micro kit according to the manufacturer's instructions (QIAgen), or with TRIZOL treatment
followed by chloroform extraction and isopropanol/ethanol precipitation. To extract total RNA with
TRIZOL, the tissue was immediately homogenised in 1ml TRIZOL (Invitrogen) with the aid of a 1ml
syringe and needle. lOOpl chloroform was then added and the sample vortexed for 15 seconds before
being placed on ice for 5 minutes. The sample was then centrifuged for 15 minutes at 13,000rpm, 4°C,
and the upper (non-pink) layer transferred to a fresh screw cap eppendorf tube. An equal volume of
isopropanol was added, and the sample vortexed for 15 seconds. The sample was then put on ice for 15
minutes, followed by a further centrifugation as before. The resulting supernatant was discarded and the
pellet washed in 70% ethanol (made up in DEPC-dH20). RNA was re-suspended in 50pl DEPC-dH20,
and the concentration determined by spectrophotometery.
If RT-PCR was to be performed using intron-spanning primers - hence giving differently sized
spliced (expressed) and unspliced (genomic) products - then DNase treatment was not necessary. RNA
which was to be used to generate cDNA for use in RT-PCRs which did not differentiate between spliced
and unspliced sequences was treated with DNase, to remove contaminating genomic DNA. lpl DNasel
(RNase-free; Roche) was typically used to treat 3-5pg RNA in a 30pl reaction (3pl 10X transcription
buffer [Roche]; to final volume with DEPC-dH20) at 37°C for 15 minutes. Following DNA digestion, the
DNase was removed by phenol-chloroform extraction and NaOAc/ethanol precipitation to prevent DNase
digestion of newly amplified DNA in subsequent RT-PCRs.
7.6.2.2 cDNA synthesis
A First Strand cDNA Synthesis kit (Roche) was used according to the manufacturer's instructions
for cDNA synthesis prior to RT-PCR.
7.6.2.3 RT (Reverse Transcription) PCR
RT-PCR primers are detailed in Table 7.6, and the programs used are summarised in Table 7.4.





























































55 210-240 F TAYCCNGARCGNCCNATYAT
R AGAGTNAGDATNACCCACCA
Table 7.6 - RT-PCR primers used
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7.7 Analysis of gene expression
Gene expression patterns were examined in both whole and sectioned tissues. Sectioning was
performed physically using either a microtome or vibratome, or virtually by Optical Projection
Tomography (OPT) analysis. Embedding and sectioning procedures for each technique are described
below.
7.7.1 Agarose embedding
Fixed tissue was placed in a 50ml falcon tube and brought to 58°C in PBS in preparation for
embedding. Tissue was then incubated at 58°C in increasing concentrations of LMP agarose (Invitrogen)
in PBS: 1%, 2%, 3%, and 4%. The final (4%) wash was made using high-grade LMP. Each incubation
lasted at least 15 minutes to allow the tissue to sink. The molten 4% LMP agarose containing the tissue
was poured into a chilled small histological mould or petrel dish. Samples were orientated under a
microscope using forceps and monitored at room temperature until the agarose set. In preparation for
sectioning, the solid agarose block was trimmed using a surgical blade (Swann Morton) and stuck to the
vibratome mount in the desired orientation with super-glue. Embedding and sectioning were performed on
the same day for the best results (to prevent pulling away of the gel from the tissue).
7.7.1.1 Vibratome sectioning
Agarose-embedded samples were sectioned at 30-100pm on a vibratome. Sections were
carefully transferred out of the vibratome waterbath onto a Superfrost Plus slide (VWR International) with
the aid of a fine paintbrush. Excess water was removed from the slide using the tip of an absorbent tissue,
and a drop of PBS placed on each section. Sections were then covered with a glass coverslip (VWR
International) and the edges sealed with vulcanising solution (Rema Tip Top, Germany). Slides were
stored flat at 4°C in the dark.
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7.7.2 Wax embedding
Thinner histological sections were permitted by microtome sectioning of wax embedded samples.
Prior to wax embedding, tissue was dehydrated in an increasing ethanol series: 30 (x2), 50 (x2), 70 (x2),
85 (x2), 95 (x2), and 100% (x3) EtOH in dH20. Each EtOH wash lasted 15 minutes, with the exception of
the 100% washes which were of a half hour duration each. Tissue was then washed three times in
Histoclear (National Diagnostics), for 20-45 minutes each, depending on tissue size. The final Histoclear
wash was performed at 60°C. The tissue was then poured in a small volume of the hot Histoclear into a
pre-warmed watchmaker's glass dish or glass bottle, and molten wax added to this to create a 1:1 mixture.
After 5 minutes at 60°C the molten Histoclear:wax mix was removed and replaced with liquid paraffin
wax. Three 45 minute incubations in wax were performed at 60°C, with the wax being replaced for each
wash. Samples were then transferred to fresh molten wax in a pre-warmed plastic mould; transferral was
facilitated by heated metal implements or heated pastettes with cut ends, and was performed on a heated
surface. The tissue was orientated (using heated forceps or needles) with the aid of a microscope and then
allowed to set at room temperature. Blocks were stored at room temperature or 4°C.
7.7.2.7 Microtome sectioning
The room-temperature wax block was trimmed to the desired size and the edges angled with a
scalpel-blade to improve the capture of sections and facilitate correct orientation of the sections. Wax-
embedded samples were sectioned at 5- 10pm, depending on developmental stage, on a microtome
according to standard operating procedures. Strings of serial sections were floated out in a 42°C waterbath
and transferred to Superfrost Plus slides (VWR International) with the aid of a fine paintbrush. Slides were
placed on a 37°C slide dryer for up to an hour and then incubated at 50°C overnight.
To de-wax the sections, the slides were washed three times in Histoclear for 5 minutes each,
followed by two 10 minute washes in 100% ethanol and then a rinse in 100% ethanol. Sections were then
subjected to a decreasing ethanol wash series: 90, 70, 50, and 30%, in dH20, for 5 minutes each. A two
minute water wash followed and sections were then counterstained with Nuclear Fast Red (Vector
Laboratories) if required, for 0.5-2 minutes. Following counterstaining, the sections were rinsed in running
tap water for 10 minutes, and then dehydrated back through the ethanol series (30 seconds each wash this
time). Slides were then washed three times for 2 minutes each in 100% ethanol, followed by three 5
minute washes in Histoclear. To mount the slides, Histomount (National Diagnostics) was added to each
slide and a coverslip placed gently on top.
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7.7.3 Optical projection tomography (OPT) analysis
7.7.3.1 Preparation of tissue
Fixed tissue was embedded in 1% LMP agarose (in sterile dH20). The set agarose block was
trimmed with a surgical blade and glued to a cylindrical metal mount in the required orientation. The
block was then placed in a clean glass scintillation vial and dehydrated at room temperature overnight with
methanol. Samples were optically cleared for scanning the next day by replacing the methanol with fresh
BABB (1 part Benzyl Alcohol (Sigma) to 2 parts Benzyl Benzoate (Sigma)). Samples were monitored
every 15-30 minutes and OPT scanned once the tissue reached the desired transparency.
7.7.3.2 OPT scanning and data analysis
Samples were scanned in a BABB-filled cuvette by transmission OPT on an OPT scanner
(BIOPTONICS). Information regarding OPT can be found at
http://genex.hgu.mrc.ac.uk/OPT Microscopy/. Data reconstructions and 3D movies were produced using
scripts written by Dr. James Sharpe. GIMP software (a Unix version of Photoshop) was used to capture
still images
7.7.4 Microscopy
Tissue sections were analysed on a Zeiss Axioplan II fluorescence microscope (Carl Zeiss Ltd.,
Welwyn Garden City, UK) equipped with colour additive filters (Andover Corp, Salem, NH) for
sequential colour imaging and a Photometries CoolSnap HQ monochrome CCD camera (Roper Scientific,
Tucson, Arizona). Image capture was performed using scripts written for IPLab Spectrum (Scanalytics
Inc., Fairfax, VA) which controlled camera capture and filter selection via motorised filter wheels (Ludl
Electronic Products Ltd., Hawthorne, NY).
Fast-Red stained tissue was examined by confocal microscopy, using a Zeiss LSM510 confocal
system attached to a Zeiss Axiovert 100m microscope. The system was fitted with an Argon laser (488
and 514 lines), and two HeNe lasers (lines at 543nm and 633nm). Images were captured and viewed using
Zeiss LSM510 v3.00 software.
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7.8 Gut organ culture
7.8.1 Preparation of explant tissue
In preparation for gut cultures, all media was heated to 37°C. Embryos were harvested as
described in Section 7.5.2. Uteri were removed from sacrificed pregnant mice as quickly as possible and
placed in 37°C DMEM (GIBCO) culture medium. Once the embryos had been dissected out from the
uteri, and all extra-embryonic membranes removed, they were incubated in DMEM containing 10% foetal
calf serum (FCS) (Hyclone) and 1% Pen/Strep (Sigma) at 37°C/5% C02; each embryo was removed from
incubation only when it was to be dissected. DMEM is a cell-culture medium rich in amino acids, salts,
glucose and vitamins. Pen/Strep is a combination of penicillin and dihydrostreptomycin; these antibiotics
are active against mainly Gram-positive and Gram-negative bacteria respectively. The gas equilibrium of
5% COi is known to be optimal for culture of embryos with more than 30 somites (>~E10.0/TS16) (Copp
and Cockroft, 1990).
Guts were dissected out in warm DMEM/10% FCS/1% Pen/Strep using forceps cleaned in 70%
ethanol/dH20, and returned to incubation at 37°C/5% C02 until all guts were ready for culturing. To aid in
maintaining the structure of the guts in culture, and to provide landmarks for orientation, the oesophagus,
lungs, and duodenum were left attached. Cutting and division of explants was achieved using tungsten
needles.
Guts were cultured at 37°C/5% C02 in 24-well plates for 24-48hrs on either filter discs or
Matrigel; each technique is described below.
7.8.2 Culture on filter discs
Millicell-CM culture plate inserts (Millipore) were placed in a 24-well plate, on top of
DMEM/10% FCS/1% Pen/Strep. A thin layer of agarose (in PBS) was then added to each disc to provide
support for gut cultures, and a further 200pi of DMEM/10% FCS/1% Pen/Strep dispensed onto this. Each
gut was placed on a filter disc, positioned with forceps using a brightfield microscope, and excess media
pipetted off such that the gut suctioned onto the disc but was not left dry.
Time Ohr (tO) photographs were taken once all guts had been prepared for culture using the
QCapture imaging system (Qlmaging). The remaining wells of the culture plate were each filled with-lml
of media, to prevent evaporation from the explant cultures. The plate was then incubated at 37°C/5% C02
for the desired culture period.
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7.8.3 Culture on Matrigel
The reduced growth factor form ofMatrigel (BD Biosciences) was used to avoid potential
interference with normal growth by exogenous factors. Matrigel is a commercially available substance
which provides a biologically active extracellular matrix on which to submersion culture cells or tissue. It
is composed of solubilised basement membrane extracts from Engelbreth-Holm-Swarm (EHS) mouse
sarcomas. Matrigel is a solid both in -20°C storage and at 37°C, but can be dispensed as a liquid at 0-4°C.
Accordingly, an aliquot of Matrigel was thawed on ice during gut dissections, and kept chilled along with
pipette tips and a 24-well plate until needed. The Matrigel was then mixed 1:1 with chilled DMEM/10%
FCS/1% Pen/Strep just prior to positioning of the guts within the 24-well plate. The 1:1 ratio was found to
be optimal, as growth and survival was poorer at a higher concentration of Matrigel, whilst support and
adhesion was lost with too high a concentration of media.
Guts were removed from incubation and transferred in DMEM/10% FCS/1% Pen/Strep to the
chilled 24-well plate, then positioned with forceps using a brightfield microscope. Following each
orientation, culture media was pipetted off and 20pl of chilled 1:1 Matrigel: DMEM/10% FCS/1%
Pen/Strep was dispensed onto the gut.
A preliminary lhr incubation at 37°C/5% C02 was performed to polymerise the Matrigel once all
guts had been processed. If the guts were to be manipulated using aluminium foil strips (prepared using a
sterile scalpel blade) then this was performed at RT during this time window. Photographs were also taken
at tO during this time using the QCapture imaging system (Qlmaging). At the end of the 1 hr incubation,
200pl DMEM/10% FCS/1% Pen/Strep was added on top of each gut culture, and 1ml of this media also
placed in each well of an empty row in the plate to minimise evaporation. The plate was then returned to
incubation at 37°C/5% C02 for 24-48hrs. When the culture period was 48hrs, guts were checked at 24hrs
and 50pl additional DMEM/10% FCS/1% Pen/Strep added if they were drying out.
7.8.4 Analysis ofgut cultures
After culturing guts for the required time, they were removed from incubation and photographed
using the QCapture system (Qlmaging). Forceps were then used to excise the guts from the Matrigel and
the guts moved to a new 24-well plate to be washed and fixed. CD1 (non-transgenic) guts were washed
three times in PBS, and then fixed in 4% PFA/PBS for 15 minutes. Guts derived from NGRS-LacZ
(transgenic mice) were washed three times in detergent wash, fixed for 15 minutes in 4% PFA/PBS, and
then assayed for LacZ expression by staining with X-gal overnight (Section 7.5.6). Stain solution was
removed the following morning and guts were washed three times in PBS, followed by fixation in 4%
PFA/PBS for 20 minutes. Both sides of the stained guts were then photographed using QCapture.
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7.9 Bioinformatics
The following bioinformatics programs and resources were used:
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Appendix Table 1 - Nkx2-5 regulatory elements
Expression is in transient transgenics, unless otherwise stated. All genomic locations are relative
to the translational start point and, where necessary, have been altered from the original base
numbering to reflect this. Exons are numbered according to (Schwartz and Olson, 1999).
Abbreviations used: l/OFT - inflow/outflow tract; PH - pharynx (pharyngeal endoderm); TH -
thyroid; ST - stomach; SP - spleen; PCS - pericardial sac; RV - right ventricle; AVC - atrial-
ventricular canal; IVS - interventricular septum; LV - left ventricle; AT - atrium; RVT - right
ventricle trabecula; PY - pyloric region of stomach; CC - cardiac crescent; LPM - lateral
plate mesoderm; PP - pancreatic primordium; A - deletion; pBS - pBluescript
Generation of the NGRS-LacZ construct
The NGRS was originally cloned, and the NGRS-LacZ construct generated, as part of my Msc
(University of Edinburgh, 2003). A BLAST analysis of the murine genome with the Nkx2-5 sequence
(NCBI: AF091351) identified a contig covering the AR7 upstream region reported to confer distal
stomach and spleen expression (Reecy et al„ 1999). Primers flanking this region were designed based on
this contig sequence, using the Primer3 program. A Hindlll recognition site was included at the 5'
terminus of each primer to facilitate excision and cloning into the reporter construct. Suitability of this
restriction enzyme was confirmed by restriction mapping of the region to be amplified, using Webcutter.
The NGRS was isolated as a 1956nt fragment from genomic (C57BL/6) mouse DNA by gel extraction of a
PCR product generated by high fidelity PCR, and was subcloned into pGEM-T Easy. This construct was
used to transform competent DH5a cells. Colony PCR was performed on DNA extracted from white
Ampicillin-resistant colonies. Sequencing of gel-extracted PCR products, using vector-based Ml3
primers, confirmed the identity and integrity of the enhancer fragment. One colony was picked on this
basis, and plasmid DNA prepared from this (Miniprep). The NGRS was then excised from pGEM-T Easy
by Hindlll digestion and isolated by gel extraction. This sticky-ended ~2kb fragment was ligated into
pi230, a LacZ reporter construct containing a B-globin promoter (based on pBGZ40). Miniprep DNA
from a colony transformed with this construct - as confirmed by colony PCR — was analysed by Hindlll
digestion to confirm identity. Identity and sequence integrity of a large-scale (Maxi) preparation of the
plasmid DNA was confirmed by restriction digests {Hindlll, Notl, Sail, and combinations thereof) and
sequence analysis. The NGRS in the final construct used for the MSc microinjections lies in a reverse
orientation with respect to the promoter and LacZ; it still, however, confers the expected expression
pattern.
New preparations were used for each microinjection session during my PhD. A ~5.5kb DNA
fragment containing the NGRS, LacZ reporter gene, and 8-globin promoter was excised from the final
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NGRS-1230 reporter construct, using SpeI and Sail. This fragment was gel-extracted using Agarase -
followed by phenol/chloroform extraction, and ethanol precipitation - or by electro-elution from gel slices.
Finally, the fragment was resuspended in reduced-EDTA (0.1M) TE buffer, and microinjected into mouse
oocytes.
From the original, MSc, microinjection session 5/16 El2.5 embryos were positive for LacZ by
PCR, and two of these exhibited X-gal staining (spleen, pyloric sphincter, dorsal stomach mesenchyme,
thyroid, cardiac outflow tract). Full details were provided in my thesis: Sally Burn, MSc (Res), University
of Edinburgh, 2003.
Primer sequences:
Sequences of primers used to amplify the 1956nt NGRS region were as follows, orientated 5' to 3':
f: AAGCTTCAGGCATCTTGCTTTCTTCC
r: AAGCTTGCAAAGGCCTGATTTGTGTTC
High fidelity PCR program for initial isolation of NGRS from genomic DNA:
1) 3 minutes denaturation at 94°c
2) 94°c for 30s
3) 59°c for 50s
4) 70°c for 120s; back to 2) for 29 cycles
5) 5 minutes at 70°c.
Generation of stable NGRS-LacZtransgenic lines
Attempts to generate a transgenic line stably expressing the NGRS-LacZ transgene were initially
unsuccessful and transgenic mice were only generated in the third round of microinjection sessions. One
factor that may have been instrumental in the final success was the use of electro-elution to recover the
linearised construct from the agarose gel on which it was separated; standard gel extraction techniques had
been used prior to this.
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Appendix Table 2 - NGRS-LacZ Line 4 plugs
Transgenic parent Age Number embryos Number transgenic
4 F.8.5 11 5
Ft E8.5 14 1
Ft E9.0 9 4
4 E9.5 12 | 7
Ft E9.5 13 8
4 E10.5 12 5
4 E10.5 10 6 I
4 El 1.5 J 14 9
4 E12.5 15 7
F1 E12-5 J 15 7
F1 E12.5 11 5 1
F1 E12.5 13 9
F1 E12.5 12 4
F1 E12.5 12 I 4
4 E13.5 14 3
Transgenic parents: 4 = founder male; F1 = offspring of male 4.
All matings were with CD1 females/males.
This table does not include mice found not to be pregnant upon dissection.
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Appendix Table 3 - NGRS-LacZ Line 21 plugs
t ransgenic parent Age Number embryos Number transgenic
Ft E8.5 9 5
Ft E9.5 13 7
__ J E9.5 11 3
Ft | E10.5 j 14 5 1
Ft El 1.5 11 4
F1 El 1.5 11 1 6
. F1 1 E12.5 9 4
F1 E12.5 11 5
F1 E13.5 _j 12 3
Fl E13.5 11 3
F3 El 3.5 |
_ 12 J 6
F3 El3.5 J 9 3
F3 E13.5 6 1
Fl E14.5 12 7
Fl E15.5 13 6
Fl E16.5 J 13 5
Fl E17.5 12 6
. Fl . 1 E18.5 io 1 4
Fl E18.5 12 1 5
Transgenic parents: F1 = offspring of female 21, F3 = offspring of F2 generation.
All matings were with CD1 females/males.
This table does not include mice found not to be pregnant upon dissection.
Appendix Table 4 - NGRS-LacZ Line 4IBapxT1' plugs
Age No. embryos No. LacZ+ No. Bapxl'1' J % No. LacZ/Bapxl'1'
E9.5 2 o. 0 0
E9.5 | 3 3 0 1 0
E9.5 8 6 3 1
E10.5 | 9 4 I 3 1
E10.5 16 8 | 2 1
E10.5 8 5 0 0
El 1.5 8
, J 2 0 0 1
El 1.5 8 2 1 0 1
E12.5
_ 1 1 _ 2 J 1 0
E12.5 8 I 4 1 0 0
El 2.5 8 2 1 1 1
Matings: F1 generation Line 4 males x Bapxl*1' females, to generate LacZ/Bapx1+l~ mice which
were then crossed with Bapx1+I' mice to produce LacZ/Bapxf'"offspring. Bapxl*1' mice were
stock from the Biomedical Research facility (BRF) and transmitted the Bapxl null allele poorly.
This table does not include mice found not to be pregnant upon dissection.
Appendix Table 5 - NGRS-LacZ Line 2MBapxl'1' plugs
Age No. embryos No. LacZ+ Jg No. Bapxl'1' No. LacZ/Bapxl'1'
E9.5
. . .. 6 J 5 1 1 1
E9.5 9 5
. . o J 0
E10.5 11 5 2 2
El 1.5 10 8 3 J 3
El 1.5 8 3 0 0
E12.5 J 10 4 2 2
E12.5 7 | 6 3 3
E16.5 8 4 0 o I
E18.5 | 10 5 0 0 1
E18.5 6 __J 2 2 0
Matings: F1 generation Line 21 males x Bapxl*'' females, to generate LacZ/Bapxl*1' mice which
were then crossed with Bapxl mice to produce LacZ/Sapxf' offspring.
Bapxl*1' mice were stock from the Transgenic Unit and transmitted the Bapxl null allele well.




Generation of the NGRS-CreERT2 construct
The source of the intron-CreERT2-poly(A) DNA fragment was the pK5-CreERT2 construct,
kindly provided by Pierre Chambon. pK5-CreERT2 was generated by cloning a ~0.85kb Stul-Sall
fragment - containing sequences for the rabbit P-globin intron II, a multiple cloning site (MCS), and the
SV40 polyadenylation signal - from the pSG5 vector (Green et al„ 1988) into the Stul-Xhol sites of
pMCS-1 (Feng et al., 1997), to create pGS\ a ~2kb fragment encoding CreERT2 (Feil et al., 1997) was
then inserted into the EcoRl site of the MCS between the intron and poly(A) sequences to generate pGS-
CreERT2. A ~5.2kb Sail bovine keratin K5 promoter region from pKI8-BK5P was then placed upstream
of the intron, thus creating the final pK5-CreERT2 construct (Indra et al., 1999). pK5-CreERT2 was
sequenced to facilitate restriction mapping, as suitable sequence data was not available. The Sail K5
promoter fragment was removed and the vector religated to allow excision of the intron-CreERT2-poly(A)
fragment with Notl for use in the NGRS-CreERT2 construct. This relegated vector is referred to as
pCreERT2.
To generate NGRS-CreERT2, the pZErO-1 vector was linearised at the MCS Notl site and
dephosphorylated with Calf Intestinal Phosphatase (CIP) to prevent self-ligation. The Notl fragment from
pCreERT2 containing the intron, CreERT2, and SV40 poly(A) sequences was ligated into this site,
creating pZ-ICEA. Plasmids containing this insert were identified by colony PCR with primers for Cre
(~lkb product), and positive colonies were cultured overnight in 3ml L-Zeo. Hindlll digestion of
Miniprep DNA prepared from these cultures showed the orientation of the insert (one Hindlll site lies 3'
with respect to the insert, in the vector, and a second is located between the Cre and ERT2 coding
sequences; if the insert is orientated correctly - with respect to the restriction sites needed for subsequent
cloning steps - then fragments of -1.2 and ~4.8kb are generated, whereas incorrectly orientated inserts
will produce -2 and ~4kb fragments). Sail digestion and CIP treatment of a correctly orientated and
sequenced pZ-ICEA construct was performed in preparation for ligation of the ~2kb NGRS and P-globin
promoter sequences which had been excised as a Sail fragment from a vector in which it was cloned as a
Sa/I-ended PCR product. Sail cuts 5' to the intron in pZ-ICEA, and is the cloning site for the original
keratin K5 promoter region. Orientation of the NGRS/fi-globin promoter Sail fragment was checked using
Notl digestion (Notl restriction sites are located 5' to the Sail insertion site, ~0.3kb from the 3' end of the
NGRS/fS-globin promoter insert, and 3' to the poly(A); a correct orientation will produce approximately
3.3, 1.8, and 2.8kb bands, and incorrect orientation produces approximately 4.8, 0.3, and 2.8kb fragments).
This final construct was sequenced and is referred to in this thesis as NGRS-CreERT2.
A ~5kb fragment containing the NGRS, p-globin promoter, rabbit P-globin intron II, Cre, ERT2,
and SV40 poly(A) sequences was excised for microinjection using Nsil (Kpnl is also a suitable enzyme).
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Generation of the NGRS-LoxSTOPLox-LacZ construct
To generate the NGRS-LoxSTOPLox-LacZ construct, a ~60bp region including the fi-globin
promoter was removed from NGRS-LacZ using Pstl and the vector was dephosphorylated. The excised
region was then replaced by ligation of a sequence identical but for an Nsil site at the 3' end:
CTGCAGCCCGGGCTGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTTACATTTGCTTCTAG
CATGCATCTGCAG
(Blue: Pstl recognition site; red: Nsil recognition sequence; underlined: fi-globin promoter sequence)







Insertion of the double-stranded annealed oligo sequence was verified by colony PCR
("IfOligoIn" PCR program and primers, provided in Chapter 7). Miniprep DNA was produced and Pstl
(analysed on a 3% agarose gel), Nsil, and Smal + EcoRl digests performed to confirm correct insertion. A
further PCR identified the orientation of the inserted DNA ("OligoOri" PCR program and primers, as
described). Sequencing was also performed to ensure the correct sequence was present.
The ~1,4kb LoxSTOPLox cassette was amplified by PCR from a host vector (pBS302) using
KOD Hi-fidelity Taq polymerase and the "LSL" program and primers detailed in Chapter 7. The PCR
product was gel-extracted and its ends digested with Nsil. Following phenol/chloroform treatment and
ethanol precipitation, the LoxSTOPLox fragment was subcloned into the Nsil site of pZErO-1 and
sequenced. A suitable clone was then digested with Nsil and the released LoxSTOPLox DNA was ligated
into the Nsil site of the altered NGRS-LacZ vector (digested with Nsil and dephosphorylated). Colony
PCR was performed to identify clones carrying the LoxSTOPLox cassette in the correct orientation
("LSTOPLOri" primers and PCR program), and Miniprep DNA was subjected to restriction digestion to
confirm correct cloning of the final construct (Sail, Spel, Pstl, Nsil, Hindlll, Sail + SpeI).
A ~7kb fragment containing the NGRS, fi-globin promoter, LoxSTOPLox, and LacZ sequences
was excised for microinjection using Sail + Spel, and electro-eluled from a 1% SEAKEM GTG
agarose/MilliQ TAE gel. DNA was then prepared for microinjection as described in Chapter 7.
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Appendix Table 6 - NGRS-LoxSTOPLox-LacZ
genotyping results



















2 i X + - No LacZ fragment
3 Yes + - Yes Correct+recomb
4 X + - No LacZ fragment
5 | X + - No LacZ fra
6 X - - - NTG
1 1 X - - - NTG
8 1 X + - No LacZ fragment












2 I X - - - NTG
3 1 X - - - NTG
4 1 X - - - NTG
5 | X + - No LacZ fragment
6 1 X - - - NTG
7 1 X + - No LacZ fragment
8 1 X - - NTG
9 1 X - - NTG
10 | X - - | NTG












2 | X - - - NTG
3 | X + - No LacZ fragmenj |
4 I X - - NTG
5 1 X - - NTG
6 I X + + No* Correct
7 I X + + No * Correct
8 1 X + + No* Correct
9 ! X - - - NTG
101 X - - | NTG
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1 X - - - NTG 8/19 NTG
2 X - - - NTG 11/19 TG:
3/19 Fragment
4/19 Correct3 X
- - - NTG
4 X - - - NTG 4/19 3rd
5 X - - - NTG defective TG
or leaky6 X + - No




8 Yes + + No & ■■■
9 X - - - NTG
10 X - - - NTG
11 X + - No
12 Yes + + No* Defective/"leaky"
13 X + - No Knaa
14 X + + No* Correct
15 x I + + No* Correct
16 X - - - NTG
17 Yes + + No * R 1
18 X + + No* Correct
19 X + + No* Correct













2 X + Yes Conect+recomb
3 X - - - NTG
4 X - - - NTG
5 X + - Yes Correct+recomb
6 X + - Yes Correct+recomb 3/9 TG
Female
line:
7 X - - - NTG
8 X - - - NTG
male #10 9 X + - Yes Correct+recomb
x gl-Cre
#60
10 X - - - NTG
11 X - - - NTG
12 X - - - NTG
13 X - - - NTG
14 X + - Yes Correct+recomb
1 X + + No * Correct 9/17 TG
2 X + + No * Correct
3 X - - NTG
4 X - - - NTG






_ x + 1+1 No* Correct
7 X + + No* Correct
8 1 X + + No * Correct
9 1 X - - | NTG
10 | x I - J - - NTG
11 X
. - 1 - " 1 NTG
12 | X + + N° * _J Correct
13 X + + No & Correct
14 X + + No* Correct
15 | X - - - NTG
16 x | - NTG





18 X + + J No & Correct 7/13 TG
19 X + + No * Correct
20 | X - - - NTG
21 X + + 1 No* Correct
22 X + + No & | Correct
23 X 1 - - - NTG
24 | X - - - NTG
25 | x | + + No & Correct
26 | X - - 1 NTG
27 J * 1 + + No & Correct
28 | X - - 1 | NTG
29 X - 1 - 1 - NTG
30 | x ! + + No & Correct
The presence of X-gal staining is indicated by "Yes" in the "Blue?" column. Absence of staining
is denoted by "x".
The PCR assays are depicted in Figure 3.5.
PCR 1 - LacZ: LacZ+ = "+", LacZ- =
PCR 2 - STOP: The presence of a product (+) indicated that the STOP sequence was present
and not therefore recombined out of the genome. The absence of a PCR product (-) meant
either a) the embryo had never carried the STOP sequence, or b) that the STOP sequence had
been recombined out of the genome by Cre. These possibilities were distinguished between by
the third PCR, which tested for recombination.
PCR 3 - Recombination: successful recombination of the LoxSTOPLox sequence resulted in a
0.23kb PCR product ("Yes"). If recombination had not occurred, a 1.6kb product was produced;
this was, however, often not amplifiable from the yolk sac DNA. Failure to amplify the large non-
recombincd band is denoted by "No "No &" signifies that a band was amplified.






It should be noted that whilst a greater number of /VG/W-LacZ-positive embryos could have been
obtained from each litter had two transgenic parents been mated - as opposed to a transgenic male with a
CD1 female - this was not the general procedure, but for valid reasons. Firstly, there were not enough
transgenic females of breeding age in the NGRS-LacZ colony when the culture studies were performed.
Secondly, the expression pattern in embryos homozygous for the transgene had not been studied
sufficiently at the start of these experiments (though this was later tested and the pattern found to be the
same as in those with one CD1 parent; data not shown). Finally, on the occasions when a transgenic with
transgenic mating was used, the number of embryos recovered was significantly less than when mating
involved a CD 1 mouse.
Genotyping:
A genotyping step was not included as gathering tissue for this would have slowed the progress
of getting explants rapidly from the uterus into culture and at least the first two days of culture would still
need to be undertaken before a genotyping result was obtained. Similarly, X-gal staining of the cardiac
outflow tract or thyroid primordium (LacZ-positive sites in the El 1.5 NGRS-LacZ embryo) would not give
a result until after the labour-intensive part of the culture process (dissection, introduction to culture,
initial photography) had already been performed.
Controls:
A recommendation for whole embryo cultures is that 15-25% of the embryos are used as non-
manipulated cultured controls (Klug, 1991). By the end of the studies discussed in this thesis, the standard
practice was to keep -25% of a litter as uncultured controls (to monitor the extent of staining and spleen
development at tO), and to use 50% of the remaining guts as non-manipulated cultured controls.
Deviations from the described protocol:
In the culture experiment described in Section 4.7.2, and shown in Figure 4.10, the explants
were cultured for 48 hours as per the standard protocol, with the exception that the culture medium was
changed at 24 hours in an attempt to counteract the poor health of the explants. This did not however seem
to benefit the guts and may have been detrimental as the microenvironment of growth factors established
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